"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,WO,A1,WO 2007/133188 A1,005-150-055-785-18X,2007-11-22,2007,US 2006/0016546 W,2006-05-01,US 2006/0016546 W,2006-05-01,TREATMENT OF DISEASE STATES AND ADVERSE PHYSIOLOGICAL CONDITIONS UTILIZING ANTI-FUNGAL COMPOSITIONS,"A method for treatment or prophylaxis of a disease state or other physiological condition, e.g., autism, delayed development, acid reflux disease, vaginal yeast infections, impaired hearing, chronic ear infections, seasonal allergies, Fibromyalgia syndrome, Crohn's disease, colitis, irritable bowel syndrome, interstitial cystitis, acne, sinusitis, rheumatoid arthritis, chronic fatigue syndrome, asthma, attention deficit disorder, attention deficit/hyperactivity disorder, rosacea, multiple sclerosis, hyperglycemia, or Meniere's disease, by administration of an anti-fungal composition that includes at least one of the bacilli (1) Bacillus subtilis , (2) Lactobacillus sporogenes , and (3) Streptococcus faecalis .",COBB & COMPANY LLP;;COBB MARK;;COBB ALYSON,COBB MARK;;COBB ALYSON,,https://lens.org/005-150-055-785-18X,Patent Application,yes,5,14,1,1,0,A61K35/742;;A61K35/744;;A61K35/747,C12N1/00;;A01N63/00,,1,0,,,"""""Pages from www.ghtdirect.com/threelac describing composition and function of Threelac"""", 1 January 2007 (2007-01-01), XP008093370, Retrieved from the Internet <URL:http://www.ghthealth.com/ghthealth/product/detail/threelac.aspx>",PENDING
2,MX,A,MX PA03003379 A,052-410-632-554-350,2004-05-04,2004,MX PA03003379 A,2001-10-17,IB 0101946 W;;US 24133700 P,2000-10-19,APPARATUS AND METHOD FOR HYDROFORMING A TUBULAR PART.,"A method and apparatus for shaping a raw tube (40) into a formed part. The part can be configured within a die assembly including a hydroforming die structure (12, 14) and a pair of tube-engaging punches (81). The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK,,https://lens.org/052-410-632-554-350,Patent Application,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/045;;B21D26/047;;B21D51/16,,0,0,,,,EXPIRED
3,US,A1,US 2010/0303782 A1,077-829-531-952-130,2010-12-02,2010,US 84028910 A,2010-07-20,US 84028910 A;;US 84099207 A;;US 92895104 A;;US 49925503 P,2003-08-29,PROBIOTIC COMPOSITION USEFUL FOR DIETARY AUGMENTATION AND/OR COMBATING DISEASE STATES AND ADVERSE PHYSIOLOGICAL CONDITIONS,"A probiotic composition including the bacilli (1) Bacillus subtilis, (2) Bacillus coagulans, and (3) Enterococcus faecium. The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the disclosure may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders, such as irritable bowel syndrome, autism, and fibromyalgia.",COBB MARK L;;COBB ALYSON,COBB MARK L;;COBB ALYSON,COBB & COMPANY (2010-07-26);;COBB & ASSOCIATES (2011-04-11),https://lens.org/077-829-531-952-130,Patent Application,yes,35,79,4,16,0,A61K35/742;;A61K35/744;;A61K31/702;;Y10S435/822;;A23P10/30;;A23L33/135;;A23L33/21;;A61P1/04;;A61P11/06;;A61P17/10;;A61P19/02;;A61P25/16;;A61P25/24;;A61P27/14;;A61P29/00;;A61P31/10;;A61P3/10;;A61K31/702;;A61K35/742;;A61K35/744;;Y10S435/822;;A23P10/30;;A23L33/21;;A23L33/135,A61K35/74;;A61K35/742;;A61K35/744;;A61P1/04;;A61P3/10;;A61P11/06;;A61P17/10;;A61P19/02;;A61P25/16;;A61P25/24;;A61P27/14;;A61P31/10,424/93.462;;424/93.46;;424/93.4,0,0,,,,INACTIVE
4,US,B2,US 7731976 B2,090-936-693-465-022,2010-06-08,2010,US 84099607 A,2007-08-19,US 84099607 A;;US 92895104 A;;US 49925503 P,2003-08-29,Treatment of irritable bowel syndrome using probiotic composition,"A method of treating irritable bowel syndrome using a probiotic composition including the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium . The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders.",COBB AND COMPANY LLP,COBB MARK L;;COBB ALYSON,COBB & ASSOCIATES (2011-04-11),https://lens.org/090-936-693-465-022,Granted Patent,yes,34,100,2,16,0,A61K35/744;;A61K35/744;;A61K9/0034;;A61K9/0034;;A61K9/4866;;A61K9/4866;;A61K35/742;;A61K35/742;;A61K47/36;;A61K47/36;;A61P1/14,A61K39/116;;A61K35/742;;A61K35/744,424/203.1;;424/234.1;;424/246.1;;424/93.1;;424/93.3;;424/93.44;;424/93.46;;424/93.462,22,5,069-257-822-029-740;;091-533-856-281-640;;091-533-856-281-640;;081-252-246-238-959;;040-942-802-256-308,18473099;;16809947;;16809947;;21840798;;10.3920/bm2008.1005;;11157348;;10.1093/ajcn/73.2.399s,"""Candida Support"", ""Accessed Online Jun. 13, 2008 at: http://www.candidasupport.org/3lac.html"", Jun. 13, 2008.;;""ThreeLac Study-Nine Month Results"", ""Acessed Online Jun. 12, 2008 at http://www.autism-study.com/"", Jun. 12, 2008.;;Chou, Yen-Yi, et al., ""Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium.."", ""J. Microbiol Immunol. Infect."", Apr. 2008, pp. 124-129, vol. 41.;;""How does candida harm my body?"", ""First found online at http://www.1stcandidacure.com/candidacureplan.html"", Aug. 26, 2004.;;""Chronic Fatigue, Fybromyalgia and other Autoimmune disease"", ""First found online at http://www.candidasupport.org/faq'sandingredie.html"", Aug. 20, 2003.;;""Eliminate the underlying cause"", ""First found online at http://www.candidfree.net/pages/1/index.html"", Sep. 21, 2004.;;Edelson, Stephen M., ""The candida yeast-autism connection"", ""First found online at http://www.autism.org/candida.html"", Aug. 20, 2003.;;Harrison, Robert , ""Candida Research Article"", ""Found online at http://www.candidayeastinfection.com/researcharticle.html"", Jul. 13, 2007.;;""Lactobacillus Sporogenes-Introduction to LactoSpore"", ""Found online at http://www.lactospore.com"".;;Lewis, Carol, ""Irritable Bowel Syndrome: A poorly understood disorder"", ""FDA Consumer Magazine"", Jul.-Aug. 2001, pp. 1-9, Publisher: U.S. Food and Drug Administration.;;""Primal Defense-Product Information"", ""First found online at http://www.forhealthsolutions.net/primal-defense.html"", Aug. 20, 2003.;;""ThreeLac Candida Defense-How does Nature's Biotics help?"", ""First found online at http://www.gethealthyagain.com/candida"", Aug. 20, 2003.;;""Benefits of Threelac"", ""http://www.ghtdirect.com/threelac-main.aspx"".;;UniProt Consortium, ""Entercoccus faecium (scientific name) , accessed at www.uniprot.org/taxonomy/1352"", ""www.uniprot.org"", Jul. 20. 2009, pp. 1-2.;;Kim, Y. et al. , ""The Effects of Probiotics on Symptoms of Irritiable Bowel Syndrome"", ""Korean J. Gastroenterology"", Jun. 2006, pp. 413-419, vol. 47, No. 6 (Original Korean Text).;;Kim, Y. et al. , ""The Effects of Probiotics on Symptoms of Irritiable Bowel Syndrome"", ""Korean J. Gastroenterology"", Jun. 2006, pp. 413-419, vol. 47, No. 6 (English Abstract Only).;;Inovative Fulfillment Solutions, ""Nutraceutical News, accessed at www.ifssoultions.com/news20070708.html"", Jul./Aug. 2007 , pp. 1-5, Publisher: Innovative Fulfillment Solutions.;;SYMBIONFORLIFE.COM, ""SymbionTM Webpages from symbionforlife.com website, accessed Jul. 20, 2009"", ""symbionforlife.com"", Jul. 20, 2009, pp. 1-27.;;Tomkins, T. ET , ""A comprehensive review of post-market clinical studies performed in adults with an Asian probiotic formulation"", ""Beneficial Microbes"", 2009, Publisher: Wageningen Academic Publishers.;;Trenev, N. , ""Probiotics: Nature's Internal Healers"", ""Probitoics"", 1998, pp. 129, 132-133, Publisher: Avery Trade.;;Bezkorovainy, A. , ""Probiotics: determinants of survival and growth in the gut"", ""Am. J. Clin. Nutr."", 2001, pp. 399S-405S, vol. 73, Publisher: American Society for Clinical Nutrition.;;Vecchi, E. et al., ""Lactobacillus Sporogenes or Bacillus Coagulans Misidentification or Mislabelling?"", ""Int. Journal of Probiotics and Prebiotics"", 2006, pp. 3-10, vol. 1, No. 1.",ACTIVE
5,US,A1,US 2007/0280910 A1,185-178-955-656-545,2007-12-06,2007,US 84099207 A,2007-08-19,US 84099207 A;;US 92895104 A;;US 49925503 P,2003-08-29,PROBIOTIC COMPOSITION USEFUL FOR DIETARY AUGMENTATION AND/OR COMBATING DISEASE STATES AND ADVERSE PHYSIOLOGICAL CONDITIONS,"A probiotic composition including the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium . The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders, such as irritable bowel syndrome, autism, and fibromyalgia.",COBB MARK L;;COBB ALYSON,COBB MARK L;;COBB ALYSON,COBB & ASSOCIATES (2011-04-11),https://lens.org/185-178-955-656-545,Patent Application,yes,31,25,7,16,0,A61K35/744;;A61K35/744;;A61K9/0095;;A61K9/0095;;A61K9/02;;A61K9/02;;A61K9/4858;;A61K9/4858;;A61K35/742;;A61K35/742;;A61P1/00;;A61P25/00;;A61P31/00;;Y02A50/30;;Y02A50/30;;Y10S435/822;;Y10S435/822,A61K35/74;;A61K35/742;;A61K35/744;;A61K47/00;;A61P31/00,424/93.44;;424/93.46;;424/93.462;;514/777,0,0,,,,ACTIVE
6,US,A1,US 2007/0280911 A1,091-377-719-738-040,2007-12-06,2007,US 84099407 A,2007-08-19,US 84099407 A;;US 92895104 A;;US 49925503 P,2003-08-29,TREATMENT OF AUTISM USING PROBIOTIC COMPOSITION,"A method of treating autism using a probiotic composition including the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium . The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders.",COBB MARK L;;COBB ALYSON,COBB MARK L;;COBB ALYSON,COBB & ASSOCIATES (2011-04-11),https://lens.org/091-377-719-738-040,Patent Application,yes,30,31,2,16,0,A61K35/742;;A61K35/744;;A61K9/0034;;A61K47/36;;A61K9/4866;;A61P25/00;;A61K35/744;;A61K35/742;;A61K9/0034;;A61K47/36;;A61K9/4866,A61K35/74;;A61K35/742;;A61K35/744;;A61P25/00,424/93.44,0,0,,,,ACTIVE
7,US,A1,US 2007/0071739 A1,158-692-344-533-215,2007-03-29,2007,US 53575206 A,2006-09-27,US 53575206 A;;US 72086905 P,2005-09-27,TREATMENT OF BIPOLAR DISORDER UTILIZING ANTI-FUNGAL COMPOSITIONS,"A method for treatment or prophylaxis of a bipolar disorder disease state, by administration of an anti-fungal composition that includes at least one of the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium.",COBB MARK L;;COBB ALYSON,COBB MARK L;;COBB ALYSON,COBB & ASSOCIATES (2011-04-11),https://lens.org/158-692-344-533-215,Patent Application,yes,37,16,4,5,0,A61K33/00;;A61K33/00;;A61K35/742;;A61K35/742;;A61K35/744;;A61K35/744;;A61K45/06;;A61K45/06;;C12N1/20;;C12N1/20,C12N1/12;;C12N1/20,424/93.46;;435/252.1,0,0,,,,INACTIVE
8,WO,A2,WO 2009/026306 A2,078-928-427-791-445,2009-02-26,2009,US 2008/0073615 W,2008-08-19,US 84099207 A;;US 84099407 A;;US 84099607 A,2007-08-19,PROBIOTIC COMPOSITION USEFUL FOR DIETARY AUGMENTATION AND/OR COMBATING DISEASE STATES AND ADVERSE PHYSIOLOGICAL CONDITIONS,"A probiotic composition including the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium . The composition may further include a carrier medium, such as fructo- oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders, such as irritable bowel syndrome, autism, and fibromyalgia.",COBB MARK L;;COBB ALYSON,COBB MARK L;;COBB ALYSON,,https://lens.org/078-928-427-791-445,Patent Application,yes,0,73,7,16,0,A61K35/744;;A61K35/744;;A61K9/0095;;A61K9/0095;;A61K9/02;;A61K9/02;;A61K9/4858;;A61K9/4858;;A61K35/742;;A61K35/742;;A61P1/00;;A61P25/00;;A61P31/00;;Y02A50/30;;Y02A50/30;;Y10S435/822;;Y10S435/822,A61K35/74;;A61K35/742;;A61K35/744;;A61K47/00;;A61P31/00,,1,0,,,See references of EP 2315582A4,PENDING
9,US,B2,US 7759105 B2,178-506-108-379-002,2010-07-20,2010,US 84099207 A,2007-08-19,US 84099207 A;;US 92895104 A;;US 49925503 P,2003-08-29,Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions,"A probiotic composition including the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium . The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders, such as irritable bowel syndrome, autism, and fibromyalgia.",COBB & COMPANY LLP,COBB MARK L;;COBB ALYSON,COBB & ASSOCIATES (2011-04-11),https://lens.org/178-506-108-379-002,Granted Patent,yes,35,14,7,16,0,A61K35/744;;A61K35/744;;A61K9/0095;;A61K9/0095;;A61K9/02;;A61K9/02;;A61K9/4858;;A61K9/4858;;A61K35/742;;A61K35/742;;A61P1/00;;A61P25/00;;A61P31/00;;Y02A50/30;;Y02A50/30;;Y10S435/822;;Y10S435/822,C12N1/12;;A01N25/00;;A01N63/00;;A01N65/00;;A61K35/742;;A61K35/744;;C12N1/20,435/252.1;;435/252.4;;435/822;;424/93.1;;424/93.3;;424/93.4;;424/93.44;;424/93.46;;424/93.462;;514/777,22,4,040-942-802-256-308;;091-533-856-281-640;;069-257-822-029-740;;081-252-246-238-959,11157348;;10.1093/ajcn/73.2.399s;;16809947;;18473099;;21840798;;10.3920/bm2008.1005,"ThreeLac® Study-Nine Month Results, copyright © 2005-2006 (http://www.autism-study.com/ retrieved online Jun. 12, 2008).;;Candida Support, copyright © 2002-2008 (http://candidasupport.org/ retrieved online Jun. 12, 2008).;;Vecchi et al. International Journal of Probiotics and Prebiotics vol. 1, No. 1, pp. 3-10, 2006.;;Bezkorovainy et al. American Journal of Clinical Nutrition, vol. 73, No. 2, 399S-405S, Feb. 2001.;;Trenev, Natasha. (Probiotics: Nature's Internal Healers. 1998. Avery Trade, New York) p. 129 and 132-233.;;Kim et al. Korean J Gastroenterol. Jun. 2006; 47 (6):413-419.;;Nutraceutical News Jul./Aug. 2007 (http://www.ifssolutions.com/news20070708.html) retrieved Jul. 20, 2009.;;Product information for SymbionTM (http://www.symbionforlife.com) retrieved Jul. 20, 2009.;;Enterococcus faecium (scientific name)-synonym is Streptococcus faecium. (http://www.uniprot.org/taxonomy/1352) retrieved Jul. 20, 2009.;;Chou, Yen-Yi, et al., ""Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium . . . "", ""J. Microbiol. Immunol. Infect."", Apr. 2008, pp. 124-129, vol. 41.;;""Global Health Trax Inc. website advertisment for Threelac product"", ""http://www.ghtdirect.com/threelac-main.aspx"", 2007, Publisher: Global Health Trax Inc. website.;;Tomkins, T. et , ""A comprehensive review of post-market clinical studies performed in adults with an Asian probiotic formulation"", ""Beneficial Microbes"", Article in Press, published online 2009, Publisher: Wageningen Academic Publishers.;;, ""How does candida harm my body?"", ""First found online at http://www.1stcandidacure.com/candidacureplan.html"", Aug. 26, 2004 .;;, ""Chronic Fatigue, Fybromyalgia and other Autoimmune disease"", ""First found online at http://www.candidasupport.org/faq'sandingredie.html"", Aug. 20, 2003.;;, ""Eliminate the underlying cause"", ""First found online at http://www.candidfree.net/pages/1/index.html"", Sep. 21, 2004.;;Edelson, Stephen M., ""The candida yeast-autism connection"", ""First found online at http://www.autism.org/candida.html"", Aug. 20, 2003.;;Harrison, Robert , ""Candida Research Article"", ""Found online at http://www.candidayeastinfection.com/researcharticle.html"", Jul. 13, 2007.;;, ""Lactobacillus Sporogenes-Introduction to LactoSpore"", ""Found online at http://www.lactospore.com"", 2000.;;Lewis, Carol, ""Irritable Bowel Syndrome: A poorly understood disorder"", ""FDA Consumer Magazine"", Jul.-Aug. 2001, pp. 1-9, Publisher: U.S. Food and Drug Administration.;;, ""Primal Defense-Product Information"", ""First found online at http://www.forhealthsolutions.net/primal-defense.html"", Aug. 20, 2003.;;, ""ThreeLac Candida Defense-How does Nature's Biotics help?"", ""First found online at http://www.gethealthyagain.com/candida"", Aug. 20, 2003.;;, ""Benefits of Threelac"", ""http://www.ghtdirect.com/threelac-main.aspx"", Aug. 14, 2007.",ACTIVE
10,US,B2,US 8192733 B2,165-080-399-582-758,2012-06-05,2012,US 84028910 A,2010-07-20,US 84028910 A;;US 84099207 A;;US 92895104 A;;US 49925503 P,2003-08-29,Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions,"A probiotic composition including the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium . The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the disclosure may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders, such as irritable bowel syndrome, autism, and fibromyalgia.",COBB MARK L;;COBB ALYSON;;COBB & ASSOCIATES,COBB MARK L;;COBB ALYSON,COBB & COMPANY (2010-07-26);;COBB & ASSOCIATES (2011-04-11),https://lens.org/165-080-399-582-758,Granted Patent,yes,43,31,4,16,0,A61K35/742;;A61K35/744;;A61K31/702;;Y10S435/822;;A23P10/30;;A23L33/135;;A23L33/21;;A61P1/04;;A61P11/06;;A61P17/10;;A61P19/02;;A61P25/16;;A61P25/24;;A61P27/14;;A61P29/00;;A61P31/10;;A61P3/10;;A61K31/702;;A61K35/742;;A61K35/744;;Y10S435/822;;A23P10/30;;A23L33/21;;A23L33/135,A01N25/00;;A01N63/00;;A01N65/00;;A61K35/742;;A61K35/744;;C12N1/12;;C12N1/20,424/93.3;;424/93.1;;424/93.4;;424/93.44;;424/93.46;;424/93.462;;435/252.1;;435/252.4;;435/822;;514/777,23,6,040-942-802-256-308;;069-257-822-029-740;;091-533-856-281-640;;081-252-246-238-959;;055-798-029-541-216;;045-008-866-371-865,11157348;;10.1093/ajcn/73.2.399s;;18473099;;16809947;;21840798;;10.3920/bm2008.1005;;16102604;;10.1016/j.femsre.2004.12.001;;33451235;;10.1111/j.1541-4337.2003.tb00017.x,"Bezkorovainy, A. , ""Probiotics: determinants of survival and growth in the gut"", ""Am. J. Clin. Nutr. "", 2001, pp. 399S-405S, vol. 73, Publisher: American Society for Clinical Nutrition.;;""How does candida harm my body?"", ""accessed Aug. 26, 2004 at http://www.1stcandidacure.com/candidacureplan.html"" .;;""Chronic Fatigue, Fybromyalgia and other Autoimmune disease"", ""accessed at http://www.candidasupport.org/faq'sandingredie.html"", Aug. 20, 2003.;;""Eliminate the underlying cause"", ""accessed Sep. 21, 2004 at http://www.candidfree.net/pages/1/index.html"".;;""Candida Support"", ""Accessed Jun. 13, 2008 at: http://www.candidasupport.org/3lac.html"", Jun. 13, 2008.;;Chou, Yen-Yi, et al, ""Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium.."", ""J. Microbiol. Immunol. Infect."", Apr. 2008, pp. 124-129, vol. 41.;;Wvvw.Uniprot.Org, ""Entercoccus faecium (scientific name) , accessed Jul. 20, 2009 at www.uniprot.org/taxonomy/1352"", Publisher: www.uniprot.org, pp. 1-2.;;Edelson, Stephen M., ""The candida yeast-autism connection"", ""accessed Aug. 20, 2003 at http://www.autism.org/candida.html"".;;""Global Health Trax Inc. website advertisment for Threelac product"", accessed 2007 at ""http://www.ghtdirect.com/threelac-main.aspx"", Publisher: Global Health Trax Inc. website.;;Harrison, Robert , ""Candida Research Article"", ""Found online at http://www.candidayeastinfection.com/researcharticle.html"", Jul. 13, 2007.;;Kim, Y. et al. , ""The Effects of Probiotics on Symptoms of Irritiable Bowel Syndrome"", ""Korean J. Gastroenterology"", Jun. 2006, pp. 413-419, vol. 47, No. 6 (Only English Abstract Available).;;Vecchi, E. et al., ""Lactobacillus Sporogenes or Bacillus Coagulans Misidentification or Mislabelling?"", ""Int. Journal of Probiotics and Prebiotics "", 2006, pp. 3-10, vol. 1, No. 1.;;""Lactobacillus Sporogenes-Introduction to LactoSpore"", ""accessed Sep. 2004 at http://www.lactospore.com"".;;Lewis, Carol, ""Irritable Bowel Syndrome: A poorly understood disorder"", ""FDA Consumer Magazine"", Jul.-Aug. 2001, pp. 1-9, Publisher: U.S. Food and Drug Administration.;;Inovative Fulfillment Solutions, ""Nutraceutical News"", accessed Jul./Aug. 2007 at www.ifssoultions.com/news20070708.html, pp. 15, Publisher: Innovative Fulfillment Solutions.;;""Primal Defense-Product Information"", ""accessed Aug. 20, 2003 at http://www.forhealthsolutions.net/primal-defense.html"".;;Symbionforlife.com, ""SymbionTM Webpages from symbionforlife.com website, accessed Jul. 20, 2009"", ""symbionforlife.com"", Jul. 20, 2009, pp. 1-27.;;""ThreeLac Candida Defense-How does Nature's Biotics help?"", ""accessed Aug. 20, 2003 at http://www.gethealthyagain.com/candida"".;;""ThreeLac Study-Nine Month Results"", ""accessed Jun. 12, 2008 at http://www.autism-study.com/"", Jun. 12, 2008.;;Tomkins, T. Et , ""A comprehensive review of post-market clinical studies performed in adults with an Asian probiotic formulation"", ""Beneficial Microbes"", 2009, Publisher: Wageningen Academic Publishers.;;Trenev, N. , ""Probiotics: Nature's Internal Healers"", ""Probitoics"", 1998, pp. 129, 132-133, Publisher: Avery Trade.;;Hong, H., et al., ""The Use of Bacterial Spore Formers As Probiotics"", ""FEMS Microbiology Reviews"", Dec. 16, 2004, pp. 813-835, vol. 29, No. 4.;;Sanders, M., et al., ""Sporeformers As Human Probiotics: Bacillus, Sporolactobacillus, and Brevibacillus"", ""Comprehensive Reviews in Food Science and Food Safety"", Jul. 2003, pp. 101-110, vol. 2, No. 3.",INACTIVE
11,US,B2,US 8246946 B2,131-696-619-803-80X,2012-08-21,2012,US 53575206 A,2006-09-27,US 53575206 A;;US 72086905 P,2005-09-27,Treatment of bipolar disorder utilizing anti-fungal compositions,"A method for treatment or prophylaxis of a bipolar disorder disease state, by administration of an anti-fungal composition that includes at least one of the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium.",COBB MARK L;;COBB ALYSON;;COBB & ASSOCIATES,COBB MARK L;;COBB ALYSON,COBB & ASSOCIATES (2011-04-11),https://lens.org/131-696-619-803-80X,Granted Patent,yes,45,4,4,5,0,A61K33/00;;A61K33/00;;A61K35/742;;A61K35/742;;A61K35/744;;A61K35/744;;A61K45/06;;A61K45/06;;C12N1/20;;C12N1/20,A01N63/00;;A01N65/00,424/93.3;;424/93.1;;424/93.46;;424/93.462,24,7,091-533-856-281-640;;091-533-856-281-640;;081-252-246-238-959;;040-942-802-256-308;;069-257-822-029-740;;055-798-029-541-216;;045-008-866-371-865,16809947;;16809947;;21840798;;10.3920/bm2008.1005;;11157348;;10.1093/ajcn/73.2.399s;;18473099;;16102604;;10.1016/j.femsre.2004.12.001;;33451235;;10.1111/j.1541-4337.2003.tb00017.x,"www.uniprot.org, ""Entercoccus faecium (scientific name) , accessed at www.uniprot.org/taxonomy/1352"", ""www.uniprot.org"", Jul. 20, 2009, pp. 1-2.;;Kim, Y. et al. , ""The Effects of Probiotics on Symptoms of Irritiable Bowel Syndrome"", ""Korean J. Gastroenterology"", Jun. 2006, pp. 413-419, vol. 47, No. 6 (Original Korean Text).;;Kim, Y. et al. , ""The Effects of Probiotics on Symptoms of Irritiable Bowel Syndrome"", ""Korean J. Gastroenterology"", Jun. 2006, pp. 413-419, vol. 47, No. 6 (English Abstract Only).;;Inovative Fulfillment Solutions, ""Nutraceutical News, accessed at www.ifssoultions.com/news20070708.html"", Jul./Aug. 2007 , pp. 1-5, Publisher: Innovative Fulfillment Solutions.;;Symbionforlife.Com, ""SymbionTM Webpages from symbionforlife.com website, accessed Jul. 20, 2009"", ""symbionforlife.com"", Jul. 20, 2009, pp. 1-27.;;Tomkins, T. ET , ""A comprehensive review of post-market clinical studies performed in adults with an Asian probiotic formulation"", ""Beneficial Microbes"", 2009, Publisher: Wageningen Academic Publishers.;;Trenev, N. , ""Probiotics: Nature's Internal Healers"", ""Probitoics"", 1998, pp. 129 132-133, Publisher: Avery Trade.;;Bezkorovainy, A. , ""Probiotics: determinants of survival and growth in the gut "", ""Am. J. Clin. Nutr. "", 2001, pp. 399S-405S, vol. 73, Publisher: American Society for Clinical Nutrition.;;Vecchi, E. et al., ""Lactobacillus Sporogenes or Bacillus Coagulans Misidentification or Mislabelling?"", ""Int. Journal of Probiotics and Prebiotics "", 2006, pp. 3-10, vol. 1, No. 1.;;""How does candida harm my body?"", ""First found online at http://www.1stcandidacure.com/candidacureplan.html"", Aug. 26, 2004, Anonymous 1 pg.;;""Chronic Fatigue, Fybromyalgia and other Autoimmune disease"", ""First found online at http://www.candidasupport.org/faq'sandingredie.html"", Aug. 20, 2003, Anonymous 1 pg.;;""Eliminate the underlying cause"", ""First found online at http://www.candidfree.net/pages/1/index.html"", Sep. 21, 2004, Mark Cobb, 30 pgs.;;""Candida Support"", ""Accessed Online Jun. 13, 2008 at: http://www.candidasupport.org/3lac.html"", Jun. 13, 2008, Anonymous 19 pgs.;;Chou, Yen-Yi, et al., ""Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium. . . "", ""J. Microbiol. Immunol. Infect."", Apr. 2008, pp. 124-129, vol. 41.;;Edelson, Stephen M., ""The candida yeast-autism connection"", ""First found online at http://www.autism.org/candida.html"", Aug. 20, 2003.;;""Global Health Trax Inc. website advertisment for Threelac product"", ""http://www.ghtdirect.com/threelac-main.aspx"", 2007, Publisher: Global Health Trax Inc. website, Anonymous 3 pgs.;;Harrison, Robert , ""Candida Research Article"", ""Found online at http://www.candidayeastinfection.com/researcharticle.html"", Jul. 13, 2007, 9 pgs.;;""Lactobacillus sporogenes-Introduction to LactoSpore"", ""Found online at http://www.lactospore.com"", Anonymous, 25 pgs.;;Lewis, Carol, ""Irritable Bowel Syndrome: A poorly understood disorder"", ""FDA Consumer Magazine"", Jul.-Aug. 2001, pp. 1-9, Publisher: U.S. Food and Drug Administration.;;""Primal Defense-Product Information"", ""First found online at http://www.forhealthsolutions.net/primal-defense.html"", Aug. 20, 2003, Anonymous, 2 pgs.;;""ThreeLac Candida Defense-How does Nature's Biotics help?"", ""First found online at http://www.gethealthyagain.com/candida"", Aug. 20, 2003, Anonymous, 2 pgs.;;""ThreeLac Study-Nine Month Results"", ""Accessed Online Jun. 12, 2008 at http://www.autism-study.com/"", Jun. 12, 2008, Jang M. and Green J.A., 8 pgs.;;Hong, H., et al., ""The Use of Bacterial Spore Formers As Probiotics"", ""FEMS Microbiology Reviews"", Dec. 16, 2004, pp. 813-835, vol. 29, No. 4.;;Sanders, M., et al., ""Sporeformers As Human Probiotics: Bacillus, Sporolactobacillus, and Brevibacillus"", ""Comprehensive Reviews in Food Science and Food Safety"", Jul. 2003, pp. 101-110, vol. 2, No. 3.",INACTIVE
12,WO,A3,WO 2007/038466 A3,198-596-411-727-222,2007-12-06,2007,US 2006/0037374 W,2006-09-27,US 72086905 P,2005-09-27,TREATMENT OF BIPOLAR DISORDER UTILIZING ANTI-FUNGAL COMPOSITIONS,"A method for treatment or prophylaxis of a bipolar disorder disease state, by administration of an anti-fungal composition that includes at least one of the bacilli (1) Bacillus s ubtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium .",COBB & COMPANY;;COBB MARK L;;COBB ALYSON,COBB MARK L;;COBB ALYSON,,https://lens.org/198-596-411-727-222,Search Report,yes,2,0,4,5,0,A61K33/00;;A61K33/00;;A61K35/742;;A61K35/742;;A61K35/744;;A61K35/744;;A61K45/06;;A61K45/06;;C12N1/20;;C12N1/20,A61K38/16;;A61K31/397;;A61K31/545,,0,0,,,,PENDING
13,WO,A3,WO 2009/026306 A3,162-907-423-102-114,2009-04-16,2009,US 2008/0073615 W,2008-08-19,US 84099207 A;;US 84099407 A;;US 84099607 A,2007-08-19,PROBIOTIC COMPOSITION USEFUL FOR DIETARY AUGMENTATION AND/OR COMBATING DISEASE STATES AND ADVERSE PHYSIOLOGICAL CONDITIONS,"A probiotic composition including the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium . The composition may further include a carrier medium, such as fructo- oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders, such as irritable bowel syndrome, autism, and fibromyalgia.",COBB MARK L;;COBB ALYSON,COBB MARK L;;COBB ALYSON,,https://lens.org/162-907-423-102-114,Search Report,yes,4,0,7,16,0,A61K35/744;;A61K35/744;;A61K9/0095;;A61K9/0095;;A61K9/02;;A61K9/02;;A61K9/4858;;A61K9/4858;;A61K35/742;;A61K35/742;;A61P1/00;;A61P25/00;;A61P31/00;;Y02A50/30;;Y02A50/30;;Y10S435/822;;Y10S435/822,A61K9/26;;A61K35/74;;A61K35/742;;A61K35/744;;A61K47/00;;A61P31/00,,1,0,,,See also references of EP 2315582A4,PENDING
14,US,A1,US 2007/0280912 A1,177-500-862-195-543,2007-12-06,2007,US 84099607 A,2007-08-19,US 84099607 A;;US 92895104 A;;US 49925503 P,2003-08-29,TREATMENT OF IRRITABLE BOWEL SYNDROME USING PROBIOTIC COMPOSITION,"A method of treating irritable bowel syndrome using a probiotic composition including the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium . The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders.",COBB MARK L;;COBB ALYSON,COBB MARK L;;COBB ALYSON,COBB & ASSOCIATES (2011-04-11),https://lens.org/177-500-862-195-543,Patent Application,yes,30,13,2,16,0,A61K35/744;;A61K35/744;;A61K9/0034;;A61K9/0034;;A61K9/4866;;A61K9/4866;;A61K35/742;;A61K35/742;;A61K47/36;;A61K47/36;;A61P1/14,A61K35/74;;A61K35/742;;A61K35/744;;A61P1/14,424/93.44,0,0,,,,ACTIVE
15,WO,A2,WO 2007/038466 A2,011-167-980-027-771,2007-04-05,2007,US 2006/0037374 W,2006-09-27,US 72086905 P,2005-09-27,TREATMENT OF BIPOLAR DISORDER UTILIZING ANTI-FUNGAL COMPOSITIONS,"A method for treatment or prophylaxis of a bipolar disorder disease state, by administration of an anti-fungal composition that includes at least one of the bacilli (1) Bacillus s ubtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium .",COBB & COMPANY;;COBB MARK L;;COBB ALYSON,COBB MARK L;;COBB ALYSON,,https://lens.org/011-167-980-027-771,Patent Application,yes,0,4,4,5,0,A61K33/00;;A61K33/00;;A61K35/742;;A61K35/742;;A61K35/744;;A61K35/744;;A61K45/06;;A61K45/06;;C12N1/20;;C12N1/20,C12N1/12;;C12N1/20,,0,0,,,,PENDING
16,US,B2,US 7749509 B2,180-868-493-858-383,2010-07-06,2010,US 84099407 A,2007-08-19,US 84099407 A;;US 92895104 A;;US 49925503 P,2003-08-29,Treatment of autism using probiotic composition,"A method of treating autism using a probiotic composition including the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium . The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the invention may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders.",COBB AND COMPANY LLP,COBB MARK L;;COBB ALYSON,COBB & ASSOCIATES (2011-04-11),https://lens.org/180-868-493-858-383,Granted Patent,yes,34,75,2,16,0,A61K35/742;;A61K35/744;;A61K9/0034;;A61K47/36;;A61K9/4866;;A61P25/00;;A61K35/744;;A61K35/742;;A61K9/0034;;A61K47/36;;A61K9/4866,A61K39/116;;A61K35/742;;A61K35/744,424/203.1;;424/93.4;;424/93.46;;424/93.1;;424/93.462;;435/243;;435/252.1,22,5,069-257-822-029-740;;091-533-856-281-640;;091-533-856-281-640;;081-252-246-238-959;;040-942-802-256-308,18473099;;16809947;;16809947;;21840798;;10.3920/bm2008.1005;;11157348;;10.1093/ajcn/73.2.399s,"""Candida Support"", ""Accessed Online Jun. 13, 2008 at: http://www.candidasupport.org/3lac.html"", Jun. 13, 2008.;;""ThreeLac Study-Nine Month Results"", ""Accessed Online Jun. 12, 2008 at http://www.autism-study.com/"", Jun. 12, 2008.;;Chou, Yen-Yi, et al., ""Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium . . . "", ""J. Microbiol. Immunol. Infect."", Apr. 2008, pp. 124-129, vol. 41.;;""How does candida harm my body?"", ""First found online at http://www.1stcandidacure.com/candidacureplan.html"", Aug. 26, 2004.;;""Chronic Fatigue, Fybromyalgia and other Autoimmune disease"", ""First found online at http://www.candidasupport.org/faq'sandingredie.html"", Aug. 20, 2003.;;""Eliminate the underlying cause"", ""First found online at http://www.candidfree.net/pages/1/index.html"", Sep. 21, 2004.;;Edelson, Stephen M., ""The candida yeast-autism connection"", ""First found online at http://www.autism.org/candida.html"", Aug. 20, 2003.;;Harrison, Robert , ""Candida Research Article"", ""Found online at http://www.candidayeastinfection.com/researcharticle.html"", Jul. 13, 2007.;;""Lactobacillus Sporogenes-Introduction to LactoSpore"", ""Found online at http://www.lactospore.com"".;;Lewis, Carol, ""Irritable Bowel Syndrome: A poorly understood disorder"", ""FDA Consumer Magazine"", Jul.-Aug. 2001, pp. 1-9, Publisher: U.S. Food and Drug Admininstration.;;""Primal Defense-Product Information"", ""First found online at http://www.forhealthsolutions.net/primal-defense.html"", Aug. 20, 2003.;;""ThreeLac Candida Defense-How does Nature's Biotics help?"", ""First found online at http://www.gethealthyagain.com/candida"", Aug. 20, 2003.;;""Benefits of Threelac"", ""http://www.ghtdirect.com/threelac-main.aspx"".;;UniProt Consortium, ""Entercoccus faecium (scientific name) , accessed at www.uniprot.org/taxonomy/1352"", ""www.uniprot.org"", Jul. 20, 2009, pp. 1-2.;;Kim, Y. et al. , ""The Effects of Probiotics on Symptoms of Irritable Bowel Syndrome"", ""Korean J. Gastroenterology"", Jun. 2006, pp. 413-419, vol. 47, No. 6 (Original Korean Text).;;Kim, Y. et al. , ""The Effects of Probiotics on Symptoms of Irritable Bowel Syndrome"", ""Korean J. Gastroenterology"", Jun. 2006, pp. 413-419, vol. 47, No. 6 (English Abstract Only).;;Inovative Fulfillment Solutions, ""Nutraceutical News, accessed at www.ifssoultions.com/news20070708.html"", Jul./Aug. 2007 , pp. 1-5, Publisher: Innovative Fulfillment Solutions.;;SYMBIONFORLIFE.COM, ""SymbionTM Webpages from symbionforlife.com website, accessed Jul. 20, 2009"", ""symbionforlife.com"", Jul. 20, 2009, pp. 1-27.;;Tomkins, T. ET , ""A comprehensive review of post-market clinical studies performed in adults with an Asian probiotic formulation"", ""Beneficial Microbes"", Article in Press, published online 2009, Publisher: Wageningen Academic Publishers.;;Trenev, N. , ""Probiotics: Nature's Internal Healers"", ""Probiotics"", 1998, pp. 129, 132-133, Publisher: Avery Trade.;;Bezkorovainy, A. , ""Probiotics: determinants of survival and growth in the gut"", ""Am. J. Clin. Nutr."", 2001, pp. 399S-405S, vol. 73, Publisher: American Society for Clinical Nutrition.;;Vecchi, E. et al., ""Lactobacillus Sporogenes for Bacillus Coagulans Misidentification or Mislabelling?"", ""Int. Journal of Probiotics and Prebiotics"", 2006, pp. 3-10, vol. 1, No. 1.",ACTIVE
17,US,B2,US 8771673 B2,010-542-543-185-830,2014-07-08,2014,US 201213489111 A,2012-06-05,US 201213489111 A;;US 84028910 A;;US 84099207 A;;US 92895104 A;;US 49925503 P,2003-08-29,Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions,"A method of combating rheumatoid arthritis, comprising administering to a human subject in need thereof, an effective oral dose of a probiotic composition in an oral dose form including, as the only bacterial species therein, the bacterial species of Bacillus subtilis, Bacillus coagulans , and Enterococcus faecium . The initial occurrence, and progress of remission of the rheumatoid arthritis condition incident to such probiotic therapy, may be established and monitored by assay of rheumatoid factor and/or anti-CCP antibodies present in a blood sample of the human subject.",COBB MARK L;;COBB ALYSON J;;COBB & ASSOCIATES,COBB MARK L;;COBB ALYSON J,COBB & ASSOCIATES (2012-06-05),https://lens.org/010-542-543-185-830,Granted Patent,yes,50,68,4,16,0,A61K35/742;;A61K35/744;;A61K31/702;;Y10S435/822;;A23P10/30;;A23L33/135;;A23L33/21;;A61P1/04;;A61P11/06;;A61P17/10;;A61P19/02;;A61P25/16;;A61P25/24;;A61P27/14;;A61P29/00;;A61P31/10;;A61P3/10;;A61K31/702;;A61K35/742;;A61K35/744;;Y10S435/822;;A23P10/30;;A23L33/21;;A23L33/135,A01N25/00;;A01N63/00;;A01N65/00;;A61K35/742;;A61K35/744;;C12N1/12;;C12N1/20,424/93.3;;424/93.1;;424/93.4;;424/93.44;;424/93.46;;424/93.462;;435/822;;514/777,54,8,040-942-802-256-308;;069-257-822-029-740;;055-798-029-541-216;;091-533-856-281-640;;045-008-866-371-865;;081-252-246-238-959;;006-487-425-963-837;;052-297-375-765-71X,11157348;;10.1093/ajcn/73.2.399s;;18473099;;16102604;;10.1016/j.femsre.2004.12.001;;16809947;;33451235;;10.1111/j.1541-4337.2003.tb00017.x;;21840798;;10.3920/bm2008.1005;;10.1006/biol.1997.0099;;9324997;;10.1111/j.1443-9573.2004.00157.x;;15612659,"Symbion for Life, ""Do you have Gluten Intolerance, Irritable Bowel Syndrome, Fibromyalgia or Chronic Fatigue Syndrome?"", http://www.symbionforlife.com, accessed Feb. 12, 2010, pp. 1-4.;;Vecchi, E., et al., ""Lactobacillus sporogenes or Bacillus coagulans: Misidentification or Mislabelling?"", ""International Journal of Probiotics and Prebiotics "", Feb. 2006, pp. 3-10, vol. 1, No. 1.;;Jan. 9, 2009 Office Action in U.S. Appl. No. 11/840,994, issued by Jennifer E. Graser.;;Feb. 4, 2010 Office Action in U.S. Appl. No. 11/840,992, issued by Oluwatosin A. Ogunbiyi.;;Feb. 15, 2011 Office Action in U.S. Appl. No. 12/840,289, issued by Oluwatosin A. Ogunbiyi.;;Mar. 12, 2012 Notice of Allowance in U.S. Appl. No. 12/840,289, issued by Oluwatosin A. Ogunbiyi.;;Mar. 20, 2007 Office Action in U.S. Appl. No. 10/928,951, issued by Jennifer E. Graser.;;Apr. 6, 2009 Office Action in U.S. Appl. No. 11/535,752, issued by Thane E. Underdahl.;;Apr. 7, 2010 Notice of Allowance in U.S. Appl. No. 11/840,994, issued by Jennifer E. Graser.;;Apr. 15, 2010 Notice of Allowance in U.S. Appl. No. 11/840,996, issued by Jennifer E. Graser.;;May 20, 2010 Notice of Allowance in U.S. Appl. No. 11/840,992, issued by Oluwatosin A. Ogunbiyi.;;Jun. 1, 2009 Office Action in U.S. Appl. No. 11/840,992, issued by Oluwatosin A. Ogunbiyi.;;Jun. 9, 2009 Office Action in U.S. Appl. No. 11/535,752, issued by Thane E. Underdahl.;;Jun. 26, 2012 Notice of Allowance in U.S. Appl. No. 11/535,752, issued by Thane E. Underdahl.;;Jul. 1, 2008 Office Action U.S. Appl. No. 11/840,992, issued by Oluwatosin A. Ogunbiyi.;;Jul. 13, 2006 Office Action in U.S. Appl. No. 10/928,951, issued by Jennifer E. Graser.;;Jul. 24, 2009 Office Action in U.S. Appl. No. 11/840,992, issued by Oluwatosin A. Ogunbiyi.;;Jul. 29, 2011 Office Action in U.S. Appl. No. 12/840,289, issued by Oluwatosin A. Ogunbiyi.;;Aug. 6, 2007 Advisory Action in U.S. Appl. No. 10/928,951, issued by Jennifer E. Graser.;;Sep. 1, 2010 Office Action in U.S. Appl. No. 12/840,289, issued by Oluwatosin A. Ogunbiyi.;;Sep. 4, 2009 Office Action in U.S. Appl. No. 11/840,996, issued by Jennifer E. Graser.;;Sep. 8, 2009 Office Action in U.S. Appl. No. 11/840,994, issued by Jennifer E. Graser.;;Oct. 3, 2006 Office Action in U.S. Appl. No. 10/928,951, issued by Jennifer E. Graser.;;Oct. 31, 2007 Office Action in U.S. Appl. No. 10/928,951, issued by Jennifer E. Graser.;;Nov. 25, 2009 Office Action in U.S. Appl. No. 11/535,752, issued by Thane E. Underdahl.;;Dec. 18, 2008 Office Action in U.S. Appl. No. 11/840,992, issued by Oluwatosin A. Ogunbiyi.;;Dec. 30, 2008 Office Action in U.S. Appl. No. 11/840,996, issued by Jennifer E. Graser.;;Bezkorovainy, A. , ""Probiotics: Determinants of Survival and Growth in the Gut"", ""The American Journal of Clinical Nutrition"", Feb. 2001, pp. 399S-405S, vol. 73 (2 Suppl).;;Candida Cure Plan, ""How Does Candida Harm My Body?"", http://www.1stcandidacure.com/candidacureplan.html, accessed Aug. 26, 2004.;;Candida Support, ""Chronic Fatigue, Fybromyalgia and Other Autoimmune Disease"", http://www.candidasupport.org/treatment-faq'sandingredie.html, Oct. 12, 2000.;;Candida Free, ""Eliminate the Underlying Cause"", http://www.candidafree.net/pages/1/index.html, accessed Sep. 21, 2004, pp. 1-30.;;Candida Support, ""Threelac"", http://www.candidasupport.org/3lac.html, accessed Jun. 13, 2008, pp. 1-27.;;Chou, Y., et al., ""Vancomycin-Resistant Enterococcal Bacteremia: Comparison of Clinical Features and Outcome Between Enterococcus faecium and Enterococcus faecalis"", ""Journal of Microbiology, Immunology and Infection"", Apr. 2008, pp. 124-129, vol. 41, No. 2.;;Uniprot, ""Species Enterococcus faecium (Streptococcus faecium)"", www.uniprot.org/taxonomy/1352, accessed Jul. 20, 2009, pp. 1-2.;;Edelson, S., ""The Candida Yeast-Autism Connection"", http://www.autism.org/candida.html, accessed Aug. 20, 2003, Publisher: Center for the Study of Autism.;;Global Health Trax Inc., ""Welcome From: Global Health Trax Inc."", http://www.ghtdirect.com/threelac-main.aspx, accessed 2007, pp. 1-3.;;Harrison, R., ""Japanese Scientists Discover an Ingenious Way to Help Fight Candida & Yeast Problems Even Without the Candida Diet or Mega Doses of Pills!"", http://www.candidayeastinfection.com/researcharticle.html, accessed Jul. 13, 2007, pp. 1-9.;;Harrison, R., ""Japanese Scientists Discover an Ingenious Way to Eliminate Candida & Yeast Problems Even Without the Candida Diet or Mega Doses of Pills!"", http://www.candidayeastinfection.com/researcharticle.html, accessed Aug. 2003, pp. 1-10.;;Hong, H., et al., ""The Use of Bacterial Spore Formers as Probiotics"", ""FEMS Microbiology Reviews"", Dec. 16, 2004, pp. 813-835, vol. 29, No. 4.;;Kim, Y., et al. , ""The Effects of Probiotics on Symptoms of Irritable Bowel Syndrome"", ""Korean Journal of Gastroenterology"", Jun. 2006, pp. 413-419 (English Abstract), vol. 47, No. 6.;;Sabinsa Corporation, ""Lactobacillus sporogenes-Introduction to Lactospore"", http://www.lactospore.com, accessed Sep. 2004, pp. 1-25.;;Lewis, C., ""Irritable Bowel Syndrome: A Poorly Understood Disorder"", ""FDA Consumer Magazine"", Jul.-Aug. 2001, Publisher: U.S. Food and Drug Administration.;;Innovative Fulfillment Solutions, ""Nutraceutical News"", Jul./Aug. 2007, http://www.ifssoultions.com/news20070708.html, pp. 1-5.;;For Health Solutions, ""Primal Defense"", http://www.forhealthsolutions.net/primal-defense.html, accessed Aug. 20, 2003.;;Sabinsa Corporation, ""Lactospore"", http://www.lactospore.com/back2.htm, 2000, pp. 1-5.;;Sanders, M., et al., ""Sporeformers as Human Probiotics: Bacillus, Sporolactobacillus, and Brevibacillus"", ""Comprehensive Reviews in Food Science and Food Safety"", Jul. 2003, pp. 101-110, vol. 2, No. 3.;;Symbion for Life, ""About Symbion Probiotics"", http://www.symbionforlife.com/about-symbion-probiotics.html, accessed Jul. 20, 2009, pp. 1-27.;;Get Healthy Again, ""Threelac Candida Defense-How Does Nature'S Biotics Help?"", http://www.gethealthyagain.com/candida, accessed Aug. 20, 2003, pp. 1-2.;;""Threelac Study-Nine Month Results"", http://www.autism-study.com/, accessed Jun. 12, 2008, pp. 1-8.;;Tomkins, T., et al., ""A Comprehensive Review of Post-Market Clinical Studies Performed in Adults With an Asian Probiotic Formulation"", ""Beneficial Microbes"", Jun. 30, 2009, pp. 93-106, vol. 1, No. 1.;;Trenev, N. , ""Choosing the Right Probiotics"", ""Probiotics: Nature's Internal Healers"", May 1, 1998, p. 129, 132-133, Publisher: Avery Trade.;;Note: Applicant hereby offers to furnish to examiner upon request with copies of Office Actions cited herein.;;Vollenbroich, D., et al., ""Mechanism of Inactivation of Enveloped Viruses by the Biosurfactant Surfactin from Bacillus subtilis"", ""Biologicals"", Sep. 1997, pp. 289-297, vol. 25, No. 3.;;Zhao, H., et al., ""Intestinal microflora in patients with liver cirrhosis"", ""Chinese Journal of Digestive Diseases"", Apr. 6, 2004, pp. 64-67, vol. 5, No. 2.",INACTIVE
18,US,A1,US 2013/0022577 A1,022-935-312-453-108,2013-01-24,2013,US 201213591217 A,2012-08-21,US 201213591217 A;;US 53575206 A;;US 72086905 P,2005-09-27,PROBIOTIC COMPOSITIONS USEFUL FOR TREATMENT OF BIPOLAR DISORDER,"Compositions and methods for treatment or prophylaxis of a bipolar disorder disease state, in which the compositions include the bacilli (1) Bacillus subtilis , (2) Bacillus coagulans , and (3) Enterococcus faecium . The compositions may be embodied in suitable dose forms such as capsules containing the microbial species in combination with a substrate for the microbial species, e.g., fructo-oligosaccharides, for oral administration according to a predetermined dosage schedule.",COBB & ASSOCIATES;;COBB MARK L;;COBB ALYSON J,COBB MARK L;;COBB ALYSON J,COBB & ASSOCIATES (2012-09-19),https://lens.org/022-935-312-453-108,Patent Application,yes,5,8,1,5,0,A61K45/06;;A61K33/00;;A61K35/742;;A61K35/744;;C12N1/20;;A61P25/00;;C12N1/20;;A61K33/00;;A61K35/742;;A61K45/06;;A61K35/744,A61K35/74;;A61K35/742;;A61K35/744;;A61P25/00,424/93.3,2,2,052-297-375-765-71X;;006-487-425-963-837,10.1111/j.1443-9573.2004.00157.x;;15612659;;10.1006/biol.1997.0099;;9324997,"Zhao et al., Chinese Journal of Digestive Diseases, vol. 5, no. 2, p. 64-67, 2004;;Vollenbroich, Biologicals, vol. 25, no. 3, p. 289-297, 1997",DISCONTINUED
19,US,A1,US 2006/0177424 A1,081-786-349-463-688,2006-08-10,2006,US 92895104 A,2004-08-27,US 92895104 A;;US 49925503 P,2003-08-29,Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions,"A method for treatment or prophylaxis of a disease state or other physiological condition, e.g., autism, delayed development, acid reflux disease, vaginal yeast infections, impaired hearing, chronic ear infections, seasonal allergies, Fibromyalgia syndrome, Crohn's disease, colitis, irritable bowel syndrome, interstitial cystitis, acne, sinusitis, rheumatoid arthritis, chronic fatigue syndrome, asthma, attention deficit disorder, attention deficit/hyperactivity disorder, rosacea, multiple sclerosis, hyperglycemia, or Ménière's disease, by administration of an anti-fungal composition that includes at least one of the bacilli (1) Bacillus subtilis, (2) Lactobacillus sporogenes, and (3) Streptococcus faecalis.",COBB MARK L;;COBB ALYSON J,COBB MARK L;;COBB ALYSON J,COBB & COMPANY LLP (2004-08-27),https://lens.org/081-786-349-463-688,Patent Application,yes,13,85,1,16,0,A61K35/742;;A61K35/744;;A61K35/747;;A61K35/744;;A61K35/747;;A61K35/742,A61K35/74;;A61K35/742;;A61K35/744;;A61K35/747,424/93.4;;424/93.45,0,0,,,,DISCONTINUED
20,US,A1,US 2012/0244124 A1,128-683-195-886-945,2012-09-27,2012,US 201213489111 A,2012-06-05,US 201213489111 A;;US 84028910 A;;US 84099207 A;;US 92895104 A;;US 49925503 P,2003-08-29,PROBIOTIC COMPOSITION USEFUL FOR DIETARY AUGMENTATION AND/OR COMBATING DISEASE STATES AND ADVERSE PHYSIOLOGICAL CONDITIONS,"A method of combating rheumatoid arthritis, comprising administering to a human subject in need thereof, an effective oral dose of a probiotic composition in an oral dose form including, as the only bacterial species therein, the bacterial species of Bacillus subtilis, Bacillus coagulans , and Enterococcus faecium . The initial occurrence, and progress of remission of the rheumatoid arthritis condition incident to such probiotic therapy, may be established and monitored by assay of rheumatoid factor and/or anti-CCP antibodies present in a blood sample of the human subject.",COBB MARK L;;COBB ALYSON J;;COBB & ASSOCIATES,COBB MARK L;;COBB ALYSON J,COBB & ASSOCIATES (2012-06-05),https://lens.org/128-683-195-886-945,Patent Application,yes,3,5,4,16,0,A61K35/742;;A61K35/744;;A61K31/702;;Y10S435/822;;A23P10/30;;A23L33/135;;A23L33/21;;A61P1/04;;A61P11/06;;A61P17/10;;A61P19/02;;A61P25/16;;A61P25/24;;A61P27/14;;A61P29/00;;A61P31/10;;A61P3/10;;A61K31/702;;A61K35/742;;A61K35/744;;Y10S435/822;;A23P10/30;;A23L33/21;;A23L33/135,A61K35/74;;A61K35/742;;A61K35/744;;A61P29/00,424/93.3,0,0,,,,INACTIVE
21,CA,A1,CA 2426029 A1,160-022-426-648-63X,2002-04-25,2002,CA 2426029 A,2001-10-17,IB 0101946 W;;US 24133700 P,2000-10-19,APPARATUS AND METHOD FOR HYDROFORMING A TUBULAR PART,"A method and apparatus for shaping a raw tube (40) into a formed part. The part can be configured within a die assembly including a hydroforming die structure (12, 14) and a pair of tube-engaging punches (81). The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/160-022-426-648-63X,Patent Application,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,EXPIRED
22,AU,A,AU 2001/094124 A,178-436-378-710-286,2002-04-29,2002,AU 2001/094124 A,2001-10-16,IB 0101946 W;;US 24133700 P,2000-10-19,Apparatus and method for hydroforming a tubular part,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/178-436-378-710-286,Patent Application,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,PENDING
23,BR,A,BR 0114789 A,191-627-108-981-759,2003-08-12,2003,BR 0114789 A,2001-10-16,IB 0101946 W;;US 24133700 P,2000-10-19,Conjunto de matriz de hidroconformação para hidroconformar uma peça a partir de uma preforma tubular e método de produzir uma peça hidroconformada,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/191-627-108-981-759,Patent Application,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,DISCONTINUED
24,CN,A,CN 1471444 A,017-873-140-501-246,2004-01-28,2004,CN 01817647 A,2001-10-17,US 24133700 P,2000-10-19,Apparatus and method for hydroforming a tubular part,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/017-873-140-501-246,Patent Application,no,0,10,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,EXPIRED
25,NZ,A,NZ 525377 A,053-005-580-068-461,2003-09-26,2003,NZ 52537701 A,2001-10-16,IB 0101946 W;;US 24133700 P,2000-10-19,Apparatus and method for hydroforming a tubular part with shaping along entire length of tube,"A method and apparatus is disclosed for shaping a raw tube (40) into a formed part. The part can be configured within a die assembly including a hydroforming die structure (12) and a pair of tube-engaging punches (81). The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/053-005-580-068-461,Patent Application,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/045;;B21D51/16;;B21D26/047,,0,0,,,,PENDING
26,DE,T2,DE 60114038 T2,020-550-671-074-599,2006-06-22,2006,DE 60114038 T,2001-10-17,US 24133700 P;;IB 0101946 W,2000-10-19,VORRICHTUNG UND VERFAHREN ZUM HYDROFORMEN EINES ROHRFÖRMIGEN TEILS,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/020-550-671-074-599,Granted Patent,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,EXPIRED
27,WO,A1,WO 2002/032596 A1,119-893-408-954-083,2002-04-25,2002,IB 0101946 W,2001-10-17,US 24133700 P,2000-10-19,APPARATUS AND METHOD FOR HYDROFORMING A TUBULAR PART,"A method and apparatus for shaping a raw tube (40) into a formed part. The part can be configured within a die assembly including a hydroforming die structure (12, 14) and a pair of tube-engaging punches (81). The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC;;COBB MARK;;GENSEBERGER ERICH,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/119-893-408-954-083,Patent Application,yes,9,3,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/045;;B21D26/047;;B21D51/16,,0,0,,,,PATENTED
28,WO,A9,WO 2002/032596 A9,033-849-384-375-557,2003-08-28,2003,IB 0101946 W,2001-10-17,US 24133700 P,2000-10-19,APPARATUS AND METHOD FOR HYDROFORMING A TUBULAR PART,"A method and apparatus for shaping a raw tube (40) into a formed part. The part can be configured within a die assembly including a hydroforming die structure (12, 14) and a pair of tube-engaging punches (81). The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC;;COBB MARK;;GENSEBERGER ERICH,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/033-849-384-375-557,Patent Application,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/045;;B21D26/047;;B21D51/16,,0,0,,,,PATENTED
29,EP,A1,EP 1326722 A1,116-030-074-045-169,2003-07-16,2003,EP 01974611 A,2001-10-17,IB 0101946 W;;US 24133700 P,2000-10-19,APPARATUS AND METHOD FOR HYDROFORMING A TUBULAR PART,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,MAGNA INTERNATIONAL INC. (2006-01-25),https://lens.org/116-030-074-045-169,Patent Application,yes,0,1,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,EXPIRED
30,CZ,A3,CZ 20031109 A3,182-584-277-494-747,2004-01-14,2004,CZ 20031109 A,2001-10-17,US 24133700 P,2000-10-19,Process and apparatus for hydroforming a tubular component,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/182-584-277-494-747,Patent Application,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,PENDING
31,EP,B1,EP 1326722 B1,156-028-754-716-366,2005-10-12,2005,EP 01974611 A,2001-10-17,IB 0101946 W;;US 24133700 P,2000-10-19,APPARATUS AND METHOD FOR HYDROFORMING A TUBULAR PART,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,MAGNA INTERNATIONAL INC. (2006-01-25),https://lens.org/156-028-754-716-366,Granted Patent,yes,9,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,EXPIRED
32,WO,A8,WO 2002/032596 A8,103-434-343-951-573,2002-10-24,2002,IB 0101946 W,2001-10-17,US 24133700 P,2000-10-19,APPARATUS AND METHOD FOR HYDROFORMING A TUBULAR PART,"A method and apparatus for shaping a raw tube (40) into a formed part. The part can be configured within a die assembly including a hydroforming die structure (12, 14) and a pair of tube-engaging punches (81). The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC;;COBB MARK;;GENSEBERGER ERICH,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/103-434-343-951-573,Patent Application,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/045;;B21D26/047;;B21D51/16,,0,0,,,,PATENTED
33,AU,A1,AU 2001/294124 A1,162-965-433-750-401,2002-04-29,2002,AU 2001/294124 A,2001-10-17,US 24133700 P;;IB 0101946 W,2000-10-19,Apparatus and method for hydroforming a tubular part,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,GENSEBERGER ERICH;;COBB MARK,,https://lens.org/162-965-433-750-401,Patent Application,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,DISCONTINUED
34,DE,D1,DE 60114038 D1,183-204-837-437-337,2005-11-17,2005,DE 60114038 T,2001-10-17,US 24133700 P;;IB 0101946 W,2000-10-19,VORRICHTUNG UND VERFAHREN ZUM HYDROFORMEN EINES ROHRFÖRMIGEN TEILS,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/183-204-837-437-337,Granted Patent,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,EXPIRED
35,CN,C,CN 1227079 C,119-101-050-930-352,2005-11-16,2005,CN 01817647 A,2001-10-17,US 24133700 P,2000-10-19,Apparatus and method for hydro forming a tubular part,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,GENSEBERGER MARK COBB ERICH,,https://lens.org/119-101-050-930-352,Granted Patent,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,EXPIRED
36,CA,C,CA 2426029 C,152-872-648-780-32X,2009-11-24,2009,CA 2426029 A,2001-10-17,IB 0101946 W;;US 24133700 P,2000-10-19,APPARATUS AND METHOD FOR HYDROFORMING A TUBULAR PART,"A method and apparatus for shaping a raw tube (40) into a formed part. The part can be configured within a die assembly including a hydroforming die structure (12, 14) and a pair of tube-engaging punches (81). The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/152-872-648-780-32X,Granted Patent,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,EXPIRED
37,AT,T1,AT E306337 T1,148-597-672-938-985,2005-10-15,2005,AT 01974611 T,2001-10-17,US 24133700 P;;IB 0101946 W,2000-10-19,VORRICHTUNG UND VERFAHREN ZUM HYDROFORMEN EINES ROHRFÖRMIGEN TEILS,"A method and apparatus for shaping a raw tube into a formed part. The part can be configured within a die assembly including a hydroforming die structure and a pair of tube-engaging punches. The punches are inserted into the ends of the raw tube to shape the ends into the desired configuration. The middle portion of the raw tube is shaped into the desired configuration by hydroforming. Thus, the method and apparatus can shape the raw tube along its entire length, leaving no remnants of the raw tube that must be trimmed away.",COSMA INT INC,COBB MARK;;GENSEBERGER ERICH,,https://lens.org/148-597-672-938-985,Granted Patent,no,0,0,22,22,0,B21D26/045;;B21D26/047;;B21D26/045,B21D26/047;;B21D26/045;;B21D51/16,,0,0,,,,EXPIRED
38,US,A1,US 2022/0120525 A1,007-672-126-952-063,2022-04-21,2022,US 202117565043 A,2021-12-29,US 202117565043 A;;US 202017072413 A,2020-10-16,GRIP SAFETY INTERLOCK FOR FIREARM,"An example grip safety interlock can include a lower receiver with a trigger assembly, a safety selector having a detent channel, a grip having an internal recess, an extended detent pin having a detent point and an interference abutment surface, a grip safety lever having an interference ledge, and a lever bias spring positioned within the grip, extending between the grip and the grip safety lever. The grip safety lever can be positioned to pivot within the internal recess of the grip, and the extended detent pin can extend within the grip such that the detent point contacts the detent channel of the safety selector. The lever bias spring can push the grip safety lever to a first pivot position such that the interference ledge of the grip safety lever abuts the interference abutment surface of the extended detent pin to prevent movement and rotation of the safety selector.",SAFE OPERATOR SOLUTIONS LLC,ZUNG MICHAEL;;COBB JOHN MARK,SAFE OPERATOR SOLUTIONS LLC (2020-10-13),https://lens.org/007-672-126-952-063,Patent Application,yes,12,1,3,3,0,F41A17/20;;F41A17/22;;F41A35/06;;F41A17/52,F41A17/22;;F41A17/52,,0,0,,,,ACTIVE
39,US,B1,US 11243035 B1,100-897-529-889-335,2022-02-08,2022,US 202017072413 A,2020-10-16,US 202017072413 A,2020-10-16,Grip safety interlock for firearm,"An example grip safety interlock can include a lower receiver with a trigger assembly, a safety selector having a detent channel, a grip having an internal recess, an extended detent pin having a detent point and an interference abutment surface, a grip safety lever having an interference ledge, and a lever bias spring positioned within the grip, extending between the grip and the grip safety lever. The grip safety lever can be positioned to pivot within the internal recess of the grip, and the extended detent pin can extend within the grip such that the detent point contacts the detent channel of the safety selector. The lever bias spring can push the grip safety lever to a first pivot position such that the interference ledge of the grip safety lever abuts the interference abutment surface of the extended detent pin to prevent movement and rotation of the safety selector.",SAFE OPERATOR SOLUTIONS LLC,ZUNG MICHAEL;;COBB JOHN MARK,SAFE OPERATOR SOLUTIONS LLC (2020-10-13),https://lens.org/100-897-529-889-335,Granted Patent,yes,27,2,3,3,0,F41A17/20;;F41A17/22;;F41A35/06;;F41A17/52,F41A17/22;;F41A17/52;;F41A35/06,,3,0,,,"Firearms Tube, “Odin Works Ambi Modular Safety (AMS)”, 2018, https://www.youtube.com/watch?v=JGJotoMFJ7Q (accessed Aug. 20, 2020).;;U.S. Patent Application and File History for U.S. Appl. No. 16/413,062, filed May 15, 2019.;;U.S. Patent Application and File History for U.S. Appl. No. 16/601,037, filed Oct. 14, 2019.",ACTIVE
40,US,A1,US 2020/0116448 A1,166-236-930-411-115,2020-04-16,2020,US 201916601037 A,2019-10-14,US 201916601037 A;;US 201862746317 P,2018-10-16,SAFETY SELECTORS,Embodiments of safety selectors are disclosed. A safety selector can include a body configured to engage an internal safety mechanisms of a firearm. The safety selector can further include a first arm and a second arm that extend from the body. The first arm and the second arm can be oriented such that a non-zero angle exists between a first axis associated with the first arm and a second axis associated with the second arm.,SAFE OPERATOR SOLUTIONS LLC,ZUNG MICHAEL;;COBB JOHN MARK,SAFE OPERATOR SOLUTIONS LLC (2018-10-15),https://lens.org/166-236-930-411-115,Patent Application,yes,0,2,1,1,0,F41A17/46;;F41A35/06;;F41A17/00;;F41A17/02;;F41A17/56;;F41A17/74;;F41A19/10;;F41A19/12;;F41A19/46;;F41A35/06,F41A17/46;;F41A17/02;;F41A17/56;;F41A17/74;;F41A19/10;;F41A19/12;;F41A19/46;;F41A35/06,,0,0,,,,DISCONTINUED
41,CN,C,CN 100350308 C,037-909-096-188-375,2007-11-21,2007,CN 01812770 A,2001-07-05,US 61331300 A,2000-07-11,Backlight with structured sufaces,,3M INNOVATIVE PROPERTIES CO,COBB SANDFORD GARDINER MARK E,,https://lens.org/037-909-096-188-375,Granted Patent,no,5,1,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,G02B6/00;;G02F1/1335;;F21V8/00;;F21Y103/00;;G02B5/02;;G02F1/13357,,0,0,,,,EXPIRED
42,US,B2,US 10767949 B2,098-890-030-082-346,2020-09-08,2020,US 201916413062 A,2019-05-15,US 201916413062 A;;US 201862671892 P,2018-05-15,Two-stage safety selectors for firearms,"Disclosed are various embodiments of safety selector assemblies for firearms. In one embodiment, a safety selector assembly includes a body and a pivoting arm. A portion of the body is configured to be positioned within the frame of the firearm. The pivoting arm is pivotably mounted to the body of the safety selector assembly and is configured to selectively engage a safety selector stop tab that extends from the frame to restrict the body of the safety selector assembly from rotating when the pivoting arm is engaged with the safety selector stop tab.",SAFE OPERATOR SOLUTIONS LLC,ZUNG MICHAEL;;COBB JOHN MARK,,https://lens.org/098-890-030-082-346,Granted Patent,yes,9,4,2,2,0,F41A17/46;;F41A35/06;;F41A17/46;;F41A19/46,F41A17/46,,0,0,,,,ACTIVE
43,US,A1,US 2020/0025486 A1,008-328-895-978-915,2020-01-23,2020,US 201916413062 A,2019-05-15,US 201916413062 A;;US 201862671892 P,2018-05-15,TWO-STAGE SAFETY SELECTORS FOR FIREARMS,"Disclosed are various embodiments of safety selector assemblies for firearms. In one embodiment, a safety selector assembly includes a body and a pivoting arm. A portion of the body is configured to be positioned within the frame of the firearm. The pivoting arm is pivotably mounted to the body of the safety selector assembly and is configured to selectively engage a safety selector stop tab that extends from the frame to restrict the body of the safety selector assembly from rotating when the pivoting arm is engaged with the safety selector stop tab.",SAFE OPERATOR SOLUTIONS LLC,ZUNG MICHAEL;;COBB JOHN MARK,,https://lens.org/008-328-895-978-915,Patent Application,yes,9,5,2,2,0,F41A17/46;;F41A35/06;;F41A17/46;;F41A19/46,F41A17/46,,0,0,,,,ACTIVE
44,US,B2,US 11698236 B2,011-998-198-806-414,2023-07-11,2023,US 202117565043 A,2021-12-29,US 202117565043 A;;US 202017072413 A,2020-10-16,Grip safety interlock for firearm,"An example grip safety interlock can include a lower receiver with a trigger assembly, a safety selector having a detent channel, a grip having an internal recess, an extended detent pin having a detent point and an interference abutment surface, a grip safety lever having an interference ledge, and a lever bias spring positioned within the grip, extending between the grip and the grip safety lever. The grip safety lever can be positioned to pivot within the internal recess of the grip, and the extended detent pin can extend within the grip such that the detent point contacts the detent channel of the safety selector. The lever bias spring can push the grip safety lever to a first pivot position such that the interference ledge of the grip safety lever abuts the interference abutment surface of the extended detent pin to prevent movement and rotation of the safety selector.",SAFE OPERATOR SOLUTIONS LLC,ZUNG MICHAEL;;COBB JOHN MARK,SAFE OPERATOR SOLUTIONS LLC (2020-10-13),https://lens.org/011-998-198-806-414,Granted Patent,yes,29,0,3,3,0,F41A17/20;;F41A17/22;;F41A35/06;;F41A17/52,F41A17/22;;F41A17/52;;F41A35/06,,3,0,,,"Firearms Tube, “Odin Works Ambi Modular Safety (AMS)”, 2018, https:/lwww.youtube.com/watch?v=JGJoloMFJ7Q (accessed Aug. 20, 2020).;;U.S. Patent Application and File History for U.S. Appl. No. 16/413,062, filed May 15, 2019.;;U.S. Patent Application and File History for U.S. Appl. No. 16/601,037, filed Oct. 14, 2019.",ACTIVE
45,WO,A3,WO 2020/112434 A3,057-454-372-768-454,2020-07-30,2020,US 2019/0062137 W,2019-11-19,US 201862773899 P,2018-11-30,COMPACT OPTICAL IMAGING SYSTEM FOR CELL CULTURE MONITORING,"An optical imaging system for cell culture monitoring is provided. The system includes an illumination segment having an illumination source and a collimating lens positioned between a first surface of a cell culture vessel and the illumination source. The illumination source and the collimating lens are arranged to transmit light through the first surface at an angle oblique to the first surface of the cell culture vessel. The system also includes a detection segment having a detector and a lens positioned between the first surface of the cell culture vessel and the detector. The lens focuses light to the detector through an aperture stop, and the detector receives light that exits the first surface of the cell culture vessel at an angle oblique to the first surface.",CORNING INC,COBB JOSHUA MONROE;;SANSON MARK CHRISTIAN,,https://lens.org/057-454-372-768-454,Search Report,yes,8,0,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,C12M1/12;;C12M1/00;;C12M1/34,,0,0,,,,PENDING
46,US,A1,US 2006/0284973 A1,164-328-176-320-97X,2006-12-21,2006,US 15611905 A,2005-06-17,US 15611905 A,2005-06-17,Stereoscopic viewing apparatus,"An optical apparatus ( 10 ) for stereoscopic viewing has a first optical channel with a first display ( 12 l ) generating a first image and a first viewing lens assembly ( 22 l ) producing a virtual image, with at least one optical component of the first viewing lens assembly truncated ( 26 l ) along a first side. A second optical channel has a second display ( 12 r ) generating a second image and a second viewing lens assembly ( 22 r ) producing a virtual image, with at least one optical component of the second viewing lens assembly truncated ( 26 r ) along a second side. A reflective folding surface is disposed between the second display and second viewing lens assembly to fold a substantial portion of the light within the second optical channel. An edge portion of the reflective folding surface blocks a portion of the light in the first optical channel. The first side of the first viewing assembly is disposed adjacent the second side of the second viewing lens assembly.",EASTMAN KODAK CO,COBB JOSHUA M;;BRIDGES MARK E,EASTMAN KODAK COMPANY (2005-06-16),https://lens.org/164-328-176-320-97X,Patent Application,yes,18,2,6,6,0,G02B30/36;;G02B27/02;;G02B30/36,H04N15/00;;H04N13/04,348/51,0,0,,,,DISCONTINUED
47,CN,A,CN 101198895 A,146-755-088-743-116,2008-06-11,2008,CN 200680021568 A,2006-06-02,US 15611905 A,2005-06-17,Stereoscopic viewing apparatus,,EASTMAN KODAK CO,MONROE COBB JOSHUA;;EDWARD BRIDGES MARK,,https://lens.org/146-755-088-743-116,Patent Application,no,0,1,6,6,0,G02B30/36;;G02B27/02;;G02B30/36,G02B27/22,,0,0,,,,DISCONTINUED
48,DE,T2,DE 69602588 T2,144-309-583-963-80X,1999-10-14,1999,DE 69602588 T,1996-01-18,US 40005295 A;;US 9600796 W,1995-03-03,LICHTLENKENDER FILM MIT IN DER HÖHE VARIIERENDER STRUKTURIERTER OBERFLÄCHE UND DARAUS HERGESTELLTER LICHTLENKENDER ARTIKEL,,MINNESOTA MINING & MFG,WORTMAN DAVID;;COBB SANFORD;;GARDINER MARK,,https://lens.org/144-309-583-963-80X,Granted Patent,no,0,0,14,14,0,B29D11/00788;;F21V5/02;;F21V5/02;;F21V5/02;;G02B6/0053;;G02B6/0053;;G02B5/0221;;G02B5/0221;;G02B5/0231;;G02B5/0231;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;G02B6/0055;;G02B6/0055;;Y10S385/901;;Y10S385/901,F21V5/02;;F21V8/00;;G02B6/00,,0,0,,,,EXPIRED
49,WO,A1,WO 2006/138079 A1,179-788-914-841-286,2006-12-28,2006,US 2006/0021376 W,2006-06-02,US 15611905 A,2005-06-17,STEREOSCOPIC VIEWING APPARATUS,"An apparatus (10) for stereoscopic viewing has a first optical channel with a first display (12l) and a first viewing lens assembly (22l), which produces producing a virtual image. At least one optical component of the first viewing lens assembly is truncated (26l) along a first side. A second optical channel has a second display (12r) and a second viewing lens assembly (22r), which produce a virtual image. At least one optical component of the second viewing lens assembly is truncated (26r) along a second side. A reflective folding surface is disposed between the second display and second viewing lens assembly to fold a substantial portion of the light within the second optical channel. The first side of the first viewing assembly is disposed adjacent the second side of the second viewing lens assembly.",EASTMAN KODAK CO;;COBB JOSHUA MONROE;;BRIDGES MARK EDWARD,COBB JOSHUA MONROE;;BRIDGES MARK EDWARD,,https://lens.org/179-788-914-841-286,Patent Application,yes,6,0,6,6,0,G02B30/36;;G02B27/02;;G02B30/36,G02B27/22,,0,0,,,,PENDING
50,US,A,US 5917664 A,191-518-928-318-52X,1999-06-29,1999,US 59679296 A,1996-02-05,US 59679296 A,1996-02-05,Brightness enhancement film with soft cutoff,"A brightness enhancement film has a plurality of linear prisms. The prisms are disposed in pairs, each pair having first and second prisms and each prism has a prism angle and a valley angle. Either the prism angles or the valley angles, but not both, are equal.",3M INNOVATIVE PROPERTIES CO,O'NEILL MARK B;;COBB JR SANFORD,3M INNOVATIVE PROPERTIES COMPANY (1999-04-08);;MINNESOTA MINING AND MANUFACTURING COMPANY (1996-04-26),https://lens.org/191-518-928-318-52X,Granted Patent,yes,8,296,16,16,0,G02B5/045;;G02B5/124;;G02B5/04;;G02B5/124;;G02B5/045,F21V5/02;;G02B5/02;;G02B5/04;;G09F9/00;;G02B5/124;;G02F1/1335;;G02F1/13357,359/831;;359/834;;349/57;;349/62,0,0,,,,EXPIRED
51,TW,A,TW 201907202 A,032-378-435-097-266,2019-02-16,2019,TW 107114451 A,2018-04-27,US 201762491783 P;;US 201762525391 P,2017-04-28,Virtual and augmented reality devices with structured surfaces,"A virtual or an augmented reality device comprising: (i) a display component comprising a display surface, (ii) a lens air spaced from the display component; wherein at least one of the display component or the lens comprises a stray light reducing nanostructured surface.",CORNING INC,COBB JOSHUA MONROE;;KROL MARK FRANCIS,,https://lens.org/032-378-435-097-266,Patent of Addition,no,0,0,7,7,0,G02B27/0101;;G02B2027/012;;G02B27/0172;;G02B27/0018;;G02B1/118;;G02B2207/101;;G02B1/118;;G02B27/0018;;G02B27/0101;;G02B27/0172;;G02B5/18;;G02B2027/012;;G02B2207/101;;G02B1/118;;G02B2207/101;;G02B27/48;;G02B5/18;;G02B27/0018;;G02B2027/012;;G02B27/0101;;G02B27/0172,G02B27/01;;G02B1/118;;G02B5/18;;G02B27/48,,0,0,,,,PENDING
52,KR,A,KR 20080028875 A,193-465-154-164-390,2008-04-02,2008,KR 20077029272 A,2007-12-14,US 15611905 A,2005-06-17,STEREOSCOPIC VIEWING APPARATUS,"An apparatus (10) for stereoscopic viewing has a first optical channel with a first display (12l) and a first viewing lens assembly (22l), which produces producing a virtual image. At least one optical component of the first viewing lens assembly is truncated (26l) along a first side. A second optical channel has a second display (12r) and a second viewing lens assembly (22r), which produce a virtual image. At least one optical component of the second viewing lens assembly is truncated (26r) along a second side. A reflective folding surface is disposed between the second display and second viewing lens assembly to fold a substantial portion of the light within the second optical channel. The first side of the first viewing assembly is disposed adjacent the second side of the second viewing lens assembly.",EASTMAN KODAK CO,COBB JOSHUA MONROE;;BRIDGES MARK EDWARD,,https://lens.org/193-465-154-164-390,Patent Application,no,0,0,6,6,0,G02B30/36;;G02B27/02;;G02B30/36,G02B27/02,,0,0,,,,DISCONTINUED
53,US,A1,US 2018/0313981 A1,199-965-555-335-567,2018-11-01,2018,US 201815960932 A,2018-04-24,US 201815960932 A;;US 201762491783 P;;US 201762525391 P,2017-04-28,VIRTUAL AND AUGMENTED REALITY DEVICES WITH STRUCTURED SURFACES,"A virtual or an augmented reality device comprising: (i) a display component comprising a display surface, (ii) a lens air spaced from the display component; wherein at least one of the display component or the lens comprises a stray light reducing nanostructured surface.",CORNING INC,COBB JOSHUA MONROE;;KROL MARK FRANCIS,CORNING INCORPORATED (2018-04-03),https://lens.org/199-965-555-335-567,Patent Application,yes,6,6,7,7,0,G02B27/0101;;G02B2027/012;;G02B27/0172;;G02B27/0018;;G02B1/118;;G02B2207/101;;G02B1/118;;G02B27/0018;;G02B27/0101;;G02B27/0172;;G02B5/18;;G02B2027/012;;G02B2207/101;;G02B1/118;;G02B2207/101;;G02B27/48;;G02B5/18;;G02B27/0018;;G02B2027/012;;G02B27/0101;;G02B27/0172,G02B1/118;;G02B5/18;;G02B27/48,,0,0,,,,DISCONTINUED
54,US,B2,US 9517845 B2,187-085-711-668-46X,2016-12-13,2016,US 201314026716 A,2013-09-13,US 201314026716 A,2013-09-13,Movable personnel platform for unloading a unit load device,"The invention relates to an unload access system for an unit load device, comprising a framework, the framework delimiting a cargo space arranged on a ground load deck and the framework comprising an unload deck for unloading shipments out of the unit load device, whereby the unload deck is arranged distant above the ground load deck and extends in an offset plane adjacent to the cargo space, the unload deck comprises a movable platform, and the platform extends coplanar with the unload deck and is movable between a retracted position and a maximum extracted position, whereby in the maximum extracted position the platform overlaps at least partly the cargo space by extending into the cargo space and in the retracted position the platform does not overlap the cargo space.",DEUTSCHE POST AG,LAIB JASON;;COBB TRAVIS;;WEBSTER MARK;;VEASY MARK,DEUTSCHE POST AG (2015-10-27);;DHL EXPRESS (USA) INC (2015-07-14);;PFLOW INDUSTRIES INC (2015-03-19),https://lens.org/187-085-711-668-46X,Granted Patent,yes,26,0,2,2,0,B64F1/32;;B64F1/32;;B65G69/22;;B65G69/22,B64F1/32;;B65G69/22,,1,0,,,"Machine Translation of DE10308680A1 by Lexis Nexis Total Patent on May 15, 2015.",ACTIVE
55,EP,A1,EP 1894055 A1,019-548-268-459-933,2008-03-05,2008,EP 06771900 A,2006-06-02,US 2006/0021376 W;;US 15611905 A,2005-06-17,STEREOSCOPIC VIEWING APPARATUS,,EASTMAN KODAK CO,COBB JOSHUA MONROE;;BRIDGES MARK EDWARD,,https://lens.org/019-548-268-459-933,Patent Application,yes,0,0,6,6,0,G02B30/36;;G02B27/02;;G02B30/36,G02B27/22,,0,0,,,,DISCONTINUED
56,AU,A,AU 1997/018523 A,072-405-408-701-132,1997-08-22,1997,AU 1997/018523 A,1997-02-04,US 59679296 A;;US 9701627 W,1996-02-05,Brightness enhancement film with soft cutoff,,MINNESOTA MINING & MFG,O'NEILL MARK B;;COBB SANFORD JR,,https://lens.org/072-405-408-701-132,Patent Application,no,0,0,16,16,0,G02B5/045;;G02B5/124;;G02B5/04;;G02B5/124;;G02B5/045,G09F9/00;;F21V5/02;;G02B5/02;;G02B5/04;;G02B5/124;;G02F1/1335;;G02F1/13357,,0,0,,,,EXPIRED
57,EP,A2,EP 3887500 A2,080-980-660-501-66X,2021-10-06,2021,EP 19824033 A,2019-11-19,US 201862773899 P;;US 2019/0062137 W,2018-11-30,COMPACT OPTICAL IMAGING SYSTEM FOR CELL CULTURE MONITORING,,CORNING INC,COBB JOSHUA MONROE;;SANSON MARK CHRISTIAN,,https://lens.org/080-980-660-501-66X,Patent Application,yes,0,0,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,C12M1/12;;C12M1/00;;C12M1/34,,0,0,,,,PENDING
58,US,B2,US 11921102 B2,147-233-284-056-223,2024-03-05,2024,US 16690583,2019-11-21,,,Compact optical imaging system for cell culture monitoring,"An optical imaging system for cell culture monitoring is provided. The system includes an illumination segment having an illumination source and a collimating lens positioned between a first surface of a cell culture vessel and the illumination source. The illumination source and the collimating lens are arranged to transmit light through the first surface at an angle oblique to the first surface of the cell culture vessel. The system also includes a detection segment having a detector and a lens positioned between the first surface of the cell culture vessel and the detector. The lens focuses light to the detector through an aperture stop, and the detector receives light that exits the first surface of the cell culture vessel at an angle oblique to the first surface.",CORNING INCORPORATED,Joshua Monroe Cobb;;Mark Christian Sanson,CORNING INCORPORATED (2019-11-20),https://lens.org/147-233-284-056-223,Granted Patent,yes,50,0,1,1,0,G01N33/4833;;C12M23/12;;C12M41/46;;G01N21/55;;G01N33/5005;;G02B21/361;;G02B21/002;;G02B21/04;;G02B21/36,C12M3/00;;C12M1/00;;C12M1/32;;C12M1/34;;G01N21/55;;G01N33/483;;G01N33/50;;G02B21/36;;G02B21/00;;G02B21/04,,3,0,,,"International Search Report and Written Opinion of the International Searching Authority; PCT/US2019/062137; dated Jun. 25, 2020; 18 Pages; European Patent Office.;;International Search Report and Written Opinion of the European International Searching Authority; PCT/US2019/063712; dated Feb. 27, 2020; 13 pgs.;;Invitation to Pay Additional Fees and Partial Search Report of the European International Searching Authority; PCT/US2019/062137; dated Mar. 2, 2020; 17 pgs.",UNKNOWN
59,CA,A1,CA 2242424 A1,159-810-743-005-955,1997-08-07,1997,CA 2242424 A,1997-02-04,US 59679296 A;;US 9701627 W,1996-02-05,BRIGHTNESS ENHANCEMENT FILM WITH SOFT CUTOFF,"A brightness enhancement film (40) has a plurality of linear prisms (46, 48, 50). The prisms are disposed in pairs, each pair having first and second prisms and each prism has a prism angle and a valley angle. Either the prism angles or the valley angles, but not both, are equal.",MINNESOTA MINING & MFG,O'NEILL MARK B;;COBB SANFORD JR,,https://lens.org/159-810-743-005-955,Patent Application,no,0,0,16,16,0,G02B5/045;;G02B5/124;;G02B5/04;;G02B5/124;;G02B5/045,G09F9/00;;F21V5/02;;G02B5/02;;G02B5/04;;G02B5/124;;G02F1/1335;;G02F1/13357,,0,0,,,,EXPIRED
60,WO,A1,WO 1997/028468 A1,014-159-715-993-425,1997-08-07,1997,US 9701627 W,1997-02-04,US 59679296 A,1996-02-05,BRIGHTNESS ENHANCEMENT FILM WITH SOFT CUTOFF,"A brightness enhancement film (40) has a plurality of linear prisms (46, 48, 50). The prisms are disposed in pairs, each pair having first and second prisms and each prism has a prism angle and a valley angle. Either the prism angles or the valley angles, but not both, are equal.",MINNESOTA MINING & MFG,O'NEILL MARK B;;COBB SANFORD JR,,https://lens.org/014-159-715-993-425,Patent Application,yes,4,20,16,16,0,G02B5/045;;G02B5/124;;G02B5/04;;G02B5/124;;G02B5/045,F21V5/02;;G02B5/02;;G02B5/04;;G09F9/00;;G02B5/124;;G02F1/1335;;G02F1/13357,G2J JB7G          JB7G,0,0,,,,PATENTED
61,EP,B1,EP 0879430 B1,083-506-705-239-978,2003-09-10,2003,EP 97904158 A,1997-02-04,US 9701627 W;;US 59679296 A,1996-02-05,BRIGHTNESS ENHANCEMENT FILM WITH SOFT CUTOFF,,MINNESOTA MINING & MFG,O'NEILL MARK B;;COBB SANFORD JR,,https://lens.org/083-506-705-239-978,Granted Patent,yes,4,2,16,16,0,G02B5/045;;G02B5/124;;G02B5/04;;G02B5/124;;G02B5/045,G09F9/00;;F21V5/02;;G02B5/02;;G02B5/04;;G02B5/124;;G02F1/1335;;G02F1/13357,,0,0,,,,EXPIRED
62,CN,A,CN 110832381 A,127-134-169-104-382,2020-02-21,2020,CN 201880043252 A,2018-04-27,US 201762491783 P;;US 201762525391 P;;US 2018/0029705 W,2017-04-28,Virtual and augmented reality devices with structured surfaces,"A virtual or an augmented reality device comprising: (i) a display component comprising a display surface, (ii) a lens air spaced from the display component; wherein at least one of the display component or the lens comprises a stray light reducing nanostructured surface.",CORNING INC,COBB JOSHUA MONROE;;KROL MARK FRANCIS,,https://lens.org/127-134-169-104-382,Patent Application,no,0,0,7,7,0,G02B27/0101;;G02B2027/012;;G02B27/0172;;G02B27/0018;;G02B1/118;;G02B2207/101;;G02B1/118;;G02B27/0018;;G02B27/0101;;G02B27/0172;;G02B5/18;;G02B2027/012;;G02B2207/101;;G02B1/118;;G02B2207/101;;G02B27/48;;G02B5/18;;G02B27/0018;;G02B2027/012;;G02B27/0101;;G02B27/0172,G02B27/01;;G02B1/118;;G02B27/00,,0,0,,,,DISCONTINUED
63,CN,A,CN 113166701 A,180-655-059-277-851,2021-07-23,2021,CN 201980079297 A,2019-11-19,US 201862773899 P;;US 2019/0062137 W,2018-11-30,COMPACT OPTICAL IMAGING SYSTEM FOR CELL CULTURE MONITORING,"An optical imaging system for cell culture monitoring is provided. The system includes an illumination segment having an illumination source and a collimating lens positioned between a first surface of a cell culture vessel and the illumination source. The illumination source and the collimating lens are arranged to transmit light through the first surface at an angle oblique to the first surface of the cell culture vessel. The system also includes a detection segment having a detector and a lens positioned between the first surface of the cell culture vessel and the detector. The lens focuses light to the detector through an aperture stop, and the detector receives light that exits the first surface of the cell culture vessel at an angle oblique to the first surface.",CORNING INC,COBB JOSHUA MONROE;;SANSON MARK CHRISTIAN,,https://lens.org/180-655-059-277-851,Patent Application,no,0,0,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,C12M1/12;;C12M1/00;;C12M1/34,,0,0,,,,PENDING
64,EP,A1,EP 0879430 A1,184-968-916-109-514,1998-11-25,1998,EP 97904158 A,1997-02-04,US 9701627 W;;US 59679296 A,1996-02-05,BRIGHTNESS ENHANCEMENT FILM WITH SOFT CUTOFF,,MINNESOTA MINING & MFG,O'NEILL MARK B;;COBB SANFORD JR,,https://lens.org/184-968-916-109-514,Patent Application,yes,0,1,16,16,0,G02B5/045;;G02B5/124;;G02B5/04;;G02B5/124;;G02B5/045,G09F9/00;;F21V5/02;;G02B5/02;;G02B5/04;;G02B5/124;;G02F1/1335;;G02F1/13357,,0,0,,,,EXPIRED
65,WO,A2,WO 2020/112434 A2,099-498-995-587-172,2020-06-04,2020,US 2019/0062137 W,2019-11-19,US 201862773899 P,2018-11-30,COMPACT OPTICAL IMAGING SYSTEM FOR CELL CULTURE MONITORING,"An optical imaging system for cell culture monitoring is provided. The system includes an illumination segment having an illumination source and a collimating lens positioned between a first surface of a cell culture vessel and the illumination source. The illumination source and the collimating lens are arranged to transmit light through the first surface at an angle oblique to the first surface of the cell culture vessel. The system also includes a detection segment having a detector and a lens positioned between the first surface of the cell culture vessel and the detector. The lens focuses light to the detector through an aperture stop, and the detector receives light that exits the first surface of the cell culture vessel at an angle oblique to the first surface.",CORNING INC,COBB JOSHUA MONROE;;SANSON MARK CHRISTIAN,,https://lens.org/099-498-995-587-172,Patent Application,yes,0,0,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,C12M1/12;;C12M1/00;;C12M1/34,,0,0,,,,PENDING
66,EP,A1,EP 3615985 A1,021-596-258-791-607,2020-03-04,2020,EP 18725720 A,2018-04-27,US 201762491783 P;;US 201762525391 P;;US 2018/0029705 W,2017-04-28,VIRTUAL AND AUGMENTED REALITY DEVICES WITH STRUCTURED SURFACES,,CORNING INC,COBB JOSHUA MONROE;;KROL MARK FRANCIS,,https://lens.org/021-596-258-791-607,Patent Application,yes,0,0,7,7,0,G02B27/0101;;G02B2027/012;;G02B27/0172;;G02B27/0018;;G02B1/118;;G02B2207/101;;G02B1/118;;G02B27/0018;;G02B27/0101;;G02B27/0172;;G02B5/18;;G02B2027/012;;G02B2207/101;;G02B1/118;;G02B2207/101;;G02B27/48;;G02B5/18;;G02B27/0018;;G02B2027/012;;G02B27/0101;;G02B27/0172,G02B27/01;;G02B1/118;;G02B27/00,,0,0,,,,DISCONTINUED
67,WO,A1,WO 2018/200903 A1,086-281-462-743-938,2018-11-01,2018,US 2018/0029705 W,2018-04-27,US 201762491783 P;;US 201762525391 P,2017-04-28,VIRTUAL AND AUGMENTED REALITY DEVICES WITH STRUCTURED SURFACES,"A virtual or an augmented reality device comprising: (i) a display component comprising a display surface, (ii) a lens air spaced from the display component; wherein at least one of the display component or the lens comprises a stray light reducing nanostructured surface.",CORNING INC,COBB JOSHUA MONROE;;KROL MARK FRANCIS,,https://lens.org/086-281-462-743-938,Patent Application,yes,4,0,7,7,0,G02B27/0101;;G02B2027/012;;G02B27/0172;;G02B27/0018;;G02B1/118;;G02B2207/101;;G02B1/118;;G02B27/0018;;G02B27/0101;;G02B27/0172;;G02B5/18;;G02B2027/012;;G02B2207/101;;G02B1/118;;G02B2207/101;;G02B27/48;;G02B5/18;;G02B27/0018;;G02B2027/012;;G02B27/0101;;G02B27/0172,G02B27/01;;G02B1/118;;G02B27/00,,1,1,033-352-177-399-464,10.1109/jphotov.2014.2304359,"PERL EMMETT E ET AL: ""Ultrabroadband and Wide-Angle Hybrid Antireflection Coatings With Nanostructures"", IEEE JOURNAL OF PHOTOVOLTAICS, I E E E, US, vol. 4, no. 3, 1 May 2014 (2014-05-01), pages 962 - 967, XP011545893, ISSN: 2156-3381, [retrieved on 20140417], DOI: 10.1109/JPHOTOV.2014.2304359",PENDING
68,GB,A,GB 2335597 A,055-863-924-836-473,1999-09-29,1999,GB 9806487 A,1998-03-27,GB 9806487 A,1998-03-27,Stereoisomers of Troglitazone in the Treatment of Diabetes,"The 2R-diastereoisomeric pair of troglitazone show greater potency and selectivity as an agonist of peroxisome proliferator activated receptor (PPAR-gamma) than the 2S-diastereoisomeric pair. Best results are achieved with the (2R, 5S)-stereoisomer alone. The invention therefore provides improved hypoglycaemics for the treatment of type II non-insulin dependent diabetes mellitus (NIDDM).",GLAXO GROUP LTD;;SANKYO CO,COBB JEFFREY EDMOND;;WILLSON TIMOTHY MARK,,https://lens.org/055-863-924-836-473,Patent Application,no,3,9,2,2,0,A61K31/425,A61K31/425,A5B BHA           BHA2;;A5B B180          BHA2;;A5B B48Y          BHA2;;A5B B482          BHA2;;A5B B50Y          BHA2;;A5B B503          BHA2;;A5B B54Y          BHA2;;A5B B546          BHA2;;A5B B55Y          BHA2;;A5B B550          BHA2;;A5B B56Y          BHA2;;A5B B565          BHA2;;A5B B57Y          BHA2;;A5B B576          BHA2;;A5B B58Y          BHA2;;A5B B586          BHA2;;A5B B61Y          BHA2;;A5B B616          BHA2;;A5B B65Y          BHA2;;A5B B651          BHA2;;A5B B654          BHA2;;A5B B828          BHA2;;A5B B829          BHA2;;U1S S2413,1,0,,,"Annu. Rep. Sankyo Res. Lab., 1994, 46, 1-57 (HIROYOSHI) ""Troglitazone (CS-045)... Drug""",DISCONTINUED
69,KR,A,KR 20190139307 A,111-745-000-650-224,2019-12-17,2019,KR 20197034989 A,2018-04-27,US 201762491783 P;;US 201762525391 P;;US 2018/0029705 W,2017-04-28,구조화된 표면을 갖는 가상 및 증강 현실 디바이스,"가상 또는 증강 현실 디바이스는: (i) 디스플레이 표면을 포함한 디스플레이 구성요소; (ii) 상기 디스플레이 구성요소로부터 공간을 두고 이격된 렌즈;를 포함하며, 상기 디스플레이 구성요소 또는 상기 렌즈 중 적어도 하나는 미광 감소 나노구조화된 표면을 포함한다.",CORNING INC,COBB JOSHUA MONROE;;KROL MARK FRANCIS,,https://lens.org/111-745-000-650-224,Patent Application,no,0,0,7,7,0,G02B27/0101;;G02B2027/012;;G02B27/0172;;G02B27/0018;;G02B1/118;;G02B2207/101;;G02B1/118;;G02B27/0018;;G02B27/0101;;G02B27/0172;;G02B5/18;;G02B2027/012;;G02B2207/101;;G02B1/118;;G02B2207/101;;G02B27/48;;G02B5/18;;G02B27/0018;;G02B2027/012;;G02B27/0101;;G02B27/0172,G02B1/118;;G02B5/18;;G02B27/00;;G02B27/01,,0,0,,,,PENDING
70,US,B2,US 7791326 B2,179-733-211-128-734,2010-09-07,2010,US 610007 A,2007-12-28,US 610007 A,2007-12-28,"AC-powered, microprocessor-based, dimming LED power supply","A dimmable, light-emitting diode (LED) power supply adapted to provide a direct current (DC), constant current (“constant current source”) from a conventional, phase-controlled 120 VAC, 60 Hz power source is disclosed. The constant current source of the present invention utilizes two processes to control dimming. In a first process, the phase angle of the input voltage is used to control the duty cycle of a line frequency pulse width modulation (PWM). In a second process, a proportional-current limit adjustment is used to control the average current to the LED during the ON time of the line frequency by PWM. As a result, at relatively low phase angles, peak currents can be lowered, reducing flicker and improving the audible noise levels generated by the circuit.",TEXAS INSTRUMENTS INC,DAHLMAN MARK COBB;;GLENN JOHN CHARLES,TEXAS INSTRUMENTS INCORPORATED (2007-12-28),https://lens.org/179-733-211-128-734,Granted Patent,yes,4,68,2,2,0,H05B45/10;;Y02B20/30;;H05B45/375;;H05B45/18;;H05B45/10;;Y02B20/30;;H05B45/375;;H05B45/18,G05F1/40;;G05F1/00,323/284;;323/282;;323/277;;323/234;;323/351;;315/291;;315/247;;315/274;;315/224,0,0,,,,ACTIVE
71,AU,B2,AU 723293 B2,196-826-018-886-081,2000-08-24,2000,AU 1997/018523 A,1997-02-04,US 59679296 A;;US 9701627 W,1996-02-05,Brightness enhancement film with soft cutoff,,MINNESOTA MINING & MFG,O'NEILL MARK B;;COBB SANFORD JR,,https://lens.org/196-826-018-886-081,Granted Patent,no,2,0,16,16,0,G02B5/045;;G02B5/124;;G02B5/04;;G02B5/124;;G02B5/045,G09F9/00;;F21V5/02;;G02B5/02;;G02B5/04;;G02B5/124;;G02F1/1335;;G02F1/13357,,0,0,,,,EXPIRED
72,CA,C,CA 2242424 C,199-955-762-936-702,2008-05-06,2008,CA 2242424 A,1997-02-04,US 59679296 A;;US 9701627 W,1996-02-05,BRIGHTNESS ENHANCEMENT FILM WITH SOFT CUTOFF,"A brightness enhancement film (40) has a plurality of linear prisms (46, 48, 50). The prisms are disposed in pairs, each pair having first and second prisms and each prism has a prism angle and a valley angle. Either the prism angles or the valley angles, but not both, are equal.",MINNESOTA MINING & MFG,O'NEILL MARK B;;COBB SANFORD JR,,https://lens.org/199-955-762-936-702,Granted Patent,no,0,0,16,16,0,G02B5/045;;G02B5/124;;G02B5/04;;G02B5/124;;G02B5/045,G02F1/1335;;G09F9/00;;F21V5/02;;G02B5/02;;G02B5/04;;G02B5/124;;G02F1/13357,,0,0,,,,EXPIRED
73,US,A1,US 2020/0173977 A1,011-954-292-600-442,2020-06-04,2020,US 201916690583 A,2019-11-21,US 201916690583 A;;US 201862773899 P,2018-11-30,COMPACT OPTICAL IMAGING SYSTEM FOR CELL CULTURE MONITORING,"An optical imaging system for cell culture monitoring is provided. The system includes an illumination segment having an illumination source and a collimating lens positioned between a first surface of a cell culture vessel and the illumination source. The illumination source and the collimating lens are arranged to transmit light through the first surface at an angle oblique to the first surface of the cell culture vessel. The system also includes a detection segment having a detector and a lens positioned between the first surface of the cell culture vessel and the detector. The lens focuses light to the detector through an aperture stop, and the detector receives light that exits the first surface of the cell culture vessel at an angle oblique to the first surface.",CORNING INC,COBB JOSHUA MONROE;;SANSON MARK CHRISTIAN,,https://lens.org/011-954-292-600-442,Patent Application,yes,2,1,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,C12M1/34;;G01N33/483;;G01N21/55;;G02B21/36,,0,0,,,,ACTIVE
74,DE,D1,DE 69602588 D1,095-305-823-335-690,1999-07-01,1999,DE 69602588 T,1996-01-18,US 40005295 A;;US 9600796 W,1995-03-03,LICHTLENKENDER FILM MIT IN DER HÖHE VARIIERENDER STRUKTURIERTER OBERFLÄCHE UND DARAUS HERGESTELLTER LICHTLENKENDER ARTIKEL,,MINNESOTA MINING & MFG,WORTMAN DAVID;;COBB SANFORD;;GARDINER MARK,,https://lens.org/095-305-823-335-690,Granted Patent,no,0,0,14,14,0,B29D11/00788;;F21V5/02;;F21V5/02;;F21V5/02;;G02B6/0053;;G02B6/0053;;G02B5/0221;;G02B5/0221;;G02B5/0231;;G02B5/0231;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;G02B6/0055;;G02B6/0055;;Y10S385/901;;Y10S385/901,F21V5/02;;F21V8/00;;G02B6/00,,0,0,,,,EXPIRED
75,EP,A1,EP 1734106 A1,111-814-848-184-431,2006-12-20,2006,EP 05253644 A,2005-06-14,EP 05253644 A,2005-06-14,Cleaning composition and method,"A cleaning composition comprising from 80 to 95% by weight of water, from 1 to 25% percent by weight of an amphiphilic solvent, from 0.1 to 10 percent by weight of a volatile hydrocarbon and from 0.1 to 1% by weight of cationic surfactant exhibits good cleaning performance and a visual indication of activity. The composition is on or adjacent to a phase boundary of its phase diagram and exhibits self-induced surface motility of the Marangoni type.",RECKITT BENCKISER UK LTD,COBB VICTORIA;;COKE MARK;;YOUNG JAMES,,https://lens.org/111-814-848-184-431,Patent Application,yes,9,1,4,4,0,C11D1/62;;C11D3/18;;C11D3/2068;;C11D3/28;;C11D3/43;;C11D3/18;;C11D3/43;;C11D3/28;;C11D3/2068;;C11D1/62,C11D3/43;;C11D1/62;;C11D3/18;;C11D3/20;;C11D3/28,,0,0,,,,DISCONTINUED
76,US,A1,US 2009/0167203 A1,198-740-280-241-460,2009-07-02,2009,US 610007 A,2007-12-28,US 610007 A,2007-12-28,"AC-powered, microprocessor-based, dimming LED power supply","A dimmable, light-emitting diode (LED) power supply adapted to provide a direct current (DC), constant current (“constant current source”) from a conventional, phase-controlled 120 VAC, 60 Hz power source is disclosed. The constant current source of the present invention utilizes two processes to control dimming. In a first process, the phase angle of the input voltage is used to control the duty cycle of a line frequency pulse width modulation (PWM). In a second process, a proportional-current limit adjustment is used to control the average current to the LED during the ON time of the line frequency by PWM. As a result, at relatively low phase angles, peak currents can be lowered, reducing flicker and improving the audible noise levels generated by the circuit.",DAHLMAN MARK COBB;;GLENN JOHN CHARLES,DAHLMAN MARK COBB;;GLENN JOHN CHARLES,TEXAS INSTRUMENTS INCORPORATED (2007-12-28),https://lens.org/198-740-280-241-460,Patent Application,yes,4,91,2,2,0,H05B45/10;;Y02B20/30;;H05B45/375;;H05B45/18;;H05B45/10;;Y02B20/30;;H05B45/375;;H05B45/18,H05B41/36,315/291,0,0,,,,ACTIVE
77,US,A1,US 2008/0171685 A1,043-614-885-079-103,2008-07-17,2008,US 91237006 A,2006-06-13,EP 05253644 A;;GB 2006002170 W,2005-06-14,Cleaning Composition and Method,"A cleaning composition comprising from 80 to 98% by weight of water, from 1 to 25% percent by weight of an amphiphilic solvent, from 0.1 to 10 percent by weight of a volatile hydrocarbon and from 0.1 to 1% by weight of cationic surfactant exhibits good cleaning performance and a visual indication of activity. The composition is on or adjacent to a phase boundary of its phase diagram and exhibits self-induced surface motility of the Marangoni type.",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;COKE MARK;;YOUNG JAMES,RECKITT BENCKISER (UK) LIMITED (2007-09-13),https://lens.org/043-614-885-079-103,Patent Application,yes,2,8,4,4,0,C11D3/18;;C11D3/18;;C11D1/62;;C11D1/62;;C11D3/2068;;C11D3/2068;;C11D3/28;;C11D3/28;;C11D3/43;;C11D3/43,C11D17/08,510/433;;510/405,0,0,,,,DISCONTINUED
78,WO,A1,WO 2006/134350 A1,029-272-349-036-447,2006-12-21,2006,GB 2006002170 W,2006-06-13,EP 05253644 A,2005-06-14,CLEANING COMPOSITION AND METHOD,"A cleaning composition comprising from 80 to 98% by weight of water, from 1 to 25% percent by weight of an amphophilic solvent, from 0.1 to 10 percent by weight of a volatile hydrocarbon and from 0.1 to 1% by weight of cationic surfactant exhibits good cleaning performance and a visual indication of activity. The composition is on or adjacent to a phase boundary of its phase diagram and exhibits self-induced surface motility of the Marangoni type.",RECKITT BENCKISER UK LTD;;COBB VICTORIA HEATHER;;COKE MARK;;YOUNG JAMES,COBB VICTORIA HEATHER;;COKE MARK;;YOUNG JAMES,,https://lens.org/029-272-349-036-447,Patent Application,yes,8,6,4,4,0,C11D3/18;;C11D3/18;;C11D1/62;;C11D1/62;;C11D3/2068;;C11D3/2068;;C11D3/28;;C11D3/28;;C11D3/43;;C11D3/43,C11D3/43;;C11D1/62;;C11D3/18;;C11D3/20;;C11D3/28,,0,0,,,,PENDING
79,EP,A1,EP 1896562 A1,051-187-858-467-385,2008-03-12,2008,EP 06764860 A,2006-06-13,GB 2006002170 W;;EP 05253644 A;;EP 06764860 A,2005-06-14,CLEANING COMPOSITION AND METHOD,,RECKITT BENCKISER HEALTHCARE,COBB VICTORIA HEATHER;;COKE MARK;;YOUNG JAMES,,https://lens.org/051-187-858-467-385,Patent Application,yes,0,0,4,4,0,C11D3/18;;C11D3/18;;C11D1/62;;C11D1/62;;C11D3/2068;;C11D3/2068;;C11D3/28;;C11D3/28;;C11D3/43;;C11D3/43,C11D3/43;;C11D1/62;;C11D3/18;;C11D3/20;;C11D3/28,,1,0,,,See references of WO 2006134350A1,DISCONTINUED
80,WO,A2,WO 2001/042964 A2,003-404-767-799-541,2001-06-14,2001,US 0033481 W,2000-12-07,US 45741099 A,1999-12-07,METHOD AND APPARATUS FOR STRUCTURE PREDICTION BASED ON MODEL CURVATURE,"Methods and apparatuses for structure prediction based on model curvature are described. A simulation result corresponding to an integrated circuit or other structure is generated. The result includes contour data representing a feature value, for example, height (or intensity) of the structure at various points. Three or more points are used to determine a curvature of the result at a predetermined location. The curvature information can be used to determine boundaries of the struture. For example, when used with an integrated circuit layout, the curvature can be used for optical and process correction (OPC) purposes to modify an integrated circuit layout such that the resulting integrated circuit more closely resembles the designed integrated circuit than would otherwise be possible. In one embodiment, both slope and curvature of the integrated circuit structure are used for OPC purposes.",MENTOR GRAPHICS CORP,GRANIK YURI;;COBB NICOLAS BAILEY;;SCHELLENBERG FRANKLIN MARK,,https://lens.org/003-404-767-799-541,Patent Application,yes,0,4,6,6,0,G03F7/70441;;G03F7/70441;;G03F1/36;;G03F1/36,G03F1/00;;G03F1/36;;G03F7/20;;G06F1/14;;G06F7/60;;G06F17/00;;G06F17/10;;G06F17/50;;G06G7/62,,0,0,,,,PENDING
81,WO,A3,WO 2002/004858 A3,000-401-989-598-347,2002-05-23,2002,US 0121294 W,2001-07-05,US 61331300 A,2000-07-11,BACKLIGHT WITH STRUCTURED SUFACES,"A backlight includes a lightguide (16), a light source (12) disposed with respect to the lightguide (16) to introduce light into the lightguide (16) and a turning film. Optical structures (40) are formed in one of an output surface (18) and a back surface (20) of the lightguide (16). The optical structures (40) are arranged to extract light from the lightguide (16). A back reflector (24) is disposed adjacent the back surface (20). The optical structures (40) are formed to include a varying pattern arranged to mask non-uniformities in the output of the lightguide (16).",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANDFORD;;KRETMAN WADE D,,https://lens.org/000-401-989-598-347,Search Report,yes,5,0,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,G02B6/00;;F21V8/00;;F21Y103/00;;G02F1/13357,,6,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1997, no. 10 31 October 1997 (1997-10-31);;PATENT ABSTRACTS OF JAPAN vol. 1999, no. 10 31 March 1999 (1999-03-31);;PATENT ABSTRACTS OF JAPAN vol. 1999, no. 12 29 October 1999 (1999-10-29);;PATENT ABSTRACTS OF JAPAN vol. 1999, no. 14 22 December 1999 (1999-12-22);;PATENT ABSTRACTS OF JAPAN vol. 1995, no. 09 31 October 1995 (1995-10-31);;See also references of EP 1301743A2",PATENTED
82,US,B1,US 7046905 B1,189-790-718-257-088,2006-05-16,2006,US 61331300 A,2000-07-11,US 61331300 A;;US 41547199 A,1999-10-08,Blacklight with structured surfaces,"A backlight includes a lightguide, a light source disposed with respect to the lightguide to introduce light into the lightguide and a turning film. Optical structures are formed in one of an output surface and a back surface of the lightguide. The optical structures are arranged to extract light from the lightguide. A back reflector is disposed adjacent the back surface. The optical structures are formed to include a varying pattern arranged to mask non-uniformities in the output of the lightguide.",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY A DELAWARE CORP (2001-02-22),https://lens.org/189-790-718-257-088,Granted Patent,yes,107,72,5,34,0,G02B6/0036;;G02B6/0043;;G02B6/0046;;G02B6/0055;;G02B6/0061;;G02B6/0038;;Y10S385/901;;G02B6/0046;;G02B6/0061;;G02B6/0055;;G02B6/0036;;G02B6/0043;;G02B6/0038;;G02B6/0001;;Y10S385/901,G02B6/10,385/146;;385/31,7,0,,,"IBM Technical Disclosure Bulletin, vol. 29, No. 11, Backlighting for Liquid Crystal Display, Apr. 1987.;;IBM Technical Disclosure Bulletin, vol. 31, No. 2, Flat Panel Backlight Reflecting Device, Jul. 1988.;;IBM Technical Disclosure Bulletin, vol. 33, No. 1B, Polarized Backlight for Liquid Crystal Display, Jun. 1990.;;IBM Technical Disclosure Bulletin, vol. 33, No. 9, High Efficiency Back Light for LCD, Feb. 1991.;;JP 096031217A, Machine Translation, ISTA's Paterra(tm), 20 pages.;;JP 2000089009A, Machine Translation, ISTA's Paterra(tm), 20 pages.;;International Search Report PCT/US01/21294 dated Jan. 25, 2001.",EXPIRED
83,CA,A1,CA 2413700 A1,090-961-107-878-014,2002-01-17,2002,CA 2413700 A,2001-07-05,US 61331300 A;;US 0121294 W,2000-07-11,BACKLIGHT WITH STRUCTURED SUFACES,"A backlight includes a lightguide (16), a light source (12) disposed with respect to the lightguide (16) to introduce light into the lightguide (16) a nd a turning film. Optical structures (40) are formed in one of an output surfa ce (18) and a back surface (20) of the lightguide (16). The optical structures (40) are arranged to extract light from the lightguide (16). A back reflecto r (24) is disposed adjacent the back surface (20). The optical structures (40) are formed to include a varying pattern arranged to mask non-uniformities in the output of the lightguide (16).",3M INNOVATIVE PROPERTIES CO,KRETMAN WADE D;;GARDINER MARK E;;COBB SANDFORD,,https://lens.org/090-961-107-878-014,Patent Application,no,0,0,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,G02B6/00;;F21V8/00;;F21Y103/00;;G02F1/13357,,0,0,,,,EXPIRED
84,EP,A2,EP 1301743 A2,052-588-052-788-394,2003-04-16,2003,EP 01953417 A,2001-07-05,US 0121294 W;;US 61331300 A,2000-07-11,BACKLIGHT WITH STRUCTURED SUFACES,,3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANDFORD;;KRETMAN WADE D,,https://lens.org/052-588-052-788-394,Patent Application,yes,1,1,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,G02B6/00;;F21V8/00;;F21Y103/00;;G02F1/13357,,1,0,,,See also references of WO 0204858A3,DISCONTINUED
85,CA,C,CA 2413700 C,072-257-798-907-029,2007-01-09,2007,CA 2413700 A,2001-07-05,US 61331300 A;;US 0121294 W,2000-07-11,BACKLIGHT WITH STRUCTURED SUFACES,"A backlight includes a lightguide (16), a light source (12) disposed with respect to the lightguide (16) to introduce light into the lightguide (16) a nd a turning film. Optical structures (40) are formed in one of an output surfa ce (18) and a back surface (20) of the lightguide (16). The optical structures (40) are arranged to extract light from the lightguide (16). A back reflecto r (24) is disposed adjacent the back surface (20). The optical structures (40) are formed to include a varying pattern arranged to mask non-uniformities in the output of the lightguide (16).",3M INNOVATIVE PROPERTIES CO,KRETMAN WADE D;;COBB SANDFORD;;GARDINER MARK E,,https://lens.org/072-257-798-907-029,Granted Patent,no,0,0,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,G02B6/00;;F21V8/00;;F21Y103/00,,0,0,,,,EXPIRED
86,US,B1,US 6643616 B1,043-213-352-049-545,2003-11-04,2003,US 45741099 A,1999-12-07,US 45741099 A,1999-12-07,Integrated device structure prediction based on model curvature,"
    Methods and apparatuses for structure prediction based on model curvature are described. A simulation result corresponding to an integrated circuit or other structure is generated. The result includes contour data representing a feature value, for example, height (or intensity) of the structure at various points. Three or more points are used to determine a curvature of the result at a predetermined location. The curvature information can be used to determine boundaries of the structure. For example, when used with an integrated circuit layout, the curvature can be used for optical and process correction (OPC) purposes to modify an integrated circuit layout such that the resulting integrated circuit more closely resembles the designed integrated circuit than would otherwise be possible. In one embodiment, both slope and curvature of the integrated circuit structure are used for OPC purposes. 
",GRANIK YURI;;COBB NICOLAS BAILEY;;SCHELLENBERG FRANKLIN MARK,GRANIK YURI;;COBB NICOLAS BAILEY;;SCHELLENBERG FRANKLIN MARK,MENTOR GRAPHICS CORPORATION (1999-12-06),https://lens.org/043-213-352-049-545,Granted Patent,yes,11,98,6,6,0,G03F7/70441;;G03F7/70441;;G03F1/36;;G03F1/36,G03F1/00;;G03F1/36;;G03F7/20;;G06F1/14;;G06F7/60;;G06F17/00;;G06F17/10;;G06F17/50;;G06G7/62,703/13;;703/1;;703/2;;716/19;;716/21,15,5,001-238-390-282-791;;050-875-921-106-682;;186-794-367-386-433;;020-558-043-304-468;;060-700-760-037-417,10.1109/icvd.1999.745134;;10.1016/s0167-9317(99)00015-5;;10.1117/12.275977;;10.1117/12.310719;;10.1117/12.373322,"Washington, Allyn. Basic Technical Mathematics with Calculus, Second Edition. 1970. pp. 245-247,260-262,505-525.*;;Schellenberg, F.M. ""Design for Manufacturing in the Semiconductor Industry: The Litho / Design Workshops"", Proceeding , 12th Int'l Conference on VLSI Design, 1999. Jan. 7-10, 1999.*;;Schellenberg, Frank M. ""Sub-Wavelength Lithography Using OPC"", Semiconductor Fabtech, Edition 9, Mar. 1999.*;;SPIE Proceedings vol. 3873. 19th Annual Symposium on Photomask Technology, Editors: Abboud, Frank et al. Published 1999. p. 21.*;;SPIE Proceedings vol. 2726. Optical Microlithography IX, Editors: Fuller, Gene et al. Published 1996. p. 15.*;;Benchmark Technologies, OPC Reference Standard (J111A) Reticle. Oct. 12, 1999.*;;Mentor Graphics Intrenet Site, Technical Papers, ""Resolution Enhancement Technologies (OPC/PSM)"". Jul. 16, 2002.*;;Rieger et al. ""Using Behavior Modeling for Proximity Correction"". Proc. SPIE vol. 2197, Optical/Laser Microlithography VII, pp. 371-376. May 1994.*;;Stirniman et al. ""Optimizing Proximity Correction for Wafer Fabrication Processes"". Proc. SPIE vol. 2322, 14<th >Annual Bacus Symposium on Photomask Technology and Management. pp. 239-246. Dec. 1994.*;;""Fast Optical and Proscess Proximity Correction Algorithms for Integrated Circuit Manufacturing,""Nicolas Bailey Cobb, PhD Dissertation, University of California at Berkeley, pp. 64-71, Spring 1988.;;""Lithography Simulation with Aerial Image-Variable Threshold Resist Model"" John Randall et al., International Conference on Mirco and Nano Engineering vol. 46, pp. 59-60, Sep. 1998.;;""Mathematical and CAD Framework for Proximity Correction"" Nick Cobb et al., Optical Microlithography IX, SPIE- The International Society for Optical Engineering vol. 2726, pp. 208-222, Mar. 1996.;;""Experimental Results on Optical Proximity Correction with Variable Threshold Resist Model"" Nick Cobb et al., Optical Microlithography X, SPIE- The International Society for Optical Engineering vol. 3051, pp. 458-468, Mar. 1997.;;Schellenberg, et al., ""SEMATECH J111 Project: OPC Validation,"" Proc. SPIE Optical Microlithography XI, Luc Van den Hove, ed., vol. 3334, 1998, pp. 892-911.;;Spence, et al., ""Integration of Optical Proximity Correction Strategies in Strong Phase Shifers Design for Poly-Gate Layers,"" Paper No. 3873-273 in Proc. SPIE 19th Annual Symposium of Photomask Technology, Gene E. Fuller, ed., vol. 3873, 1999, pp., 277-287.",EXPIRED
87,CN,A,CN 1464955 A,078-173-958-014-116,2003-12-31,2003,CN 01812770 A,2001-07-05,US 61331300 A,2000-07-11,Backlight with structured sufaces,,3M INNOVATIVE PROPERTIES CO,SANDFORD COBB;;GARDINER MARK E;;KRETMAN WADE D,,https://lens.org/078-173-958-014-116,Patent Application,no,0,5,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,G02B6/00;;F21V8/00;;F21Y103/00;;G02F1/13357,,0,0,,,,EXPIRED
88,AU,A,AU 2001/020820 A,192-700-031-605-61X,2001-06-18,2001,AU 2001/020820 A,2000-12-07,US 45741099 A;;US 0033481 W,1999-12-07,Method and apparatus for structure prediction based on model curvature,,MENTOR GRAPHICS CORP,GRANIK YURI;;COBB NICOLAS BAILEY;;SCHELLENBERG FRANKLIN MARK,,https://lens.org/192-700-031-605-61X,Patent Application,no,0,0,6,6,0,G03F7/70441;;G03F7/70441;;G03F1/36;;G03F1/36,G03F1/00;;G03F1/36;;G03F7/20;;G06F1/14;;G06F7/60;;G06F17/00;;G06F17/10;;G06F17/50;;G06G7/62,,0,0,,,,DISCONTINUED
89,US,B1,US 9916068 B1,042-966-796-052-761,2018-03-13,2018,US 201313800192 A,2013-03-13,US 201313800192 A,2013-03-13,Graphical user interface for displaying alarm security level of groups of elements,"A method of generating a graphical user interface is disclosed. The method includes monitoring a plurality of elements of a computer system and collecting information related to each of the plurality of elements. The method also includes creating a first group icon including information related to a first element group, the first element group including a first set of elements of the plurality of elements, and creating a first set of element icons, each element icon including information related to an element of the first set of elements. The method also includes graphically displaying the first group icon, graphically displaying the first set of element icons in response to a signal indicating a user has selected the first group icon, and graphically displaying a first element-specific frame in response to a signal indicating the user has selected a particular element icon of the first set of element icons.",BELL MARK;;OCONNOR TIMOTHY;;COBB JUSTIN;;ADAMSON KEN;;CA INC,BELL MARK;;O'CONNOR TIMOTHY;;COBB JUSTIN;;ADAMSON KEN,CA INC (2013-03-12),https://lens.org/042-966-796-052-761,Granted Patent,yes,12,6,1,1,0,G06F11/0772;;G06F11/3055;;G06F11/3065;;G06F3/04842;;G06F11/0772;;G06F11/3065;;G06F11/3055,G06F3/0484,,0,0,,,,ACTIVE
90,WO,A2,WO 2002/004858 A2,091-576-568-298-827,2002-01-17,2002,US 0121294 W,2001-07-05,US 61331300 A,2000-07-11,BACKLIGHT WITH STRUCTURED SUFACES,"A backlight includes a lightguide (16), a light source (12) disposed with respect to the lightguide (16) to introduce light into the lightguide (16) and a turning film. Optical structures (40) are formed in one of an output surface (18) and a back surface (20) of the lightguide (16). The optical structures (40) are arranged to extract light from the lightguide (16). A back reflector (24) is disposed adjacent the back surface (20). The optical structures (40) are formed to include a varying pattern arranged to mask non-uniformities in the output of the lightguide (16).",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANDFORD;;KRETMAN WADE D,,https://lens.org/091-576-568-298-827,Patent Application,yes,0,27,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,G02B6/00;;F21V8/00;;F21Y103/00;;G02F1/13357,,0,0,,,,PATENTED
91,WO,A3,WO 2001/042964 A3,183-625-496-872-343,2002-03-14,2002,US 0033481 W,2000-12-07,US 45741099 A,1999-12-07,METHOD AND APPARATUS FOR STRUCTURE PREDICTION BASED ON MODEL CURVATURE,"Methods and apparatuses for structure prediction based on model curvature are described. A simulation result corresponding to an integrated circuit or other structure is generated. The result includes contour data representing a feature value, for example, height (or intensity) of the structure at various points. Three or more points are used to determine a curvature of the result at a predetermined location. The curvature information can be used to determine boundaries of the struture. For example, when used with an integrated circuit layout, the curvature can be used for optical and process correction (OPC) purposes to modify an integrated circuit layout such that the resulting integrated circuit more closely resembles the designed integrated circuit than would otherwise be possible. In one embodiment, both slope and curvature of the integrated circuit structure are used for OPC purposes.",MENTOR GRAPHICS CORP,GRANIK YURI;;COBB NICOLAS BAILEY;;SCHELLENBERG FRANKLIN MARK,,https://lens.org/183-625-496-872-343,Search Report,yes,2,0,6,6,0,G03F7/70441;;G03F7/70441;;G03F1/36;;G03F1/36,G03F1/00;;G03F1/36;;G03F7/20;;G06F1/14;;G06F7/60;;G06F17/00;;G06F17/10;;G06F17/50;;G06G7/62,,0,0,,,,PENDING
92,US,A,US 3194942 A,067-167-391-608-887,1965-07-13,1965,US 13958361 A,1961-09-19,US 13958361 A,1961-09-19,Automatic relay welding machine,,MARK F GOURAN CO,GOURAN MARK F;;COBB CLYDE A;;LEON KAZAN,,https://lens.org/067-167-391-608-887,Granted Patent,no,6,0,1,1,0,B23K9/0026;;B23K9/0026,B23K9/00,,0,0,,,,EXPIRED
93,HK,A1,HK 1056210 A1,106-657-532-677-267,2004-02-06,2004,HK 03106684 A,2003-09-17,US 61331300 A;;US 0121294 W,2000-07-11,BACKLIGHT WITH STRUCTURED SURFACES,,3M INNOVATIVE PROPERTIES CO,MARK E GARDINER;;SANDFORD COBB;;WADE D KRETMAN,,https://lens.org/106-657-532-677-267,Patent Application,no,0,0,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,F21V/;;G02B6/00;;F21V8/00;;F21Y103/00;;G02F1/13357,,0,0,,,,PENDING
94,US,A1,US 2013/0291839 A1,152-006-153-316-743,2013-11-07,2013,US 201213461857 A,2012-05-02,US 201213461857 A,2012-05-02,Bleed Element With Overmolded Seal for Evaporative Emissions Canister,"A deflector mounts a carbon scrubber element at an atmospheric port of an evaporative emissions canister. A substantially cylindrical shell has an open end and a closed end. A spacer plate extends outwardly from the shell. An elastomeric ring is overmolded within the shell at a longitudinal position between the ends. The elastomeric ring has an inner diameter configured to sealingly receive the carbon element. A plurality of vapor apertures are formed in the shell between the spacer plate and the elastomeric ring. A plurality of elastomeric ribs are overmolded by the interior surface within the shell the vapor apertures and the closed end, and are configured to be spaced around the carbon element to suspend the carbon element spaced away from the shell without blocking a gaseous flow from the vapor vents to the carbon element.",LIN JHUN-SOU;;HIPP MARK E;;KERSMAN CHRISTOPHER M;;COBB MARK;;FORD GLOBAL TECH LLC,LIN JHUN-SOU;;HIPP MARK E;;KERSMAN CHRISTOPHER M;;COBB MARK,FORD GLOBAL TECHNOLOGIES LLC (2012-04-30),https://lens.org/152-006-153-316-743,Patent Application,yes,29,7,2,2,0,F02M25/0854;;F02M33/02;;F02M25/0854,F02M33/02,123/519;;123/518,0,0,,,,INACTIVE
95,US,B2,US 8881710 B2,102-496-992-286-232,2014-11-11,2014,US 201213461857 A,2012-05-02,US 201213461857 A,2012-05-02,Bleed element with overmolded seal for evaporative emissions canister,"A deflector mounts a carbon scrubber element at an atmospheric port of an evaporative emissions canister. A substantially cylindrical shell has an open end and a closed end. A spacer plate extends outwardly from the shell. An elastomeric ring is overmolded within the shell at a longitudinal position between the ends. The elastomeric ring has an inner diameter configured to sealingly receive the carbon element. A plurality of vapor apertures are formed in the shell between the spacer plate and the elastomeric ring. A plurality of elastomeric ribs are overmolded by the interior surface within the shell the vapor apertures and the closed end, and are configured to be spaced around the carbon element to suspend the carbon element spaced away from the shell without blocking a gaseous flow from the vapor vents to the carbon element.",LIN JHUN-SOU;;HIPP MARK E;;KERSMAN CHRISTOPHER M;;COBB MARK;;FORD GLOBAL TECH LLC,LIN JHUN-SOU;;HIPP MARK E;;KERSMAN CHRISTOPHER M;;COBB MARK,FORD GLOBAL TECHNOLOGIES LLC (2012-04-30),https://lens.org/102-496-992-286-232,Granted Patent,yes,45,1,2,2,0,F02M25/0854;;F02M33/02;;F02M25/0854,F02M33/02;;F02M25/08,123/519;;123/518,0,0,,,,INACTIVE
96,AU,A,AU 2001/075868 A,087-044-037-839-725,2002-01-21,2002,AU 2001/075868 A,2001-07-05,US 61331300 A;;US 0121294 W,2000-07-11,Backlight with structured sufaces,,3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANDFORD JR;;KRETMAN WADE D,,https://lens.org/087-044-037-839-725,Patent Application,no,0,0,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,G02B6/00;;F21V8/00;;F21Y103/00;;G02F1/13357,,0,0,,,,PENDING
97,WO,A1,WO 1996/027757 A1,003-733-556-862-210,1996-09-12,1996,US 9600796 W,1996-01-18,US 40005295 A,1995-03-03,LIGHT DIRECTING FILM HAVING VARIABLE HEIGHT STRUCTURED SURFACE AND LIGHT DIRECTING ARTICLE CONSTRUCTED THEREFROM,A light directing film (50) including a first surface and a second structured surface (52). The structured surface (52) includes a repeating pattern of prism zones including at least a first zone having a plurality of prism elements (56) with peaks disposed at a first distance from a reference plane and a second zone having a plurality of prism elements (54) with peaks disposed less than the first distance from a reference plane. The width of the first zone preferably measures less than about 300 microns.,MINNESOTA MINING & MFG,WORTMAN DAVID L;;COBB SANFORD JR;;GARDINER MARK E,,https://lens.org/003-733-556-862-210,Patent Application,yes,3,37,14,14,0,B29D11/00788;;F21V5/02;;F21V5/02;;F21V5/02;;G02B6/0053;;G02B6/0053;;G02B5/0221;;G02B5/0221;;G02B5/0231;;G02B5/0231;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;G02B6/0055;;G02B6/0055;;Y10S385/901;;Y10S385/901,F21V5/02;;F21V8/00;;G02B6/00,,0,0,,,,PATENTED
98,CA,C,CA 2212223 C,122-046-900-372-430,2007-03-20,2007,CA 2212223 A,1996-01-18,US 40005295 A;;US 9600796 W,1995-03-03,LIGHT DIRECTING FILM HAVING VARIABLE HEIGHT STRUCTURED SURFACE AND LIGHT DIRECTING ARTICLE CONSTRUCTED THEREFROM,A light directing film (50) including a first surface and a second structure d surface (52). The structured surface (52) includes a repeating pattern of prism zones including at least a first zone having a plurality of prism elements (56) with peaks disposed at a first distance from a reference plane and a second zone having a plurality of pris m elements (54) with peaks disposed less than the first distance from a reference plane. The width of the first zone preferably measures less than about 300 microns.,MINNESOTA MINING & MFG,GARDINER MARK E;;COBB SANFORD JR;;WORTMAN DAVID L,,https://lens.org/122-046-900-372-430,Granted Patent,no,0,0,14,14,0,B29D11/00788;;F21V5/02;;F21V5/02;;F21V5/02;;G02B6/0053;;G02B6/0053;;G02B5/0221;;G02B5/0221;;G02B5/0231;;G02B5/0231;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;G02B6/0055;;G02B6/0055;;Y10S385/901;;Y10S385/901,G02B5/00;;F21V5/02;;F21V8/00;;G02B6/00;;G02F1/1335,,0,0,,,,EXPIRED
99,AU,B8,AU 2001/275868 B8,192-482-267-556-524,2006-05-11,2006,AU 2001/275868 A,2001-07-05,US 61331300 A;;US 0121294 W,2000-07-11,Backlight with structured surfaces,,3M INNOVATIVE PROPERTIES CO,KRETMAN WADE D;;GARDINER MARK E;;COBB SANDFORD JR,,https://lens.org/192-482-267-556-524,Amended Patent,no,3,0,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,F21V8/00;;G02B6/00;;F21Y103/00;;G02F1/13357,,0,0,,,,EXPIRED
100,AU,B2,AU 694619 B2,012-903-088-738-31X,1998-07-23,1998,AU 1996/049008 A,1996-01-18,US 40005295 A;;US 9600796 W,1995-03-03,Light directing film having variable height structured surface and light directing article constructed therefrom,,MINNESOTA MINING & MFG,WORTMAN DAVID L;;COBB SANFORD JR;;GARDINER MARK E,,https://lens.org/012-903-088-738-31X,Granted Patent,no,3,0,14,14,0,B29D11/00788;;F21V5/02;;F21V5/02;;F21V5/02;;G02B6/0053;;G02B6/0053;;G02B5/0221;;G02B5/0221;;G02B5/0231;;G02B5/0231;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;G02B6/0055;;G02B6/0055;;Y10S385/901;;Y10S385/901,F21V5/02;;F21V8/00;;G02B6/00,,0,0,,,,EXPIRED
101,CN,A,CN 1221494 A,057-761-975-070-995,1999-06-30,1999,CN 97195360 A,1997-03-03,US 63107396 A,1996-04-12,Variable pitch structured optical film,,MINNESOTA MINING & MFG,COBB SANFORD JR;;GARDINER MARK E;;KOTCHICK KEITH M,,https://lens.org/057-761-975-070-995,Patent Application,no,0,2,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0231;;G02B5/00;;G02B5/00;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;Y10S385/901;;Y10S385/901;;Y10S428/913;;Y10S428/913;;Y10T428/24355;;Y10T428/24355;;Y10T428/24479;;Y10T428/24479;;Y10T428/24537;;Y10T428/24537;;Y10T428/2457;;Y10T428/2457;;Y10T428/24669;;Y10T428/24669,G02B5/00;;G02B5/02;;G02B5/04;;G02F1/1335,,0,0,,,,EXPIRED
102,US,A1,US 2006/0019930 A1,075-837-874-929-642,2006-01-26,2006,US 51412705 A,2005-07-06,GB 0211136 A;;GB 0302096 W,2002-05-15,Treatment and prevention of tissue damage,"An agent for use in medicine, which agent comprises a plurality of ligands covalently co-linked so as to form a complex with a plurality of C-reactive protein (CRP) molecules in the presence thereof, wherein (i) at least two of the ligands are the same or different and are capable of being bound by ligand binding sites present on the CRP molecules; or (ii) at least one of the ligands is capable of being bound by a ligand binding site present on a CRP molecule, and at least one other of the ligands is capable of being bound by a ligand binding site present on a serum amyloid P component (SAP) molecule.",PEPYS MARK B;;LEY STEVEN V;;COBB ALEXANDER J,PEPYS MARK B;;LEY STEVEN V;;COBB ALEXANDER J,PENTRAXIN THERAPEUTICS LIMITED (2007-06-22),https://lens.org/075-837-874-929-642,Patent Application,yes,1,9,17,17,0,A61K49/0004;;A61K47/544;;A61P1/04;;A61P1/18;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61K49/0004;;A61K47/544,A61K31/675;;A61K45/00;;A61K49/00;;A61P1/18;;A61P9/10;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00;;C07F9/547,514/91;;548/413,0,0,,,,EXPIRED
103,CA,A1,CA 2212223 A1,120-178-575-069-519,1996-09-12,1996,CA 2212223 A,1996-01-18,US 40005295 A;;US 9600796 W,1995-03-03,LIGHT DIRECTING FILM HAVING VARIABLE HEIGHT STRUCTURED SURFACE AND LIGHT DIRECTING ARTICLE CONSTRUCTED THEREFROM,A light directing film (50) including a first surface and a second structured surface (52). The structured surface (52) includes a repeating pattern of prism zones including at least a first zone having a plurality of prism elements (56) with peaks disposed at a first distance from a reference plane and a second zone having a plurality of prism elements (54) with peaks disposed less than the first distance from a reference plane. The width of the first zone preferably measures less than about 300 microns.,MINNESOTA MINING & MFG,COBB SANFORD JR;;GARDINER MARK E;;WORTMAN DAVID L,,https://lens.org/120-178-575-069-519,Patent Application,no,0,0,14,14,0,B29D11/00788;;F21V5/02;;F21V5/02;;F21V5/02;;G02B6/0053;;G02B6/0053;;G02B5/0221;;G02B5/0221;;G02B5/0231;;G02B5/0231;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;G02B6/0055;;G02B6/0055;;Y10S385/901;;Y10S385/901,F21V5/02;;F21V8/00;;G02B6/00,,0,0,,,,EXPIRED
104,US,A1,US 2014/0184371 A1,007-270-972-772-908,2014-07-03,2014,US 201213729124 A,2012-12-28,US 201213729124 A,2012-12-28,"INSULATING MATERIAL CONTAINING POLY(PHENYLENE-1,3,4-OXADIAZOLE)","A nonwoven web of poly(phenylene-1,3,4-oxadiazole) and polymetaphenylene isopthalamide. was found to have greater retention of tensile strength than kraft paper after immersion in oil at high temperature, making it useful as an insulation material for transformers.",DU PONT,HARMER MARK ANDREW;;WILLIAMS SHARLENE RENEE;;COBB MICHAEL W,,https://lens.org/007-270-972-772-908,Patent Application,yes,0,13,1,1,0,H01F27/32;;H01B3/307;;H01B3/303;;H01F27/12;;Y10T428/24149;;H01B3/303;;H01F27/12;;Y10T428/24149;;H01F27/32;;H01B3/307,H01F27/12;;H01B3/30,336/58;;162/157.2;;428/116,0,0,,,,DISCONTINUED
105,EP,A1,EP 0813667 A1,051-033-878-000-369,1997-12-29,1997,EP 96905180 A,1996-01-18,US 9600796 W;;US 40005295 A,1995-03-03,LIGHT DIRECTING FILM HAVING VARIABLE HEIGHT STRUCTURED SURFACE AND LIGHT DIRECTING ARTICLE CONSTRUCTED THEREFROM,,MINNESOTA MINING & MFG,WORTMAN DAVID L;;COBB SANFORD JR;;GARDINER MARK E,,https://lens.org/051-033-878-000-369,Patent Application,yes,0,0,14,14,0,B29D11/00788;;F21V5/02;;F21V5/02;;F21V5/02;;G02B6/0053;;G02B6/0053;;G02B5/0221;;G02B5/0221;;G02B5/0231;;G02B5/0231;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;G02B6/0055;;G02B6/0055;;Y10S385/901;;Y10S385/901,F21V5/02;;F21V8/00;;G02B6/00,,1,0,,,See references of WO 9627757A1,EXPIRED
106,US,S,US D0447780 S,134-635-530-838-395,2001-09-11,2001,US 10209899 F,1999-03-17,US 10209899 F,1999-03-17,Exercise treadmill,,PRECOR INC,ARNOLD PETER J;;WILLIAMS MARK;;CRIST DAVID;;COBB CURTIS,ILLINOIS TOOL WORKS INC (2000-07-14);;PRECOR INCORPORATED (2003-02-06),https://lens.org/134-635-530-838-395,Design Right,yes,14,13,1,1,0,,,D21/669;;2102,1,0,,,"Precor USA brochure: ""9.25/9.45 Cardiologic Treadmill"" (1995).",EXPIRED
107,AU,B2,AU 2001/275868 B2,197-001-293-585-961,2006-02-02,2006,AU 2001/275868 A,2001-07-05,US 61331300 A;;US 0121294 W,2000-07-11,Backlight with structured sufaces,,3M INNOVATIVE PROPERTIES CO,KRETMAN WADE D;;GARDINER MARK E;;COBB SANDFORD JR,,https://lens.org/197-001-293-585-961,Granted Patent,no,3,0,14,34,0,G02B6/0036;;G02F1/1335;;G02B6/0038;;G02B6/0061;;G02B6/0071,F21V8/00;;G02B6/00;;F21Y103/00;;G02F1/13357,,0,0,,,,EXPIRED
108,US,A,US 5771328 A,008-673-374-922-702,1998-06-23,1998,US 83213297 A,1997-04-03,US 83213297 A;;US 40005295 A,1995-03-03,Light directing film having variable height structured surface and light directing article constructed therefrom,A light directing film including a first surface and a second structured surface. The structured surface includes a repeating pattern of prism zones including at least a first zone having a plurality of prism elements with peaks disposed at a first distance from a reference plane and a second zone having a plurality of prism elements with peaks disposed less than the first distance from a reference plane. The width of the first zone preferably measures less than about 300 microns.,MINNESOTA MINING & MFG,WORTMAN DAVID L;;COBB JR SANFORD;;GARDINER MARK E,,https://lens.org/008-673-374-922-702,Granted Patent,yes,38,606,14,14,0,B29D11/00788;;F21V5/02;;F21V5/02;;F21V5/02;;G02B6/0053;;G02B6/0053;;G02B5/0221;;G02B5/0221;;G02B5/0231;;G02B5/0231;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;G02B6/0055;;G02B6/0055;;Y10S385/901;;Y10S385/901,F21V5/02;;F21V8/00;;G02B6/00,385/146;;385/36;;385/901;;359/834;;359/837;;349/62;;349/65,3,0,,,"Commercial literature, 3M Instruction Sheet No. 78 8063 2625 8, Instructions for Field Change for 3M IR Compatible Safelight Kit, IFC No.: 831/952 20, Jan. 1989, pp. 1 7.;;Commercial literature, entitled 3M IR Safelight, Medical Imaging Systems, Imaging Systems Group, 3M Health Care, St. Paul, MN 1991, pp. 1 2 no month.;;McCartney et al., Article entitled S7 7 Directional Diffuser Lens Array for Backlit LCDs , Honeywell Inc., presented at the Japan Display 92 Converence, pp. 259 262 no month.",EXPIRED
109,EP,B1,EP 0813667 B1,075-094-893-275-408,1999-05-26,1999,EP 96905180 A,1996-01-18,US 9600796 W;;US 40005295 A,1995-03-03,LIGHT DIRECTING FILM HAVING VARIABLE HEIGHT STRUCTURED SURFACE AND LIGHT DIRECTING ARTICLE CONSTRUCTED THEREFROM,,MINNESOTA MINING & MFG,WORTMAN DAVID L;;COBB SANFORD JR;;GARDINER MARK E,,https://lens.org/075-094-893-275-408,Granted Patent,yes,3,0,14,14,0,B29D11/00788;;F21V5/02;;F21V5/02;;F21V5/02;;G02B6/0053;;G02B6/0053;;G02B5/0221;;G02B5/0221;;G02B5/0231;;G02B5/0231;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;G02B6/0055;;G02B6/0055;;Y10S385/901;;Y10S385/901,F21V5/02;;F21V8/00;;G02B6/00,,0,0,,,,EXPIRED
110,AU,A,AU 1996/049008 A,090-655-753-241-522,1996-09-23,1996,AU 1996/049008 A,1996-01-18,US 40005295 A;;US 9600796 W,1995-03-03,Light directing film having variable height structured surface and light directing article constructed therefrom,,MINNESOTA MINING & MFG,WORTMAN DAVID L;;COBB SANFORD JR;;GARDINER MARK E,,https://lens.org/090-655-753-241-522,Patent Application,no,0,0,14,14,0,F21V5/02;;G02B5/0221;;G02B5/0231;;G02B5/0278;;G02B5/045;;G02B6/0053;;G02B6/0055;;Y10S385/901;;B29D11/00788;;F21V5/02;;G02B6/0053;;G02B5/0221;;G02B5/045;;G02B5/0278;;G02B5/0231;;F21V5/02;;G02B6/0055;;Y10S385/901,F21V5/02;;F21V8/00;;G02B6/00,,0,0,,,,EXPIRED
111,US,A1,US 2011/0082889 A1,071-260-347-005-764,2011-04-07,2011,US 86997210 A,2010-08-27,US 86997210 A;;US 24951309 P,2009-10-07,ONLINE DATABASE MODELING,"Aspects of the present invention relate to methods and system of implementing online database modeling. The method includes providing an database modeling diagram framework. The framework is in communication with an online database, and the online database provides access to live data. The method further includes providing online access to the online database for the database modeling diagram framework via an intermediary API, representing a database structure of the online database in a database model within an interface of the database modeling diagram framework, and populating the database model with live data from the online database. Further, the method includes displaying the database model with the live data from the online database within the database modeling diagram framework interface.",ORACLE INT CORP,MCARDLE LEON JAMES;;WARNER MARK PAUL HAMILTON;;COBB JOHN LAURENCE,ORACLE INTERNATIONAL CORPORATION (2010-08-24),https://lens.org/071-260-347-005-764,Patent Application,yes,5,9,2,2,0,G06F16/288;;G06F16/288,G06F17/30,707/792;;X707E17005,0,0,,,,ACTIVE
112,WO,A1,WO 2024/036065 A1,096-741-535-242-681,2024-02-15,2024,US 2023/0071444 W,2023-08-01,US 202263394341 P,2022-08-02,"ELECTROCHEMICAL CELLS AND ELECTROCHEMICAL CELL STACKS WITH SERIES CONNECTIONS, AND METHODS OF PRODUCING, OPERATING, AND MONITORING THE SAME","Embodiments described herein relate to electrochemical cells and multicells. A multicell can include a cell packaging that includes two or more electrochemical cells connected in series internal to the cell packaging. In some aspects, an apparatus includes a plurality of electrochemical cell stacks each including a plurality of electrochemical cells connected in series, a first electrically conductive plate including a first section and a second section, and a second electrically conductive plate. The first section of the first electrically conductive plate is in contact with a first terminal end of a first electrochemical cell stack from the plurality of electrochemical cell stacks. The second section of the first electrically conductive plate is in contact with a first terminal end of a second electrochemical cell stack from the plurality of electrochemical cell stacks.",24M TECH INC;;COBB KENNETH DOUGLAS,COBB KENNETH DOUGLAS;;HARTZOG CHAD ALAN;;YOUNG MARK;;CHEN JUNZHENG,,https://lens.org/096-741-535-242-681,Patent Application,yes,5,0,8,8,0,H02J7/342;;H02J7/35;;H02J7/0069;;H01M50/209;;H01M50/503;;H01M50/509;;H01M10/0481;;Y02E60/10;;Y02E60/50;;H01M4/625;;H01M4/626;;G01R31/392;;G01R31/3835;;H01M50/531;;H01M10/48;;H01M50/209;;H01M50/264;;H01M50/51;;H01M50/503;;H02S40/36;;H02S40/38;;H01M50/251;;H01M50/569;;H01M4/06;;H01M2220/10,H02J7/00;;H01M10/00;;H01M10/04;;H01M50/209;;H01M50/503;;H01M50/509;;H02J7/34;;H02J7/35,,0,0,,,,PENDING
113,EP,A1,EP 0925067 A1,181-416-605-533-575,1999-06-30,1999,EP 97941608 A,1997-09-16,US 9716294 W;;US 2619796 P,1996-09-16,COMPOSITION AND METHOD FOR REPAIRING NEUROLOGICAL TISSUE,,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,PURDUE RESEARCH FOUNDATION (2003-08-13),https://lens.org/181-416-605-533-575,Patent Application,yes,0,0,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61P25/00;;A61P43/00;;C12N5/071,,0,0,,,,EXPIRED
114,EP,A1,EP 1503800 A1,100-239-291-279-507,2005-02-09,2005,EP 03727670 A,2003-05-14,GB 0302096 W;;GB 0211136 A,2002-05-15,TREATMENT AND PREVENTION OF TISSUE DAMAGE ASSOCIATED WITH INCREASED C-REACTIVE PROTEIN PRODUCTION,,PENTRAXIN THERAPEUTICS LTD,PEPYS MARK B;;LEY STEVEN VICTOR;;COBB ALEXANDER JOHN ANDRE,PENTRAXIN THERAPEUTICS LIMITED (2011-11-15),https://lens.org/100-239-291-279-507,Patent Application,yes,0,0,17,17,0,A61K49/0004;;A61K47/544;;A61P1/04;;A61P1/18;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61K49/0004;;A61K47/544,A61K31/688;;A61K45/00;;A61K31/663;;A61K31/675;;A61K47/48;;A61K49/00;;A61P1/18;;A61P7/02;;A61P9/10;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00,,0,0,,,,EXPIRED
115,AU,A1,AU 2003/234000 A1,126-179-029-766-133,2003-12-02,2003,AU 2003/234000 A,2003-05-14,GB 0211136 A;;GB 0302096 W,2002-05-15,TREATMENT AND PREVENTION OF TISSUE DAMAGE,,UNIV LONDON,PEPYS MARK B;;LEY STEVEN VICTOR;;COBB ALEXANDER JOHN ANDRE,,https://lens.org/126-179-029-766-133,Patent Application,no,0,0,17,17,0,A61K49/0004;;A61K47/544;;A61P1/04;;A61P1/18;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61K49/0004;;A61K47/544,A61K45/00;;A61K31/675;;A61K49/00;;A61P1/18;;A61P9/10;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00,,0,0,,,,EXPIRED
116,CA,A1,CA 2485852 A1,154-464-823-499-130,2003-11-27,2003,CA 2485852 A,2003-05-14,GB 0211136 A;;GB 0302096 W,2002-05-15,TREATMENT AND PREVENTION OF TISSUE DAMAGE,"An agent for use in medicine, which agent comprises a plurality of ligands covalently co-linked so as to form a complex with a plurality of C-reactive protein (CRP) molecules in the presence thereof, wherein (i) at least two of the ligands are the same or different and are capable of being bound by liga nd binding sites present on the CRP molecules; or (ii) at least one of the ligands is capable of being bound by a ligand binding site present on a CRP molecule, and at least one other of the ligands is capable of being bound by a ligand binding site present on a serum amyloid P component (SAP) molecule.</ SDOAB>",UNIV LONDON,COBB ALEXANDER JOHN ANDRE;;LEY STEVEN VICTOR;;PEPYS MARK B,,https://lens.org/154-464-823-499-130,Patent Application,no,0,0,17,17,0,A61K49/0004;;A61K47/544;;A61P1/04;;A61P1/18;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61K49/0004;;A61K47/544,A61K45/00;;A61K31/675;;A61K49/00;;A61P1/18;;A61P9/10;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00,,0,0,,,,EXPIRED
117,ES,T3,ES 2213835 T3,189-617-239-301-45X,2004-09-01,2004,ES 97941608 T,1997-09-16,US 2619796 P,1996-09-16,INJERTO DE TEJIDOS INTESTINALES SUBMUCOSALES PARA LA REPARACION DE TEJIDOS NEUROLOGICOS.,LA INVENCION SE REFIERE A CONSTRUCCIONES DE INJERTOS DE TEJIDO UTILES PARA ESTIMULAR EL CRECIMIENTO Y LA CICATRIZACION DE ESTRUCTURAS DE TEJIDO DE TIPO NEUROLOGICO DETERIORADAS O ENFERMAS. MAS PARTICULARMENTE LA INVENCION SE DIRIGE A UNA CONSTRUCCION DE INJERTO DE TEJIDO DE SUBMUCOSA Y A UN PROCEDIMIENTO PARA INDUCIR LA FORMACION DE ESTRUCTURAS NEUROLOGICAS ENDOGENAS EN UNA ZONA CON NECESIDAD DE TEJIDO NEUROLOGICO ENDOGENO.,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,,https://lens.org/189-617-239-301-45X,Granted Patent,no,0,0,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61P25/00;;A61P43/00;;C12N5/071,,0,0,,,,EXPIRED
118,WO,A1,WO 1998/010775 A1,156-381-228-089-224,1998-03-19,1998,US 9716294 W,1997-09-16,US 2619796 P,1996-09-16,COMPOSITION AND METHOD FOR REPAIRING NEUROLOGICAL TISSUE,The present invention relates to tissue graft constructs useful in promoting regrowth and healing of damaged or diseased neurological related tissue structures. More particularly this invention is directed to a submucosa tissue graft construct and a method of inducing the formation of endogenous neurological structures at a site in need of endogenous neurological related tissue growth.,PURDUE RESEARCH FOUNDATION;;COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,,https://lens.org/156-381-228-089-224,Patent Application,yes,3,10,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61P25/00;;A61P43/00;;C12N5/071,,1,0,,,See also references of EP 0925067A4,PATENTED
119,DE,D1,DE 69739928 D1,189-987-778-665-015,2010-08-19,2010,DE 69739928 T,1997-09-16,US 2619796 P,1996-09-16,Gewebetransplantat aus der Magensubmukosa zur Reparatur neurologischen Gewebes,,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,,https://lens.org/189-987-778-665-015,Granted Patent,no,0,0,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K35/37;;A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61L27/36;;A61P25/00;;A61P43/00;;C12N5/071,,0,0,,,,EXPIRED
120,EP,A1,EP 1430899 A1,012-234-631-921-285,2004-06-23,2004,EP 04002373 A,1997-09-16,EP 97941608 A;;US 2619796 P,1996-09-16,Graft from submucosal intestinal tissue for repairing neurological tissue,The present invention relates to tissue graft constructs useful in promoting regrowth and healing of damaged or diseased neurological related tissue structures. More particularly this invention is directed to a submucosa tissue graft construct and a method of inducing the formation of endogenous neurological structures at a site in need of endogenous neurological related tissue growth.,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,,https://lens.org/012-234-631-921-285,Patent Application,yes,3,0,2,18,0,A61K35/38;;A61K38/1825;;A61K38/185;;C12N5/0679;;C12N2501/115;;C12N2501/13,A61K35/38;;A61K38/18;;C12N5/071,,2,2,047-730-013-110-103;;034-953-878-731-749,10.1073/pnas.92.10.4621;;pmc41996;;7753852;;10.1016/s0022-5347(17)36555-2;;1613871,"TUSZYNSKI ET AL.: ""Bridging grafts and transient nerve growth factor infucsions promote long-term central nervous system neuronal rescue and partial functional recovery."", PROC. NAT. ACAD. SCI. USA, vol. 92, 1995, pages 4621 - 4625, XP000942165;;BALL R A ET AL: ""Entubulization repair of severed cavernous nerves in the rat resulting in return of erectile function."", JOURNAL OF UROLOGY, (1992 JUL) 148 (1) 211-5., XP000986367",EXPIRED
121,CA,A1,CA 2263898 A1,016-754-270-842-622,1998-03-19,1998,CA 2263898 A,1997-09-16,US 2619796 P;;US 9716294 W,1996-09-16,COMPOSITION AND METHOD FOR REPAIRING NEUROLOGICAL TISSUE,The present invention relates to tissue graft constructs useful in promoting regrowth and healing of damaged or diseased neurological related tissue structures. More particularly this invention is directed to a submucosa tissue graft construct and a method of inducing the formation of endogenous neurological structures at a site in need of endogenous neurological related tissue growth.,PURDUE RESEARCH FOUNDATION,BADYLAK STEPHEN F;;ISOM GARY;;COBB MARK A;;SHARMA ARCHANA,,https://lens.org/016-754-270-842-622,Patent Application,no,0,0,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61P25/00;;A61P43/00;;C12N5/071,,0,0,,,,EXPIRED
122,AU,A,AU 1997/043485 A,196-193-020-462-328,1998-04-02,1998,AU 1997/043485 A,1997-09-16,US 2619796 P;;US 9716294 W,1996-09-16,Composition and method for repairing neurological tissue,,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,,https://lens.org/196-193-020-462-328,Patent Application,no,0,0,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61P25/00;;A61P43/00;;C12N5/071,,0,0,,,,EXPIRED
123,DK,T3,DK 0925067 T3,075-786-083-609-995,2004-05-03,2004,DK 97941608 T,1997-09-16,US 2619796 P,1996-09-16,Graft fra submucosavæv til reparation af neurologisk væv,,PURDUE RESEARCH FOUNDATION,BADYLAK STEPHEN F;;COBB MARK A;;ISOM GARY;;SHARMA ARCHANA,,https://lens.org/075-786-083-609-995,Granted Patent,no,0,0,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61P25/00;;A61P43/00;;C12N5/071,,0,0,,,,EXPIRED
124,US,A1,US 2024/0047832 A1,100-465-595-983-355,2024-02-08,2024,US 202318228921 A,2023-08-01,US 202318228921 A;;US 202263394341 P,2022-08-02,"ELECTROCHEMICAL CELLS AND ELECTROCHEMICAL CELL STACKS WITH SERIES CONNECTIONS, AND METHODS OF PRODUCING, OPERATING, AND MONITORING THE SAME","Embodiments described herein relate to electrochemical cells and multicells. A multicell can include a cell packaging that includes two or more electrochemical cells connected in series internal to the cell packaging. In some aspects, an apparatus includes a plurality of electrochemical cell stacks each including a plurality of electrochemical cells connected in series, a first electrically conductive plate including a first section and a second section, and a second electrically conductive plate. The first section of the first electrically conductive plate is in contact with a first terminal end of a first electrochemical cell stack from the plurality of electrochemical cell stacks. The second section of the first electrically conductive plate is in contact with a first terminal end of a second electrochemical cell stack from the plurality of electrochemical cell stacks.",24M TECH INC,HARTZOG CHAD ALAN;;YOUNG MARK;;COBB KENNETH DOUGLAS;;CHEN JUNZHENG,24M TECHNOLOGIES INC (2023-08-30),https://lens.org/100-465-595-983-355,Patent Application,yes,0,0,8,8,0,H02J7/342;;H02J7/35;;H02J7/0069;;H01M50/209;;H01M50/503;;H01M50/509;;H01M10/0481;;Y02E60/10;;Y02E60/50;;H01M4/625;;H01M4/626;;G01R31/392;;G01R31/3835;;H01M50/531;;H01M10/48;;H01M50/209;;H01M50/264;;H01M50/51;;H01M50/503;;H02S40/36;;H02S40/38;;H01M50/251;;H01M50/569;;H01M4/06;;H01M2220/10,H01M50/503;;H01M50/209;;H01M50/264;;H01M50/51,,0,0,,,,PENDING
125,US,B1,US 6241981 B1,088-843-333-822-984,2001-06-05,2001,US 24262899 A,1999-02-19,US 24262899 A;;US 2619796 P;;US 9716294 W,1996-09-16,Composition and method for repairing neurological tissue,The present invention relates to tissue graft constructs useful in promoting regrowth and healing of damaged or diseased nuerological related tissue structures. More particularly this invention is directed to a submucosa tissue graft construct and a method of inducing the formation of endogenous neurological structures at a site in need of endogenous neurological related tissue growth.,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,PURDUE RESEARCH FOUNDATION (1997-10-05);;CLARIAN HEALTH PARTNERS INC (2002-07-15),https://lens.org/088-843-333-822-984,Granted Patent,yes,6,90,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61P25/00;;A61P43/00;;C12N5/071,424/93.1;;435/335,0,0,,,,EXPIRED
126,EP,A4,EP 0925067 A4,120-640-627-743-489,2001-05-30,2001,EP 97941608 A,1997-09-16,US 9716294 W;;US 2619796 P,1996-09-16,COMPOSITION AND METHOD FOR REPAIRING NEUROLOGICAL TISSUE,,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,PURDUE RESEARCH FOUNDATION (2003-08-13),https://lens.org/120-640-627-743-489,Search Report,no,1,0,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61P25/00;;A61P43/00;;C12N5/071,,3,2,047-730-013-110-103;;034-953-878-731-749,10.1073/pnas.92.10.4621;;pmc41996;;7753852;;10.1016/s0022-5347(17)36555-2;;1613871,"TUSZYNSKI ET AL.: ""Bridging grafts and transient nerve growth factor infucsions promote long-term central nervous system neuronal rescue and partial functional recovery."", PROC. NAT. ACAD. SCI. USA, vol. 92, 1995, pages 4621 - 4625, XP000942165;;BALL R A ET AL: ""Entubulization repair of severed cavernous nerves in the rat resulting in return of erectile function."", JOURNAL OF UROLOGY, (1992 JUL) 148 (1) 211-5., XP000986367;;See also references of WO 9810775A1",EXPIRED
127,US,B2,US 8326902 B2,104-234-470-653-552,2012-12-04,2012,US 86997210 A,2010-08-27,US 86997210 A;;US 24951309 P,2009-10-07,Online database modeling,"Aspects of the present invention relate to methods and system of implementing online database modeling. The method includes providing an database modeling diagram framework. The framework is in communication with an online database, and the online database provides access to live data. The method further includes providing online access to the online database for the database modeling diagram framework via an intermediary API, representing a database structure of the online database in a database model within an interface of the database modeling diagram framework, and populating the database model with live data from the online database. Further, the method includes displaying the database model with the live data from the online database within the database modeling diagram framework interface.",MCARDLE LEON JAMES;;WARNER MARK PAUL HAMILTON;;COBB JOHN LAURENCE;;ORACLE INT CORP,MCARDLE LEON JAMES;;WARNER MARK PAUL HAMILTON;;COBB JOHN LAURENCE,ORACLE INTERNATIONAL CORPORATION (2010-08-24),https://lens.org/104-234-470-653-552,Granted Patent,yes,5,4,2,2,0,G06F16/288;;G06F16/288,G06F17/30,707/972;;707/679;;707/802,0,0,,,,ACTIVE
128,AU,B2,AU 731768 B2,012-166-567-767-444,2001-04-05,2001,AU 1997/043485 A,1997-09-16,US 2619796 P;;US 9716294 W,1996-09-16,Composition and method for repairing neurological tissue,,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,,https://lens.org/012-166-567-767-444,Granted Patent,no,2,0,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61P25/00;;A61P43/00;;C12N5/071,,0,0,,,,EXPIRED
129,CA,C,CA 2263898 C,152-247-467-770-452,2009-12-08,2009,CA 2263898 A,1997-09-16,US 2619796 P;;US 9716294 W,1996-09-16,COMPOSITION AND METHOD FOR REPAIRING NEUROLOGICAL TISSUE,The present invention relates to tissue graft constructs useful in promoting regrowth and healing of damaged or diseased neurological related tissue structures. More particularly this invention is directed to a submucosa tissue graft construct and a method of inducing the formation of endogenous neurological structures at a site in need of endogenous neurological related tissue growth.,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,,https://lens.org/152-247-467-770-452,Granted Patent,no,0,0,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/18;;A61K38/22;;A61K35/12;;A61K35/38;;A61L27/38;;A61P25/00;;A61P43/00;;C12N5/071,,0,0,,,,EXPIRED
130,AU,B2,AU 2003/234000 B2,042-974-284-005-371,2008-06-05,2008,AU 2003/234000 A,2003-05-14,GB 0211136 A;;GB 0302096 W,2002-05-15,Treatment and prevention of tissue damage,,PENTRAXIN THERAPEUTICS LTD,COBB ALEXANDER JOHN ANDRE;;PEPYS MARK B;;LEY STEVEN VICTOR,,https://lens.org/042-974-284-005-371,Granted Patent,no,0,0,17,17,0,A61K49/0004;;A61K47/544;;A61P1/04;;A61P1/18;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61K49/0004;;A61K47/544,A61K45/00;;A61K31/675;;A61K49/00;;A61P1/18;;A61P9/10;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00,,0,0,,,,EXPIRED
131,EP,B1,EP 1430899 B1,000-389-216-539-901,2010-07-07,2010,EP 04002373 A,1997-09-16,EP 97941608 A;;US 2619796 P,1996-09-16,Graft from submucosal intestinal tissue for repairing neurological tissue,,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,,https://lens.org/000-389-216-539-901,Granted Patent,yes,3,0,2,18,0,A61K35/38;;A61K38/1825;;A61K38/185;;C12N5/0679;;C12N2501/115;;C12N2501/13,A61K35/37;;A61K35/38;;A61K38/18;;A61L27/36;;C12N5/071,,2,0,,,"TUSZYNSKI ET AL.: ""Bridging grafts and transient nerve growth factor infucsions promote long-term central nervous system neuronal rescue and partial functional recovery."" PROC. NAT. ACAD. SCI. USA, vol. 92, 1995, pages 4621-4625, XP000942165;;BALL R A ET AL: ""Entubulization repair of severed cavernous nerves in the rat resulting in return of erectile function."" JOURNAL OF UROLOGY, (1992 JUL) 148 (1) 211-5., XP000986367",EXPIRED
132,WO,A1,WO 2003/097104 A1,029-152-667-428-677,2003-11-27,2003,GB 0302096 W,2003-05-14,GB 0211136 A,2002-05-15,TREATMENT AND PREVENTION OF TISSUE DAMAGE,"An agent for use in medicine, which agent comprises a plurality of ligands covalently co-linked so as to form a complex with a plurality of C-reactive protein (CRP) molecules in the presence thereof, wherein (i) at least two of the ligands are the same or different and are capable of being bound by ligand binding sites present on the CRP molecules; or (ii) at least one of the ligands is capable of being bound by a ligand binding site present on a CRP molecule, and at least one other of the ligands is capable of being bound by a ligand binding site present on a serum amyloid P component (SAP) molecule.",UNIV LONDON;;PEPYS MARK B;;LEY STEVEN VICTOR;;COBB ALEXANDER JOHN ANDRE,PEPYS MARK B;;LEY STEVEN VICTOR;;COBB ALEXANDER JOHN ANDRE,,https://lens.org/029-152-667-428-677,Patent Application,yes,1,0,17,17,0,A61K49/0004;;A61K47/544;;A61P1/04;;A61P1/18;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/00;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61K49/0004;;A61K47/544,A61K45/00;;A61K31/675;;A61K49/00;;A61P1/18;;A61P9/10;;A61P13/12;;A61P17/00;;A61P17/02;;A61P19/02;;A61P21/00;;A61P29/00;;A61P31/00;;A61P31/04;;A61P31/12;;A61P33/00;;A61P35/00;;A61P37/08;;A61P39/00;;A61P43/00,,4,4,005-114-381-600-322;;018-550-865-882-269;;004-054-731-115-338;;035-291-840-076-730,10.1038/417254a;;12015594;;7979374;;10.1006/abbi.1994.1451;;7880233;;10.1056/nejm199408183310701;;10.1042/cs104065pb,"PEPYS M B ET AL: ""Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis"", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 417, no. 6886, 2002, pages 254 - 259, XP002219442, ISSN: 0028-0836;;CHRISTNER R B ET AL: ""Binding of human serum amyloid P-component to phosphocholine."", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 1 NOV 1994, vol. 314, no. 2, 1 November 1994 (1994-11-01), pages 337 - 343, XP002255627, ISSN: 0003-9861;;LIUZZO G ET AL: ""The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina."", THE NEW ENGLAND JOURNAL OF MEDICINE. 18 AUG 1994, vol. 331, no. 7, 18 August 1994 (1994-08-18), pages 417 - 424, XP008022408, ISSN: 0028-4793;;HIRSCHFIELD G M ET AL: ""Therapeutic inhibition of C-reactive protein - novel drugs, novel mechanisms."", CLINICAL SCIENCE (LONDON), vol. 104, no. SUPPLEMENT 49, 2003, & SPRING MEETING OF THE MEDICAL RESEARCH SOCIETY; LONDON, UK; FEBRUARY 05, 2003, pages 65P - 66P, XP008022417, ISSN: 0143-5221",PENDING
133,EP,B1,EP 0925067 B1,147-293-189-686-205,2004-02-04,2004,EP 97941608 A,1997-09-16,US 9716294 W;;US 2619796 P,1996-09-16,GRAFT FROM SUBMUCOSAL INTESTINAL TISSUE FOR REPAIRING NEUROLOGICAL TISSUE,,PURDUE RESEARCH FOUNDATION,COBB MARK A;;BADYLAK STEPHEN F;;ISOM GARY;;SHARMA ARCHANA,PURDUE RESEARCH FOUNDATION (2003-08-13),https://lens.org/147-293-189-686-205,Granted Patent,yes,4,0,16,18,0,A61K35/38;;A61K35/38;;A61K35/12;;A61K35/12;;A61K38/1825;;A61K38/1825;;A61K38/185;;A61K38/185;;A61P25/00;;A61P43/00;;C12N5/0679;;C12N5/0679;;C12N2501/115;;C12N2501/115;;C12N2501/13;;C12N2501/13,A61K38/22;;A61K35/12;;A61K35/38;;A61K38/18;;A61P25/00;;A61P43/00;;C12N5/071,,2,0,,,"TUSZYNSKI ET AL.: ""Bridging grafts and transient nerve growth factor infucsions promote long-term central nervous system neuronal rescue and partial functional recovery."" PROC. NAT. ACAD. SCI. USA, vol. 92, 1995, pages 4621-4625, XP000942165;;BALL R A ET AL: ""Entubulization repair of severed cavernous nerves in the rat resulting in return of erectile function."" JOURNAL OF UROLOGY, (1992 JUL) 148 (1) 211-5. , XP000986367",EXPIRED
134,WO,A1,WO 1997/046544 A1,148-144-394-968-866,1997-12-11,1997,EP 9702776 W,1997-05-26,EP 96201543 A,1996-06-03,ACID CATALYSED PROCESS FOR PREPARING 2-MERCAPTOBENZOTHIAZOLE AND DERIVATIVES THEREOF,"A process for preparing 2-mercaptobenzothiazole or a benzo-ring-substituted 2-mercaptobenzothiazole is provided wherein (i) a substrate selected from aniline, a ring-substituted aniline, an appropriate precursor, an appropriate derivative thereof, or mixtures thereof, (ii) carbon disulphide and (iii) sulphur, are reacted under conventional conditions in the presence of a catalyst, the catalyst being an acid, acidic substance or acid-forming substance selected from the group comprising a carboxylic acid, an inorganic or organic acid, an anhydride or mixed anhydride of these acids, a Lewis-acid or a Lewis-acid in the presence of a co-catalyst, a solid acidic inorganic material, a hydroxy-aryl derivative and one or more halogens, or any mixture thereof.",AKZO NOBEL NV;;COBB ALEC;;PEEMANS RUDI;;COENEGRACHTS PIERRE;;ISAACS NEIL S;;HILTON MARK J;;COULSON MARK,COBB ALEC;;PEEMANS RUDI;;COENEGRACHTS PIERRE;;ISAACS NEIL S;;HILTON MARK J;;COULSON MARK,,https://lens.org/148-144-394-968-866,Patent Application,yes,5,6,1,1,0,C07D277/72,C07D277/72,,0,0,,,,DISCONTINUED
135,US,A1,US 2005/0001043 A1,082-245-395-540-167,2005-01-06,2005,US 91042804 A,2004-08-03,US 91042804 A;;US 41547199 A,1999-10-08,Optical elements having programmed optical structures,"An optical element, such as a lightguide or an optical film, is formed with a predetermined, programmed pattern of optical structures. The optical structures may be arranged to selectively correct for non-uniformities in the output a lightguide, or may be arranged to otherwise enhance the performance of a display.",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/082-245-395-540-167,Patent Application,yes,94,16,15,34,0,G02B6/0038;;G02B6/0038;;G02F1/1335;;G02B6/0051;;G02B6/0051;;G02B6/0053;;G02B6/0053;;G02F1/133615;;G02F1/133615;;Y10S385/901;;Y10S385/901,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/08;;G02F1/13357,235/494,0,0,,,,EXPIRED
136,US,B2,US 6845212 B2,001-178-666-596-774,2005-01-18,2005,US 41547199 A,1999-10-08,US 41547199 A,1999-10-08,Optical element having programmed optical structures,"An optical element, such as a lightguide or an optical film, is formed with a predetermined, programmed pattern of optical structures. The optical structures may be arranged to selectively correct for non-uniformities in the output a lightguide, or may be arranged to otherwise enhance the performance of a display.",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY (1999-12-22),https://lens.org/001-178-666-596-774,Granted Patent,yes,108,142,15,34,0,G02B6/0038;;G02B6/0038;;G02F1/1335;;G02B6/0051;;G02B6/0051;;G02B6/0053;;G02B6/0053;;G02F1/133615;;G02F1/133615;;Y10S385/901;;Y10S385/901,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/08;;G02F1/13357,385/146;;385/901;;385/33;;359/619;;362/31,6,0,,,"IBM Technical Disclosure Bulletin, vol. 29, No. 11, Backlighting for Liquid Crystal Display, Apr. 1987.;;IBM Technical Disclosure Bulletin, vol. 31, No. 2, Flat Panel Backlight Reflecting Device, Jul. 1988.;;IBM Technical Disclosure Bulletin, vol. 33, No. 1B, Polarized Backlight for Liquid Crystal Display, Jun. 1990.;;IBM Technical Disclosure Bulletin, vol. 33, No. 9, High Efficiency Back Light for LCD, Feb. 1991.;;JP 096031217A, Machine Translation, ISTA's Paterra(tm), 20 pages.;;JP 2000089009A, Machine Translation, ISTA's Paterra(tm), 20 pages.",EXPIRED
137,WO,A1,WO 2013/109615 A1,073-490-100-182-386,2013-07-25,2013,US 2013/0021720 W,2013-01-16,US 201261587922 P,2012-01-18,RELEASABLE MOORING SYSTEMS AND METHODS FOR DRILLING VESSELS,"Disclosed herein are mooring systems and methods for drilling vessels, e.g., for mooring of exploratory drilling vessels in arctic ocean waters. The disclosed systems and methods may be implemented in one exemplary embodiment to provide for both a quick disconnect of the mooring system when danger approaches and relatively easy re-connect when the vessel returns to the well site. This may be achieved by connecting the mooring system using dockable buoys in lieu of directly connecting the mooring lines to the vessel. The dockable buoys may be designed for both easy disconnect and easy re-connect to the drilling vessel via receptacles either integral with the hull, e.g., in the case of a drillship, or external to the hull, e.g., in the case of a MODU.",INTERMOOR INC;;VESELIS TODD B;;COBB DAVID E;;FULTON THOMAS M;;WILLIAMSON MARK,VESELIS TODD B;;COBB DAVID E;;FULTON THOMAS M;;WILLIAMSON MARK,,https://lens.org/073-490-100-182-386,Patent Application,yes,4,1,3,3,0,B63B22/02;;B63B22/02;;B63B35/4413;;B63B35/4413;;B63B2022/028;;B63B2022/028;;B63B2241/10;;B63B2241/10,E21B7/132,,0,0,,,,PENDING
138,US,A1,US 2003/0103760 A1,112-093-468-591-632,2003-06-05,2003,US 41547199 A,1999-10-08,US 41547199 A,1999-10-08,OPTICAL ELEMENT HAVING PROGRAMMED OPTICAL STRUCTURES,"
   An optical element, such as a lightguide or an optical film, is formed with a predetermined, programmed pattern of optical structures. The optical structures may be arranged to selectively correct for non-uniformities in the output a lightguide, or may be arranged to otherwise enhance the performance of a display. 
",GARDINER MARK E.;;COBB SANFORD;;EPSTEIN KENNETH A.;;KRETMAN WADE D.,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY (1999-12-22),https://lens.org/112-093-468-591-632,Patent Application,yes,6,20,15,34,0,G02B6/0038;;G02B6/0038;;G02F1/1335;;G02B6/0051;;G02B6/0051;;G02B6/0053;;G02B6/0053;;G02F1/133615;;G02F1/133615;;Y10S385/901;;Y10S385/901,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/08;;G02F1/13357,385/146,0,0,,,,EXPIRED
139,US,A1,US 2008/0156350 A1,030-381-452-703-744,2008-07-03,2008,US 91201006 A,2006-04-20,EP 05008726 A;;GB 2006001439 W,2005-04-21,Device and Method,"A device for treating a surface to give a cleaning benefit comprises a container ( 302 ) containing a cleaning liquid. The liquid can be delivered to an outlet zone ( 306 ). By virtue of the outlet zone and a separate defining means ( 322 ) which may be provided the cleaning liquid is accurately discharged onto the desired area of the surface. Suitably the cleaning liquid forms a gel patch, which can be peeled away, to remove a stain.",RECKITT BENCKISER UK LTD,BARLOW LOUISE MARGARET;;COBB VICTORIA H;;ILIFFE COREEN;;LAW JONATHAN MARK,RECKITT BENCKISER (UK) LIMITED (2007-10-02),https://lens.org/030-381-452-703-744,Patent Application,yes,8,3,7,7,0,A47L13/26;;A47L25/08;;C11D17/041;;D06L1/00;;D06L4/10;;D06L4/00;;D06L1/00;;A47L13/26;;A47L25/08;;C11D17/041;;D06L4/00;;D06L4/10,D06B1/08;;B08B3/04;;B08B7/00;;D06L1/00;;D06L4/00;;D06L4/10,134/4;;134/95.1;;8/148,0,0,,,,DISCONTINUED
140,US,B2,US 7221847 B2,058-185-239-437-182,2007-05-22,2007,US 91042804 A,2004-08-03,US 91042804 A;;US 41547199 A,1999-10-08,Optical elements having programmed optical structures,"An optical element, such as a lightguide or an optical film, is formed with a predetermined, programmed pattern of optical structures. The optical structures may be arranged to selectively correct for non-uniformities in the output a lightguide, or may be arranged to otherwise enhance the performance of a display.",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/058-185-239-437-182,Granted Patent,yes,102,20,15,34,0,G02B6/0038;;G02B6/0038;;G02F1/1335;;G02B6/0051;;G02B6/0051;;G02B6/0053;;G02B6/0053;;G02F1/133615;;G02F1/133615;;Y10S385/901;;Y10S385/901,G02B5/02;;G02B6/10;;F21V8/00;;F21Y103/00;;G02B5/08;;G02B27/10;;G02F1/13357,385/146;;385/33;;385/901;;359/619;;362/31,9,0,,,"IBM Technical Disclosure Bulletin, vol. 29, No. 11, Backlighting for Liquid Crystal Display, Apr. 1987.;;IBM Technical Disclosure Bulletin, vol. 31, No. 2, Flat Panel Backlight Reflecting Device, Jul. 1988.;;IBM Technical Disclosure Bulletin, vol. 33, No. 1B, Polarized Backlight for Liquid Crystal Display, Jun. 1990.;;IBM Technical Disclosure Bulletin, vol. 33, No. 9, High Efficiency Back Light for LCD, Feb. 1991.;;JP 096031217, Machine Transcription, ISTA's Paterra(TM), 20 pages.;;JP 2000089009, Machine Transcription, ISTA's Paterra(TM), 20 pages.;;IBM Technical Disclosure Bulletin, vol. 33, No. 1B, Polarized Backlight for Liquid Crystal Display, Jun. 1990.;;JP 096031217, Machine Transcription, ISTA's Paterra(TM), 20 pages, Feb. 2, 1996.;;JP 2000089009, Machine Transcription, ISTA's Paterra(TM), 20 pages, Mar. 31, 2000.",EXPIRED
141,US,B2,US 6707611 B2,017-225-334-497-753,2004-03-16,2004,US 35388803 A,2003-01-29,US 35388803 A;;US 4787202 A;;US 41587399 A,1999-10-08,Optical film with variable angle prisms,"
    An optical turning film has a first surface including an array of prisms. The array has a plurality of first prisms, with each of the first prisms having a first prism configuration, and a plurality of second prisms, with each of the second prisms having a second prism configuration different from the first prism configuration. The optical film also has a second surface opposing the first surface, and light rays incident to the first surface are directed by the plurality of first prism and the plurality of second prisms along a direction substantially parallel to a viewing axis. 
",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY (1999-12-22),https://lens.org/017-225-334-497-753,Granted Patent,yes,106,110,13,13,0,G02B6/0031;;G02B6/0046;;G02B6/005;;G02B6/0053;;G02B6/0068;;G02B6/0071;;G02B5/04;;G02B6/0053;;G02B6/0071;;G02B6/0031;;G02B6/0046;;G02B6/0068;;G02B6/005,F21V8/00;;G02F1/13357;;G02B5/04,359/619;;359/627;;359/628,6,0,,,"IBM Technical Disclosure Bulletin, vol. 29, No. 11, Backlighting for Liquid Crystal Display, Apr. 1987.;;IBM Technical Disclosure Bulletin, vol. 31, No. 2, Flat Panel Backlight Reflecting Device, Jul. 1988.;;IBM Technical Disclosure Bulletin, vol. 33, No. 1B, Polarized Backlight for Liquid Crystal Display, Jun. 1990.;;IBM Technical Disclosure Bulletin, vol. 33, No. 9, High Efficiency Back Light for LCD, Feb. 1991.;;Patent Abstracts of Japan, vol. 007, No. 090 (P-191). Apr. 14, 1983 & JP 58 017402 A (Kunishiro Kanagata Kogto KK), Feb. 1, 1983.;;Patent Abstracts of Japan, vol. 1997, No. 03, Mar. 31, 1997 & JP 08 313710 A (Mitsubishi Rayon Co Ltd), Nov. 29, 1996.",EXPIRED
142,US,A1,US 2009/0038082 A1,122-680-303-951-993,2009-02-12,2009,US 91144306 A,2006-04-20,EP 05008725 A;;GB 2006001444 W,2005-04-21,Device and Method for Applying a Treatment Agent to a Surface,"A device for treating a surface to give a cleaning benefit comprises one or more containers ( 402 ) containing cleaning liquid. When the actuator ( 416 ) is depressed cleaning liquid is delivered to an outlet zone ( 406 ) located over a stain, where it forms a gel patch. Continued depression of the actuator means causes a piston 436 to press the gel patch against the surface, caused improved absorption of the stain, into the patch. The gel patch can then be peeled away, to remove the stain.",RECKITT BENCKISER UK LTD,BARLOW LOUISE MARGARET;;COBB VICTORIA H;;ILIFFE COREEN;;LAW JONATHAN MARK,RECKITT BENCKISER (UK) LIMITED (2007-10-02),https://lens.org/122-680-303-951-993,Patent Application,yes,41,2,7,7,0,B08B1/00;;B08B3/04;;B08B3/10;;D06L1/00;;D06L4/10;;D06L4/00;;B08B3/04;;D06L1/00;;B08B3/10;;B08B1/00;;D06L4/10;;D06L4/00,D06F5/00,8/137;;68/213,0,0,,,,DISCONTINUED
143,EP,A1,EP 1218776 A1,100-745-482-787-223,2002-07-03,2002,EP 00961552 A,2000-09-01,US 0024355 W;;US 41587399 A,1999-10-08,OPTICAL FILM WITH VARIABLE ANGLE PRISMS,,3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/100-745-482-787-223,Patent Application,yes,2,0,13,13,0,G02B6/0031;;G02B6/0046;;G02B6/005;;G02B6/0053;;G02B6/0068;;G02B6/0071;;G02B5/04;;G02B6/0053;;G02B6/0071;;G02B6/0031;;G02B6/0046;;G02B6/0068;;G02B6/005,F21V8/00;;G02F1/13357;;G02B5/04,,1,0,,,See also references of WO 0127663A1,DISCONTINUED
144,US,B2,US 6560026 B2,009-243-627-366-924,2003-05-06,2003,US 4787202 A,2002-01-16,US 4787202 A;;US 41587399 A,1999-10-08,Optical film with variable angle prisms,"
    An optical turning film has a first surface including an array of prisms. The array has a plurality of first prisms, with each of the first prisms having a first prism configuration, and a plurality of second prisms, with each of the second prisms having a second prism configuration different from the first prism configuration. The optical film also has a second surface opposing the first surface, and light rays incident to the first surface are directed by the plurality of first prism and the plurality of second prisms along a direction substantially parallel to a viewing axis. 
",GARDINER MARK E.;;COBB SANFORD;;EPSTEIN KENNETH A.;;KRETMAN WADE D.,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY (1999-12-22),https://lens.org/009-243-627-366-924,Granted Patent,yes,107,78,13,13,0,G02B6/0031;;G02B6/0046;;G02B6/005;;G02B6/0053;;G02B6/0068;;G02B6/0071;;G02B5/04;;G02B6/0053;;G02B6/0071;;G02B6/0031;;G02B6/0046;;G02B6/0068;;G02B6/005,F21V8/00;;G02F1/13357;;G02B5/04,359/628;;359/640,6,0,,,"IBM Technical Disclosure Bulletin, vol. 29, No. 11, Backlighting for Liquid Crystal Display, Apr. 1987.;;IBM Technical Disclosure Bulletin, vol. 31, No. 2, Flat Panel Backlight Reflecting Device, Jul. 1988.;;IBM Technical Disclosure Bulletin, vol. 33, No. 1B, Polarized Backlight for Liquid Crystal Display, Jun. 1990.;;IBM Technical Disclosure Bulletin, vol. 33, No. 9, High Efficiency Back Light for LCD, Feb. 1991.;;Patent Abstracts of Japan, vol. 007, No. 090 (P-191), Apr. 14, 1983 & JP 58 017402 A (Kunishiro Kanagata Kogto KK), Feb. 1, 1983.;;Patent Abstracts of Japan, vol. 1997, No. 03, Mar. 31, 1997 Mar. 1, 1997 & JP 08 313710 A (Mitsubishi Rayon Co Ltd), Nov. 29, 1996.",EXPIRED
145,US,B1,US 6356391 B1,146-000-940-747-580,2002-03-12,2002,US 41587399 A,1999-10-08,US 41587399 A,1999-10-08,Optical film with variable angle prisms,"
    An optical turning film has a first surface including an array of prisms. The array has a plurality of first prisms, with each of the first prisms having a first prism configuration, and a plurality of second prisms, with each of the second prisms having a second prism configuration different from the first prism configuration. The optical film also has a second surface opposing the first surface, and light rays incident to the first surface are directed by the plurality of first prism and the plurality of second prisms along a direction substantially parallel to a viewing axis. 
",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY (1999-12-22),https://lens.org/146-000-940-747-580,Granted Patent,yes,110,185,13,13,0,G02B6/0031;;G02B6/0046;;G02B6/005;;G02B6/0053;;G02B6/0068;;G02B6/0071;;G02B5/04;;G02B6/0053;;G02B6/0071;;G02B6/0031;;G02B6/0046;;G02B6/0068;;G02B6/005,F21V8/00;;G02F1/13357;;G02B5/04,359/628;;359/638;;359/640;;359/619;;359/837,6,0,,,"IBM Technical Disclosure Bulletin, vol. 29, No. 11, Backlighting for Liquid Crystal Display, Apr. 1987.;;IBM Technical Disclosure Bulletin, vol. 31, No. 2, Flat Panel Backlight Reflecting Device, Jul. 1988.;;IBM Technical Disclosure Bulletin, vol. 33, No. 1B, Polarized Backlight for Liquid Crystal Display, Jun. 1990.;;IBM Technical Disclosure Bulletin, vol. 33, No. 9, High Efficiency Back Light for LCD, Feb. 1991.;;Patent Abstracts of Japan, vol. 007, No. 090 (P-191), Apr. 14, 1983 & JP 58 017402 A (Kunishiro Kanagata Kyogo KK), Feb. 1, 1983.;;Patent Abstracts of Japan, vol. 1997, No. 03, Mar. 31, 1997 & JP 08 313710 A (Mitsubishi Rayon Co Ltd), Nov. 29, 1996.",EXPIRED
146,US,A1,US 2013/0183876 A1,171-743-364-277-536,2013-07-18,2013,US 201313742853 A,2013-01-16,US 201313742853 A;;US 201261587922 P,2012-01-18,Releasable Mooring Systems And Methods For Drilling Vessels,Releasable mooring systems and methods for drilling vessels that may be implemented with dockable and releasable mooring buoys to provide for both a quick disconnect of the mooring system from a drilling vessel and for re-connection of the drilling vessel when the vessel returns to the well site.,VESELIS TODD B;;COBB DAVID E;;FULTON THOMAS M;;WILLIAMSON MARK;;INTERMOOR INC,VESELIS TODD B;;COBB DAVID E;;FULTON THOMAS M;;WILLIAMSON MARK,INTERMOOR INC (2013-01-10),https://lens.org/171-743-364-277-536,Patent Application,yes,6,8,3,3,0,B63B22/02;;B63B22/02;;B63B35/4413;;B63B35/4413;;B63B2022/028;;B63B2022/028;;B63B2241/10;;B63B2241/10,B63B22/02,441/3,0,0,,,,ACTIVE
147,US,A1,US 2002/0057497 A1,105-985-501-296-353,2002-05-16,2002,US 4787202 A,2002-01-16,US 4787202 A;;US 41587399 A,1999-10-08,Optical film with variable angle prisms,"
   An optical turning film has a first surface including an array of prisms. The array has a plurality of first prisms, with each of the first prisms having a first prism configuration, and a plurality of second prisms, with each of the second prisms having a second prism configuration different from the first prism configuration. The optical film also has a second surface opposing the first surface, and light rays incident to the first surface are directed by the plurality of first prism and the plurality of second prisms along a direction substantially parallel to a viewing axis. 
",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY (1999-12-22),https://lens.org/105-985-501-296-353,Patent Application,yes,0,67,13,13,0,G02B6/0031;;G02B6/0046;;G02B6/005;;G02B6/0053;;G02B6/0068;;G02B6/0071;;G02B5/04;;G02B6/0053;;G02B6/0071;;G02B6/0031;;G02B6/0046;;G02B6/0068;;G02B6/005,F21V8/00;;G02F1/13357;;G02B5/04,359/625;;359/639;;X35964;;359/678,0,0,,,,EXPIRED
148,US,A,US 5404247 A,003-034-936-684-716,1995-04-04,1995,US 10084493 A,1993-08-02,US 10084493 A,1993-08-02,Telecentric and achromatic f-theta scan lens system and method of use,"An airspaced, diffraction limited, seven element telecentric f-theta lens having a first meniscus lens concave to the incident side; a first bi-concave lens; a second meniscus lens convex to the incident side; a third meniscus lens concave to the incident side; a pair of bi-convex lenses; and a second bi-concave lens is disclosed. The second, third and fourth as well as the sixth and seventh lens elements are edge contact spaced.",IBM,COBB JOSHUA M;;LAPLANTE MARK J;;LONG DAVID C;;TOPOLOVEC FRANZ,INTERNATIONAL BUSINESS MACHINES CORPORATION (1993-07-29),https://lens.org/003-034-936-684-716,Granted Patent,yes,10,55,1,1,0,G02B13/0005;;G02B13/22;;G02B13/0005;;G02B13/22,G02B13/00;;G02B13/22,G2J JB7W11        JB7W11,0,0,,,,EXPIRED
149,US,A1,US 2003/0112521 A1,009-636-084-520-733,2003-06-19,2003,US 35388803 A,2003-01-29,US 35388803 A;;US 4787202 A;;US 41587399 A,1999-10-08,Optical film with variable angle prisms,"
   An optical turning film has a first surface including an array of prisms. The array has a plurality of first prisms, with each of the first prisms having a first prism configuration, and a plurality of second prisms, with each of the second prisms having a second prism configuration different from the first prism configuration. The optical film also has a second surface opposing the first surface, and light rays incident to the first surface are directed by the plurality of first prism and the plurality of second prisms along a direction substantially parallel to a viewing axis. 
",MINNESOTA MINING & MFG,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY (1999-12-22),https://lens.org/009-636-084-520-733,Patent Application,yes,0,61,13,13,0,G02B6/0031;;G02B6/0046;;G02B6/005;;G02B6/0053;;G02B6/0068;;G02B6/0071;;G02B5/04;;G02B6/0053;;G02B6/0071;;G02B6/0031;;G02B6/0046;;G02B6/0068;;G02B6/005,F21V8/00;;G02F1/13357;;G02B5/04,359/619,0,0,,,,EXPIRED
150,WO,A1,WO 2006/111751 A1,002-636-193-860-150,2006-10-26,2006,GB 2006001439 W,2006-04-20,EP 05008726 A,2005-04-21,DEVICE AND METHOD,"A device for treating a surface to give a cleaning benefit comprises a container (302) containing a cleaning liquid. The liquid can be delivered to an outlet zone (306) . By virtue of the outlet zone and a separate defining means (322) which may be provided the cleaning liquid is accurately discharged onto the desired area of the surface. Suitably the cleaning liquid forms a gel patch, which can be peeled away, to remove a stain.",RECKITT BENCKISER UK LTD;;COBB VICTORIA H;;ILIFFE COREEN;;JOWETT LOUISE MARGARET;;LAW JONATHAN MARK,COBB VICTORIA H;;ILIFFE COREEN;;JOWETT LOUISE MARGARET;;LAW JONATHAN MARK,,https://lens.org/002-636-193-860-150,Patent Application,yes,10,0,7,7,0,A47L13/26;;A47L25/08;;C11D17/041;;D06L1/00;;D06L4/10;;D06L4/00;;D06L1/00;;A47L13/26;;A47L25/08;;C11D17/041;;D06L4/00;;D06L4/10,A47L25/08;;A47L13/26;;B65D81/32;;B65D83/00;;C11D17/04;;D06L1/00;;D06L3/00;;D06L4/00;;D06L4/10,,0,0,,,,PENDING
151,WO,A1,WO 2001/027663 A1,123-461-566-238-678,2001-04-19,2001,US 0024355 W,2000-09-01,US 41587399 A,1999-10-08,OPTICAL FILM WITH VARIABLE ANGLE PRISMS,"An optical turning film has a first surface including an array of prisms. The array has a plurality of first prisms, with each of the first prisms having a first prism configuration, and a plurality of second prisms, with each of the second prisms having a second prism configuration different from the first prism configuration. The optical film also has a second surface opposing the first surface, and light rays incident to the first surface are directed by the plurality of first prisms and the plurality of second prisms along a direction substantially parallel to a viewing axis.",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/123-461-566-238-678,Patent Application,yes,8,31,13,13,0,G02B6/0031;;G02B6/0046;;G02B6/005;;G02B6/0053;;G02B6/0068;;G02B6/0071;;G02B5/04;;G02B6/0053;;G02B6/0071;;G02B6/0031;;G02B6/0046;;G02B6/0068;;G02B6/005,F21V8/00;;G02B5/04;;G02F1/13357,,4,0,,,"PATENT ABSTRACTS OF JAPAN vol. 007, no. 090 (P - 191) 14 April 1983 (1983-04-14);;PATENT ABSTRACTS OF JAPAN vol. 1997, no. 03 31 March 1997 (1997-03-31);;PATENT ABSTRACTS OF JAPAN vol. 018, no. 333 (P - 1759) 23 June 1994 (1994-06-23);;See also references of EP 1218776A1",PENDING
152,US,B2,US 9315242 B2,012-826-873-586-001,2016-04-19,2016,US 201313742853 A,2013-01-16,US 201313742853 A;;US 201261587922 P,2012-01-18,Releasable mooring systems and methods for drilling vessels,Releasable mooring systems and methods for drilling vessels that may be implemented with dockable and releasable mooring buoys to provide for both a quick disconnect of the mooring system from a drilling vessel and for re-connection of the drilling vessel when the vessel returns to the well site.,VESELIS TODD B;;COBB DAVID E;;FULTON THOMAS M;;WILLIAMSON MARK;;INTERMOOR INC,VESELIS TODD B;;COBB DAVID E;;FULTON THOMAS M;;WILLIAMSON MARK,INTERMOOR INC (2013-01-10),https://lens.org/012-826-873-586-001,Granted Patent,yes,17,4,3,3,0,B63B22/02;;B63B22/02;;B63B35/4413;;B63B35/4413;;B63B2022/028;;B63B2022/028;;B63B2241/10;;B63B2241/10,B63B22/02;;B63B35/44,,3,0,,,"International Search Report, PCT/US2013/021720, INTM:002PCT, Mar. 25, 2013, 3 pgs.;;STP, Submerged Turret Production, APL, Available on the Internet prior to the Jan. 18, 2012 filing date of the U.S. Appl. No. 61/587,922, to which the present application claims priority, 8 pgs.;;STL, Submerged Turret Loading, APL, This reference describes technology publicly known prior to the Jan. 18, 2012 filing date of the U.S. Appl. No. 61/587,922, to which the present application claims priority, 8 pgs.",ACTIVE
153,WO,A1,WO 2006/111754 A1,194-637-806-445-644,2006-10-26,2006,GB 2006001444 W,2006-04-20,EP 05008725 A,2005-04-21,DEVICE AND METHOD FOR APPLYING A TREATMENT AGENT TO A SURFACE,"A device for treating a surface to give a cleaning benefit comprises one or more containers (402) containing cleaning liquid. When the actuator (416) is depressed cleaning liquid is delivered to an outlet zone (406) located over a stain, where it forms a gel patch. Continued depression of the actuator means causes a piston (436) to press the gel patch against the surface, caused improved absorption of the stain, into the patch. The gel patch can then be peeled away, to remove the stain.",RECKITT BENCKISER UK LTD;;COBB VICTORIA H;;ILIFFE COREEN;;JOWETT LOUISE MARGARET;;LAW JONATHAN MARK,COBB VICTORIA H;;ILIFFE COREEN;;JOWETT LOUISE MARGARET;;LAW JONATHAN MARK,,https://lens.org/194-637-806-445-644,Patent Application,yes,3,0,7,7,0,B08B1/00;;B08B3/04;;B08B3/10;;D06L1/00;;D06L4/10;;D06L4/00;;B08B3/04;;D06L1/00;;B08B3/10;;B08B1/00;;D06L4/10;;D06L4/00,B08B3/04,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 014, no. 057 (C - 0684) 2 February 1990 (1990-02-02);;PATENT ABSTRACTS OF JAPAN vol. 014, no. 090 (C - 0691) 20 February 1990 (1990-02-20)",PENDING
154,US,A1,US 2006/0055886 A1,013-081-495-685-565,2006-03-16,2006,US 93966104 A,2004-09-13,US 93966104 A,2004-09-13,Autostereoscopic display apparatus having glare suppression,"An improved autostereoscopic display apparatus ( 10 ) that forms left and right virtual images for pupil imaging by forming, through a beamsplitter ( 16 ), a real intermediate image near the focal surface of a curved mirror ( 24 ). A circular polarizer ( 90 ) is disposed at a position between viewing pupils ( 14 l , 14 r ) and the beamsplitter ( 16 ), minimizing glare due to stray light reflection from the curved mirror surface.",EASTMAN KODAK CO,COBB JOSHUA M;;BRIDGES MARK E;;WAUGH ALLAN M;;RODDY JAMES E,EASTMAN KODAK COMPANY (2004-09-02),https://lens.org/013-081-495-685-565,Patent Application,yes,10,7,2,2,0,G03B21/005;;G03B21/005,G03B21/00;;G02B30/60,353/7,0,0,,,,INACTIVE
155,WO,A1,WO 2001/027527 A1,028-112-154-558-078,2001-04-19,2001,US 0024204 W,2000-08-31,US 41547199 A,1999-10-08,OPTICAL ELEMENT HAVING PROGRAMMED OPTICAL STRUCTURES,"An optical element, such as a lightguide or an optical film, is formed with a predetermined, programmed pattern of optical structures. The optical structures may be arranged to selectively correct for non-uniformities in the output of a lightguide, or may be arranged to otherwise enhance the performance of a display.",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD JR;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/028-112-154-558-078,Patent Application,yes,4,31,15,34,0,G02B6/0038;;G02B6/0038;;G02F1/1335;;G02B6/0051;;G02B6/0051;;G02B6/0053;;G02B6/0053;;G02F1/133615;;G02F1/133615;;Y10S385/901;;Y10S385/901,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/08;;G02F1/13357,,5,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1997, no. 10 31 October 1997 (1997-10-31);;PATENT ABSTRACTS OF JAPAN vol. 1999, no. 03 31 March 1999 (1999-03-31);;PATENT ABSTRACTS OF JAPAN vol. 1999, no. 12 29 October 1999 (1999-10-29);;PATENT ABSTRACTS OF JAPAN vol. 1999, no. 14 22 December 1999 (1999-12-22);;PATENT ABSTRACTS OF JAPAN vol. 1995, no. 09 31 October 1995 (1995-10-31)",PATENTED
156,AU,A,AU 2001/011877 A,076-188-219-229-032,2001-04-23,2001,AU 2001/011877 A,2000-08-31,US 41547199 A;;US 0024204 W,1999-10-08,Optical element having programmed optical structures,,3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD JR;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/076-188-219-229-032,Patent Application,no,0,0,15,34,0,G02B6/0038;;G02B6/0038;;G02F1/1335;;G02B6/0051;;G02B6/0051;;G02B6/0053;;G02B6/0053;;G02F1/133615;;G02F1/133615;;Y10S385/901;;Y10S385/901,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/08;;G02F1/13357,,0,0,,,,DISCONTINUED
157,US,B2,US 7873256 B2,089-525-561-808-861,2011-01-18,2011,US 22682905 A,2005-09-14,US 22682905 A;;US 61331300 A;;US 41547199 A,1999-10-08,Backlight with structured surfaces,"A backlight includes a lightguide, a light source disposed with respect to the lightguide to introduce light into the lightguide and a turning film. Optical structures are formed in one of an output surface and a back surface of the lightguide. The optical structures are arranged to extract light from the lightguide. A back reflector is disposed adjacent the back surface. The optical structures are formed to include a varying pattern arranged to mask non-uniformities in the output of the lightguide.",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB JR SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY (2005-10-31),https://lens.org/089-525-561-808-861,Granted Patent,yes,100,3,5,34,0,G02B6/0036;;G02B6/0043;;G02B6/0046;;G02B6/0055;;G02B6/0061;;G02B6/0038;;Y10S385/901;;G02B6/0046;;G02B6/0061;;G02B6/0055;;G02B6/0036;;G02B6/0043;;G02B6/0038;;G02B6/0001;;Y10S385/901,G02B6/10,385/146;;385/33;;385/901;;359/619,5,0,,,"IBM Technical Disclosure Bulletin, vol. 29, No. 11, Backlighting for Liquid Crystal Display, Apr. 1987.;;IBM Technical Disclosure Bulletin, vol. 31, No. 2, Flat Panel Backlight Reflecting Device, Jul. 1988.;;IBM Technical Disclosure Bulletin, vol. 33, No. 1B, Polarized Backlight for Liquid Crystal Display, Jun. 1990.;;IBM Technical Disclosure Bulletin, vol. 33, No. 9, High Efficiency Back Light for LCD, Feb. 1991.;;IBM Technical Disclosure Bulletin, vol. 39, No. 9, Monolithic GaN Light Emitting Arrays for Display Illumination, Sep. 1996.",EXPIRED
158,PL,T3,PL 1714605 T3,133-588-771-915-704,2011-11-30,2011,PL 05008726 T,2005-04-21,EP 05008726 A,2005-04-21,Device and method,"A device for treating a surface to give a cleaning benefit comprises a container (302) containing a cleaning liquid. The liquid can be delivered to an outlet zone (306). By virtue of the outlet zone and a separate defining means (322) which may be provided the cleaning liquid is accurately discharged onto the desired area of the surface. Suitably the cleaning liquid forms a gel patch, which can be peeled away, to remove a stain.",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;ILIFFE COREEN JANE;;JOWETT MARGARET LOUISE;;LAW JONATHAN MARK,,https://lens.org/133-588-771-915-704,Patent Application,no,0,0,7,7,0,A47L13/26;;A47L25/08;;C11D17/041;;D06L1/00;;D06L4/10;;D06L4/00;;D06L1/00;;A47L13/26;;A47L25/08;;C11D17/041;;D06L4/00;;D06L4/10,A47L25/08;;A47L13/26;;B65D81/32;;B65D83/00;;C11D17/04;;D06L1/00;;D06L3/00;;D06L4/00;;D06L4/10,,0,0,,,,PENDING
159,WO,A1,WO 2018/190913 A1,011-658-864-684-834,2018-10-18,2018,US 2017/0063955 W,2017-11-30,US 201715483219 A,2017-04-10,STRUCTURALLY REINFORCED COMPOSITE COLD SHIELD FOR USE IN INFRARED SENSORS OR OTHER DEVICES,"An Infrared Detector Dewar system (100) includes a housing (106) and an infrared detector (104, 202). The system also includes one or more strut members (108, 206) coupled on a first end to the housing. The system further includes cold shield (102, 200) coupled to the infrared detector and to a second end of the one or more strut members. The cold shield includes a reinforcement ring (300) aligned with the one or more strut members. The cold shield is formed by forming a support member having disc (306) encased by a support ring (308). The support member is positioned within a mandrel (404) such that the reinforcement ring is disposed to align with a strut position. The cold shield is then formed by electroplating copper over the mandrel and at least a portion of the support member, and then by removing/dissolving all aforementioned mandrels.",RAYTHEON CO,AVERS GAVIN;;BREST MICHAEL;;ELBOGEN MARK;;COBB CHRISTOPHER;;RINEHART DANIEL;;GRAHAM JASON,,https://lens.org/011-658-864-684-834,Patent Application,yes,4,0,12,12,0,G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/06;;G01J5/06;;G01J5/0804;;G01J5/0831;;G01J5/061;;G01J5/084;;G01J2005/065;;G01J5/06;;G01J2005/065;;G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/0804,G01J5/08;;G01J5/06,,0,0,,,,PENDING
160,DE,D1,DE 602005012802 D1,067-328-914-741-295,2009-04-02,2009,DE 602005012802 T,2005-04-21,EP 05008725 A,2005-04-21,Vorrichtung und Methode für das Aufbringen einer Behandlungsmittels auf eine Oberfläche,"A device for treating a surface to give a cleaning benefit comprises one or more containers (402) containing cleaning liquid. When the actuator (416) is depressed cleaning liquid is delivered to an outlet zone (406) located over a stain, where it forms a gel patch. Continued depression of the actuator means causes a piston 436 to press the gel patch against the surface, caused improved absorption of the stain, into the patch. The gel patch can then be peeled away, to remove the stain.",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;ILIFFE COREEN JANE;;BARLOW MARGARET LOUISE;;LAW JONATHAN MARK,,https://lens.org/067-328-914-741-295,Granted Patent,no,0,0,7,7,0,B08B1/00;;B08B3/04;;B08B3/10;;D06L1/00;;D06L4/10;;D06L4/00;;B08B3/04;;D06L1/00;;B08B3/10;;B08B1/00;;D06L4/10;;D06L4/00,B08B3/04,,0,0,,,,INACTIVE
161,US,A1,US 2010/0092043 A1,193-475-721-160-628,2010-04-15,2010,US 53054808 A,2008-03-10,US 53054808 A;;US 89402907 P;;US 2008/0056373 W,2007-03-09,METHOD AND SYSTEM FOR CHARACTERIZING MOVEMENT OF AN OBJECT,Motion of an object is characterized based on data indicative of a plurality of pixilated images of the object. An outline of the object may be extracted from the data for each pixilated image of the object. Changes over time in a shape and/or position of the outline may be used to determine a speed associated with the object.,TRIGONIMAGERY LLC,BORMAN GILBERT A;;GRENLEY GEORGE R;;COBB RICHARD E;;LAHTI MARK C,TRIGONIMAGERY LLC (2009-09-02),https://lens.org/193-475-721-160-628,Patent Application,yes,6,8,5,5,0,G06T7/20;;G06T7/20;;G06T2207/30236;;G06T2207/30236,G06K9/00,382/107;;382/190;;382/224,0,0,,,,ACTIVE
162,US,B2,US 11069982 B2,021-443-675-934-325,2021-07-20,2021,US 201916238125 A,2019-01-02,US 201916238125 A,2019-01-02,Anechoic chamber and method of calibrating a radar system,"A portable anechoic chamber is described herein. The chamber includes a housing including an interior, and the housing defines an opening sized to provide access to the interior. A layer of radar absorbent material lines the interior, and a reflective device is positioned within the interior. The reflective device is positioned to receive and reflect a radar beam emitted from a radar source.",HONDA MOTOR CO LTD,COBB DERRICK I;;BETZ DAVID B;;AYERS BRIAN D;;ZICCARDI ROBERT MARK,HONDA MOTOR CO. LTD (2018-12-20),https://lens.org/021-443-675-934-325,Granted Patent,yes,41,1,2,2,0,G01S7/4052;;G01S7/40;;G01S7/4008;;G01S7/4086;;G01S13/931;;G01S2013/93271;;G01S2013/93272;;H01Q17/00,H01Q17/00;;G01S7/40,,2,1,093-724-776-510-874,10.1109/scored.2009.5442944,"Abdullah et al., “Design of Portable Mini Anechoic Chamber Using Low Cost Composite Absorber”, Nov. 11-18, 2009, pp. 526-528, Publisher: Proceedings of 2009 IEEE Student Conference on Research and Development, Published in: UPM Serdang, Malaysia. (Year: 2009).;;“Target Simulator for Collision Avoidance Radar (short range) Passive Radar Test System (Passive RTS)”; Product Information; Keycom Characteristics Technologies; available at http://www.keycom.co.jp/eproducts/rat/rat09/page.html; last visited Jan. 2, 2019; 5 pp.",ACTIVE
163,ES,T3,ES 2364406 T3,117-503-907-408-600,2011-09-01,2011,ES 05008726 T,2005-04-21,EP 05008726 A,2005-04-21,DISPOSITIVO Y PROCEDIMIENTO.,"A device for treating a surface to give a cleaning benefit comprises a container (302) containing a cleaning liquid. The liquid can be delivered to an outlet zone (306). By virtue of the outlet zone and a separate defining means (322) which may be provided the cleaning liquid is accurately discharged onto the desired area of the surface. Suitably the cleaning liquid forms a gel patch, which can be peeled away, to remove a stain.",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;ILIFFE COREEN JANE;;JOWETT MARGARET LOUISE;;LAW JONATHAN MARK,,https://lens.org/117-503-907-408-600,Granted Patent,no,0,0,7,7,0,A47L13/26;;A47L25/08;;C11D17/041;;D06L1/00;;D06L4/10;;D06L4/00;;D06L1/00;;A47L13/26;;A47L25/08;;C11D17/041;;D06L4/00;;D06L4/10,A47L25/08;;A47L13/26;;B65D81/32;;B65D83/00;;C11D17/04;;D06L1/00;;D06L3/00;;D06L4/00;;D06L4/10,,0,0,,,,ACTIVE
164,ES,T3,ES 2321003 T3,121-139-549-578-605,2009-06-01,2009,ES 05008725 T,2005-04-21,EP 05008725 A,2005-04-21,DISPOSITIVO Y METODO PARA APLICAR UN AGENTE DE TRATAMIENTO A UNA SUPERFICIE.,"A device for treating a surface to give a cleaning benefit comprises one or more containers (402) containing cleaning liquid. When the actuator (416) is depressed cleaning liquid is delivered to an outlet zone (406) located over a stain, where it forms a gel patch. Continued depression of the actuator means causes a piston 436 to press the gel patch against the surface, caused improved absorption of the stain, into the patch. The gel patch can then be peeled away, to remove the stain.",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;ILIFFE COREEN JANE;;BARLOW MARGARET LOUISE;;LAW JONATHAN MARK,,https://lens.org/121-139-549-578-605,Granted Patent,no,0,0,7,7,0,B08B1/00;;B08B3/04;;B08B3/10;;D06L1/00;;D06L4/10;;D06L4/00;;B08B3/04;;D06L1/00;;B08B3/10;;B08B1/00;;D06L4/10;;D06L4/00,B08B3/04,,0,0,,,,ACTIVE
165,US,B2,US 7165842 B2,186-939-453-861-063,2007-01-23,2007,US 93966104 A,2004-09-13,US 93966104 A,2004-09-13,Autostereoscopic display apparatus having glare suppression,"An improved autostereoscopic display apparatus ( 10 ) forms left and right virtual images for pupil imaging by forming, through a beamsplitter ( 16 ), a real intermediate image near the focal surface of a curved mirror ( 24 ). A circular polarizer ( 90 ) is disposed at a position between viewing pupils ( 14 l , 14 r ) and the beamsplitter ( 16 ), minimizing glare due to stray light reflection from the curved mirror surface.",EASTMAN KODAK CO,COBB JOSHUA M;;BRIDGES MARK E;;WAUGH ALLAN M;;RODDY JAMES E,EASTMAN KODAK COMPANY (2004-09-02),https://lens.org/186-939-453-861-063,Granted Patent,yes,10,7,2,2,0,G03B21/005;;G03B21/005,G03B21/14;;G02B27/22;;G02B30/60;;G03B27/14;;H04N13/04,353/7;;353/8;;353/10;;353/20;;359/462;;359/471;;359/479;;359/630;;348/42;;348/52,0,0,,,,INACTIVE
166,US,B2,US 8588472 B2,191-174-712-164-078,2013-11-19,2013,US 53054808 A,2008-03-10,US 53054808 A;;US 89402907 P;;US 2008/0056373 W,2007-03-09,Method and system for characterizing movement of an object,Motion of an object is characterized based on data indicative of a plurality of pixilated images of the object. An outline of the object may be extracted from the data for each pixilated image of the object. Changes over time in a shape and/or position of the outline may be used to determine a speed associated with the object.,BORMAN GILBERT A;;GRENLEY GEORGE R;;COBB RICHARD E;;LAHTI MARK C;;TRIGONIMAGERY LLC,BORMAN GILBERT A;;GRENLEY GEORGE R;;COBB RICHARD E;;LAHTI MARK C,TRIGONIMAGERY LLC (2009-09-02),https://lens.org/191-174-712-164-078,Granted Patent,yes,6,2,5,5,0,G06T7/20;;G06T7/20;;G06T2207/30236;;G06T2207/30236,G06K9/00;;G06K9/46;;G06K9/62,382/107;;382/190;;382/224,1,0,,,"International Search Report and Written Opinion of the International Searching Authority, dated Aug. 6, 2008 for International Application No. PCT/US 08/56373 filed Mar. 10, 2008, 7 pgs.",ACTIVE
167,US,A1,US 2008/0050088 A1,019-958-749-786-021,2008-02-28,2008,US 92899907 A,2007-10-30,US 92899907 A;;US 22682905 A;;US 61331300 A;;US 41547199 A,1999-10-08,BACKLIGHT WITH STRUCTURED SURFACES,"A backlight includes a lightguide, a light source disposed with respect to the lightguide to introduce light into the lightguide and a turning film. Optical structures are formed in one of an output surface and a back surface of the lightguide. The optical structures are arranged to extract light from the lightguide. A back reflector is disposed adjacent the back surface. The optical structures are formed to include a varying pattern arranged to mask non-uniformities in the output of the lightguide.",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD JR;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/019-958-749-786-021,Patent Application,yes,99,1,5,34,0,G02B6/0036;;G02B6/0043;;G02B6/0046;;G02B6/0055;;G02B6/0061;;G02B6/0038;;Y10S385/901;;G02B6/0046;;G02B6/0061;;G02B6/0055;;G02B6/0036;;G02B6/0043;;G02B6/0038;;G02B6/0001;;Y10S385/901,G02B6/10,385/146,0,0,,,,EXPIRED
168,AT,T1,AT E511782 T1,138-872-756-185-483,2011-06-15,2011,AT 05008726 T,2005-04-21,EP 05008726 A,2005-04-21,VORRICHTUNG UND VERFAHREN,"A device for treating a surface to give a cleaning benefit comprises a container (302) containing a cleaning liquid. The liquid can be delivered to an outlet zone (306). By virtue of the outlet zone and a separate defining means (322) which may be provided the cleaning liquid is accurately discharged onto the desired area of the surface. Suitably the cleaning liquid forms a gel patch, which can be peeled away, to remove a stain.",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;ILIFFE COREEN JANE;;JOWETT MARGARET LOUISE;;LAW JONATHAN MARK,,https://lens.org/138-872-756-185-483,Granted Patent,no,0,0,7,7,0,A47L13/26;;A47L25/08;;C11D17/041;;D06L1/00;;D06L4/10;;D06L4/00;;D06L1/00;;A47L13/26;;A47L25/08;;C11D17/041;;D06L4/00;;D06L4/10,D06L1/00;;D06L4/00;;D06L4/10,,0,0,,,,INACTIVE
169,EP,A1,EP 1714605 A1,001-545-587-326-970,2006-10-25,2006,EP 05008726 A,2005-04-21,EP 05008726 A,2005-04-21,Device and method,"A device for treating a surface to give a cleaning benefit comprises a container (302) containing a cleaning liquid. The liquid can be delivered to an outlet zone (306). By virtue of the outlet zone and a separate defining means (322) which may be provided the cleaning liquid is accurately discharged onto the desired area of the surface. Suitably the cleaning liquid forms a gel patch, which can be peeled away, to remove a stain.
",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;ILIFFE COREEN JANE;;JOWETT MARGARET LOUISE;;LAW JONATHAN MARK,,https://lens.org/001-545-587-326-970,Patent Application,yes,16,4,7,7,0,A47L13/26;;A47L25/08;;C11D17/041;;D06L1/00;;D06L4/10;;D06L4/00;;D06L1/00;;A47L13/26;;A47L25/08;;C11D17/041;;D06L4/00;;D06L4/10,A47L25/08;;A47L13/26;;B65D81/32;;B65D83/00;;C11D17/04;;D06L1/00;;D06L3/00;;D06L4/00;;D06L4/10,,0,0,,,,ACTIVE
170,AT,T1,AT E422973 T1,012-941-138-244-121,2009-03-15,2009,AT 05008725 T,2005-04-21,EP 05008725 A,2005-04-21,VORRICHTUNG UND METHODE FÜR DAS AUFBRINGEN EINER BEHANDLUNGSMITTELS AUF EINE OBERFLÄCHE,"A device for treating a surface to give a cleaning benefit comprises one or more containers (402) containing cleaning liquid. When the actuator (416) is depressed cleaning liquid is delivered to an outlet zone (406) located over a stain, where it forms a gel patch. Continued depression of the actuator means causes a piston 436 to press the gel patch against the surface, caused improved absorption of the stain, into the patch. The gel patch can then be peeled away, to remove the stain.",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;ILIFFE COREEN JANE;;BARLOW MARGARET LOUISE;;LAW JONATHAN MARK,,https://lens.org/012-941-138-244-121,Granted Patent,no,0,0,7,7,0,B08B1/00;;B08B3/04;;B08B3/10;;D06L1/00;;D06L4/10;;D06L4/00;;B08B3/04;;D06L1/00;;B08B3/10;;B08B1/00;;D06L4/10;;D06L4/00,,,0,0,,,,INACTIVE
171,EP,B1,EP 1714605 B1,196-761-550-652-455,2011-06-08,2011,EP 05008726 A,2005-04-21,EP 05008726 A,2005-04-21,Device and method,"A device for treating a surface to give a cleaning benefit comprises a container (302) containing a cleaning liquid. The liquid can be delivered to an outlet zone (306). By virtue of the outlet zone and a separate defining means (322) which may be provided the cleaning liquid is accurately discharged onto the desired area of the surface. Suitably the cleaning liquid forms a gel patch, which can be peeled away, to remove a stain.",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;ILIFFE COREEN JANE;;JOWETT MARGARET LOUISE;;LAW JONATHAN MARK,,https://lens.org/196-761-550-652-455,Granted Patent,yes,10,2,7,7,0,A47L13/26;;A47L25/08;;C11D17/041;;D06L1/00;;D06L4/10;;D06L4/00;;D06L1/00;;A47L13/26;;A47L25/08;;C11D17/041;;D06L4/00;;D06L4/10,A47L25/08;;A47L13/26;;B65D81/32;;B65D83/00;;C11D17/04;;D06L1/00;;D06L3/00;;D06L4/00;;D06L4/10,,0,0,,,,ACTIVE
172,US,B2,US 8588574 B2,046-535-860-623-030,2013-11-19,2013,US 92899907 A,2007-10-30,US 92899907 A;;US 22682905 A;;US 61331300 A;;US 41547199 A,1999-10-08,Backlight with structured surfaces,"A backlight includes a lightguide, a light source disposed with respect to the lightguide to introduce light into the lightguide and a turning film. Optical structures are formed in one of an output surface and a back surface of the lightguide. The optical structures are arranged to extract light from the lightguide. A back reflector is disposed adjacent the back surface. The optical structures are formed to include a varying pattern arranged to mask non-uniformities in the output of the lightguide.",GARDINER MARK E;;COBB JR SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D;;3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB JR SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/046-535-860-623-030,Granted Patent,yes,99,2,5,34,0,G02B6/0036;;G02B6/0043;;G02B6/0046;;G02B6/0055;;G02B6/0061;;G02B6/0038;;Y10S385/901;;G02B6/0046;;G02B6/0061;;G02B6/0055;;G02B6/0036;;G02B6/0043;;G02B6/0038;;G02B6/0001;;Y10S385/901,G02B27/10;;G02B6/10,385/146;;385/33;;385/901;;359/619,5,0,,,"IBM Technical Disclosure Bulletin, vol. 29, No, 11, Backlighting for Liquid Crystal Display, Apr. 1987.;;IBM Technical Disclosure Bulletin, vol. 31, No. 2, Flat Panel Backlight Reflecting Devcie, Jul. 1988.;;IBM Technical Disclosure Bulletin, vol. 33, No. 1B, Polarized Backlight for Liquid Crystal Display, Jun. 1990.;;IBM Technical Disclosure Bulletin, vol. 33, No. 9, High Efficiency Back Light for LCD, Feb. 1991.;;IBM Technical Disclosure Bulletin, vol. 39, No. 9, Monolithic GaN Light Emitting Arrays for Display Illumination, Sep. 1996.",EXPIRED
173,EP,A1,EP 1714712 A1,082-964-263-534-858,2006-10-25,2006,EP 05008725 A,2005-04-21,EP 05008725 A,2005-04-21,Device and method for applying a treatment agent to a surface,"A device for treating a surface to give a cleaning benefit comprises one or more containers (402) containing cleaning liquid. When the actuator (416) is depressed cleaning liquid is delivered to an outlet zone (406) located over a stain, where it forms a gel patch. Continued depression of the actuator means causes a piston 436 to press the gel patch against the surface, caused improved absorption of the stain, into the patch. The gel patch can then be peeled away, to remove the stain.
",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;ILIFFE COREEN JANE;;BARLOW MARGARET LOUISE;;LAW JONATHAN MARK,,https://lens.org/082-964-263-534-858,Patent Application,yes,3,2,7,7,0,B08B1/00;;B08B3/04;;B08B3/10;;D06L1/00;;D06L4/10;;D06L4/00;;B08B3/04;;D06L1/00;;B08B3/10;;B08B1/00;;D06L4/10;;D06L4/00,B08B3/04,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 014, no. 057 (C - 0684) 2 February 1990 (1990-02-02);;PATENT ABSTRACTS OF JAPAN vol. 014, no. 090 (C - 0691) 20 February 1990 (1990-02-20)",INACTIVE
174,WO,A1,WO 2008/112617 A1,165-262-208-452-625,2008-09-18,2008,US 2008/0056373 W,2008-03-10,US 89402907 P,2007-03-09,METHOD AND SYSTEM FOR CHARACTERIZING MOVEMENT OF AN OBJECT,Motion of an object is characterized based on data indicative of a plurality of pixilated images of the object. An outline of the object may be extracted from the data for each pixilated image of the object. Changes over time in a shape and/or position of the outline may be used to determine a speed associated with the object.,TRIGONIMAGERY LLC;;BORMAN GILBERT A;;GRENLEY GEORGE R;;COBB RICHARD E;;LAHTI MARK C,BORMAN GILBERT A;;GRENLEY GEORGE R;;COBB RICHARD E;;LAHTI MARK C,,https://lens.org/165-262-208-452-625,Patent Application,yes,4,0,5,5,0,G06T7/20;;G06T7/20;;G06T2207/30236;;G06T2207/30236,G06K9/00,,0,0,,,,PENDING
175,US,A1,US 2020/0212589 A1,189-542-442-955-586,2020-07-02,2020,US 201916238125 A,2019-01-02,US 201916238125 A,2019-01-02,ANECHOIC CHAMBER AND METHOD OF CALIBRATING A RADAR SYSTEM,"A portable anechoic chamber is described herein. The chamber includes a housing including an interior, and the housing defines an opening sized to provide access to the interior. A layer of radar absorbent material lines the interior, and a reflective device is positioned within the interior. The reflective device is positioned to receive and reflect a radar beam emitted from a radar source.",HONDA MOTOR CO LTD,COBB DERRICK I;;BETZ DAVID B;;AYERS BRIAN D;;ZICCARDI ROBERT MARK,HONDA MOTOR CO. LTD (2018-12-20),https://lens.org/189-542-442-955-586,Patent Application,yes,0,3,2,2,0,G01S7/4052;;G01S7/40;;G01S7/4008;;G01S7/4086;;G01S13/931;;G01S2013/93271;;G01S2013/93272;;H01Q17/00,H01Q17/00;;G01S7/40,,0,0,,,,ACTIVE
176,AU,A,AU 2000/073493 A,105-998-697-346-844,2001-04-23,2001,AU 2000/073493 A,2000-09-01,US 41587399 A;;US 0024355 W,1999-10-08,Optical film with variable angle prisms,,3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD JR;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/105-998-697-346-844,Patent Application,no,0,0,13,13,0,G02B6/0031;;G02B6/0046;;G02B6/005;;G02B6/0053;;G02B6/0068;;G02B6/0071;;G02B5/04;;G02B6/0053;;G02B6/0071;;G02B6/0031;;G02B6/0046;;G02B6/0068;;G02B6/005,G02B5/04;;F21V8/00;;G02F1/13357,,0,0,,,,DISCONTINUED
177,EP,B1,EP 1218665 B1,023-500-698-184-281,2006-05-17,2006,EP 00973361 A,2000-08-31,US 0024204 W;;US 41547199 A,1999-10-08,OPTICAL ELEMENT HAVING PROGRAMMED OPTICAL STRUCTURES,,3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD JR;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/023-500-698-184-281,Granted Patent,yes,4,0,15,34,0,G02B6/0038;;G02B6/0038;;G02F1/1335;;G02B6/0051;;G02B6/0051;;G02B6/0053;;G02B6/0053;;G02F1/133615;;G02F1/133615;;Y10S385/901;;Y10S385/901,F21V8/00;;G02B5/02;;F21Y103/00;;G02B5/08;;G02F1/1335;;G02F1/13357,,5,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1997, no. 10, 31 October 1997 (1997-10-31) -& JP 09 145933 A (HITACHI LTD;HITACHI ELECTRON DEVICES KK), 6 June 1997 (1997-06-06);;PATENT ABSTRACTS OF JAPAN vol. 1999, no. 03, 31 March 1999 (1999-03-31) -& JP 10 339815 A (SANYO ELECTRIC CO LTD), 22 December 1998 (1998-12-22);;PATENT ABSTRACTS OF JAPAN vol. 1999, no. 12, 29 October 1999 (1999-10-29) -& JP 11 202135 A (OHTSU TIRE &AMP;RUBBER CO LTD:THE), 30 July 1999 (1999-07-30);;PATENT ABSTRACTS OF JAPAN vol. 1999, no. 14, 22 December 1999 (1999-12-22) -& JP 11 250714 A (OMRON CORP), 17 September 1999 (1999-09-17);;PATENT ABSTRACTS OF JAPAN vol. 1995, no. 09, 31 October 1995 (1995-10-31) -& JP 07 159622 A (NIPPON CHEMITEC KK;OTHERS: 01), 23 June 1995 (1995-06-23)",EXPIRED
178,AU,A,AU 2000/037421 A,090-031-296-048-683,2000-10-04,2000,AU 2000/037421 A,2000-03-13,US 12463599 P;;US 0006537 W,1999-03-16,Nuclear receptor arylating compounds,,GLAXO GROUP LTD,BLANCHARD STEVEN GERARD;;COBB JEFFERY EDMUND;;COLLINS JON LOREN;;WILLSON TIMOTHY MARK,,https://lens.org/090-031-296-048-683,Patent Application,no,0,0,4,4,0,A61P3/04;;A61P5/00;;A61P17/02;;A61P19/10;;A61P43/00;;C07D221/14;;C07C233/65;;C07C233/66;;C07C235/56;;C07C2603/64,A61K31/166;;A61K31/473;;A61P3/04;;A61P5/00;;A61P17/02;;A61P19/10;;A61P43/00;;C07C233/65;;C07C233/66;;C07C235/56;;C07D221/14,,0,0,,,,DISCONTINUED
179,WO,A1,WO 2000/055118 A1,195-542-488-879-862,2000-09-21,2000,US 0006537 W,2000-03-13,US 12463599 P,1999-03-16,NUCLEAR RECEPTOR ARYLATING COMPOUNDS,The present invention discloses novel nuclear receptor ligands of formula (IA) or (IB). These compounds are useful for arylating a cysteine in a nuclear receptor.,GLAXO GROUP LTD;;BLANCHARD STEVEN GERARD;;COBB JEFFERY EDMUND;;COLLINS JON LOREN;;WILLSON TIMOTHY MARK,BLANCHARD STEVEN GERARD;;COBB JEFFERY EDMUND;;COLLINS JON LOREN;;WILLSON TIMOTHY MARK,,https://lens.org/195-542-488-879-862,Patent Application,yes,9,10,4,4,0,A61P3/04;;A61P5/00;;A61P17/02;;A61P19/10;;A61P43/00;;C07D221/14;;C07C233/65;;C07C233/66;;C07C235/56;;C07C2603/64,A61K31/166;;A61K31/473;;A61P3/04;;A61P5/00;;A61P17/02;;A61P19/10;;A61P43/00;;C07C233/65;;C07C233/66;;C07C235/56;;C07D221/14,,8,1,045-348-699-111-847,10.1016/s0040-4020(98)00922-3,"NAGARAJAN K ET AL: ""CONDENSED HETEROTRICYCLES*: AMINO & AMINOALKYLDIBENZUB,FU1,4OXAZEPIN- 11(10H)-ONES"", INDIAN JOURNAL OF CHEMISTRY,IN,JODHPUR, vol. 12, 1 March 1974 (1974-03-01), pages 236 - 246, XP000650379;;PATENT ABSTRACTS OF JAPAN vol. 1997, no. 07 31 July 1997 (1997-07-31);;HANS-G. BOIT: ""Beilsteins Handbuch der organischen Chemie, 4th Edition, 3th Suppl., vol. 12"", 1972, SPRINGER - VERLAG, BERLIN . HEIDELBERG . NEW YORK, XP002141466;;FRIEDRICH RICHTER: ""Beilsteins Handbuch der organischen Chemie, 4th Edition, second Suppl., vol. 12"", 1950, SPRINGER-VERLAG, BERLIN . GÖTTINGEN . HEIDELBERG, XP002141467;;CHEMICAL ABSTRACTS, vol. 116, no. 19, 11 May 1992, Columbus, Ohio, US; abstract no. 194121x, NEMAZANYI, A. G. ET AL.: ""Synthesis and structure of 3-amino-4-heteroaryl-1(2H)isoquinolones."" page 708; column 1; XP002141468;;CHEMICAL ABSTRACTS, vol. 85, no. 11, 13 September 1976, Columbus, Ohio, US; abstract no. 77216n, EGE, GUENTER ET AL.: ""Ring-fission of cyclic azo compounds,..."" page 475; column 2; XP002141469;;CHEMICAL ABSTRACTS, vol. 71, no. 11, 15 September 1969, Columbus, Ohio, US; abstract no. 49619p, OSIEKA, HANS page 355; column 2; XP002141470;;BROGGINI G ET AL: ""A new Entry to [1,2,4]Triazolo[1,5-a][1,4]benzodiazepin-6-ones via Intramolecular Nitrilimine Cycloaddition to the Cyano Group"", TETRAHEDRON,NL,ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, vol. 54, no. 49, 3 December 1998 (1998-12-03), pages 14859 - 14868, XP004142608, ISSN: 0040-4020",PENDING
180,US,A1,US 2014/0072181 A1,022-774-117-307-864,2014-03-13,2014,US 201314080277 A,2013-11-14,US 201314080277 A;;US 53054809 A;;US 2008/0056373 W;;US 89402907 P,2007-03-09,METHOD AND SYSTEM FOR CHARACTERIZING MOVEMENT OF AN OBJECT,Motion of an object is characterized based on data indicative of a plurality of pixilated images of the object. An outline of the object may be extracted from the data for each pixilated image of the object. Changes over time in a shape and/or position of the outline may be used to determine a speed associated with the object.,TRIGONIMAGERY LLC,BORMAN GILBERT A;;GRENLEY GEORGE R;;COBB RICHARD E;;LAHTI MARK C,,https://lens.org/022-774-117-307-864,Patent Application,yes,0,0,5,5,0,G06T7/20;;G06T7/20;;G06T2207/30236;;G06T2207/30236,G06T7/20,382/107,0,0,,,,DISCONTINUED
181,EP,A1,EP 1161412 A1,075-275-604-575-758,2001-12-12,2001,EP 00916297 A,2000-03-13,US 0006537 W;;US 12463599 P,1999-03-16,NUCLEAR RECEPTOR ARYLATING COMPOUNDS,,GLAXO GROUP LTD,BLANCHARD STEVEN GERARD;;COBB JEFFERY EDMUND;;COLLINS JON LOREN;;WILLSON TIMOTHY MARK,,https://lens.org/075-275-604-575-758,Patent Application,yes,0,0,4,4,0,A61P3/04;;A61P5/00;;A61P17/02;;A61P19/10;;A61P43/00;;C07D221/14;;C07C233/65;;C07C233/66;;C07C235/56;;C07C2603/64,A61K31/166;;A61K31/473;;A61P3/04;;A61P5/00;;A61P17/02;;A61P19/10;;A61P43/00;;C07C233/65;;C07C233/66;;C07C235/56;;C07D221/14,,1,0,,,See references of WO 0055118A1,DISCONTINUED
182,US,A1,US 2006/0051048 A1,082-448-538-979-012,2006-03-09,2006,US 22682905 A,2005-09-14,US 22682905 A;;US 61331300 A;;US 41547199 A,1999-10-08,Backlight with structured surfaces,"A backlight includes a lightguide, a light source disposed with respect to the lightguide to introduce light into the lightguide and a turning film. Optical structures are formed in one of an output surface and a back surface of the lightguide. The optical structures are arranged to extract light from the lightguide. A back reflector is disposed adjacent the back surface. The optical structures are formed to include a varying pattern arranged to mask non-uniformities in the output of the lightguide.",GARDINER MARK E;;COBB SANFORD JR;;EPSTEIN KENNETH A;;KRETMAN WADE D,GARDINER MARK E;;COBB SANFORD JR;;EPSTEIN KENNETH A;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY (2005-10-31),https://lens.org/082-448-538-979-012,Patent Application,yes,99,56,5,34,0,G02B6/0036;;G02B6/0043;;G02B6/0046;;G02B6/0055;;G02B6/0061;;G02B6/0038;;Y10S385/901;;G02B6/0046;;G02B6/0061;;G02B6/0055;;G02B6/0036;;G02B6/0043;;G02B6/0038;;G02B6/0001;;Y10S385/901,G02B6/10,385/146;;385/31,0,0,,,,EXPIRED
183,EP,B1,EP 1714712 B1,145-921-314-909-132,2009-02-18,2009,EP 05008725 A,2005-04-21,EP 05008725 A,2005-04-21,Device and method for applying a treatment agent to a surface,"A device for treating a surface to give a cleaning benefit comprises one or more containers (402) containing cleaning liquid. When the actuator (416) is depressed cleaning liquid is delivered to an outlet zone (406) located over a stain, where it forms a gel patch. Continued depression of the actuator means causes a piston 436 to press the gel patch against the surface, caused improved absorption of the stain, into the patch. The gel patch can then be peeled away, to remove the stain.",RECKITT BENCKISER UK LTD,COBB VICTORIA HEATHER;;ILIFFE COREEN JANE;;BARLOW MARGARET LOUISE;;LAW JONATHAN MARK,,https://lens.org/145-921-314-909-132,Granted Patent,yes,3,0,7,7,0,B08B1/00;;B08B3/04;;B08B3/10;;D06L1/00;;D06L4/10;;D06L4/00;;B08B3/04;;D06L1/00;;B08B3/10;;B08B1/00;;D06L4/10;;D06L4/00,B08B3/04,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 014, no. 057 (C-0684), 2 February 1990 (1990-02-02) & JP 01 284299 A (SHIGEZO KOJIMA; others: 01), 15 November 1989 (1989-11-15);;PATENT ABSTRACTS OF JAPAN vol. 014, no. 090 (C-0691), 20 February 1990 (1990-02-20) & JP 01 301874 A (TANAKA KIKINZOKU KOGYO KK), 6 December 1989 (1989-12-06)",INACTIVE
184,EP,A1,EP 1218665 A1,071-265-321-654-283,2002-07-03,2002,EP 00973361 A,2000-08-31,US 0024204 W;;US 41547199 A,1999-10-08,OPTICAL ELEMENT HAVING PROGRAMMED OPTICAL STRUCTURES,,3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD JR;;EPSTEIN KENNETH A;;KRETMAN WADE D,,https://lens.org/071-265-321-654-283,Patent Application,yes,0,1,15,34,0,G02B6/0038;;G02B6/0038;;G02F1/1335;;G02B6/0051;;G02B6/0051;;G02B6/0053;;G02B6/0053;;G02F1/133615;;G02F1/133615;;Y10S385/901;;Y10S385/901,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/08;;G02F1/13357,,1,0,,,See references of WO 0127527A1,EXPIRED
185,WO,A2,WO 2012/162653 A2,070-502-274-905-085,2012-11-29,2012,US 2012/0039682 W,2012-05-25,US 201161489787 P;;US 201161489854 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489847 P,2011-05-25,CLOSED-CELL TANNIN-BASED FOAMS,"Disclosed are foam compositions and processes to form closed-cell tannin-based foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a tannin-based resin derived from a tannin, a first monomer, and a second monomer, wherein the first monomer comprises formaldehyde, paraformaldehyde, furfural, glyoxal, acetaldehyde, 5-hydroxymethylfurfural, acrolein, levulinate esters, sugars, 2,5-furandicarboxylic acid, 2,5-furandicarboxylic aldehyde, urea, difurfural (DFF), or mixtures thereof, and the second monomer comprises furfuryl alcohol, glycerol, sorbitol, lignin, or mixtures thereof, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising one or more blowing agents.",DU PONT;;COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,,https://lens.org/070-502-274-905-085,Patent Application,yes,0,0,16,33,0,B32B5/022;;B32B5/022;;B32B5/024;;B32B5/024;;B32B5/18;;B32B5/18;;B32B7/12;;B32B7/12;;B32B13/045;;B32B13/045;;B32B15/046;;B32B15/046;;B32B15/18;;B32B15/18;;B32B15/20;;B32B15/20;;B32B21/047;;B32B21/047;;B32B27/065;;B32B27/065;;B32B27/32;;B32B27/32;;B32B27/34;;B32B27/34;;B32B27/36;;B32B27/36;;B32B29/007;;B32B29/007;;B32B2250/40;;B32B2250/40;;B32B2255/26;;B32B2255/26;;B32B2266/02;;B32B2266/0214;;B32B2266/0228;;B32B2266/0278;;B32B2266/06;;B32B2266/08;;B32B2266/08;;B32B2266/104;;B32B2266/126;;B32B2307/304;;B32B2307/304;;B32B2419/00;;B32B2419/00;;C08J9/12;;C08J9/12;;C08G65/40;;C08J9/141;;C08J9/146;;C08J2205/052;;C08J2205/052;;C08J2397/00;;C08J2397/00;;C08J2399/00;;C08J2399/00;;C08J2459/00;;C08J2459/00;;Y10T428/249976;;Y10T428/249976,C08J9/12,,3,3,005-416-524-580-204;;018-449-835-963-31X;;125-459-258-962-082,10.1017/s1431927609990444;;19709464;;10.1002/anie.200604274;;17659519;;10.1016/j.tca.2005.06.026,"TONDI ET AL., MICROSCOPY AND MICROANALYSIS, vol. 15, pages 384 - 394;;CHHEDA: ""Liquid Phase catalytic Processing of Biomass-derived Oxygenated Hydrocarbons to fuels and Chemicals"", ANGEWANDTE CHEMIE, INT., vol. 46, 2007, pages 7164 - 7183;;YI HE, THERMOCHIMICA ACTA, vol. 436, 2005, pages 122 - 129",PENDING
186,WO,A3,WO 2012/162653 A3,001-558-213-412-287,2013-01-17,2013,US 2012/0039682 W,2012-05-25,US 201161489787 P;;US 201161489854 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489847 P,2011-05-25,CLOSED-CELL TANNIN-BASED FOAMS,"Disclosed are foam compositions and processes to form closed-cell tannin-based foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a tannin-based resin derived from a tannin, a first monomer, and a second monomer, wherein the first monomer comprises formaldehyde, paraformaldehyde, furfural, glyoxal, acetaldehyde, 5-hydroxymethylfurfural, acrolein, levulinate esters, sugars, 2,5-furandicarboxylic acid, 2,5-furandicarboxylic aldehyde, urea, difurfural (DFF), or mixtures thereof, and the second monomer comprises furfuryl alcohol, glycerol, sorbitol, lignin, or mixtures thereof, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising one or more blowing agents.",DU PONT;;COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,,https://lens.org/001-558-213-412-287,Search Report,yes,0,0,16,33,0,B32B5/022;;B32B5/022;;B32B5/024;;B32B5/024;;B32B5/18;;B32B5/18;;B32B7/12;;B32B7/12;;B32B13/045;;B32B13/045;;B32B15/046;;B32B15/046;;B32B15/18;;B32B15/18;;B32B15/20;;B32B15/20;;B32B21/047;;B32B21/047;;B32B27/065;;B32B27/065;;B32B27/32;;B32B27/32;;B32B27/34;;B32B27/34;;B32B27/36;;B32B27/36;;B32B29/007;;B32B29/007;;B32B2250/40;;B32B2250/40;;B32B2255/26;;B32B2255/26;;B32B2266/02;;B32B2266/0214;;B32B2266/0228;;B32B2266/0278;;B32B2266/06;;B32B2266/08;;B32B2266/08;;B32B2266/104;;B32B2266/126;;B32B2307/304;;B32B2307/304;;B32B2419/00;;B32B2419/00;;C08J9/12;;C08J9/12;;C08G65/40;;C08J9/141;;C08J9/146;;C08J2205/052;;C08J2205/052;;C08J2397/00;;C08J2397/00;;C08J2399/00;;C08J2399/00;;C08J2459/00;;C08J2459/00;;Y10T428/249976;;Y10T428/249976,C08J9/12;;B32B5/18,,2,2,094-564-833-981-610;;012-234-036-850-910,10.1016/j.indcrop.2008.07.003;;10.4067/s0718-221x2008000300005,"TONDI G ET AL: ""Tannin-based rigid foams: Characterization and modification"", INDUSTRIAL CROPS AND PRODUCTS, ELSEVIER, NL, vol. 29, no. 2-3, 1 March 2009 (2009-03-01), pages 356 - 363, XP025951523, ISSN: 0926-6690, [retrieved on 20080909], DOI: 10.1016/J.INDCROP.2008.07.003;;G TONDI ET AL: ""NATURAL TANNIN-BASED RIGID FOAMS AS INSULATION FOR DOORS AND WALL PANELS"", MADERAS. CIENCIA Y TECNOLOGÍA, vol. 10, no. 3, 1 January 2008 (2008-01-01), pages 219 - 227, XP055046154, DOI: 10.4067/S0718-221X2008000300005",PENDING
187,US,B2,US 10052247 B2,042-740-995-234-072,2018-08-21,2018,US 201615244647 A,2016-08-23,US 201615244647 A;;US 201562208875 P;;US 201662329176 P,2015-08-24,Wheelchair with four wheel independent suspension and modular seating,"This invention provides a wheelchair with four wheel independent suspension and modular seating, allowing for customized seat selection and a variable ride. It includes a chair assembly, a chassis assembly and a suspension assembly. The chair assembly includes a seat; a seat mount; a seat angle adjuster; and a pillar. The chassis assembly includes a chassis; and a handle assembly. The suspension assembly includes a forward suspension assembly and a rear suspension assembly. In another embodiment, the wheelchair includes a chair assembly with handles, a main cross beam and a suspension spring assembly.",DREAM ROLLER MOBILITY LLC,VEREEN III ROYAL LEO;;NEARBURG MARK KLEBER;;COBB PRICE DANIELS;;MITCHUM THOMAS ALLAN,DREAM ROLLER MOBILITY LLC (2016-11-30),https://lens.org/042-740-995-234-072,Granted Patent,yes,82,10,4,4,0,B60G2300/24;;A61G7/1025;;A61G5/107;;A61G5/128;;A61G5/1078;;B60G2200/13;;B60G5/06;;A61G5/1075;;A61G7/103;;A61G5/107;;A61G5/128;;A61G5/1078;;A61G5/1091;;B60G2200/13;;B60G5/06;;A61G5/1075;;B60G2300/24;;A61G7/1025,A61G5/10;;A61G5/12;;A61G7/10;;B60G5/06,,5,0,,,"USA Techguide, “Invacare Orbit”, “http://www.usatechguide.org/itemreview.php?itemid=839”, May 14, 2015, Publisher: USA Techguide, Published in: US.;;Especial Needs, “Kid Kart Xpress Pediatric Wheelchair”, “http://www.especialneeds.com/strollers-wheelchairs-ramps-strollers-pushchairs-stroller-sty . . . ”, May 14, 2015, Publisher: eSpecial Needs, Published in: US.;;dlf-data.org, “Minny Ultra-Lightweight Wheelchair”, “http://www.dlf-data.org.uk/product.php?product_id=0038101&groupid=2766”, May 14, 2015, Publisher: dlf-data.org, Published in: UK.;;Spinlife, “Spinlife”, “http://www.spinlife.com/images/alternate/223_3_13.jpg”, May 14, 2015, Publisher: Spinlife, Published in: US.;;ADI, “Variable Leve—User Interface”, “http://adirides.com/disc-brake-systems/variable-lever/”, May 14, 2015, Publisher: ADI, Published in: US.",ACTIVE
188,US,B2,US 9701803 B2,188-250-530-321-603,2017-07-11,2017,US 201214118906 A,2012-05-25,US 201214118906 A;;US 201161489787 P;;US 201161489854 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489847 P;;US 2012/0039682 W,2011-05-25,Closed-cell tannin-based foams,"Disclosed are foam compositions and processes to form closed-cell tannin-based foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a tannin-based resin derived from a tannin, a first monomer, and a second monomer, wherein the first monomer comprises formaldehyde, paraformaldehyde, furfural, glyoxal, acetaldehyde, 5-hydroxymethylfurfural, acrolein, levulinate esters, sugars, 2,5-furandicarboxylic acid, 2,5-furandicarboxylic aldehyde, urea, difurfural (DFF), or mixtures thereof, and the second monomer comprises furfuryl alcohol, glycerol, sorbitol, lignin, or mixtures thereof, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising one or more blowing agents.",COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE;;DU PONT,COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,DUPONT SAFETY & CONSTRUCTION INC (2019-06-17),https://lens.org/188-250-530-321-603,Granted Patent,yes,9,3,16,33,0,B32B5/022;;B32B5/022;;B32B5/024;;B32B5/024;;B32B5/18;;B32B5/18;;B32B7/12;;B32B7/12;;B32B13/045;;B32B13/045;;B32B15/046;;B32B15/046;;B32B15/18;;B32B15/18;;B32B15/20;;B32B15/20;;B32B21/047;;B32B21/047;;B32B27/065;;B32B27/065;;B32B27/32;;B32B27/32;;B32B27/34;;B32B27/34;;B32B27/36;;B32B27/36;;B32B29/007;;B32B29/007;;B32B2250/40;;B32B2250/40;;B32B2255/26;;B32B2255/26;;B32B2266/02;;B32B2266/0214;;B32B2266/0228;;B32B2266/0278;;B32B2266/06;;B32B2266/08;;B32B2266/08;;B32B2266/104;;B32B2266/126;;B32B2307/304;;B32B2307/304;;B32B2419/00;;B32B2419/00;;C08J9/12;;C08J9/12;;C08G65/40;;C08J9/141;;C08J9/146;;C08J2205/052;;C08J2205/052;;C08J2397/00;;C08J2397/00;;C08J2399/00;;C08J2399/00;;C08J2459/00;;C08J2459/00;;Y10T428/249976;;Y10T428/249976,C08J9/12;;B32B5/02;;B32B5/18;;B32B7/12;;B32B13/04;;B32B15/04;;B32B15/18;;B32B15/20;;B32B21/04;;B32B27/06;;B32B27/32;;B32B27/34;;B32B27/36;;B32B29/00;;C08G65/40;;C08J9/14,,13,11,135-677-566-825-010;;082-180-992-479-021;;113-315-666-137-112;;007-509-204-871-622;;023-263-699-117-594;;050-700-818-690-417;;020-153-118-598-718;;012-234-036-850-910;;094-564-833-981-610;;005-416-524-580-204;;005-416-524-580-204,10.1002/app.1994.070531117;;10.1002/app.28545;;10.1016/j.matchemphys.2010.02.062;;10.1016/j.matchemphys.2010.03.084;;10.1002/app.1979.070230634;;10.1016/j.carbon.2009.01.041;;19576764;;10.1016/j.biortech.2009.05.055;;10.4067/s0718-221x2008000300005;;10.1016/j.indcrop.2008.07.003;;10.1017/s1431927609990444;;19709464;;10.1017/s1431927609990444;;19709464,"Takahashi et al., Phenol Resin Foamed Article, Mar. 22, 2007, machine translation of JP2007-070512.;;Meikleham, N. E. et al., Acid- and Alkali-Catalyzed Tannin-Based Rigid Foams, Journal of Applied Polymer Science, 1994, pp. 1547-1556, vol. 53.;;Link, Martin et al., Formaldehyde-Free Tannin-Based Foams and Their Use as Lightweight Panels, BioResources, 2011, pp. 4218-4228, vol. 6, No. 4.;;Pizzi, A. et al., Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Structure Determination of Complex Theromset Networks: Polyflavonoid Tannin-Furanic Rigid Foams, Journal of Applied Polymer Science, 2008, pp. 1451-1456, vol. 110.;;Zhao, W. et al., Effect of composition and processing parameters on the characteristics of tannin-based rigid foams. Part I: Cell structure, Materials Chemistry and Physics, 2010, pp. 175-182, vol. 122.;;Zhao, W. et al., Effect of composition and processing parameters on the characteristics of tannin-based rigid foams. Part II: Physical Properties, Materials Chemistry and Physics, 2010, pp. 210-217, vol. 123.;;Pizzi, A., Tannin-Based Neutral and Alkaline Phenolic-Type Foams, Journal of Applied Polymer Science, 1979, pp. 1901-1905, vol. 23.;;Tondi, G. et al., Tannin-based carbon foams, Carbon, 2009, pp. 1480-1492, vol. 47.;;Tondi, G. et al., Tannin-based rigid foams: A survey of chemical and physical properties, Bioresource Technology, 2009, pp. 5162-5169, vol. 100.;;Tondi, G. et al., Natural Tannin-Based Rigid Foams as Insulation for Doors and Wall Panels, Maderas. Ciencia y Tecnologia, 2008, pp. 219-227.;;Tondi, G. et al., Tannin-based rigid foams: Characterization and modification, Industrial Crops and Products, 2009, pp. 356-363, vol. 29.;;Tondi, G. et al., X-Ray Microtomography Studies of Tannin-Derived Organic and Carbon Foams, Microscopy and Microanalysis, 2009, pp. 384-394, vol. 15.;;Tondi et al., “X-Ray Microtomography Studies of Tannin-Derived Organic and Carbon Foams”, Microscopy and Microanalysis, 15, 384-394, 2009.",ACTIVE
189,EP,A2,EP 2714783 A2,006-136-267-259-793,2014-04-09,2014,EP 12724839 A,2012-05-25,US 201161489787 P;;US 201161489854 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489847 P;;US 2012/0039682 W,2011-05-25,CLOSED-CELL TANNIN-BASED FOAMS,,DU PONT,COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,E. I. DU PONT DE NEMOURS AND COMPANY (2016-01-13),https://lens.org/006-136-267-259-793,Patent Application,yes,0,0,16,33,0,B32B5/022;;B32B5/022;;B32B5/024;;B32B5/024;;B32B5/18;;B32B5/18;;B32B7/12;;B32B7/12;;B32B13/045;;B32B13/045;;B32B15/046;;B32B15/046;;B32B15/18;;B32B15/18;;B32B15/20;;B32B15/20;;B32B21/047;;B32B21/047;;B32B27/065;;B32B27/065;;B32B27/32;;B32B27/32;;B32B27/34;;B32B27/34;;B32B27/36;;B32B27/36;;B32B29/007;;B32B29/007;;B32B2250/40;;B32B2250/40;;B32B2255/26;;B32B2255/26;;B32B2266/02;;B32B2266/0214;;B32B2266/0228;;B32B2266/0278;;B32B2266/06;;B32B2266/08;;B32B2266/08;;B32B2266/104;;B32B2266/126;;B32B2307/304;;B32B2307/304;;B32B2419/00;;B32B2419/00;;C08J9/12;;C08J9/12;;C08G65/40;;C08J9/141;;C08J9/146;;C08J2205/052;;C08J2205/052;;C08J2397/00;;C08J2397/00;;C08J2399/00;;C08J2399/00;;C08J2459/00;;C08J2459/00;;Y10T428/249976;;Y10T428/249976,C08J9/12,,1,0,,,See references of WO 2012162653A2,DISCONTINUED
190,WO,A2,WO 2012/162656 A2,056-344-222-916-980,2012-11-29,2012,US 2012/0039687 W,2012-05-25,US 201161489790 P;;US 201161489854 P;;US 201161489787 P;;US 201161489795 P;;US 201161489803 P;;US 201161489847 P,2011-05-25,CLOSED-CELL TANNIN-BASED FOAMS,"Disclosed are foam compositions and processes to form closed-cell tannin-based foams. The process comprises forming an agglomerate-free solution comprising a tannin, a first monomer, a second monomer, and water, wherein the first monomer comprises formaldehyde, paraformaldehyde, furfural, glyoxal, acetaldehyde, 5-hydroxymethylfurfural, acroleim, levulinate esters, sugars, 2,5-furandicarboxylic acid, 2,5-furandicarboxylic aldehyde, urea, difurfural (DFF), or mixtures thereof, and the second monomer comprises furfuryl alcohol, glycerol, sorbitol, lignin, or mixtures thereof. The process also comprises mixing one or more blowing agents with the agglomerate-free solution to form a pre-foam mixture and mixing an acid catalyst with the pre-foam mixture to form a foam composition. The process comprises adding a surfactant to at least one of the agglomerate-free solution, pre-foam mixture, or the foam composition. The process further comprises processing the foam composition to form a tannin-based foam.",DU PONT;;COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,,https://lens.org/056-344-222-916-980,Patent Application,yes,0,0,16,33,0,B32B5/022;;B32B5/022;;B32B5/024;;B32B5/024;;B32B5/18;;B32B5/18;;B32B7/12;;B32B7/12;;B32B13/045;;B32B13/045;;B32B15/046;;B32B15/046;;B32B15/18;;B32B15/18;;B32B15/20;;B32B15/20;;B32B21/047;;B32B21/047;;B32B27/065;;B32B27/065;;B32B27/32;;B32B27/32;;B32B27/34;;B32B27/34;;B32B27/36;;B32B27/36;;B32B29/007;;B32B29/007;;B32B2250/40;;B32B2250/40;;B32B2255/26;;B32B2255/26;;B32B2266/02;;B32B2266/0214;;B32B2266/0228;;B32B2266/0278;;B32B2266/06;;B32B2266/08;;B32B2266/08;;B32B2266/104;;B32B2266/126;;B32B2307/304;;B32B2307/304;;B32B2419/00;;B32B2419/00;;C08J9/12;;C08J9/12;;C08G65/40;;C08J9/141;;C08J9/146;;C08J2205/052;;C08J2205/052;;C08J2397/00;;C08J2397/00;;C08J2399/00;;C08J2399/00;;C08J2459/00;;C08J2459/00;;Y10T428/249976;;Y10T428/249976,C08J9/12,,0,0,,,,PENDING
191,US,A1,US 2018/0344548 A1,093-657-264-895-929,2018-12-06,2018,US 201816039582 A,2018-07-19,US 201816039582 A;;US 201615244647 A;;US 201562208875 P;;US 201662329176 P,2015-08-24,WHEELCHAIR WITH FOUR WHEEL INDEPENDENT SUSPENSION AND MODULAR SEATING,"This invention provides a wheelchair with four-wheel independent suspension and modular seating, allowing for customized seat selection and a variable ride. It includes a chair assembly, a chassis assembly and a suspension assembly. The chair assembly includes a seat; a seat mount; a seat angle adjuster; and a pillar. The chassis assembly includes a chassis; and a handle assembly. The suspension assembly incudes a forward suspension assembly and a rear suspension assembly. In another embodiment, the wheelchair includes a chair assembly with handles, a main cross beam and a suspension spring assembly.",DREAM ROLLER MOBILITY LLC,VEREEN III ROYAL LEO;;NEARBURG MARK KLEBER;;COBB PRICE DANIELS;;MITCHUM THOMAS ALLAN,DREAM ROLLER MOBILITY LLC (2018-07-18),https://lens.org/093-657-264-895-929,Patent Application,yes,0,4,4,4,0,B60G2300/24;;A61G7/1025;;A61G5/107;;A61G5/128;;A61G5/1078;;B60G2200/13;;B60G5/06;;A61G5/1075;;A61G7/103;;A61G5/107;;A61G5/128;;A61G5/1078;;A61G5/1091;;B60G2200/13;;B60G5/06;;A61G5/1075;;B60G2300/24;;A61G7/1025,A61G5/10;;A61G5/12;;A61G7/10;;B60G5/06,,0,0,,,,DISCONTINUED
192,US,A1,US 2017/0056261 A1,020-138-390-300-540,2017-03-02,2017,US 201615244647 A,2016-08-23,US 201615244647 A;;US 201562208875 P;;US 201662329176 P,2015-08-24,WHEELCHAIR WITH FOUR WHEEL INDEPENDENT SUSPENSION AND MODULAR SEATING,"This invention provides a wheelchair with four wheel independent suspension and modular seating, allowing for customized seat selection and a variable ride. It includes a chair assembly, a chassis assembly and a suspension assembly. The chair assembly includes a seat; a seat mount; a seat angle adjuster; and a pillar. The chassis assembly includes a chassis; and a handle assembly. The suspension assembly includes a forward suspension assembly and a rear suspension assembly. In another embodiment, the wheelchair includes a chair assembly with handles, a main cross beam and a suspension spring assembly.",DREAM ROLLER MOBILITY LLC,VEREEN III ROYAL LEO;;NEARBURG MARK KLEBER;;COBB PRICE DANIELS;;MITCHUM THOMAS ALLAN,DREAM ROLLER MOBILITY LLC (2016-11-30),https://lens.org/020-138-390-300-540,Patent Application,yes,35,13,4,4,0,B60G2300/24;;A61G7/1025;;A61G5/107;;A61G5/128;;A61G5/1078;;B60G2200/13;;B60G5/06;;A61G5/1075;;A61G7/103;;A61G5/107;;A61G5/128;;A61G5/1078;;A61G5/1091;;B60G2200/13;;B60G5/06;;A61G5/1075;;B60G2300/24;;A61G7/1025,A61G5/10;;A61G5/12,,0,0,,,,ACTIVE
193,CA,A1,CA 2834598 A1,077-501-487-090-983,2012-11-29,2012,CA 2834598 A,2012-05-25,US 201161489787 P;;US 201161489854 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489847 P;;US 2012/0039682 W,2011-05-25,CLOSED-CELL TANNIN-BASED FOAMS,"Disclosed are foam compositions and processes to form closed-cell tannin-based foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a tannin-based resin derived from a tannin, a first monomer, and a second monomer, wherein the first monomer comprises formaldehyde, paraformaldehyde, furfural, glyoxal, acetaldehyde, 5-hydroxymethylfurfural, acrolein, levulinate esters, sugars, 2,5-furandicarboxylic acid, 2,5-furandicarboxylic aldehyde, urea, difurfural (DFF), or mixtures thereof, and the second monomer comprises furfuryl alcohol, glycerol, sorbitol, lignin, or mixtures thereof, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising one or more blowing agents.",DU PONT,COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,,https://lens.org/077-501-487-090-983,Patent Application,no,0,0,16,33,0,B32B5/022;;B32B5/022;;B32B5/024;;B32B5/024;;B32B5/18;;B32B5/18;;B32B7/12;;B32B7/12;;B32B13/045;;B32B13/045;;B32B15/046;;B32B15/046;;B32B15/18;;B32B15/18;;B32B15/20;;B32B15/20;;B32B21/047;;B32B21/047;;B32B27/065;;B32B27/065;;B32B27/32;;B32B27/32;;B32B27/34;;B32B27/34;;B32B27/36;;B32B27/36;;B32B29/007;;B32B29/007;;B32B2250/40;;B32B2250/40;;B32B2255/26;;B32B2255/26;;B32B2266/02;;B32B2266/0214;;B32B2266/0228;;B32B2266/0278;;B32B2266/06;;B32B2266/08;;B32B2266/08;;B32B2266/104;;B32B2266/126;;B32B2307/304;;B32B2307/304;;B32B2419/00;;B32B2419/00;;C08J9/12;;C08J9/12;;C08G65/40;;C08J9/141;;C08J9/146;;C08J2205/052;;C08J2205/052;;C08J2397/00;;C08J2397/00;;C08J2399/00;;C08J2399/00;;C08J2459/00;;C08J2459/00;;Y10T428/249976;;Y10T428/249976,C08J9/12;;B32B5/18,,0,0,,,,DISCONTINUED
194,WO,A3,WO 2012/162656 A3,195-519-619-457-032,2014-08-28,2014,US 2012/0039687 W,2012-05-25,US 201161489790 P;;US 201161489854 P;;US 201161489787 P;;US 201161489795 P;;US 201161489803 P;;US 201161489847 P,2011-05-25,CLOSED-CELL TANNIN-BASED FOAMS,"Disclosed are foam compositions and processes to form closed-cell tannin-based foams. The process comprises forming an agglomerate-free solution comprising a tannin, a first monomer, a second monomer, and water, wherein the first monomer comprises formaldehyde, paraformaldehyde, furfural, glyoxal, acetaldehyde, 5-hydroxymethylfurfural, acroleim, levulinate esters, sugars, 2,5-furandicarboxylic acid, 2,5-furandicarboxylic aldehyde, urea, difurfural (DFF), or mixtures thereof, and the second monomer comprises furfuryl alcohol, glycerol, sorbitol, lignin, or mixtures thereof. The process also comprises mixing one or more blowing agents with the agglomerate-free solution to form a pre-foam mixture and mixing an acid catalyst with the pre-foam mixture to form a foam composition. The process comprises adding a surfactant to at least one of the agglomerate-free solution, pre-foam mixture, or the foam composition. The process further comprises processing the foam composition to form a tannin-based foam.",DU PONT;;COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,COBB MICHAEL W;;GALANTE VINCENT;;HARMER MARK ANDREW;;KAPUR VIVEK;;WILLIAMS SHARLENE RENEE,,https://lens.org/195-519-619-457-032,Search Report,yes,0,0,16,33,0,B32B5/022;;B32B5/022;;B32B5/024;;B32B5/024;;B32B5/18;;B32B5/18;;B32B7/12;;B32B7/12;;B32B13/045;;B32B13/045;;B32B15/046;;B32B15/046;;B32B15/18;;B32B15/18;;B32B15/20;;B32B15/20;;B32B21/047;;B32B21/047;;B32B27/065;;B32B27/065;;B32B27/32;;B32B27/32;;B32B27/34;;B32B27/34;;B32B27/36;;B32B27/36;;B32B29/007;;B32B29/007;;B32B2250/40;;B32B2250/40;;B32B2255/26;;B32B2255/26;;B32B2266/02;;B32B2266/0214;;B32B2266/0228;;B32B2266/0278;;B32B2266/06;;B32B2266/08;;B32B2266/08;;B32B2266/104;;B32B2266/126;;B32B2307/304;;B32B2307/304;;B32B2419/00;;B32B2419/00;;C08J9/12;;C08J9/12;;C08G65/40;;C08J9/141;;C08J9/146;;C08J2205/052;;C08J2205/052;;C08J2397/00;;C08J2397/00;;C08J2399/00;;C08J2399/00;;C08J2459/00;;C08J2459/00;;Y10T428/249976;;Y10T428/249976,C08J9/12;;B32B5/18,,2,2,012-234-036-850-910;;094-564-833-981-610,10.4067/s0718-221x2008000300005;;10.1016/j.indcrop.2008.07.003,"G TONDI ET AL: ""NATURAL TANNIN-BASED RIGID FOAMS AS INSULATION FOR DOORS AND WALL PANELS"", MADERAS. CIENCIA Y TECNOLOGÍA, vol. 10, no. 3, 1 January 2008 (2008-01-01), XP055046154, DOI: 10.4067/S0718-221X2008000300005;;TONDI G ET AL: ""Tannin-based rigid foams: Characterization and modification"", INDUSTRIAL CROPS AND PRODUCTS, ELSEVIER, NL, vol. 29, no. 2-3, 1 March 2009 (2009-03-01), pages 356 - 363, XP025951523, ISSN: 0926-6690, [retrieved on 20080909], DOI: 10.1016/J.INDCROP.2008.07.003",PENDING
195,WO,A1,WO 2017/035245 A1,088-174-488-599-945,2017-03-02,2017,US 2016/0048418 W,2016-08-24,US 201615244647 A;;US 201662329176 P;;US 201562208875 P,2015-08-24,WHEELCHAIR WITH FOUR WHEEL INDEPENDENT SUSPENSION AND MODULAR SEATING,"This invention provides a wheelchair with four wheel independent suspension and modular seating, allowing for customized seat selection and a variable ride. It includes a chair assembly, a chassis assembly and a suspension assembly. The chair assembly includes a seat; a seat mount; a seat angle adjuster; and a pillar. The chassis assembly includes a chassis; and a handle assembly. The suspension assembly includes a forward suspension assembly and a rear suspension assembly. In another embodiment, the wheelchair includes a chair assembly with handles, a main cross beam and a suspension spring assembly.",DREAM ROLLER MOBILITY LLC;;VEREEN III ROYAL LEO;;NEARBURG MARK KLEBER;;COBB PRICE DANIELS;;MITCHUM THOMAS ALLAN,VEREEN III ROYAL LEO;;NEARBURG MARK KLEBER;;COBB PRICE DANIELS;;MITCHUM THOMAS ALLAN,,https://lens.org/088-174-488-599-945,Patent Application,yes,5,1,4,4,0,B60G2300/24;;A61G7/1025;;A61G5/107;;A61G5/128;;A61G5/1078;;B60G2200/13;;B60G5/06;;A61G5/1075;;A61G7/103;;A61G5/107;;A61G5/128;;A61G5/1078;;A61G5/1091;;B60G2200/13;;B60G5/06;;A61G5/1075;;B60G2300/24;;A61G7/1025,A61G5/10;;A61G5/02,,0,0,,,,PENDING
196,WO,A3,WO 2012/162649 A3,094-882-315-355-242,2014-01-03,2014,US 2012/0039675 W,2012-05-25,US 201161489854 P;;US 201161489787 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489847 P;;US 201161489807 P,2011-05-25,MIXED TANNIN-PHENOLIC FOAMS,"Disclosed are foam compositions and processes to form mixed tannin-phenolic foams. The process comprises forming a phenolic resole by mixing a phenol with a first monomer at a temperature in the range of room temperature to 90 °C, wherein the first monomer comprises formaldehyde, paraformaldehyde, furfural, glyoxal, acetaldehyde, 5-hydroxymethylfurfural, 5-furandicarboxylic aldehyde, difurfural (DFF), or mixtures thereof. The process also comprises adding a tannin to the phenolic resole to form a mixed-resin, wherein the phenol, the tannin, and the first monomer are present in a weight ratio 1:0.05:0.3 to 1:3:3.",DU PONT;;COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/094-882-315-355-242,Search Report,yes,1,0,9,33,0,C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;Y10T428/249976;;Y10T428/249976;;C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;B32B5/18;;C08J9/146;;B29C44/02;;B29C44/3415;;B29K2061/00;;B29K2105/046;;B29K2995/0015;;B29K2995/0016;;B29L2031/10;;C08J9/141;;C08J2361/12;;E04C2/284,C08J9/14;;C08J9/00,,2,1,120-073-550-851-036,10.1016/j.indcrop.2009.03.005,"MOUBARIK A ET AL: ""Cornstarch and tannin in phenol-formaldehyde resins for plywood production"", INDUSTRIAL CROPS AND PRODUCTS, ELSEVIER, NL, vol. 30, no. 2, 1 September 2009 (2009-09-01), pages 188 - 193, XP026349783, ISSN: 0926-6690, [retrieved on 20090417];;DATABASE WPI Week 200955, Derwent World Patents Index; AN 2009-L65006, XP002714166",PENDING
197,CN,A,CN 115405923 A,096-908-817-460-478,2022-11-29,2022,CN 202210964736 A,2018-09-05,US 201762554327 P;;US 201862690185 P;;CN 201880057140 A;;IB 2018056780 W,2017-09-05,LOW LON Ox AND CO BURNER METHODS AND APPARATUS,"Emissions of NOX and/or CO at a stack are reduced by systems and methods in which primary fuel is sufficiently mixed with a specific range of excess combustion air. The primary fuel-air mixture is then discharged and anchored within a combustion chamber of the combustor. Further, the systems and methods provide for dynamic control of NOx content in emissions from the furnace by adjusting the flow of primary and secondary stage fuels, and in some cases controlling the amount or arrangement of combustion air into the furnace.",JOHN ZINK CO LLC,CARROLL CHAD;;ERAZO JAIME;;SMIRNOV VALERIY;;COBB THOMAS;;VACCARI MARK;;BATTISTI SEAN;;COSEGA JOS ¨,,https://lens.org/096-908-817-460-478,Patent Application,no,0,0,17,17,0,F23D14/02;;F23D14/46;;F23D14/64;;F23D14/84;;F23D14/48;;F23N5/18;;F23N1/00;;F27D99/0033;;F27D19/00;;F27D2019/004;;F23D2207/00;;F23N5/18;;F23D14/02;;F23D14/64;;F23N2900/05003;;F23N2221/10;;F23N5/18;;F23D14/02;;F23D14/64;;F23N2900/05003;;F23N1/022;;F23C6/047;;F23C9/00;;F23C2900/06041;;F23D14/02;;F23D14/64;;F23D14/70;;F23D17/002;;F23D2207/00;;F23D2900/14021;;F23N2900/05003,F23D14/02;;F23D14/46;;F23D14/48;;F23D14/64;;F23D14/84;;F23N1/00;;F23N5/18;;F27D19/00;;F27D99/00,,0,0,,,,PENDING
198,CA,C,CA 2384825 C,106-196-113-822-483,2006-05-30,2006,CA 2384825 A,2000-09-08,US 41510099 A;;US 0024590 W,1999-10-08,DISPLAY ILLUMINATION DEVICE AND METHOD OF ENHANCING BRIGHTNESS IN A DISPLAY ILLUMINATION DEVICE,An illumination device (110) including a lightguide (112) operates under the principle of frustrate total internal reflection. The illumination device (120) includes optical elements and combinations of optical elements for enhancing the apparent brightness of the lightguide (112).,3M INNOVATIVE PROPERTIES CO,KRETMAN WADE D;;WORTMAN DAVID L;;COBB SANFORD;;GARDINER MARK E;;EPSTEIN KENNETH A,,https://lens.org/106-196-113-822-483,Granted Patent,no,0,0,14,14,0,G02B6/0053;;G02F1/1335;;G02B6/0055;;G02B6/0056;;G02F1/133504;;G02F1/133536;;G02F1/133545;;G02F1/133615;;G02F1/13362,F21V8/00;;G02B5/02;;F21Y103/00;;G02B5/30;;G02B6/00;;G02F1/1335;;G02F1/13357;;G02F1/13363,,0,0,,,,EXPIRED
199,EP,B1,EP 0892931 B1,121-184-511-865-230,2003-12-17,2003,EP 97906797 A,1997-03-03,US 9703323 W;;US 63107396 A,1996-04-12,VARIABLE PITCH STRUCTURED OPTICAL FILM,,MINNESOTA MINING & MFG,COBB SANFORD JR;;GARDINER MARK E;;KOTCHICK KEITH M;;TOYOOKA KAZUHIKO;;HIBBARD WILLIAM A,,https://lens.org/121-184-511-865-230,Granted Patent,yes,8,0,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0231;;G02B5/00;;G02B5/00;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;Y10S385/901;;Y10S385/901;;Y10S428/913;;Y10S428/913;;Y10T428/24355;;Y10T428/24355;;Y10T428/24479;;Y10T428/24479;;Y10T428/24537;;Y10T428/24537;;Y10T428/2457;;Y10T428/2457;;Y10T428/24669;;Y10T428/24669,G02B5/00;;G02B5/02;;G02B5/04;;G02F1/1335,,0,0,,,,EXPIRED
200,PL,T3,PL 2714786 T3,061-010-768-423-791,2016-04-29,2016,PL 12726683 T,2012-05-25,US 201161489807 P;;US 201161489854 P;;US 201161489847 P;;EP 12726683 A;;US 2012/0039741 W,2011-05-25,"PHENOLIC FOAMS WITH BLOWING AGENT 1, 1, 1, 4, 4, 4-HEXAFLUORO - 2 - BUTENE",,DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/061-010-768-423-791,Patent Application,no,0,0,8,33,0,B32B5/18;;B32B2250/03;;B32B2250/40;;B32B2266/0285;;B32B2266/06;;B32B2266/08;;B32B2305/022;;B32B2307/304;;B32B2307/3065;;B32B2307/72;;C08J9/146;;C08J2203/162;;C08J2205/052;;C08J2361/06;;Y10T428/249976;;Y10T428/249976;;B32B5/18;;C08J2205/052;;C08J9/146;;C08J2361/06;;B32B2266/06;;C08J2203/162;;B32B2266/08;;B32B2307/3065;;B32B2250/03;;B32B2250/40;;B32B2307/72;;B32B2307/304;;B32B2305/022;;B32B2266/0285;;C08L61/06,C08J9/14;;B32B5/18;;C08L61/06,,0,0,,,,PENDING
201,HK,A1,HK 1048510 A1,163-371-081-559-010,2003-04-04,2003,HK 02108708 A,2002-11-29,US 41510099 A;;US 0024590 W,1999-10-08,DISPLAY ILLUMINATION DEVICE AND METHOD OF ENHANCING BRIGHTNESS IN A DISPLAY ILLUMINATION DEVICE,,3M INNOVATIVE PROPERTIES CO,WADE D KRETMAN;;SANFORD COBB;;KENNETH A EPSTEIN;;MARK E GARDINER;;DAVID L WORTMAN,,https://lens.org/163-371-081-559-010,Patent Application,no,0,0,14,14,0,G02B6/0053;;G02F1/1335;;G02B6/0055;;G02B6/0056;;G02F1/133504;;G02F1/133536;;G02F1/133545;;G02F1/133615;;G02F1/13362,F21V/;;G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/30;;G02B6/00;;G02F/;;G02F1/1335;;G02F1/13357;;G02F1/13363,,0,0,,,,PENDING
202,EP,A1,EP 0892931 A1,066-397-931-806-081,1999-01-27,1999,EP 97906797 A,1997-03-03,US 9703323 W;;US 63107396 A,1996-04-12,VARIABLE PITCH STRUCTURED OPTICAL FILM,,MINNESOTA MINING & MFG,COBB SANFORD JR;;GARDINER MARK E;;KOTCHICK KEITH M;;TOYOOKA KAZUHIKO;;HIBBARD WILLIAM A,,https://lens.org/066-397-931-806-081,Patent Application,yes,0,0,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0231;;G02B5/00;;G02B5/00;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;Y10S385/901;;Y10S385/901;;Y10S428/913;;Y10S428/913;;Y10T428/24355;;Y10T428/24355;;Y10T428/24479;;Y10T428/24479;;Y10T428/24537;;Y10T428/24537;;Y10T428/2457;;Y10T428/2457;;Y10T428/24669;;Y10T428/24669,G02B5/00;;G02B5/02;;G02B5/04;;G02F1/1335,,1,0,,,See references of WO 9739369A1,EXPIRED
203,WO,A2,WO 2012/162681 A2,074-899-807-376-571,2012-11-29,2012,US 2012/0039747 W,2012-05-25,US 201161489847 P;;US 201161489854 P;;US 201161489787 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489807 P,2011-05-25,MIXED TANNIN-PHENOLIC FOAMS,"Disclosed are foam compositions and processes to form mixed tannin-phenolic foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a mixed-resin derived from a phenol, a tannin, and a first monomer, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising one or more blowing agents.",DU PONT;;COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/074-899-807-376-571,Patent Application,yes,0,1,9,33,0,C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;Y10T428/249976;;Y10T428/249976;;C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;B32B5/18;;C08J9/146;;B29C44/02;;B29C44/3415;;B29K2061/00;;B29K2105/046;;B29K2995/0015;;B29K2995/0016;;B29L2031/10;;C08J9/141;;C08J2361/12;;E04C2/284,C08J9/00,,3,2,018-449-835-963-31X;;125-459-258-962-082,10.1002/anie.200604274;;17659519;;10.1016/j.tca.2005.06.026,"MEIKLEHAM ET AL., JOURNAL OF APPLIED POLYMER SCIENCE, vol. 53, pages 1547 - 1556;;CHHEDA: ""Liquid Phase catalytic Processing of Biomass- derived Oxygenated Hydrocarbons to fuels and Chemicals"", ANGEWANDTE CHEMIE, INT., vol. 46, 2007, pages 7164 - 7183;;YI, THERMOCHIMICA ACTA, vol. 436, 2005, pages 122 - 129",PENDING
204,EP,A1,EP 1218664 A1,088-376-375-947-347,2002-07-03,2002,EP 00963606 A,2000-09-19,US 0025619 W;;US 41412499 A,1999-10-08,LIGHTGUIDE HAVING A DIRECTLY SECURED REFLECTOR AND METHOD OF MAKING THE SAME,,3M INNOVATIVE PROPERTIES CO,WORTMAN DAVID L;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D;;GARDINER MARK E,,https://lens.org/088-376-375-947-347,Patent Application,yes,0,1,9,9,0,G02B6/0038;;G02B6/0043;;G02B6/0055;;G02F1/1335;;G02B6/0055;;G02B6/0038;;G02B6/0043,F21V8/00;;G02B6/00;;F21Y103/00;;G02F1/13357,,0,0,,,,DISCONTINUED
205,WO,A1,WO 2001/027528 A1,051-332-618-178-662,2001-04-19,2001,US 0024590 W,2000-09-08,US 41510099 A,1999-10-08,DISPLAY ILLUMINATION DEVICE AND METHOD OF ENHANCING BRIGHTNESS IN A DISPLAY ILLUMINATION DEVICE,An illumination device (110) including a lightguide (112) operates under the principle of frustrate total internal reflection. The illumination device (120) includes optical elements and combinations of optical elements for enhancing the apparent brightness of the lightguide (112).,3M INNOVATIVE PROPERTIES CO,KRETMAN WADE D;;COBB SANFORD;;EPSTEIN KENNETH A;;GARDINER MARK E;;WORTMAN DAVID L,,https://lens.org/051-332-618-178-662,Patent Application,yes,3,34,14,14,0,G02B6/0053;;G02F1/1335;;G02B6/0055;;G02B6/0056;;G02F1/133504;;G02F1/133536;;G02F1/133545;;G02F1/133615;;G02F1/13362,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/30;;G02B6/00;;G02F1/1335;;G02F1/13357;;G02F1/13363,,0,0,,,,PATENTED
206,US,A1,US 2014/0079941 A1,172-801-805-063-146,2014-03-20,2014,US 201214118957 A,2012-05-25,US 201214118957 A;;US 201161489807 P;;US 201161489854 P;;US 201161489847 P;;US 2012/0039741 W,2011-05-25,"PHENOLIC FOAMS WITH BLOWING AGENT 1,1,1,4,4,4-HEXAFLUORO-2-BUTENE","Disclosed are foam compositions and processes to form closed-cell phenolic foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a phenol-formaldehyde resole derived from a phenol and formaldehyde, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising 1,1,1,4,4,4-hexafluoro-2-butene.",COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE;;DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,E. I. DU PONT DE NEMOURS AND COMPANY (2013-11-12);;THE CHEMOURS COMPANY FC LLC (2015-04-14),https://lens.org/172-801-805-063-146,Patent Application,yes,4,3,8,33,0,B32B5/18;;B32B2250/03;;B32B2250/40;;B32B2266/0285;;B32B2266/06;;B32B2266/08;;B32B2305/022;;B32B2307/304;;B32B2307/3065;;B32B2307/72;;C08J9/146;;C08J2203/162;;C08J2205/052;;C08J2361/06;;Y10T428/249976;;Y10T428/249976;;B32B5/18;;C08J2205/052;;C08J9/146;;C08J2361/06;;B32B2266/06;;C08J2203/162;;B32B2266/08;;B32B2307/3065;;B32B2250/03;;B32B2250/40;;B32B2307/72;;B32B2307/304;;B32B2305/022;;B32B2266/0285;;C08L61/06,B32B5/18;;C08L61/06,428/314.4;;521/181,0,0,,,,DISCONTINUED
207,EP,B1,EP 2714786 B1,007-894-401-901-396,2015-10-28,2015,EP 12726683 A,2012-05-25,US 201161489807 P;;US 201161489854 P;;US 201161489847 P;;US 2012/0039741 W,2011-05-25,"PHENOLIC FOAMS WITH BLOWING AGENT 1, 1, 1, 4, 4, 4-HEXAFLUORO - 2 - BUTENE",,DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,"THE CHEMOURS COMPANY FC, LLC (2016-06-22);;THE CHEMOURS COMPANY FC, LLC; US (2019-06-25);;THE CHEMOURS COMPANY FC, LLC, WILMINGTON, US (2019-08-20)",https://lens.org/007-894-401-901-396,Granted Patent,yes,2,0,8,33,0,B32B5/18;;B32B2250/03;;B32B2250/40;;B32B2266/0285;;B32B2266/06;;B32B2266/08;;B32B2305/022;;B32B2307/304;;B32B2307/3065;;B32B2307/72;;C08J9/146;;C08J2203/162;;C08J2205/052;;C08J2361/06;;Y10T428/249976;;Y10T428/249976;;B32B5/18;;C08J2205/052;;C08J9/146;;C08J2361/06;;B32B2266/06;;C08J2203/162;;B32B2266/08;;B32B2307/3065;;B32B2250/03;;B32B2250/40;;B32B2307/72;;B32B2307/304;;B32B2305/022;;B32B2266/0285;;C08L61/06,C08J9/14;;B32B5/18;;C08L61/06,,0,0,,,,ACTIVE
208,WO,A2,WO 2012/162678 A2,015-199-062-667-309,2012-11-29,2012,US 2012/0039741 W,2012-05-25,US 201161489807 P;;US 201161489854 P;;US 201161489847 P,2011-05-25,"PHENOLIC FOAMS WITH BLOWING AGENT 1, 1, 1, 4, 4, 4-HEXAFLUORO - 2 - BUTENE","Disclosed are foam compositions and processes to form closed-cell phenolic foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a phenol-formaldehyde resole derived from a phenol and formaldehyde, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising 1,1,1,4,4,4-hexafluoro-2-butene",DU PONT;;COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/015-199-062-667-309,Patent Application,yes,1,9,8,33,0,B32B5/18;;B32B2250/03;;B32B2250/40;;B32B2266/0285;;B32B2266/06;;B32B2266/08;;B32B2305/022;;B32B2307/304;;B32B2307/3065;;B32B2307/72;;C08J9/146;;C08J2203/162;;C08J2205/052;;C08J2361/06;;Y10T428/249976;;Y10T428/249976;;B32B5/18;;C08J2205/052;;C08J9/146;;C08J2361/06;;B32B2266/06;;C08J2203/162;;B32B2266/08;;B32B2307/3065;;B32B2250/03;;B32B2250/40;;B32B2307/72;;B32B2307/304;;B32B2305/022;;B32B2266/0285;;C08L61/06,C08J9/14,,1,1,125-459-258-962-082,10.1016/j.tca.2005.06.026,"YI HE, THERMOCHIMICA ACTA, vol. 436, 2005, pages 122 - 129",PENDING
209,WO,A3,WO 2012/162681 A3,054-024-608-570-649,2013-11-28,2013,US 2012/0039747 W,2012-05-25,US 201161489847 P;;US 201161489854 P;;US 201161489787 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489807 P,2011-05-25,MIXED TANNIN-PHENOLIC FOAMS,"Disclosed are foam compositions and processes to form mixed tannin-phenolic foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a mixed-resin derived from a phenol, a tannin, and a first monomer, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising one or more blowing agents.",DU PONT;;COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/054-024-608-570-649,Search Report,yes,2,0,9,33,0,C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;Y10T428/249976;;Y10T428/249976;;C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;B32B5/18;;C08J9/146;;B29C44/02;;B29C44/3415;;B29K2061/00;;B29K2105/046;;B29K2995/0015;;B29K2995/0016;;B29L2031/10;;C08J9/141;;C08J2361/12;;E04C2/284,C08J9/14;;C08J9/00,,1,1,012-234-036-850-910,10.4067/s0718-221x2008000300005,"G TONDI ET AL: ""NATURAL TANNIN-BASED RIGID FOAMS AS INSULATION FOR DOORS AND WALL PANELS"", MADERAS. CIENCIA Y TECNOLOGÍA, vol. 10, no. 3, 1 January 2008 (2008-01-01), XP055046154, DOI: 10.4067/S0718-221X2008000300005",PENDING
210,US,A1,US 2014/0093720 A1,090-498-668-290-956,2014-04-03,2014,US 201214118940 A,2012-05-25,US 201214118940 A;;US 201161489847 P;;US 201161489854 P;;US 201161489787 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489807 P;;US 2012/0039747 W,2011-05-25,MIXED TANNIN-PHENOLIC FOAMS,"Disclosed are foam compositions and processes to form mixed tannin-phenolic foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a mixed-resin derived from a phenol, a tannin, and a first monomer, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising one or more blowing agents.",COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE;;DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,E. I. DU PONT DE NEMOURS AND COMPANY (2013-11-12);;DUPONT SAFETY & CONSTRUCTION INC (2019-06-17),https://lens.org/090-498-668-290-956,Patent Application,yes,3,4,9,33,0,C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;Y10T428/249976;;Y10T428/249976;;C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;B32B5/18;;C08J9/146;;B29C44/02;;B29C44/3415;;B29K2061/00;;B29K2105/046;;B29K2995/0015;;B29K2995/0016;;B29L2031/10;;C08J9/141;;C08J2361/12;;E04C2/284,C08J9/14;;B32B5/18,428/314.4;;521/181,0,0,,,,ACTIVE
211,KR,A,KR 20000005436 A,156-200-998-272-53X,2000-01-25,2000,KR 19980708197 A,1998-10-10,US 63107396 A,1996-04-12,VARIABLE PITCH STRUCTURED OPTICAL FILM,PURPOSE: A variable pitch structured optical film is provided to increase a curve angle and to reduce a disadvantage like dazzling. CONSTITUTION: The variable pitch structured optical film comprises; a structured optical film with variable pitch peaks; and grooves to reduce the visibility of moire interference patterns; and optical displays incorporating one or more layers of the film. The pitch variations can be over groups of adjacent peaks and valleys or between adjacent pairs of peaks or valleys.,MINNESOTA MINNG AND MFG COMPAN,COBB SANFORD JR;;GARDINER MARK E;;KOTCHICK KEITH M;;TOYOOKA KAZUHIKO;;HIBBARD WILLIAM A,,https://lens.org/156-200-998-272-53X,Patent Application,no,0,0,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0231;;G02B5/00;;G02B5/00;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;Y10S385/901;;Y10S385/901;;Y10S428/913;;Y10S428/913;;Y10T428/24355;;Y10T428/24355;;Y10T428/24479;;Y10T428/24479;;Y10T428/24537;;Y10T428/24537;;Y10T428/2457;;Y10T428/2457;;Y10T428/24669;;Y10T428/24669,G02B5/00;;G02B5/02;;G02B5/04;;G02F1/1335,,0,0,,,,EXPIRED
212,CA,C,CA 2251252 C,170-935-670-225-769,2002-02-05,2002,CA 2251252 A,1997-03-03,US 63107396 A;;US 9703323 W,1996-04-12,VARIABLE PITCH STRUCTURED OPTICAL FILM,The present invention includes a structured optical film with variable pitch peaks and/or grooves to reduce the visibility of moiré interference patterns and optical displays incorporating one or more layers of the film. The pitch variations can be over groups of adjacent peaks and/or valleys or between adjacent pairs of peaks and/or valleys.,MINNESOTA MINING & MFG,COBB SANFORD JR;;GARDINER MARK E;;TOYOOKA KAZUHIKO;;KOTCHICK KEITH M;;HIBBARD WILLIAM A,,https://lens.org/170-935-670-225-769,Granted Patent,no,0,0,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0231;;G02B5/00;;G02B5/00;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;Y10S385/901;;Y10S385/901;;Y10S428/913;;Y10S428/913;;Y10T428/24355;;Y10T428/24355;;Y10T428/24479;;Y10T428/24479;;Y10T428/24537;;Y10T428/24537;;Y10T428/2457;;Y10T428/2457;;Y10T428/24669;;Y10T428/24669,G02B5/00;;G02B5/02;;G02B5/04;;G02F1/1335,,0,0,,,,EXPIRED
213,EP,A2,EP 2714786 A2,076-242-722-974-536,2014-04-09,2014,EP 12726683 A,2012-05-25,US 201161489807 P;;US 201161489854 P;;US 201161489847 P;;US 2012/0039741 W,2011-05-25,"PHENOLIC FOAMS WITH BLOWING AGENT 1, 1, 1, 4, 4, 4-HEXAFLUORO - 2 - BUTENE",,DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,"THE CHEMOURS COMPANY FC, LLC (2016-06-22);;THE CHEMOURS COMPANY FC, LLC; US (2019-06-25);;THE CHEMOURS COMPANY FC, LLC, WILMINGTON, US (2019-08-20)",https://lens.org/076-242-722-974-536,Patent Application,yes,0,0,8,33,0,B32B5/18;;B32B2250/03;;B32B2250/40;;B32B2266/0285;;B32B2266/06;;B32B2266/08;;B32B2305/022;;B32B2307/304;;B32B2307/3065;;B32B2307/72;;C08J9/146;;C08J2203/162;;C08J2205/052;;C08J2361/06;;Y10T428/249976;;Y10T428/249976;;B32B5/18;;C08J2205/052;;C08J9/146;;C08J2361/06;;B32B2266/06;;C08J2203/162;;B32B2266/08;;B32B2307/3065;;B32B2250/03;;B32B2250/40;;B32B2307/72;;B32B2307/304;;B32B2305/022;;B32B2266/0285;;C08L61/06,C08J9/14;;B32B5/18;;C08L61/06,,0,0,,,,ACTIVE
214,CA,A1,CA 2834600 A1,103-038-685-802-047,2012-11-29,2012,CA 2834600 A,2012-05-25,US 201161489847 P;;US 201161489854 P;;US 201161489787 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489807 P;;US 2012/0039747 W,2011-05-25,MIXED TANNIN-PHENOLIC FOAMS,"Disclosed are foam compositions and processes to form mixed tannin-phenolic foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a mixed-resin derived from a phenol, a tannin, and a first monomer, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising one or more blowing agents.",DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/103-038-685-802-047,Patent Application,no,0,2,9,33,0,C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;Y10T428/249976;;Y10T428/249976;;C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;B32B5/18;;C08J9/146;;B29C44/02;;B29C44/3415;;B29K2061/00;;B29K2105/046;;B29K2995/0015;;B29K2995/0016;;B29L2031/10;;C08J9/141;;C08J2361/12;;E04C2/284,C08J9/00,,0,0,,,,DISCONTINUED
215,EP,B1,EP 1218663 B1,185-341-958-826-287,2005-12-07,2005,EP 00961644 A,2000-09-08,US 0024590 W;;US 41510099 A,1999-10-08,DISPLAY ILLUMINATION DEVICE AND METHOD OF ENHANCING BRIGHTNESS IN A DISPLAY ILLUMINATION DEVICE,,3M INNOVATIVE PROPERTIES CO,KRETMAN WADE D;;COBB SANFORD;;EPSTEIN KENNETH A;;GARDINER MARK E;;WORTMAN DAVID L,,https://lens.org/185-341-958-826-287,Granted Patent,yes,3,0,14,14,0,G02B6/0053;;G02F1/1335;;G02B6/0055;;G02B6/0056;;G02F1/133504;;G02F1/133536;;G02F1/133545;;G02F1/133615;;G02F1/13362,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/30;;G02B6/00;;G02F1/1335;;G02F1/13357;;G02F1/13363,,0,0,,,,EXPIRED
216,US,B2,US 9260579 B2,014-031-907-085-584,2016-02-16,2016,US 201214118940 A,2012-05-25,US 201214118940 A;;US 201161489847 P;;US 201161489854 P;;US 201161489787 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489807 P;;US 2012/0039747 W,2011-05-25,Mixed tannin-phenolic foams,"Disclosed are foam compositions and processes to form mixed tannin-phenolic foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a mixed-resin derived from a phenol, a tannin, and a first monomer, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising one or more blowing agents.",COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE;;DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,E. I. DU PONT DE NEMOURS AND COMPANY (2013-11-12);;DUPONT SAFETY & CONSTRUCTION INC (2019-06-17),https://lens.org/014-031-907-085-584,Granted Patent,yes,7,1,9,33,0,C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;Y10T428/249976;;Y10T428/249976;;C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;B32B5/18;;C08J9/146;;B29C44/02;;B29C44/3415;;B29K2061/00;;B29K2105/046;;B29K2995/0015;;B29K2995/0016;;B29L2031/10;;C08J9/141;;C08J2361/12;;E04C2/284,C08J9/14;;B32B5/18;;C08J9/00,,11,10,135-677-566-825-010;;082-180-992-479-021;;113-315-666-137-112;;007-509-204-871-622;;023-263-699-117-594;;050-700-818-690-417;;020-153-118-598-718;;012-234-036-850-910;;094-564-833-981-610;;005-416-524-580-204,10.1002/app.1994.070531117;;10.1002/app.28545;;10.1016/j.matchemphys.2010.02.062;;10.1016/j.matchemphys.2010.03.084;;10.1002/app.1979.070230634;;10.1016/j.carbon.2009.01.041;;19576764;;10.1016/j.biortech.2009.05.055;;10.4067/s0718-221x2008000300005;;10.1016/j.indcrop.2008.07.003;;10.1017/s1431927609990444;;19709464,"Meikleham, N. E. et al., Acid- and Alkali-Catalyzed Tannin-Based Rigid Foams, Journal of Applied Polymer Science, 1994, pp. 1547-1556, vol. 53.;;Link, Martin et al., Formaldehyde-Free Tannin-Based Foams and Their Use As Lightweight Panels, BioResources, 2011, pp. 4218-4228, vol. 6, No. 4.;;Pizzi, A. et al., Matrix-Assisted Laser Desorption/lonization Time-of-Flight Structure Determination of Complex Theromset Networks: Polyflavonoid Tannin-Furanic Rigid Foams, Journal of Applied Polymer Science, 2008, pp. 1451-1456, vol. 110.;;Zhao, W. et al., Effect of composition and processing parameters on the characteristics of tannin-based rigid foams. Part I: Cell structure, Materials Chemistry and Physics, 2010, pp. 175-182, vol. 122.;;Zhao, W et al., Effect of composition and processing parameters on the characteristics of tannin-based rigid foams. Part II: Physical Properties, Materials Chemistry and Physics, 2010, pp. 210-217, vol. 123.;;Pizzi, A., Tannin-Based Neutral and Alkaline Phenolic-Type Foams, Journal of Applied Polymer Science, 1979, pp. 1901-1905, vol. 23.;;Tondi, G. et al., Tannin-based carbon foams, Carbon, 2009, pp. 1480-1492, vol. 47.;;Tondi, G. et al., Tannin-based rigid foams: A survey of chemical and physical properties, Bioresource Technology, 2009, pp. 5162-5169, vol. 100.;;Tondi, G. et al., Natural Tannin-Based Rigid Foams as Insulation for Doors and Wall Panels, Maderas. Ciencia y Tecnologia, 2008, pp. 219-227.;;Tondi, G. et al., Tannin-based rigid foams: Characterization and modification, Industrial Crops and Products, 2009, pp. 356-363, vol. 29.;;Tondi, G. et al., X-Ray Microtomography Studies of Tannin-Derived Organic and Carbon Foams, Microscopy and Microanalysis, 2009, pp. 384-394, vol. 15.",ACTIVE
217,US,B1,US 6447135 B1,017-879-162-345-237,2002-09-10,2002,US 41412499 A,1999-10-08,US 41412499 A,1999-10-08,Lightguide having a directly secured reflector and method of making the same,"
    A lightguide includes an input edge surface, a back surface and an output surface. A reflector is directly secured to the back surface by, for example, adhesive bonding. 
",3M INNOVATIVE PROPERTIES CO,WORTMAN DAVID L;;COBB SANFORD;;EPSTEIN KENNETH A;;GARDINER MARK E;;KRETMAN WADE D,3M INNOVATIVE PROPERTIES COMPANY (2000-01-17),https://lens.org/017-879-162-345-237,Granted Patent,yes,107,63,9,9,0,G02B6/0038;;G02B6/0043;;G02B6/0055;;G02F1/1335;;G02B6/0055;;G02B6/0038;;G02B6/0043,F21V8/00;;G02B6/00;;F21Y103/00;;G02F1/13357,362/31;;362/327,5,0,,,"IBM Technical Disclosure Bulletin, vol. 29, No. 11, Backlighting for Liquid Crystal Display, Apr. 1987.;;IBM Technical Disclosure Bulletin, vol. 31, No. 2, Flat Panel Backlight Reflecting Device, Jul. 1988.;;IBM Technical Disclosure Bulletin, vol. 33, No. 1B, Polarized Backlight for Liquid Crystal Display, Jun. 1990.;;IBM Technical Disclosure Bulletin, vol. 33, No. 9, High Efficiency Back Light for LCD, Feb. 1991.;;International Search Report dated Dec. 1, 2000 for International Application No. PCT/US00/25619.",EXPIRED
218,CN,A,CN 103703064 A,048-229-038-690-949,2014-04-02,2014,CN 201280025271 A,2012-05-25,US 2012/0039741 W;;US 201161489807 P;;US 201161489854 P;;US 201161489847 P,2011-05-25,"Phenolic foams with blowing agent 1, 1, 1, 4, 4, 4-hexafluoro - 2 - butene","Disclosed are foam compositions and processes to form closed-cell phenolic foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a phenol-formaldehyde resole derived from a phenol and formaldehyde, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising 1,1,1,4,4,4-hexafluoro-2-butene.",DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/048-229-038-690-949,Patent Application,no,3,1,8,33,0,B32B5/18;;B32B2250/03;;B32B2250/40;;B32B2266/0285;;B32B2266/06;;B32B2266/08;;B32B2305/022;;B32B2307/304;;B32B2307/3065;;B32B2307/72;;C08J9/146;;C08J2203/162;;C08J2205/052;;C08J2361/06;;Y10T428/249976;;Y10T428/249976;;B32B5/18;;C08J2205/052;;C08J9/146;;C08J2361/06;;B32B2266/06;;C08J2203/162;;B32B2266/08;;B32B2307/3065;;B32B2250/03;;B32B2250/40;;B32B2307/72;;B32B2307/304;;B32B2305/022;;B32B2266/0285;;C08L61/06,C08J9/14;;B32B5/18,,0,0,,,,DISCONTINUED
219,EP,A1,EP 1218663 A1,111-687-066-924-221,2002-07-03,2002,EP 00961644 A,2000-09-08,US 0024590 W;;US 41510099 A,1999-10-08,DISPLAY ILLUMINATION DEVICE AND METHOD OF ENHANCING BRIGHTNESS IN A DISPLAY ILLUMINATION DEVICE,,3M INNOVATIVE PROPERTIES CO,KRETMAN WADE D;;COBB SANFORD;;EPSTEIN KENNETH A;;GARDINER MARK E;;WORTMAN DAVID L,,https://lens.org/111-687-066-924-221,Patent Application,yes,0,0,14,14,0,G02B6/0053;;G02F1/1335;;G02B6/0055;;G02B6/0056;;G02F1/133504;;G02F1/133536;;G02F1/133545;;G02F1/133615;;G02F1/13362,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/30;;G02B6/00;;G02F1/1335;;G02F1/13357;;G02F1/13363,,1,0,,,See references of WO 0127528A1,EXPIRED
220,ES,T3,ES 2558507 T3,007-262-770-298-152,2016-02-04,2016,ES 12726683 T,2012-05-25,US 201161489807 P;;US 201161489854 P;;US 201161489847 P;;US 2012/0039741 W,2011-05-25,"Espumas fenólicas con agente de soplado 1,1,1,4,4,4-hexafluoro-2-buteno","Una espuma que comprende: (a) Una fase polimérica continua que define una pluralidad de celdas, en la que: - la fase polimérica continua comprende un resol de fenol-formaldehído derivado de un fenol y formaldehído, y - la pluralidad de celdas comprende una pluralidad de celdas abiertas y una pluralidad de celdas cerradas, con un contenido de celdas abiertas determinado conforme a la norma ASTM D6226-inferior a 50%, y (b) una fase discontinua dispuesta en al menos una parte de la pluralidad de celdas cerradas, comprendiendo la fase discontinua 1,1,1,4,4,4-hexafluoro-2-buteno.",DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/007-262-770-298-152,Granted Patent,no,0,0,8,33,0,B32B5/18;;B32B2250/03;;B32B2250/40;;B32B2266/0285;;B32B2266/06;;B32B2266/08;;B32B2305/022;;B32B2307/304;;B32B2307/3065;;B32B2307/72;;C08J9/146;;C08J2203/162;;C08J2205/052;;C08J2361/06;;Y10T428/249976;;Y10T428/249976;;B32B5/18;;C08J2205/052;;C08J9/146;;C08J2361/06;;B32B2266/06;;C08J2203/162;;B32B2266/08;;B32B2307/3065;;B32B2250/03;;B32B2250/40;;B32B2307/72;;B32B2307/304;;B32B2305/022;;B32B2266/0285;;C08L61/06,B32B5/18;;C08J9/14;;C08L61/06,,0,0,,,,ACTIVE
221,US,A1,US 2016/0083547 A1,095-057-246-043-291,2016-03-24,2016,US 201514958018 A,2015-12-03,US 201514958018 A;;US 201314118940 A;;US 2012/0039747 W;;US 201161489847 P;;US 201161489854 P;;US 201161489787 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489807 P,2011-05-25,MIXED TANNIN-PHENOLIC FOAMS,"Disclosed are foam compositions and processes to form mixed tannin-phenolic foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a mixed-resin derived from a phenol, a tannin, and a first monomer, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising one or more blowing agents.",DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/095-057-246-043-291,Patent Application,yes,2,0,9,33,0,C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;Y10T428/249976;;Y10T428/249976;;C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;B32B5/18;;C08J9/146;;B29C44/02;;B29C44/3415;;B29K2061/00;;B29K2105/046;;B29K2995/0015;;B29K2995/0016;;B29L2031/10;;C08J9/141;;C08J2361/12;;E04C2/284,C08J9/14;;B29C44/02;;B29C44/34;;E04C2/284,,0,0,,,,DISCONTINUED
222,EP,A1,EP 3290135 A1,133-042-274-112-818,2018-03-07,2018,EP 17185425 A,2017-08-08,US 201615250057 A,2016-08-29,METHODS FOR DIRECTIONALLY RECRYSTALLIZING ADDITIVELY-MANUFACTURED METALLIC ARTICLES BY HEAT TREATMENT WITH A GRADIENT FURNACE,"A method for manufacturing a metallic article includes providing or obtaining a metallic material in powder form, using an additive manufacturing process, building the metallic article from the powder-form metallic material, layer-by-layer, in a build direction, wherein as a result of the additive manufacturing process, the metallic article comprises columnar grain structures oriented in the build direction, and conveying the metallic article through a gradient furnace in a direction of conveyance from a first area of the gradient furnace to a second area of the gradient furnace to increase a size of the columnar grain structures in the metallic article. The metallic article is conveyed through the gradient furnace in an orientation such that the columnar structures oriented in the build direction are substantially parallel to the direction of conveyance.
",HONEYWELL INT INC,MENON MAMBALLYKALATHIL;;BAUGHMAN BRIAN G;;COBB JAMES J;;GODFREY DONALD G;;MORRIS MARK C,,https://lens.org/133-042-274-112-818,Patent Application,yes,6,4,4,4,0,F05D2230/22;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y40/00;;B33Y80/00;;B22F3/24;;B22F5/009;;B22F5/04;;B22F2003/248;;B22F2998/10;;C22F1/10;;Y02P10/25;;B22F10/40;;B22F12/63;;B22F10/38;;B22F10/66;;B22F10/73;;B22F10/25;;B22F10/28;;B22F10/64;;B22F10/36;;B33Y40/20;;B23K2101/001;;B23K2103/08;;F01D5/12;;F01D5/147;;F05D2230/22;;Y02P10/25;;B33Y40/20;;B22F10/25;;B22F10/28;;B22F10/73;;B22F12/63;;B22F10/40;;B22F10/36;;B22F10/38;;B22F10/64;;B22F10/66;;B33Y10/00;;B33Y40/00;;B33Y80/00;;B22F3/15;;B22F3/24;;B22F5/009;;B22F5/04;;B22F2003/247;;B22F2003/248;;B22F2301/15;;B22F2998/10;;B23K15/0086;;C22F1/10,B22F3/105;;B22F3/24;;B22F5/00;;B22F5/04;;B33Y10/00;;C22F1/00;;C22F1/10;;F01D5/12;;F01D5/14,,0,0,,,,ACTIVE
223,EP,B1,EP 3290135 B1,181-048-215-254-056,2019-06-26,2019,EP 17185425 A,2017-08-08,US 201615250057 A,2016-08-29,METHODS FOR DIRECTIONALLY RECRYSTALLIZING ADDITIVELY-MANUFACTURED METALLIC ARTICLES BY HEAT TREATMENT WITH A GRADIENT FURNACE,,HONEYWELL INT INC,MENON MAMBALLYKALATHIL;;BAUGHMAN BRIAN G;;COBB JAMES J;;GODFREY DONALD G;;MORRIS MARK C,,https://lens.org/181-048-215-254-056,Granted Patent,yes,4,0,4,4,0,F05D2230/22;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y40/00;;B33Y80/00;;B22F3/24;;B22F5/009;;B22F5/04;;B22F2003/248;;B22F2998/10;;C22F1/10;;Y02P10/25;;B22F10/40;;B22F12/63;;B22F10/38;;B22F10/66;;B22F10/73;;B22F10/25;;B22F10/28;;B22F10/64;;B22F10/36;;B33Y40/20;;B23K2101/001;;B23K2103/08;;F01D5/12;;F01D5/147;;F05D2230/22;;Y02P10/25;;B33Y40/20;;B22F10/25;;B22F10/28;;B22F10/73;;B22F12/63;;B22F10/40;;B22F10/36;;B22F10/38;;B22F10/64;;B22F10/66;;B33Y10/00;;B33Y40/00;;B33Y80/00;;B22F3/15;;B22F3/24;;B22F5/009;;B22F5/04;;B22F2003/247;;B22F2003/248;;B22F2301/15;;B22F2998/10;;B23K15/0086;;C22F1/10,B22F3/105;;B22F3/24;;B22F5/00;;B22F5/04;;B33Y10/00;;B33Y40/00;;B33Y80/00;;C22F1/10,,0,0,,,,ACTIVE
224,AU,A,AU 1997/021396 A,169-159-168-995-720,1997-11-07,1997,AU 1997/021396 A,1997-03-03,US 63107396 A;;US 9703323 W,1996-04-12,Variable pitch structured optical film,,MINNESOTA MINING & MFG,COBB SANFORD JR;;GARDINER MARK E;;KOTCHICK KEITH M;;TOYOOKA KAZUHIKO;;HIBBARD WILLIAM A,,https://lens.org/169-159-168-995-720,Patent Application,no,0,0,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0278;;G02B5/045;;Y10S428/913;;Y10S385/901;;Y10T428/24537;;Y10T428/24669;;Y10T428/2457;;Y10T428/24355;;Y10T428/24479;;G02B5/00;;Y10T428/24537;;Y10T428/24669;;Y10T428/2457;;Y10T428/24355;;Y10T428/24479;;G02B5/0231;;G02B5/045;;G02B5/00;;G02B5/0278;;Y10S385/901;;Y10S428/913,G02B5/00;;G02B5/02;;G02B5/04;;G02F1/1335,,0,0,,,,EXPIRED
225,US,A,US 5919551 A,007-107-748-020-795,1999-07-06,1999,US 63107396 A,1996-04-12,US 63107396 A,1996-04-12,Variable pitch structured optical film,The present invention includes a structured optical film with variable pitch peaks and/or grooves to reduce the visibility of moire interference patterns and optical displays incorporating one or more layers of the film. The pitch variations can be over groups of adjacent peaks and/or valleys or between adjacent pairs of peaks and/or valleys.,3M INNOVATIVE PROPERTIES CO,COBB JR SANFORD;;GARDINER MARK E;;KOTCHICK KEITH M;;TOYOOKA KAZUHIKO;;HIBBARD WILLIAM A,MINNESOTA MINING AND MANUFACTURING COMPANY (1996-05-28),https://lens.org/007-107-748-020-795,Granted Patent,yes,34,405,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0231;;G02B5/00;;G02B5/00;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;Y10S385/901;;Y10S385/901;;Y10S428/913;;Y10S428/913;;Y10T428/24355;;Y10T428/24355;;Y10T428/24479;;Y10T428/24479;;Y10T428/24537;;Y10T428/24537;;Y10T428/2457;;Y10T428/2457;;Y10T428/24669;;Y10T428/24669,G02B5/00;;G02B5/02;;G02B5/04;;G02F1/1335,428/156;;428/141;;428/156;;428/913;;428/179;;428/167;;428/163;;359/530;;359/831;;359/834;;359/833;;359/837;;362/337;;362/339;;362/26;;385/146;;385/901;;385/36,1,0,,,"Olof Bryngdahl, Moir e : Formation and Interpretation , Optica Acta , 24 (1), 70 77 (1977).",EXPIRED
226,WO,A1,WO 1997/039369 A1,080-032-929-760-956,1997-10-23,1997,US 9703323 W,1997-03-03,US 63107396 A,1996-04-12,VARIABLE PITCH STRUCTURED OPTICAL FILM,The present invention includes a structured optical film with variable pitch peaks and/or grooves to reduce the visibility of moiré interference patterns and optical displays incorporating one or more layers of the film. The pitch variations can be over groups of adjacent peaks and/or valleys or between adjacent pairs of peaks and/or valleys.,MINNESOTA MINING & MFG,COBB SANFORD JR;;GARDINER MARK E;;KOTCHICK KEITH M;;TOYOOKA KAZUHIKO;;HIBBARD WILLIAM A,,https://lens.org/080-032-929-760-956,Patent Application,yes,8,8,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0231;;G02B5/00;;G02B5/00;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;Y10S385/901;;Y10S385/901;;Y10S428/913;;Y10S428/913;;Y10T428/24355;;Y10T428/24355;;Y10T428/24479;;Y10T428/24479;;Y10T428/24537;;Y10T428/24537;;Y10T428/2457;;Y10T428/2457;;Y10T428/24669;;Y10T428/24669,G02B5/00;;G02B5/02;;G02B5/04;;G02F1/1335,G2J JB7G          JB7G,0,0,,,,PATENTED
227,WO,A3,WO 2012/162678 A3,161-152-415-795-820,2014-01-16,2014,US 2012/0039741 W,2012-05-25,US 201161489807 P;;US 201161489854 P;;US 201161489847 P,2011-05-25,"PHENOLIC FOAMS WITH BLOWING AGENT 1, 1, 1, 4, 4, 4-HEXAFLUORO - 2 - BUTENE","Disclosed are foam compositions and processes to form closed-cell phenolic foams. The foams comprises a continuous polymeric phase defining a plurality of cells, wherein the continuous polymeric phase comprises a phenol-formaldehyde resole derived from a phenol and formaldehyde, and wherein the plurality of cells comprises a plurality of open-cells and a plurality of closed-cells with an open-cell content measured according to ASTM D6226-5, of less than 50%. The foam composition also comprises a discontinuous phase disposed in at least a portion of the plurality of closed-cells, the discontinuous phase comprising 1,1,1,4,4,4-hexafluoro-2-butene",DU PONT;;COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/161-152-415-795-820,Search Report,yes,2,0,8,33,0,B32B5/18;;B32B2250/03;;B32B2250/40;;B32B2266/0285;;B32B2266/06;;B32B2266/08;;B32B2305/022;;B32B2307/304;;B32B2307/3065;;B32B2307/72;;C08J9/146;;C08J2203/162;;C08J2205/052;;C08J2361/06;;Y10T428/249976;;Y10T428/249976;;B32B5/18;;C08J2205/052;;C08J9/146;;C08J2361/06;;B32B2266/06;;C08J2203/162;;B32B2266/08;;B32B2307/3065;;B32B2250/03;;B32B2250/40;;B32B2307/72;;B32B2307/304;;B32B2305/022;;B32B2266/0285;;C08L61/06,B32B5/18;;C08J9/14,,0,0,,,,PENDING
228,CA,A1,CA 2251252 A1,032-328-450-794-523,1997-10-23,1997,CA 2251252 A,1997-03-03,US 63107396 A;;US 9703323 W,1996-04-12,VARIABLE PITCH STRUCTURED OPTICAL FILM,The present invention includes a structured optical film with variable pitch peaks and/or grooves to reduce the visibility of moiré interference patterns and optical displays incorporating one or more layers of the film. The pitch variations can be over groups of adjacent peaks and/or valleys or between adjacent pairs of peaks and/or valleys.,MINNESOTA MINING & MFG,KOTCHICK KEITH M;;HIBBARD WILLIAM A;;GARDINER MARK E;;TOYOOKA KAZUHIKO;;COBB SANFORD JR,,https://lens.org/032-328-450-794-523,Patent Application,no,0,0,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0231;;G02B5/00;;G02B5/00;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;Y10S385/901;;Y10S385/901;;Y10S428/913;;Y10S428/913;;Y10T428/24355;;Y10T428/24355;;Y10T428/24479;;Y10T428/24479;;Y10T428/24537;;Y10T428/24537;;Y10T428/2457;;Y10T428/2457;;Y10T428/24669;;Y10T428/24669,G02B5/00;;G02B5/02;;G02B5/04;;G02F1/1335,,0,0,,,,EXPIRED
229,WO,A2,WO 2012/162649 A2,050-503-208-417-680,2012-11-29,2012,US 2012/0039675 W,2012-05-25,US 201161489854 P;;US 201161489787 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489847 P;;US 201161489807 P,2011-05-25,MIXED TANNIN-PHENOLIC FOAMS,"Disclosed are foam compositions and processes to form mixed tannin-phenolic foams. The process comprises forming a phenolic resole by mixing a phenol with a first monomer at a temperature in the range of room temperature to 90 °C, wherein the first monomer comprises formaldehyde, paraformaldehyde, furfural, glyoxal, acetaldehyde, 5-hydroxymethylfurfural, 5-furandicarboxylic aldehyde, difurfural (DFF), or mixtures thereof. The process also comprises adding a tannin to the phenolic resole to form a mixed-resin, wherein the phenol, the tannin, and the first monomer are present in a weight ratio 1:0.05:0.3 to 1:3:3.",DU PONT;;COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,,https://lens.org/050-503-208-417-680,Patent Application,yes,0,4,9,33,0,C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;Y10T428/249976;;Y10T428/249976;;C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;B32B5/18;;C08J9/146;;B29C44/02;;B29C44/3415;;B29K2061/00;;B29K2105/046;;B29K2995/0015;;B29K2995/0016;;B29L2031/10;;C08J9/141;;C08J2361/12;;E04C2/284,C08J9/00,,3,2,018-449-835-963-31X;;125-459-258-962-082,10.1002/anie.200604274;;17659519;;10.1016/j.tca.2005.06.026,"MEIKLEHAM ET AL., JOURNAL OFAPPLIED POLYMER SCIENCE, vol. 53, pages 1547 - 1556;;CHHEDA: ""Liquid Phase catalytic Processing of Biomass- derived Oxygenated Hydrocarbons to fuels and Chemicals"", ANGEWANDTE CHEMIE, INT., vol. 46, 2007, pages 7164 - 7183;;YI HE, THERMOCHIMICA ACTA, vol. 436, 2005, pages 122 - 129",PENDING
230,US,B2,US 10252337 B2,170-978-498-502-76X,2019-04-09,2019,US 201615250057 A,2016-08-29,US 201615250057 A,2016-08-29,Methods for directionally recrystallizing additively-manufactured metallic articles by heat treatment with a gradient furnace,"A method for manufacturing a metallic article includes providing or obtaining a metallic material in powder form, using an additive manufacturing process, building the metallic article from the powder-form metallic material, layer-by-layer, in a build direction, wherein as a result of the additive manufacturing process, the metallic article comprises columnar grain structures oriented in the build direction, and conveying the metallic article through a gradient furnace in a direction of conveyance from a first area of the gradient furnace to a second area of the gradient furnace to increase a size of the columnar grain structures in the metallic article. The metallic article is conveyed through the gradient furnace in an orientation such that the columnar structures oriented in the build direction are substantially parallel to the direction of conveyance.",HONEYWELL INT INC,MENON MAMBALLYKALATHIL;;BAUGHMAN BRIAN G;;COBB JAMES J;;GODFREY DONALD G;;MORRIS MARK C,HONEYWELL/LKGLOBAL PATENT SERVICES (2016-08-25),https://lens.org/170-978-498-502-76X,Granted Patent,yes,6,0,4,4,0,F05D2230/22;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y40/00;;B33Y80/00;;B22F3/24;;B22F5/009;;B22F5/04;;B22F2003/248;;B22F2998/10;;C22F1/10;;Y02P10/25;;B22F10/40;;B22F12/63;;B22F10/38;;B22F10/66;;B22F10/73;;B22F10/25;;B22F10/28;;B22F10/64;;B22F10/36;;B33Y40/20;;B23K2101/001;;B23K2103/08;;F01D5/12;;F01D5/147;;F05D2230/22;;Y02P10/25;;B33Y40/20;;B22F10/25;;B22F10/28;;B22F10/73;;B22F12/63;;B22F10/40;;B22F10/36;;B22F10/38;;B22F10/64;;B22F10/66;;B33Y10/00;;B33Y40/00;;B33Y80/00;;B22F3/15;;B22F3/24;;B22F5/009;;B22F5/04;;B22F2003/247;;B22F2003/248;;B22F2301/15;;B22F2998/10;;B23K15/0086;;C22F1/10,B22F3/24;;B22F3/105;;B22F3/15;;B22F5/00;;B22F5/04;;B23K15/00;;B23K101/00;;B23K103/08;;B33Y10/00;;B33Y40/00;;B33Y80/00;;C22F1/10;;F01D5/12;;F01D5/14,,1,0,,,"Extended EP Search Report for Application No. 17185425.0 dated Feb. 1, 2018.",INACTIVE
231,EP,A2,EP 2714780 A2,012-614-338-089-180,2014-04-09,2014,EP 12724844 A,2012-05-25,US 201161489847 P;;US 201161489854 P;;US 201161489787 P;;US 201161489790 P;;US 201161489795 P;;US 201161489803 P;;US 201161489807 P;;US 2012/0039747 W,2011-05-25,MIXED TANNIN-PHENOLIC FOAMS,,DU PONT,COBB MICHAEL W;;HARMER MARK ANDREW;;KAPUR VIVEK;;LIAUW ANN Y;;WILLIAMS SHARLENE RENEE,E. I. DU PONT DE NEMOURS AND COMPANY (2016-01-13),https://lens.org/012-614-338-089-180,Patent Application,yes,0,0,9,33,0,C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;Y10T428/249976;;Y10T428/249976;;C08J9/0061;;C08J9/14;;C08J2203/162;;C08J2361/06;;C08J2497/00;;C08J2499/00;;B32B5/18;;C08J9/146;;B29C44/02;;B29C44/3415;;B29K2061/00;;B29K2105/046;;B29K2995/0015;;B29K2995/0016;;B29L2031/10;;C08J9/141;;C08J2361/12;;E04C2/284,C08J9/00,,0,0,,,,DISCONTINUED
232,US,A1,US 2018/0056396 A1,019-000-803-598-246,2018-03-01,2018,US 201615250057 A,2016-08-29,US 201615250057 A,2016-08-29,METHODS FOR DIRECTIONALLY RECRYSTALLIZING ADDITIVELY-MANUFACTURED METALLIC ARTICLES BY HEAT TREATMENT WITH A GRADIENT FURNACE,"A method for manufacturing a metallic article includes providing or obtaining a metallic material in powder form, using an additive manufacturing process, building the metallic article from the powder-form metallic material, layer-by-layer, in a build direction, wherein as a result of the additive manufacturing process, the metallic article comprises columnar grain structures oriented in the build direction, and conveying the metallic article through a gradient furnace in a direction of conveyance from a first area of the gradient furnace to a second area of the gradient furnace to increase a size of the columnar grain structures in the metallic article. The metallic article is conveyed through the gradient furnace in an orientation such that the columnar structures oriented in the build direction are substantially parallel to the direction of conveyance.",HONEYWELL INT INC,MENON MAMBALLYKALATHIL;;BAUGHMAN BRIAN G;;COBB JAMES J;;GODFREY DONALD G;;MORRIS MARK C,HONEYWELL/LKGLOBAL PATENT SERVICES (2016-08-25),https://lens.org/019-000-803-598-246,Patent Application,yes,0,10,4,4,0,F05D2230/22;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y40/00;;B33Y80/00;;B22F3/24;;B22F5/009;;B22F5/04;;B22F2003/248;;B22F2998/10;;C22F1/10;;Y02P10/25;;B22F10/40;;B22F12/63;;B22F10/38;;B22F10/66;;B22F10/73;;B22F10/25;;B22F10/28;;B22F10/64;;B22F10/36;;B33Y40/20;;B23K2101/001;;B23K2103/08;;F01D5/12;;F01D5/147;;F05D2230/22;;Y02P10/25;;B33Y40/20;;B22F10/25;;B22F10/28;;B22F10/73;;B22F12/63;;B22F10/40;;B22F10/36;;B22F10/38;;B22F10/64;;B22F10/66;;B33Y10/00;;B33Y40/00;;B33Y80/00;;B22F3/15;;B22F3/24;;B22F5/009;;B22F5/04;;B22F2003/247;;B22F2003/248;;B22F2301/15;;B22F2998/10;;B23K15/0086;;C22F1/10,B22F3/24;;B22F3/105;;B22F3/15;;B22F5/00;;B22F5/04;;B23K15/00;;B33Y10/00;;B33Y40/00;;B33Y80/00;;C22F1/10,,0,0,,,,INACTIVE
233,AU,B2,AU 727440 B2,026-232-591-359-767,2000-12-14,2000,AU 1997/021396 A,1997-03-03,US 63107396 A;;US 9703323 W,1996-04-12,Variable pitch structured optical film,,MINNESOTA MINING & MFG,COBB SANFORD JR;;GARDINER MARK E;;KOTCHICK KEITH M;;TOYOOKA KAZUHIKO;;HIBBARD WILLIAM A,,https://lens.org/026-232-591-359-767,Granted Patent,no,3,0,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0231;;G02B5/00;;G02B5/00;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;Y10S385/901;;Y10S385/901;;Y10S428/913;;Y10S428/913;;Y10T428/24355;;Y10T428/24355;;Y10T428/24479;;Y10T428/24479;;Y10T428/24537;;Y10T428/24537;;Y10T428/2457;;Y10T428/2457;;Y10T428/24669;;Y10T428/24669,G02B5/00;;G02B5/02;;G02B5/04;;G02F1/1335,,0,0,,,,EXPIRED
234,WO,A1,WO 2001/027529 A1,094-057-405-850-036,2001-04-19,2001,US 0025619 W,2000-09-19,US 41412499 A,1999-10-08,LIGHTGUIDE HAVING A DIRECTLY SECURED REFLECTOR AND METHOD OF MAKING THE SAME,"A lightguide (14, 32) includes an input edge surface (18), a back surface (20) and an output surface (22). A reflector (26) directly secured to the back surface (20) by, for example, adhesive bonding.",3M INNOVATIVE PROPERTIES CO,WORTMAN DAVID L;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D;;GARDINER MARK E,,https://lens.org/094-057-405-850-036,Patent Application,yes,2,10,9,9,0,G02B6/0038;;G02B6/0043;;G02B6/0055;;G02F1/1335;;G02B6/0055;;G02B6/0038;;G02B6/0043,F21V8/00;;G02B6/00;;F21Y103/00;;G02F1/13357,,0,0,,,,PENDING
235,CA,A1,CA 2384825 A1,142-537-672-405-289,2001-04-19,2001,CA 2384825 A,2000-09-08,US 41510099 A;;US 0024590 W,1999-10-08,DISPLAY ILLUMINATION DEVICE AND METHOD OF ENHANCING BRIGHTNESS IN A DISPLAY ILLUMINATION DEVICE,An illumination device (110) including a lightguide (112) operates under the principle of frustrate total internal reflection. The illumination device (120) includes optical elements and combinations of optical elements for enhancing the apparent brightness of the lightguide (112).,3M INNOVATIVE PROPERTIES CO,COBB SANFORD;;EPSTEIN KENNETH A;;GARDINER MARK E;;KRETMAN WADE D;;WORTMAN DAVID L,,https://lens.org/142-537-672-405-289,Patent Application,no,0,0,14,14,0,G02B6/0053;;G02F1/1335;;G02B6/0055;;G02B6/0056;;G02F1/133504;;G02F1/133536;;G02F1/133545;;G02F1/133615;;G02F1/13362,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/30;;G02B6/00;;G02F1/1335;;G02F1/13357;;G02F1/13363,,0,0,,,,EXPIRED
236,JP,A,JP 2008287265 A,107-150-774-262-279,2008-11-27,2008,JP 2008139862 A,2008-05-28,US 63107396 A,1996-04-12,VARIABLE PITCH STRUCTURED OPTICAL FILM,"<P>PROBLEM TO BE SOLVED: To attain recycling of light that will exit from a display outside of an allowable range and reduction in appearance of reflected moire, too. <P>SOLUTION: In a structured optical film having a structured surface, the structured surface 44 includes (a) a plurality of generally parallel peaks 46, each pair of adjacent peaks being separated by a valley 48, (b) a first group 50 of at least three adjacent peaks having a first definite peak pitch and (c) a second group 52 of adjacent peaks having a second peak pitch, the second group of adjacent peaks being located adjacent to the first group of adjacent peaks, wherein the first peak pitch is different from the second peak pitch. <P>COPYRIGHT: (C)2009,JPO&INPIT",MINNESOTA MINING & MFG,COBB SANFORD JR;;GARDINER MARK E;;KOTCHICK KEITH M;;TOYOOKA KAZUHIKO;;HIBBARD WILLIAM A,,https://lens.org/107-150-774-262-279,Patent Application,no,5,1,18,18,0,G02B5/00;;G02B5/0231;;G02B5/0231;;G02B5/00;;G02B5/00;;G02B5/0278;;G02B5/0278;;G02B5/045;;G02B5/045;;Y10S385/901;;Y10S385/901;;Y10S428/913;;Y10S428/913;;Y10T428/24355;;Y10T428/24355;;Y10T428/24479;;Y10T428/24479;;Y10T428/24537;;Y10T428/24537;;Y10T428/2457;;Y10T428/2457;;Y10T428/24669;;Y10T428/24669,G02B5/02;;G02B5/00;;G02B5/04;;G02F1/1335,,0,0,,,,INACTIVE
237,AU,A,AU 2001/046061 A,157-639-869-338-042,2001-04-23,2001,AU 2001/046061 A,2000-09-19,US 41412499 A;;US 0025619 W,1999-10-08,Lightguide Having a Directly Secured Reflector and Method of Making the Same,,3M INNOVATIVE PROPERTIES CO,WORTMAN DAVID L;;COBB SANFORD;;EPSTEIN KENNETH A;;KRETMAN WADE D;;GARDINER MARK E,,https://lens.org/157-639-869-338-042,Patent Application,no,0,0,9,9,0,G02B6/0038;;G02B6/0043;;G02B6/0055;;G02F1/1335;;G02B6/0055;;G02B6/0038;;G02B6/0043,G02B6/00;;F21V8/00;;F21Y103/00;;G02F1/13357,,0,0,,,,DISCONTINUED
238,AU,A,AU 2000/073566 A,126-029-124-501-420,2001-04-23,2001,AU 2000/073566 A,2000-09-08,US 41510099 A;;US 0024590 W,1999-10-08,Display illumination device and method of enhancing brightness in a display illumination device,,3M INNOVATIVE PROPERTIES CO,KRETMAN WADE D;;COBB SANFORD JR;;EPSTEIN KENNETH A;;GARDINER MARK E;;WORTMAN DAVID L,,https://lens.org/126-029-124-501-420,Patent Application,no,0,0,14,14,0,G02B6/0053;;G02B6/0055;;G02B6/0056;;G02F1/133504;;G02F1/133536;;G02F1/133615;;G02F1/13362;;G02F1/133545;;G02F1/1335,G02B5/02;;F21V8/00;;F21Y103/00;;G02B5/30;;G02B6/00;;G02F1/1335;;G02F1/13357;;G02F1/13363,,0,0,,,,PENDING
239,JP,A,JP 2019184066 A,087-054-800-429-711,2019-10-24,2019,JP 2019072484 A,2019-04-05,US 201862654757 P,2018-04-09,HYDRAULIC TENSIONER ARM PROVIDED WITH LEVER,"To provide a hydraulic tensioner device including a tensioner arm and a hydraulic tensioner.SOLUTION: The tensioner arm comprises: a body having a first end, a second end, a chain sliding surface and a surface opposite the chain sliding surface; a pivot at the first end or the second end of the body; and a banjo bolt feed at the other of the first and second ends of the body. The hydraulic tensioner is pivotably attached to the pivot and the banjo bolt and is adjacent to the surface opposite the chain sliding surface. The hydraulic tensioner receives a supply fluid from the banjo bolt. The hydraulic tensioner comprises: a housing with a bore; a hollow piston having a first end and a second end and slidably received within the bore; and a spring received within the bore of the housing and the hollow piston and biasing the hollow piston outwards from the bore of the housing.SELECTED DRAWING: Figure 2G",BORGWARNER INC,KEITH B COBB;;WIGSTEN MARK;;KEVIN TODD;;LU XIAOJIAN;;SEONGDO HONG;;PAUL FREEMANTLE;;AKIRA TAKEUCHI,,https://lens.org/087-054-800-429-711,Patent Application,no,0,0,5,5,0,F16H7/08;;F16H7/0848;;F16H7/0848;;F16H7/08;;F16H7/0848;;F16H25/18;;F16H2007/0806;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0859;;F16H2007/0859;;F16H2007/0859;;F16H2007/0872;;F16H2007/0872;;F16H2007/0893;;F16H2007/0893;;F16H2007/0893,F16H7/08,,0,0,,,,PENDING
240,US,A1,US 2019/0309831 A1,115-085-471-167-84X,2019-10-10,2019,US 201916378860 A,2019-04-09,US 201916378860 A;;US 201862654757 P,2018-04-09,HYDRAULIC TENSIONER ARM MOUNTING WITH LEVER,"Hydraulic tensioner device including a tensioner arm and a hydraulic tensioner. The tensioner arm comprising: a body having a first end, a second end, a chain sliding surface and a surface opposite the chain sliding face; a pivot at the first end or the second end of the body; and a banjo bolt feed at the other of the first end or second end of the body. The hydraulic tensioner being pivotably attached to the pivot and the banjo bolt and adjacent the surface opposite the chain sliding face, wherein the hydraulic tensioner receives supply fluid from the banjo bolt, the hydraulic tensioner comprising: a housing with a bore; a hollow piston having a first end and a second end, slidably received within the bore; and a spring received within the bore of the housing and the hollow piston biasing the hollow piston outwards from the bore of the housing.",BORGWARNER INC,COBB KEITH B;;WIGSTEN MARK;;TODD KEVIN;;LU XIAOJIAN;;HONG SEONGDO;;FREEMANTLE PAUL;;TAKEUCHI AKIRA,,https://lens.org/115-085-471-167-84X,Patent Application,yes,0,0,5,5,0,F16H7/08;;F16H7/0848;;F16H7/0848;;F16H7/08;;F16H7/0848;;F16H25/18;;F16H2007/0806;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0859;;F16H2007/0859;;F16H2007/0859;;F16H2007/0872;;F16H2007/0872;;F16H2007/0893;;F16H2007/0893;;F16H2007/0893,F16H7/08;;F16H25/18,,0,0,,,,DISCONTINUED
241,EP,A1,EP 4115007 A1,155-919-000-278-489,2023-01-11,2023,EP 21711790 A,2021-03-04,GB 202003310 A;;EP 2021055513 W,2020-03-06,METHOD FOR FORMING DIAMOND PRODUCT,,ELEMENT SIX TECH LTD;;UNIV WARWICK,TULLY JOSHUA JAMES;;COBB SAMUEL JAMES;;MACPHERSON JULIE VICTORIA;;NEWTON MARK EDWARD;;MARKHAM MATTHEW LEE,,https://lens.org/155-919-000-278-489,Patent Application,yes,0,0,8,8,0,C30B29/04;;C30B33/06;;H01L21/042;;H01L21/3063;;H01L21/02005;;C01B32/25;;C01B32/28;;C23C16/01;;C25F3/02;;C25F3/12;;C25F3/14;;C30B29/04;;C01B32/28;;C01B32/25;;C01P2002/90;;C23C14/0605;;C23C14/48;;C25F3/12;;C25F3/14;;C30B29/04;;C30B33/10,C30B29/04;;C30B33/06;;H01L21/762,,0,0,,,,PENDING
242,GB,A,GB 2594781 A,164-172-822-051-922,2021-11-10,2021,GB 202103069 A,2021-03-04,GB 202003310 A,2020-03-06,Method for forming diamond product,"A method for forming a diamond product and associated diamond products, comprising polycrystalline diamond material and a composite body comprising a single crystal diamond plate with a glue that is inert to ions capable of forming radicals during electrolysis. A damage layer comprising sp2 bonded carbon is formed (S2) and the presence of the damage layer defines a first diamond layer (S1) above and in contact with the damage layer and a second diamond layer below and in contact with the damage layer. The damage layer is electrochemically etched to separate it from the first layer. The electrochemical etching is performed in a solution containing ions, the solution having an electrical conductivity of at least 500 μS cm-1, (S4) and wherein the ions are capable of forming radicals during electrolysis. The etching may be completed at an elevated temperature with concentration of ion greater than 0.01M.",ELEMENT SIX TECH LTD;;UNIV WARWICK,JOSHUA JAMES TULLY;;SAMUEL JAMES COBB;;JULIE VICTORIA MACPHERSON;;MARK EDWARD NEWTON;;MATTHEW LEE MARKHAM,,https://lens.org/164-172-822-051-922,Patent Application,no,2,0,8,8,0,C30B29/04;;C30B33/06;;H01L21/042;;H01L21/3063;;H01L21/02005;;C01B32/25;;C01B32/28;;C23C16/01;;C25F3/02;;C25F3/12;;C25F3/14;;C30B29/04;;C01B32/28;;C01B32/25;;C01P2002/90;;C23C14/0605;;C23C14/48;;C25F3/12;;C25F3/14;;C30B29/04;;C30B33/10,C25F3/02;;C01B32/25;;C01B32/28;;C23C16/01;;C25F3/12;;C25F3/14;;C30B29/04,,0,0,,,,PENDING
243,US,A1,US 2023/0053780 A1,142-899-743-980-087,2023-02-23,2023,US 202117759173 A,2021-03-04,GB 202003310 A;;EP 2021055513 W,2020-03-06,METHOD FOR FORMING DIAMOND PRODUCT,"A method for forming a diamond product. Diamond material is provided and a damage layer comprising sp 2 bonded carbon is formed in the material. The presence of the damage layer defines a first diamond layer above and in contact with the damage layer and a second diamond layer below and in contact with the damage layer. The damage layer is electrochemically etched to separate it from the first layer, wherein the electrochemical etching is performed in a solution containing ions, the solution having an electrical conductivity of at least 500 μS cm −1 , and wherein the ions are capable of forming radicals during electrolysis. The diamond product is also described.",ELEMENT SIX TECH LTD;;UNIV WARWICK,TULLY JOSHUA JAMES;;COBB SAMUEL JAMES;;MACPHERSON JULIE VICTORIA;;NEWTON MARK EDWARD;;MARKHAM MATTHEW LEE,ELEMENT SIX (UK) LIMITED (2021-03-31);;THE UNIVERSITY OF WARWICK (2020-08-14);;ELEMENT SIX TECHNOLOGIES LIMITED (2021-06-10),https://lens.org/142-899-743-980-087,Patent Application,yes,0,0,8,8,0,C30B29/04;;C30B33/06;;H01L21/042;;H01L21/3063;;H01L21/02005;;C01B32/25;;C01B32/28;;C23C16/01;;C25F3/02;;C25F3/12;;C25F3/14;;C30B29/04;;C01B32/28;;C01B32/25;;C01P2002/90;;C23C14/0605;;C23C14/48;;C25F3/12;;C25F3/14;;C30B29/04;;C30B33/10,C25F3/12;;C01B32/25;;C01B32/28;;C23C14/06;;C23C14/48;;C25F3/14;;C30B29/04;;C30B33/10,,0,0,,,,PENDING
244,CN,A,CN 110360281 A,031-205-139-960-254,2019-10-22,2019,CN 201910283669 A,2019-04-09,US 201862654757 P,2018-04-09,HYDRAULIC TENSIONER ARM MOUNTING WITH LEVER,"A hydraulic tensioner device includes a tensioner arm and a hydraulic tensioner. The tensioner arm comprises a body having a first end, a second end, a chain sliding surface and a surface opposite thechain sliding face; a pivot at the first end or the second end of the body; and a banjo bolt feed at the other of the first end or second end of the body. The hydraulic tensioner being pivotably attached to the pivot and the banjo bolt and adjacent the surface opposite the chain sliding face, wherein the hydraulic tensioner receives supply fluid from the banjo bolt, the hydraulic tensioner comprising: a housing with a bore; a hollow piston having a first end and a second end, slidably received within the bore; and a spring received within the bore of the housing and the hollow piston biasingthe hollow piston outwards from the bore of the housing.",BORGWARNER INC,COBB KEITH B;;WIGSTEN MARK;;TODD KEVIN;;LU XIAOJIAN;;HONG SEONGDO;;FREEMANTLE PAUL;;TAKEUCHI AKIRA,,https://lens.org/031-205-139-960-254,Patent Application,no,10,0,5,5,0,F16H7/08;;F16H2007/0812;;F16H7/0848;;F16H2007/0812;;F16H2007/0859;;F16H2007/0872;;F16H2007/0893;;F16H7/0848;;F16H2007/0812;;F16H2007/0806;;F16H2007/0859;;F16H2007/0893;;F16H7/08;;F16H7/0848;;F16H25/18;;F16H2007/0893;;F16H2007/0872;;F16H2007/0859;;F16H2007/0812,F16H7/08,,0,0,,,,PENDING
245,WO,A1,WO 2021/176015 A1,143-535-622-758-593,2021-09-10,2021,EP 2021055513 W,2021-03-04,GB 202003310 A,2020-03-06,METHOD FOR FORMING DIAMOND PRODUCT,"A method for forming a diamond product. Diamond material is provided and a damage layer comprising sp 2 bonded carbon is formed in the material. The presence of the damage layer defines a first diamond layer above and in contact with the damage layer and a second diamond layer below and in contact with the damage layer. The damage layer is electrochemically etched to separate it from the first layer, wherein the electrochemical etching is performed in a solution containing ions, the solution having an electrical conductivity of at least 500 µS cm -1 , and wherein the ions are capable of forming radicals during electrolysis. The diamond product is also described.",ELEMENT SIX TECH LTD;;UNIV WARWICK,TULLY JOSHUA JAMES;;COBB SAMUEL JAMES;;MACPHERSON JULIE VICTORIA;;NEWTON MARK EDWARD;;MARKHAM MATTHEW LEE,,https://lens.org/143-535-622-758-593,Patent Application,yes,5,0,8,8,0,C30B29/04;;C30B33/06;;H01L21/042;;H01L21/3063;;H01L21/02005;;C01B32/25;;C01B32/28;;C23C16/01;;C25F3/02;;C25F3/12;;C25F3/14;;C30B29/04;;C01B32/28;;C01B32/25;;C01P2002/90;;C23C14/0605;;C23C14/48;;C25F3/12;;C25F3/14;;C30B29/04;;C30B33/10,C30B29/04;;C30B33/06;;H01L21/762,,8,6,013-990-872-656-216;;052-743-876-189-850;;129-547-583-809-706;;084-644-102-419-365;;166-088-292-740-405;;058-390-949-855-816,10.1116/1.2731327;;10.1016/j.sse.2009.12.012;;10.1063/1.107981;;10.1063/1.110089;;10.1016/j.nimb.2010.02.091;;16188474;;10.1016/j.jmr.2005.08.013,"WANG C ET AL: ""Fabrication of suspended single crystal diamond devices by electrochemical etch"", JOURNAL OF VACUUM SCIENCE AND TECHNOLOGY: PART B, AVS / AIP, MELVILLE, NEW YORK, NY, US, vol. 25, no. 3, 20 April 2007 (2007-04-20), pages 730 - 733, XP012102948, ISSN: 1071-1023, DOI: 10.1116/1.2731327;;WIDIEZ J ET AL: ""Fabrication of Silicon on Diamond (SOD) substrates by either the Bonded and Etched-back SOI (BESOI) or the Smart-Cut"" technology"", SOLID STATE ELECTRONICS, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 54, no. 2, 1 February 2010 (2010-02-01), pages 158 - 163, XP026904429, ISSN: 0038-1101, [retrieved on 20100201], DOI: 10.1016/J.SSE.2009.12.012;;PARIKH, APPL. PHYS. LETT., vol. 61, no. 26, 1992, pages 3124 - 3126;;MARCHYWKA ET AL., APPL. PHYS. LETT., vol. 63, 1993, pages 3521;;J. ELECTROCHEM. SOC., vol. 140, 1993, pages 2;;PARIKH, NANOSCALE, vol. 8, 2016, pages 6860;;ZIEGLER, J. F.: ""SRIM - The Stopping and Range of Ions in Matter"", NUCL. INSTRUMENTS METHODS PHYS. RES. SECT. B BEAM INTERACT. WITH MATER. ATOMS 2010, vol. 268, no. 11-12, 2010, pages 1818 - 1823, XP027046347;;STOLL, S.SCHWEIGER, A.: ""EasySpin, a Comprehensive Software Package for Spectral Simulation and Analysis in EPR"", J. MAGN. RESON., vol. 178, no. 1, 2006, pages 42 - 55, XP024919324, Retrieved from the Internet <URL:https://doi.org/10.1016/jjmr.2005.08.013> DOI: 10.1016/j.jmr.2005.08.013",PENDING
246,US,A1,US 2021/0232130 A1,068-563-486-767-283,2021-07-29,2021,US 202016752837 A,2020-01-27,US 202016752837 A,2020-01-27,SYSTEMS AND METHODS FOR USE IN FACILITATING A MANUFACTURING OPERATION,"A system for use in facilitating a manufacturing operation that includes a wireless beacon paired with each vehicle of multiple vehicles routable along a production line in a sequence. The wireless beacon emits a signal containing information that identifies the paired vehicle. A wireless transceiver is at a predetermined location along the production line, and the wireless transceiver scans for the signal. A server device is in communication with the wireless transceiver. The server device stores pairing data of which wireless beacon is paired with each vehicle, and sequence data of the vehicles routed along the production line, and receives, from the wireless transceiver, a signal containing the information that identifies the paired vehicle. The server device also verifies, based on the pairing data, the sequence data, and the information in the signal, that an order in which the vehicles enter the predetermined location corresponds to the sequence.",HONDA MOTOR CO LTD,MCNEILL DAVID J;;ZICCARDI ROBERT MARK;;SONODA RYAN THOMAS;;HICKMAN DYLAN;;AYERS BRIAN D;;BLUSTEIN MARK;;COBB DERRICK IAN;;HITTLE ANDREW KENT,HONDA MOTOR CO. LTD (2019-12-17),https://lens.org/068-563-486-767-283,Patent Application,yes,0,0,2,2,0,H04B17/27;;H04B17/318;;G05B19/41805;;G05B2219/31027;;G05B2219/32001;;G05B19/41895;;H04W4/46;;H04B17/318;;G05B19/4183,G05B19/418;;H04B17/318;;H04W4/46,,0,0,,,,ACTIVE
247,US,B2,US 11391807 B2,084-109-627-432-998,2022-07-19,2022,US 202016752807 A,2020-01-27,US 202016752807 A,2020-01-27,Systems and methods for use in transmitting data,"A system for use in transmitting data. The system includes at least one wireless beacon positionable in a work zone, with the at least one wireless beacon configured to emit a signal. A diagnostic device is configured to mate with an object positionable in the work zone, the diagnostic device including a wireless transceiver configured to receive the signal, and a controller in communication with the wireless transceiver. The controller is configured to receive a data package associated with the object, determine a location of the object based on an analysis of the signal, and transmit, via the wireless transceiver, the data package to the work zone when it is determined that the object is positioned within the work zone.",HONDA MOTOR CO LTD,MCNEILL DAVID J;;ZICCARDI ROBERT MARK;;SONODA RYAN THOMAS;;HICKMAN DYLAN;;AYERS BRIAN D;;BLUSTEIN MARK;;COBB DERRICK IAN;;HITTLE ANDREW KENT,HONDA MOTOR CO. LTD (2019-12-17),https://lens.org/084-109-627-432-998,Granted Patent,yes,22,0,2,2,0,H04W4/021;;H04W4/029;;H04W4/023;;H04B17/318;;G01S5/0284;;G01S11/06;;G01S1/68;;G01S1/68;;H04B17/318;;H04W4/029;;H04W4/023;;G07C5/0808,H04B17/318;;G01S1/68;;G07C5/08;;H04W4/02;;H04W4/029,,0,0,,,,ACTIVE
248,US,B2,US 11372397 B2,193-143-873-599-815,2022-06-28,2022,US 202016752837 A,2020-01-27,US 202016752837 A,2020-01-27,Systems and methods for use in facilitating a manufacturing operation,"A system for use in facilitating a manufacturing operation that includes a wireless beacon paired with each vehicle of multiple vehicles routable along a production line in a sequence. The wireless beacon emits a signal containing information that identifies the paired vehicle. A wireless transceiver is at a predetermined location along the production line, and the wireless transceiver scans for the signal. A server device is in communication with the wireless transceiver. The server device stores pairing data of which wireless beacon is paired with each vehicle, and sequence data of the vehicles routed along the production line, and receives, from the wireless transceiver, a signal containing the information that identifies the paired vehicle. The server device also verifies, based on the pairing data, the sequence data, and the information in the signal, that an order in which the vehicles enter the predetermined location corresponds to the sequence.",HONDA MOTOR CO LTD,MCNEILL DAVID J;;ZICCARDI ROBERT MARK;;SONODA RYAN THOMAS;;HICKMAN DYLAN;;AYERS BRIAN D;;BLUSTEIN MARK;;COBB DERRICK IAN;;HITTLE ANDREW KENT,HONDA MOTOR CO. LTD (2019-12-17),https://lens.org/193-143-873-599-815,Granted Patent,yes,18,0,2,2,0,H04B17/27;;H04B17/318;;G05B19/41805;;G05B2219/31027;;G05B2219/32001;;G05B19/41895;;H04W4/46;;H04B17/318;;G05B19/4183,G05B19/418;;H04B17/318;;H04W4/46,,0,0,,,,ACTIVE
249,US,A1,US 2021/0231764 A1,032-861-905-173-017,2021-07-29,2021,US 202016752807 A,2020-01-27,US 202016752807 A,2020-01-27,SYSTEMS AND METHODS FOR USE IN TRANSMITTING DATA,"A system for use in transmitting data. The system includes at least one wireless beacon positionable in a work zone, with the at least one wireless beacon configured to emit a signal. A diagnostic device is configured to mate with an object positionable in the work zone, the diagnostic device including a wireless transceiver configured to receive the signal, and a controller in communication with the wireless transceiver. The controller is configured to receive a data package associated with the object, determine a location of the object based on an analysis of the signal, and transmit, via the wireless transceiver, the data package to the work zone when it is determined that the object is positioned within the work zone.",HONDA MOTOR CO LTD,MCNEILL DAVID J;;ZICCARDI ROBERT MARK;;SONODA RYAN THOMAS;;HICKMAN DYLAN;;AYERS BRIAN D;;BLUSTEIN MARK;;COBB DERRICK IAN;;HITTLE ANDREW KENT,HONDA MOTOR CO. LTD (2019-12-17),https://lens.org/032-861-905-173-017,Patent Application,yes,0,0,2,2,0,H04W4/021;;H04W4/029;;H04W4/023;;H04B17/318;;G01S5/0284;;G01S11/06;;G01S1/68;;G01S1/68;;H04B17/318;;H04W4/029;;H04W4/023;;G07C5/0808,G07C5/08;;G01S1/68;;H04B17/318;;H04W4/02;;H04W4/029,,0,0,,,,ACTIVE
250,CN,A,CN 113166700 A,155-305-167-145-470,2021-07-23,2021,CN 201980079113 A,2019-11-27,US 201862773899 P;;US 2019/0063712 W,2018-11-30,SYSTEM AND METHOD FOR IMAGING AND ILLUMINATION FOR CELL CONFLUENCE MEASUREMENT,A cell monitoring plate comprises a flat surface on which multiple cell culturing vessels may be stacked. The flats surface has multiple optical imaging systems embedded therein to fully image a cell culture vessels stacked on the plate. Each one of the multiple optical imaging systems provides both illumination and imaging through a single aperture in the surface of the monitoring plate.,CORNING INC,COBB JOSHUA MONROE;;MARTIN GREGORY ROGER;;RACZKOWSKI ROBERT RAYMOND;;SANSON MARK CHRISTIAN;;SCHREIBER HORST;;UPTON TODD MICHAEL,,https://lens.org/155-305-167-145-470,Patent Application,no,5,0,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,C12M1/12;;C12M1/00;;C12M1/34,,0,0,,,,PENDING
251,KR,A,KR 20190118128 A,138-468-431-093-199,2019-10-17,2019,KR 20190040628 A,2019-04-08,US 201862654757 P,2018-04-09,HYDRAULIC TENSIONER ARM MOUNTING WITH LEVER,"The present invention relates to a hydraulic tensioner device including a tensioner arm and a hydraulic tensioner. The tensioner arm includes: a body including a first end part, a second end part, a chain sliding surface and a surface facing the chain sliding surface; a pivot placed in the first or second end part of the body; and a banjo bolt feed placed in the other one of the first and second end parts of the body. The hydraulic tensioner, which is attached to the pivot and the banjo bolt to be pivotable and adjacent to the surface facing the chain sliding surface, stores fluids supplied from the banjo bolt. The hydraulic tensioner includes: a housing including a bore; a hollow piston including first and second end parts, and stored in the bore to be able to be slid; and a spring stored in the bore of the housing and the hollow piston to bias the hollow piston outwards from the bore of the housing.",BORGWARNER INC,KEITH B COBB;;MARK WIGSTEN;;KEVIN TODD;;XIAOJIAN LU;;SEONGDO HONG;;PAUL FREEMANTLE;;AKIRA TAKEUCHI;;SIMMONS SEAN,,https://lens.org/138-468-431-093-199,Patent Application,no,0,0,5,5,0,F16H7/08;;F16H7/0848;;F16H7/0848;;F16H7/08;;F16H7/0848;;F16H25/18;;F16H2007/0806;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0859;;F16H2007/0859;;F16H2007/0859;;F16H2007/0872;;F16H2007/0872;;F16H2007/0893;;F16H2007/0893;;F16H2007/0893,F16H7/08,,0,0,,,,PENDING
252,WO,A1,WO 2020/113076 A1,095-356-318-261-862,2020-06-04,2020,US 2019/0063712 W,2019-11-27,US 201862773899 P,2018-11-30,SYSTEM AND METHOD FOR IMAGING AND ILLUMINATION FOR CELL CONFLUENCE MEASUREMENT,A cell monitoring plate comprises a flat surface on which multiple cell culturing vessels may be stacked. The flats surface has multiple optical imaging systems embedded therein to fully image a cell culture vessels stacked on the plate. Each one of the multiple optical imaging systems provides both illumination and imaging through a single aperture in the surface of the monitoring plate.,CORNING INC,COBB JOSHUA MONROE;;MARTIN GREGORY ROGER;;RACZKOWSKI ROBERT RAYMOND;;SANSON MARK CHRISTIAN;;SCHREIBER HORST;;UPTON TODD MICHAEL,,https://lens.org/095-356-318-261-862,Patent Application,yes,5,0,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,C12M1/00;;C12M1/12;;C12M1/34,,0,0,,,,PENDING
253,US,A1,US 2022/0120729 A1,036-420-586-098-639,2022-04-21,2022,US 202117564465 A,2021-12-29,US 202117564465 A;;US 202016797378 A;;US 2019/0063712 W;;US 201862773899 P,2018-11-30,SYSTEM AND METHOD FOR IMAGING AND ILLUMINATION FOR CELL CONFLUENCE MEASUREMENT,A cell monitoring plate comprises a flat surface on which multiple cell culturing vessels may be stacked. The flats surface has multiple optical imaging systems embedded therein to fully image a cell culture vessels stacked on the plate. Each one of the multiple optical imaging systems provides both illumination and imaging through a single aperture in the surface of the monitoring plate.,CORNING INC,COBB JOSHUA MONROE;;MARTIN GREGORY ROGER;;RACZKOWSKI ROBERT RAYMOND;;SANSON MARK CHRISTIAN;;SCHREIBER HORST;;UPTON TODD MICHAEL,,https://lens.org/036-420-586-098-639,Patent Application,yes,14,0,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,G01N33/483;;C12M1/32;;C12M1/34;;G01N21/55;;G01N33/50;;G02B21/36,,0,0,,,,ACTIVE
254,EP,A1,EP 3887501 A1,146-597-000-670-258,2021-10-06,2021,EP 19827959 A,2019-11-27,US 201862773899 P;;US 2019/0063712 W,2018-11-30,SYSTEM AND METHOD FOR IMAGING AND ILLUMINATION FOR CELL CONFLUENCE MEASUREMENT,,CORNING INC,COBB JOSHUA MONROE;;MARTIN GREGORY ROGER;;RACZKOWSKI ROBERT RAYMOND;;SANSON MARK CHRISTIAN;;SCHREIBER HORST;;UPTON TODD MICHAEL,,https://lens.org/146-597-000-670-258,Patent Application,yes,0,0,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,C12M1/12;;C12M1/00;;C12M1/34,,0,0,,,,PENDING
255,US,B2,US 11768194 B2,164-219-083-499-680,2023-09-26,2023,US 202117564465 A,2021-12-29,US 202117564465 A;;US 202016797378 A;;US 2019/0063712 W;;US 201862773899 P,2018-11-30,System and method for imaging and illumination for cell confluence measurement,A cell monitoring plate comprises a flat surface on which multiple cell culturing vessels may be stacked. The flats surface has multiple optical imaging systems embedded therein to fully image a cell culture vessels stacked on the plate. Each one of the multiple optical imaging systems provides both illumination and imaging through a single aperture in the surface of the monitoring plate.,CORNING INC,COBB JOSHUA MONROE;;MARTIN GREGORY ROGER;;RACZKOWSKI ROBERT RAYMOND;;SANSON MARK CHRISTIAN;;SCHREIBER HORST;;UPTON TODD MICHAEL,,https://lens.org/164-219-083-499-680,Granted Patent,yes,43,0,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,C12M1/32;;C12M1/34;;G01N21/55;;G01N33/483;;G01N33/50;;G02B21/00;;G02B21/04;;G02B21/36,,6,0,,,"Cobb et al., U.S. Appl. No. 16/690,583, titled “Compact Optical Imaging System for Cell Culture Monitoring,” filed Nov. 21, 2019.;;International Search Report and Writien Opinion of the European International Searching Authority; PCT/US2019/063712; dated Feb. 27, 20; 13 Pgs.;;International Search Report and Written Opinion of the International Searching Authority; PCT/US2019/063712; dated Feb. 27, 2020; 11 Pages; European Patent Office.;;International Search Report and Written Opinion of the International Searching Authority; PCT/US2019/062137; dated Jun. 25, 2020; 18 Pages; European Patent Office.;;Invitation to Pay Additional Fees and Partial Search Report of the European International Searching Authority; PCT/US2019/062137; dated Mar. 2, 2020; 17 Pgs.;;Invitation to Pay Additional Fees of the International Searching Authority PCT/US2019/062137; dated Mar. 2, 2020; 17 Pages; European Patent Office.",ACTIVE
256,US,A1,US 2020/0190453 A1,151-086-896-965-839,2020-06-18,2020,US 202016797378 A,2020-02-21,US 202016797378 A;;US 2019/0063712 W;;US 201862773899 P,2018-11-30,SYSTEM AND METHOD FOR IMAGING AND ILLUMINATION FOR CELL CONFLUENCE MEASUREMENT,A cell monitoring plate comprises a flat surface on which multiple cell culturing vessels may be stacked. The flats surface has multiple optical imaging systems embedded therein to fully image a cell culture vessels stacked on the plate. Each one of the multiple optical imaging systems provides both illumination and imaging through a single aperture in the surface of the monitoring plate.,CORNING INC,COBB JOSHUA MONROE;;MARTIN GREGORY ROGER;;RACZKOWSKI ROBERT RAYMOND;;SANSON MARK CHRISTIAN;;SCHREIBER HORST;;UPTON TODD MICHAEL,CORNING INCORPORATED (2020-02-17),https://lens.org/151-086-896-965-839,Patent Application,yes,9,1,13,13,0,C12M41/46;;C12M23/04;;C12M23/22;;C12M31/08;;C12M31/10;;C12M41/46;;G01N21/55;;G01N33/4833;;G02B21/361;;C12M23/12;;G01N33/5005;;G02B21/002;;G02B21/04;;G02B21/36,C12M1/32;;G01N33/50,,0,0,,,,DISCONTINUED
257,US,A1,US 2019/0360865 A1,084-195-850-035-104,2019-11-28,2019,US 201916538055 A,2019-08-12,US 201916538055 A;;US 201715483219 A,2017-04-10,STRUCTURALLY REINFORCED COMPOSITE COLD SHIELD FOR USE IN INFRARED SENSORS OR OTHER DEVICES,"An apparatus includes a top surface configured to couple to a variable aperture mechanism (VAM), where the top surface has an opening configured to align with an aperture of the VAM. The apparatus also includes a bottom portion configured to couple to a cooled object and a contact portion configured to couple to a strut, where the top surface, bottom portion, and contact portion form a continuous body. The apparatus further includes a plurality of baffles within the continuous body, where each of the baffles has an opening configured to align with the aperture of the VAM. In addition, the apparatus includes a reinforcement ring comprised in or within the continuous body and disposed to be aligned with the strut when the strut is coupled to the continuous body.",RAYTHEON CO,AVERS GAVIN L;;BREST MICHAEL L;;ELBOGEN MARK C;;COBB CHRISTOPHER J;;RINEHART DANIEL W;;GRAHAM JASON S,RAYTHEON COMPANY (2017-04-07),https://lens.org/084-195-850-035-104,Patent Application,yes,0,0,12,12,0,G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/06;;G01J5/06;;G01J5/0804;;G01J5/0831;;G01J5/061;;G01J5/084;;G01J2005/065;;G01J5/06;;G01J2005/065;;G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/0804,G01J5/06;;G01J5/08,,0,0,,,,ACTIVE
258,WO,A3,WO 2023/121899 A3,045-329-423-912-295,2023-08-03,2023,US 2022/0052551 W,2022-12-12,US 202117557716 A,2021-12-21,SATELLITE-BASED SOURCE OF POSITIONING SYSTEM-INDEPENDENT POSITION NAVIGATION AND TIME,"For global navigation satellite system (GNSS)-independent operation of auxiliary PNT systems, one or more ground stations of the auxiliary system have access to a non-GNSS source of precision timing. That source and known locations of the ground stations may be used to derive timing corrections to account for imperfect clocks in the satellites for non-purpose-built satellite systems being used for PNT. Crosslinks between satellites and/or propagation of timing correction through other ground stations are used to better control the timing and resulting precession of PNT in the PNT auxiliary system. The timing correction may be provided as a service to end users, other constellations, and/or other satellite operators",SATELLES INC,COBB H;;HARGROVE MARK;;GOETSCH JERRY;;GUTT GREGORY;;HIGGINS DAN;;JOHNSON PETE;;LANDON TREVOR;;LAWRENCE DAVID;;O'CONNOR MICHAEL;;PEDERSEN MARK;;SCHMALZRIED RACHEL;;TREMBLAY FRANCOIS,,https://lens.org/045-329-423-912-295,Search Report,yes,9,0,3,3,0,G01S19/02;;G01S19/00;;G01S19/40;;G01S19/07,G01S19/02;;G01S19/03;;G01S19/14;;G01S19/20;;G04F5/14,,1,0,,,"ANONYMOUS: ""How STL Works; STL: The Complement to GPS/GNSS"", SATELLES, 9 December 2021 (2021-12-09), XP093083273, Retrieved from the Internet <URL:https://satelles.com/technology/stl-complements-gps/> [retrieved on 20230919]",PENDING
259,US,B2,US 10591359 B2,096-134-121-162-265,2020-03-17,2020,US 201916538055 A,2019-08-12,US 201916538055 A;;US 201715483219 A,2017-04-10,Structurally reinforced composite cold shield for use in infrared sensors or other devices,"An apparatus includes a top surface configured to couple to a variable aperture mechanism (VAM), where the top surface has an opening configured to align with an aperture of the VAM. The apparatus also includes a bottom portion configured to couple to a cooled object and a contact portion configured to couple to a strut, where the top surface, bottom portion, and contact portion form a continuous body. The apparatus further includes a plurality of baffles within the continuous body, where each of the baffles has an opening configured to align with the aperture of the VAM. In addition, the apparatus includes a reinforcement ring comprised in or within the continuous body and disposed to be aligned with the strut when the strut is coupled to the continuous body.",RAYTHEON CO,AVERS GAVIN L;;BREST MICHAEL L;;ELBOGEN MARK C;;COBB CHRISTOPHER J;;RINEHART DANIEL W;;GRAHAM JASON S,RAYTHEON COMPANY (2017-04-07),https://lens.org/096-134-121-162-265,Granted Patent,yes,7,0,12,12,0,G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/06;;G01J5/06;;G01J5/0804;;G01J5/0831;;G01J5/061;;G01J5/084;;G01J2005/065;;G01J5/06;;G01J2005/065;;G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/0804,G01J5/06;;G01J5/08,,1,0,,,"International Search Report and Written Opinion of the International Searching Authority for PCT Patent Application No. PCT/US2017/063955 dated Mar. 15, 2018, 16 pages.",ACTIVE
260,US,A1,US 2018/0292265 A1,132-291-736-348-202,2018-10-11,2018,US 201715483219 A,2017-04-10,US 201715483219 A,2017-04-10,STRUCTURALLY REINFORCED COMPOSITE COLD SHIELD FOR USE IN INFRARED SENSORS OR OTHER DEVICES,"An Infrared Detector Dewar system includes a housing and an infrared detector. The system also includes one or more strut members coupled on a first end to the housing. The system further includes cold shield coupled to the infrared detector and to a second end of the one or more strut members. The cold shield includes a reinforcement ring aligned with the one or more strut members. The cold shield is formed by forming a support member having disc encased by a support ring. The support member is positioned within a mandrel such that the reinforcement ring is disposed to align with a strut position. The cold shield is then formed by electroplating copper over the mandrel and at least a portion of the support member, and then by removing/dissolving all aforementioned mandrels.",RAYTHEON CO,AVERS GAVIN L;;BREST MICHAEL L;;ELBOGEN MARK C;;COBB CHRISTOPHER J;;RINEHART DANIEL W;;GRAHAM JASON S,RAYTHEON COMPANY (2017-04-07),https://lens.org/132-291-736-348-202,Patent Application,yes,6,2,12,12,0,G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/06;;G01J5/06;;G01J5/0804;;G01J5/0831;;G01J5/061;;G01J5/084;;G01J2005/065;;G01J5/06;;G01J2005/065;;G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/0804,G01J5/06;;G01J5/08,,0,0,,,,ACTIVE
261,CA,A1,CA 3051196 A1,183-246-670-341-063,2018-10-18,2018,CA 3051196 A,2017-11-30,US 201715483219 A;;US 2017/0063955 W,2017-04-10,STRUCTURALLY REINFORCED COMPOSITE COLD SHIELD FOR USE IN INFRARED SENSORS OR OTHER DEVICES,"An Infrared Detector Dewar system (100) includes a housing (106) and an infrared detector (104, 202). The system also includes one or more strut members (108, 206) coupled on a first end to the housing. The system further includes cold shield (102, 200) coupled to the infrared detector and to a second end of the one or more strut members. The cold shield includes a reinforcement ring (300) aligned with the one or more strut members. The cold shield is formed by forming a support member having disc (306) encased by a support ring (308). The support member is positioned within a mandrel (404) such that the reinforcement ring is disposed to align with a strut position. The cold shield is then formed by electroplating copper over the mandrel and at least a portion of the support member, and then by removing/dissolving all aforementioned mandrels.",RAYTHEON CO,AVERS GAVIN L;;BREST MICHAEL L;;ELBOGEN MARK C;;COBB CHRISTOPHER J;;RINEHART DANIEL W;;GRAHAM JASON S,,https://lens.org/183-246-670-341-063,Patent Application,no,0,0,12,12,0,G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/06;;G01J5/06;;G01J5/0804;;G01J5/0831;;G01J5/061;;G01J5/084;;G01J2005/065;;G01J5/06;;G01J2005/065;;G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/0804,G01J5/06;;G01J5/08,,0,0,,,,PENDING
262,DE,T2,DE 69706658 T2,030-360-735-680-842,2002-06-20,2002,DE 69706658 T,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,SUBSTITUIERTE 4-HYDROXYPHENYLALKANSAURE-DERIVATE MIT AGONISTISCHER WIRKUNG AUF PPAR-GAMMA,,GLAXO GROUP LTD,WILLSON MARK;;MOOK ANTHONY;;KALDOR ISTVAN;;HENKE RICHARD;;DEATON NORMAN;;COLLINS LOREN;;COBB EDMOND;;BRACKEEN MARCUS;;SHARP JUDE;;O'CALLAGHAN MARK;;ERICKSON ALAN;;BOSWELL EVAN,,https://lens.org/030-360-735-680-842,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;C07D295/18;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
263,DE,D1,DE 69706658 D1,061-467-609-320-162,2001-10-18,2001,DE 69706658 T,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,SUBSTITUIERTE 4-HYDROXYPHENYLALKANSAURE-DERIVATE MIT AGONISTISCHER WIRKUNG AUF PPAR-GAMMA,,GLAXO GROUP LTD,WILLSON MARK;;MOOK ANTHONY;;KALDOR ISTVAN;;HENKE RICHARD;;DEATON NORMAN;;COLLINS LOREN;;COBB EDMOND;;BRACKEEN MARCUS;;SHARP JUDE;;O'CALLAGHAN MARK;;ERICKSON ALAN;;BOSWELL EVAN,,https://lens.org/061-467-609-320-162,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;C07D295/18;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
264,US,B2,US 10378958 B2,116-278-015-580-101,2019-08-13,2019,US 201715483219 A,2017-04-10,US 201715483219 A,2017-04-10,Structurally reinforced composite cold shield for use in infrared sensors or other devices,"An Infrared Detector Dewar system includes a housing and an infrared detector. The system also includes one or more strut members coupled on a first end to the housing. The system further includes cold shield coupled to the infrared detector and to a second end of the one or more strut members. The cold shield includes a reinforcement ring aligned with the one or more strut members. The cold shield is formed by forming a support member having disc encased by a support ring. The support member is positioned within a mandrel such that the reinforcement ring is disposed to align with a strut position. The cold shield is then formed by electroplating copper over the mandrel and at least a portion of the support member, and then by removing/dissolving all aforementioned mandrels.",RAYTHEON CO,AVERS GAVIN L;;BREST MICHAEL L;;ELBOGEN MARK C;;COBB CHRISTOPHER J;;RINEHART DANIEL W;;GRAHAM JASON S,RAYTHEON COMPANY (2017-04-07),https://lens.org/116-278-015-580-101,Granted Patent,yes,7,0,12,12,0,G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/06;;G01J5/06;;G01J5/0804;;G01J5/0831;;G01J5/061;;G01J5/084;;G01J2005/065;;G01J5/06;;G01J2005/065;;G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/0804,G01J5/06;;G01J5/08,,1,0,,,"International Search Report and Written Opinion of the International Searching Authority for PCT Patent Application No. PCT/US2017/063955 dated Mar. 15, 2018, 16 pages.",ACTIVE
265,WO,A2,WO 2023/121899 A2,161-576-125-302-257,2023-06-29,2023,US 2022/0052551 W,2022-12-12,US 202117557716 A,2021-12-21,SATELLITE-BASED SOURCE OF POSITIONING SYSTEM-INDEPENDENT POSITION NAVIGATION AND TIME,"For global navigation satellite system (GNSS)-independent operation of auxiliary PNT systems, one or more ground stations of the auxiliary system have access to a non-GNSS source of precision timing. That source and known locations of the ground stations may be used to derive timing corrections to account for imperfect clocks in the satellites for non-purpose-built satellite systems being used for PNT. Crosslinks between satellites and/or propagation of timing correction through other ground stations are used to better control the timing and resulting precession of PNT in the PNT auxiliary system. The timing correction may be provided as a service to end users, other constellations, and/or other satellite operators",SATELLES INC,COBB H;;HARGROVE MARK;;GOETSCH JERRY;;GUTT GREGORY;;HIGGINS DAN;;JOHNSON PETE;;LANDON TREVOR;;LAWRENCE DAVID;;O'CONNOR MICHAEL;;PEDERSEN MARK;;SCHMALZRIED RACHEL;;TREMBLAY FRANCOIS,,https://lens.org/161-576-125-302-257,Patent Application,yes,0,0,3,3,0,G01S19/02;;G01S19/00;;G01S19/40;;G01S19/07,G05D1/02;;B64G1/10,,0,0,,,,PENDING
266,EP,A1,EP 3568678 A1,033-171-460-484-100,2019-11-20,2019,EP 17825991 A,2017-11-30,US 201715483219 A;;US 2017/0063955 W,2017-04-10,STRUCTURALLY REINFORCED COMPOSITE COLD SHIELD FOR USE IN INFRARED SENSORS OR OTHER DEVICES,,RAYTHEON CO,AVERS GAVIN L;;BREST MICHAEL L;;ELBOGEN MARK C;;COBB CHRISTOPHER J;;RINEHART DANIEL W;;GRAHAM JASON S,,https://lens.org/033-171-460-484-100,Patent Application,yes,0,0,12,12,0,G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/06;;G01J5/06;;G01J5/0804;;G01J5/0831;;G01J5/061;;G01J5/084;;G01J2005/065;;G01J5/06;;G01J2005/065;;G01J5/061;;G01J5/084;;G01J5/0831;;G01J5/0804,G01J5/06;;G01J5/08,,0,0,,,,PENDING
267,DE,A1,DE 102019109216 A1,031-740-967-887-106,2019-10-10,2019,DE 102019109216 A,2019-04-08,US 201862654757 P,2018-04-09,Halterung für Hydraulikspannerarm mit Hebel,"Offenbart wird eine hydraulische Spannervorrichtung mit einem Spannerarm und einem Hydraulikspanner. Der Spannerarm umfasst: einen Körper mit einem ersten Ende, einem zweiten Ende, einer Kettengleitfläche und einer Oberfläche gegenüber der Kettengleitfläche; einen Schwenkpunkt an dem ersten Ende oder dem zweiten Ende des Körpers; und eine Hohlschraubenzufuhr an dem anderen von dem ersten Ende oder dem zweiten Ende des Körpers. Der Hydraulikspanner ist schwenkbar an dem Schwenkpunkt und der Hohlschraube und benachbart zu der Oberfläche gegenüber der Kettengleitfläche angebracht, wobei der Hydraulikspanner Zufuhrfluid von der Hohlschraube empfängt, wobei der Hydraulikspanner umfasst: ein Gehäuse mit einer Bohrung; einen hohlen Kolben mit einem ersten Ende und einem zweiten Ende, der verschiebbar innerhalb der Bohrung aufgenommen ist; und eine Feder, die innerhalb der Bohrung des Gehäuses und des hohlen Kolbens aufgenommen ist und den hohlen Kolben von der Bohrung des Gehäuses nach außen vorspannt.",BORGWARNER INC,COBB KEITH B;;WIGSTEN MARK;;TODD KEVIN;;LU XIAO JIAN;;SIMMONS SEAN;;HONG SEONGDO;;FREEMANTLE PAUL;;TAKEUCHI AKIRA,,https://lens.org/031-740-967-887-106,Patent Application,no,0,0,5,5,0,F16H7/08;;F16H7/0848;;F16H7/0848;;F16H7/08;;F16H7/0848;;F16H25/18;;F16H2007/0806;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0859;;F16H2007/0859;;F16H2007/0859;;F16H2007/0872;;F16H2007/0872;;F16H2007/0893;;F16H2007/0893;;F16H2007/0893,F16H7/08;;F02B67/06,,0,0,,,,DISCONTINUED
268,US,B1,US 7284157 B1,146-212-765-273-713,2007-10-16,2007,US 14532605 A,2005-06-03,US 14532605 A;;US 10420202 A,2002-03-22,Faulty driver protection comparing list of driver faults,"Systems and methods are provided that prevent faulty drivers from being loaded and/or can prevent faulty drivers from being installed. Thus, instability of a computer system can be mitigated. Additionally, the occurrence of data corruption, system halting and the like can be reduced. A requested driver is compared to a list of faulty drivers from a faulty driver database. If the requested driver is in the list of faulty drivers, the requested driver is deemed faulty or defective, and is prevented from being loaded. Additionally, if the requested driver is in the list of faulty drivers, the requested driver can be prevented from being installed. Otherwise, the requested driver is operable and can be installed and/or loaded.",MICROSOFT CORP,MCMICHAEL LONNY DEAN;;ROUSSOS GEORGE EVANGELOS;;LIN EUGENE;;COBB JASON TY;;JODH SANTOSH SHARAD;;LEVIDOW BJORN;;BLUVSHTEVN VADIM;;DERBECKER MARK,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2002-03-22),https://lens.org/146-212-765-273-713,Granted Patent,yes,8,23,2,2,0,G06F11/004;;G06F11/004;;G06F9/4411;;G06F9/4411,G06F11/00,714/38;;714/44;;717/173;;717/178,0,0,,,,EXPIRED
269,WO,A1,WO 2013/188328 A1,071-275-478-206-090,2013-12-19,2013,US 2013/0045064 W,2013-06-11,US 201261660106 P,2012-06-15,SULFONATED POLYOXADIAZOLE POLYMERS ARTICLES,"A shaped article having a polymer having repeat units of Formula (I) and one or both of Formula (II) and (IIa):IIa wherein Q is SO 3 M, and M is one or more cations.",DU PONT,BROWN PETER A;;CHAN JUSTIN W;;COBB MICHAEL W;;TADROS ANDREW;;TRENTACOSTA JOSEPH D;;WEINBERG MARK GARY;;WILLIAMS SHARLENE RENEE,,https://lens.org/071-275-478-206-090,Patent Application,yes,32,0,7,7,0,C08G73/08;;C08G2261/1452;;C08G2261/312;;C08G2261/314;;C08G2261/3228;;C08G2261/344;;C08L79/06;;D01F6/74,C08G73/08;;C08G75/20,,1,1,009-416-655-221-303,10.1016/j.jpowsour.2007.09.090,"GOMES ET AL: ""Single-step synthesis of sulfonated polyoxadiazoles and their use as proton conducting membranes"", JOURNAL OF POWER SOURCES, ELSEVIER SA, CH, vol. 175, no. 1, 26 November 2007 (2007-11-26), pages 49 - 59, XP022361608, ISSN: 0378-7753, DOI: 10.1016/J.JPOWSOUR.2007.09.090",PENDING
270,US,B1,US 6950964 B1,171-932-783-866-223,2005-09-27,2005,US 10420202 A,2002-03-22,US 10420202 A,2002-03-22,Driver protection,"Systems and methods are provided that prevent faulty drivers from being loaded and/or can prevent faulty drivers from being installed. Thus, instability of a computer system can be mitigated. Additionally, the occurrence of data corruption, system halting and the like can be reduced. A requested driver is compared to a list of faulty drivers from a faulty driver database. If the requested driver is in the list of faulty drivers, the requested driver is deemed faulty or defective, and is prevented from being loaded. Additionally, if the requested driver is in the list of faulty drivers, the requested driver can be prevented from being installed. Otherwise, the requested driver is operable and can be installed and/or loaded.",MICROSOFT CORP,MCMICHAEL LONNY DEAN;;ROUSSOS GEORGE EVANGELOS;;LIN EUGENE;;COBB JASON TY;;JODH SANTOSH SHARAD;;LEVIDOW BJORN;;BLUVSHTEYN VADIM;;DERBECKER MARK,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2002-03-22),https://lens.org/171-932-783-866-223,Granted Patent,yes,7,43,2,2,0,G06F11/004;;G06F11/004;;G06F9/4411;;G06F9/4411,G06F11/00,714/38;;714/44;;717/173;;717/178,0,0,,,,EXPIRED
271,EP,A1,EP 2861648 A1,075-023-639-221-764,2015-04-22,2015,EP 13731008 A,2013-06-11,US 201261660106 P;;US 2013/0045064 W,2012-06-15,SULFONATED POLYOXADIAZOLE POLYMERS ARTICLES,,DU PONT,BROWN PETER A;;CHAN JUSTIN W;;COBB MICHAEL W;;TADROS ANDREW;;TRENTACOSTA JOSEPH D;;WEINBERG MARK GARY;;WILLIAMS SHARLENE RENEE,"DUPONT SAFETY & CONSTRUCTION, INC., WILMINGTON, US (2022-07-22)",https://lens.org/075-023-639-221-764,Patent Application,yes,0,0,7,7,0,C08G73/08;;C08G2261/1452;;C08G2261/312;;C08G2261/314;;C08G2261/3228;;C08G2261/344;;C08L79/06;;D01F6/74,C08G73/08;;C08G75/20;;C08L79/06;;D01F6/74,,1,0,,,See references of WO 2013188328A1,ACTIVE
272,EP,B1,EP 2861648 B1,105-387-543-750-710,2016-07-27,2016,EP 13731008 A,2013-06-11,US 201261660106 P;;US 2013/0045064 W,2012-06-15,SULFONATED POLYOXADIAZOLE POLYMERS ARTICLES,,DU PONT,BROWN PETER A;;CHAN JUSTIN W;;COBB MICHAEL W;;TADROS ANDREW;;TRENTACOSTA JOSEPH D;;WEINBERG MARK GARY;;WILLIAMS SHARLENE RENEE,"DUPONT SAFETY & CONSTRUCTION, INC., WILMINGTON, US (2022-07-22)",https://lens.org/105-387-543-750-710,Granted Patent,yes,3,0,7,7,0,C08G73/08;;C08G2261/1452;;C08G2261/312;;C08G2261/314;;C08G2261/3228;;C08G2261/344;;C08L79/06;;D01F6/74,C08G73/08;;C08G75/20;;C08L79/06;;D01F6/74,,1,0,,,"GOMES ET AL: ""Single-step synthesis of sulfonated polyoxadiazoles and their use as proton conducting membranes"", JOURNAL OF POWER SOURCES, ELSEVIER SA, CH, vol. 175, no. 1, 26 November 2007 (2007-11-26), pages 49-59, XP022361608, ISSN: 0378-7753, DOI: 10.1016/J.JPOWSOUR.2007.09.090",ACTIVE
273,CN,A,CN 104603180 A,149-030-379-778-571,2015-05-06,2015,CN 201380042211 A,2013-06-11,US 2013/0045064 W;;US 201261660106 P,2012-06-15,Sulfonated polyoxadiazole polymers articles,"A shaped article having a polymer having repeat units of Formula (I) and one or both of Formula (II) and (IIa):IIa wherein Q is SO3M, and M is one or more cations.",DU PONT,BROWN PETER A;;CHAN JUSTIN W;;COBB MICHAEL W;;TADROS ANDREW;;TRENTACOSTA JOSEPH D;;WEINBERG MARK GARY;;WILLIAMS SHARLENE RENEE,,https://lens.org/149-030-379-778-571,Patent Application,no,5,0,7,7,0,C08G73/08;;C08G2261/1452;;C08G2261/312;;C08G2261/314;;C08G2261/3228;;C08G2261/344;;C08L79/06;;D01F6/74,C08G73/08;;C08G75/20,,0,0,,,,ACTIVE
274,US,A1,US 2003/0034445 A1,106-248-964-168-24X,2003-02-20,2003,US 93037101 A,2001-08-15,US 93037101 A,2001-08-15,Light guide for use with backlit display,"
   A light guide including a light guide body having a light re-directing side positioned opposite from a light output side. A plurality of elongate prisms are located adjacent the light output side of the light guide body. The prisms extend side-by-side relative to one another along lengths. The prisms include upper edges defining heights of the prisms. The upper edges extend along the lengths of the prisms. Each upper edge includes a plurality of edge segments having different magnitudes of slope. The light guide also includes a plurality of light extraction structures located adjacent the light re-directing side of the light guide body for reflecting light toward the light output side. The light extraction structures include elongated projections each having a plateau segment and first and second facets. The elongated projections are separated by lands that are recessed relative to the plateau segments. The first and second facets extend from the plateau segments to the lands. 
",BOYD GARY T.;;KOTCHICK KEITH M.;;EPSTEIN KENNETH A.;;COBB SANFORD;;WATSON PHILIP E.;;LAMB DAVID J.;;GARDINER MARK E.,BOYD GARY T;;KOTCHICK KEITH M;;EPSTEIN KENNETH A;;COBB SANFORD;;WATSON PHILIP E;;LAMB DAVID J;;GARDINER MARK E,3M INNOVATIVE PROPERTIES COMPANY (2001-11-12),https://lens.org/106-248-964-168-24X,Patent Application,yes,3,81,10,10,0,G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901;;G02F1/1335;;G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901,F21V8/00;;F21Y101/02;;G02B6/00;;F21Y103/00;;G02F1/13357,250/227.11,0,0,,,,EXPIRED
275,US,A1,US 2023/0194727 A1,184-291-740-133-147,2023-06-22,2023,US 202117557716 A,2021-12-21,US 202117557716 A,2021-12-21,SATELLITE-BASED SOURCE OF POSITIONING SYSTEM-INDEPENDENT POSITION NAVIGATION AND TIME,"For global navigation satellite system (GNSS)-independent operation of auxiliary PNT systems, one or more ground stations of the auxiliary system have access to a non-GNSS source of precision timing. That source and known locations of the ground stations may be used to derive timing corrections to account for imperfect clocks in the satellites for non-purpose-built satellite systems being used for PNT. Crosslinks between satellites and/or propagation of timing correction through other ground stations are used to better control the timing and resulting precession of PNT in the PNT auxiliary system. The timing correction may be provided as a service to end users, other constellations, and/or other satellite operators.",SATELLES INC,COBB H STEWART;;HARGROVE MARK;;GOETSCH JERRY;;GUTT GREGORY;;HIGGINS DAN;;JOHNSON PETE;;LANDON TREVOR;;LAWRENCE DAVID G;;O'CONNOR MICHAEL L;;PEDERSEN MARK;;SCHMALZRIED RACHEL;;TREMBLAY FRANCOIS,SATELLES INC (2021-01-11),https://lens.org/184-291-740-133-147,Patent Application,yes,5,0,3,3,0,G01S19/02;;G01S19/00;;G01S19/40;;G01S19/07,G01S19/07;;G01S19/40,,0,0,,,,PENDING
276,US,A,US 5751588 A,000-940-495-843-683,1998-05-12,1998,US 46568995 A,1995-06-06,US 46568995 A;;US 43048095 A,1995-04-28,Multi-wavelength programmable laser processing mechanisms and apparatus utilizing vaporization detection,"A desired design for electronic structures is converted into a graphic design format and sorted into a pseudo-raster format corresponding to scan lines. A laser or other machining beam is controlled by a separate tracking beam utilizing a mid-objective scanning system. The firing frequency of the machining beam is determined by the position of the tracking beam on a detector, as compared to the scan line data. Accuracy is verified by detection of plume or spectra generated during machining. Alignment of the machining and tracking beams is by interferometric methods. The system improves optical performance parameters of telecentricity, angle of scanned beam line, location of line in which the scanned line resides, astigmatism and field curvature.",IBM,FREEDENBERG CANDACE J;;LONG DAVID C;;COBB JOSHUA M;;LAPLANTE MARK J;;ZIEMINS ULDIS A;;PATTERSON DANIEL G;;BALZ JAMES G,INTERNATIONAL BUSINESS MACHINES CORPORATION (1995-07-31),https://lens.org/000-940-495-843-683,Granted Patent,yes,25,17,1,5,0,B23K26/04;;B23K26/04;;B23K26/043;;B23K26/043;;H05K3/0017;;H05K3/0017,B23K26/04;;H05K3/00,364/474.28;;364/474.08;;219/121.7;;219/121.74,3,0,,,"IBM Technical Disclosure Bulletin, vol. 13, No. 9, Feb. 1971, p. 2536.;;IBM Technical Disclosure Bulletin, vol. 16, No. 12, May 1974, pp. 3933 3934.;;IBM Technical Disclosure Bulletin, vol. 20, No. 4, Sep. 1977, pp. 1379 1380.",EXPIRED
277,CN,A,CN 110360280 A,001-052-449-222-027,2019-10-22,2019,CN 201910228379 A,2019-03-25,US 201862656252 P,2018-04-11,SEALED HYDRAULIC TENSIONER,"A sealed hydraulic tensioner includes a cylinder having a cylinder surface formed in a housing; a piston, received by the cylinder, having an inner surface forming a piston cavity and an outer surfacethat closely conforms in shape to the cylinder inhibiting the flow of fluid between the outer surface of the piston and the cylinder surface; a tensioner biasing member engaging the piston and the cylinder forcing the piston in an axial direction; a check valve regulating fluid flow between a high-pressure chamber and a low-pressure chamber; one or more apertures formed in the piston extending between the inner surface and the outer surface of the piston that communicate fluid between the piston cavity and the cylinder, wherein a substantially fixed quantity of fluid is encapsulated within the piston cavity and the cylinder.",BORGWARNER INC,COBB KEITH B;;PATTON MARK;;LU XIAOJIAN;;TODD KEVIN;;SMITH DALE N;;MAGNI FABIO;;MIELBRECHT RON J;;SWANSON GLENN;;BADDARIA GIUSEPPE,,https://lens.org/001-052-449-222-027,Patent Application,no,7,0,5,5,0,F16H7/08;;F16H2007/0812;;F16H7/08;;F16H2007/0806;;F16H2007/0859;;F16H7/08;;F02B67/06;;F16J15/16;;F16H2007/0812;;F16H2007/0859;;F16H2007/0806;;F16H2007/0893;;F16H7/08;;F16H2007/0806;;F16H2007/0812;;F16H2007/0859,F16H7/08,,0,0,,,,PENDING
278,JP,A,JP 2019184058 A,066-294-634-165-909,2019-10-24,2019,JP 2019059528 A,2019-03-27,US 201862656252 P,2018-04-11,SEALED HYDRAULIC TENSIONER,"To provide a sealed hydraulic tensioner capable of increasing degrees of freedom of arrangement, for internal combustion engines.SOLUTION: A sealed hydraulic tensioner 10 includes: a cylinder 14 having a cylinder surface 28 formed in a housing 16; a piston 12 received by the cylinder, and having an inner surface 20 forming a piston cavity 22 and an outer surface 18 that closely conforms in shape to the cylinder inhibiting a flow of fluid between the outer surface of the piston and the cylinder surface; a tensioner biasing member 68 engaging the piston and the cylinder forcing the piston in an axial direction; a check valve 60 regulating a fluid flow between a high-pressure chamber 56 and a low-pressure chamber 50; and one or more apertures 52 that are formed in the piston extending between the inner surface and the outer surface of the piston and communicate fluid between the piston cavity and the cylinder, where a substantially fixed quantity of fluid is encapsulated within the piston cavity and the cylinder.SELECTED DRAWING: Figure 1",BORGWARNER INC,KEITH B COBB;;MARK PATTON;;LU XIAOJIAN;;TODD KEVIN;;DALE N SMITH;;FABIO MAGNI;;RON J MIELBRECHT;;GLENN SWANSON;;BADDARIA GIUSEPPE,,https://lens.org/066-294-634-165-909,Patent Application,no,0,0,5,5,0,F16H7/08;;F16H7/08;;F16H7/08;;F02B67/06;;F16H7/08;;F16H2007/0806;;F16H2007/0806;;F16H2007/0806;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0859;;F16H2007/0859;;F16H2007/0859;;F16H2007/0893;;F16J15/16,F16H7/08,,0,0,,,,PENDING
279,US,A,US 5620618 A,111-864-818-893-62X,1997-04-15,1997,US 43048095 A,1995-04-28,US 43048095 A,1995-04-28,Multi-wavelength programmable laser processing mechanisms and apparatus,"A desired design for electronic structures is converted into a graphic design format and sorted into a pseudo-raster format corresponding to scan lines. A laser or other machining beam is controlled by a separate tracking beam utilizing a mid-objective scanning system. The firing frequency of the machining beam is determined by the position of the tracking beam on a detector, as compared to the scan line data. Accuracy is verified by detection of plume or spectra generated during machining. Alignment of the machining and tracking beams is by interferometric methods. The system improves optical performance parameters of telecentricity, angle of scanned beam line, location of line in which the scanned line resides, astigmatism and field curvature.",IBM,FREEDENBERG CANDACE J;;LONG DAVID C;;COBB JOSHUA M;;LAPLANTE MARK J;;ZIEMINS ULDIS A;;PATTERSON DANIEL G;;BALZ JAMES G,INTERNATIONAL BUSINESS MACHINES CORPORATION (1995-07-11),https://lens.org/111-864-818-893-62X,Granted Patent,yes,20,4,3,5,0,B23K26/04;;B23K26/04;;B23K26/043;;B23K26/043;;H05K3/0017;;H05K3/0017,B23K26/04;;H05K3/00,219/121.74;;219/121.75;;219/121.76;;219/121.8;;219/121.83,3,0,,,"IBM Technical Disclosure Bulletin, vol. 13, No. 9, Feb. 1971, p. 2536.;;IBM Technical Disclosure Bulletin, vol. 16, No. 12, May 1974, pp. 3933 3934.;;IBM Technical Disclosure Bulletin, vol. 20, No. 4, Sep. 1977, pp. 1379 1380.",EXPIRED
280,DE,A1,DE 102019108495 A1,144-655-815-762-698,2019-10-17,2019,DE 102019108495 A,2019-04-01,US 201862656252 P,2018-04-11,ABGEDICHTETER HYDRAULIKSPANNER,"Ein abgedichteter Hydraulikspanner umfasst einen Zylinder mit einer Zylinderoberfläche, der in einem Gehäuse ausgebildet ist; einen Kolben, der von dem Zylinder aufgenommen wird, mit einer inneren Oberfläche, die einen Kolbenhohlraum bildet, und einer äußeren Oberfläche, die eng an die Gestalt des Zylinders angepasst ist und die Fluidströmung zwischen der äußeren Oberfläche des Kolbens und der Zylinderoberfläche verhindert; ein Spanner-Vorspannelement, das mit dem Kolben und dem Zylinder in Eingriff steht und den Kolben in eine axiale Richtung zwingt; ein Rückschlagventil, das die Fluidströmung zwischen einer Hochdruckkammer und einer Niederdruckkammer regelt; eine oder mehrere Öffnungen, die in dem Kolben ausgebildet sind und sich zwischen der inneren Oberfläche und der äußeren Oberfläche des Kolbens erstrecken und Fluid zwischen dem Kolbenhohlraum und dem Zylinder kommunizieren, wobei eine im Wesentlichen fixierte Menge Fluid innerhalb des Kolbenhohlraums und des Zylinders eingekapselt ist.",BORGWARNER INC,COBB KEITH B;;PATTON MARK;;LU XIAOJIAN;;TODD KEVIN;;SMITH DALE N;;MAGNI FABIO;;MIELBRECHT RON J;;SWANSON GLENN;;BADDARIA GIUSEPPE,,https://lens.org/144-655-815-762-698,Patent Application,no,0,0,5,5,0,F16H7/08;;F16H7/08;;F16H7/08;;F02B67/06;;F16H7/08;;F16H2007/0806;;F16H2007/0806;;F16H2007/0806;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0859;;F16H2007/0859;;F16H2007/0859;;F16H2007/0893;;F16J15/16,F16H7/08;;F02B67/06,,0,0,,,,DISCONTINUED
281,US,A,US 5618454 A,085-855-166-660-082,1997-04-08,1997,US 46597895 A,1995-06-06,US 46597895 A;;US 43048095 A,1995-04-28,Multi-wavelength programmable laser processing mechanisms and apparatus utilizing design data translation system,"A desired design for electronic structures is converted into a graphic design format and sorted into a pseudo-raster format corresponding to scan lines. A laser or other machining beam is controlled by a separate tracking beam utilizing a mid-objective scanning system. The firing frequency of the machining beam is determined by the position of the tracking beam on a detector, as compared to the scan line data. Accuracy is verified by detection of plume or spectra generated during machining. Alignment of the machining and tracking beams is by interferometric methods. The system improves optical performance parameters of telecentricity, angle of scanned beam line, location of line in which the scanned line resides, astigmatism and field curvature.",IBM,FREEDENBERG CANDACE J;;LONG DAVID C;;COBB JOSHUA M;;LAPLANTE MARK J;;ZIEMINS ULDIS A;;PATTERSON DANIEL G;;BALZ JAMES G,INTERNATIONAL BUSINESS MACHINES CORPORATION (1995-07-31),https://lens.org/085-855-166-660-082,Granted Patent,yes,24,15,3,5,0,B23K26/04;;B23K26/04;;B23K26/043;;B23K26/043;;H05K3/0017;;H05K3/0017,B23K26/04;;H05K3/00,219/121.74;;219/121.75;;219/121.76;;219/121.8;;219/121.83,3,0,,,"IBM Technical Disclosure Bulletin, vol. 13, No. 9, Feb. 1971, p. 2536.;;IBM Technical Disclosure Bulletin, vol. 16, No. 12, May 1974, pp. 3933 3934.;;IBM Technical Disclosure Bulletin, vol. 20, No. 4, Sep. 1977, pp. 1379 1380.",EXPIRED
282,US,A,US 5541731 A,062-873-007-272-845,1996-07-30,1996,US 44430295 A,1995-05-18,US 44430295 A;;US 43048095 A,1995-04-28,Interferometric measurement and alignment technique for laser scanners,"A desired design for electronic structures is converted into a graphic design format and sorted into a pseudo-raster format corresponding to scan lines. A laser or other machining beam is controlled by a separate tracking beam utilizing a mid-objective scanning system. The firing frequency of the machining beam is determined by the position of the tracking beam on a detector, as compared to the scan line data. Accuracy is verified by detection of plume or spectra generated during machining. Evaluation and alignment of the machining and tracking beams is by interferometric methods. The system improves optical performance parameters of telecentricity, angle of scanned beam line, location of line in which the scanned line resides, astigmatism and field curvature.",IBM,FREEDENBERG CANDACE J;;LONG DAVID C;;COBB JOSHUA M;;LAPLANTE MARK J;;ZIEMINS ULDIS A;;PATTERSON DANIEL G;;BALZ JAMES G,INTERNATIONAL BUSINESS MACHINES CORPORATION (1995-07-14),https://lens.org/062-873-007-272-845,Granted Patent,yes,14,100,1,5,0,B23K26/04;;B23K26/04;;B23K26/043;;B23K26/043;;H05K3/0017;;H05K3/0017,B23K26/04;;H05K3/00,356/345;;356/363;;356/138;;219/121.8;;359/197,3,0,,,"IBM Technical Disclosure Bulletin, vol. 13, No. 9, Feb. 1971, p. 2536.;;IBM Technical Disclosure Bulletin, vol. 16, No. 12, May 1974, pp. 3933 3934.;;IBM Technical Disclosure Bulletin, vol. 20, No. 4, Sep. 1977, pp. 1379 1380.",EXPIRED
283,KR,A,KR 20190118956 A,148-520-721-987-981,2019-10-21,2019,KR 20190035652 A,2019-03-28,US 201862656252 P,2018-04-11,SEALED HYDRAULIC TENSIONER,"A sealed hydraulic tensioner comprises: a cylinder having a cylinder surface formed in a housing; a piston received by the cylinder, having an inner surface forming a piston cavity and an outer surface that closely conforms to the shape of the cylinder, and inhibiting a flow of a fluid between the outer surface of the piston and a cylinder surface; a tensioner biasing member engaging with the piston and cylinder to force the piston in an axial direction; a check valve regulating a fluid flow between a high-pressure chamber and a low-pressure chamber; and one or more apertures formed in the piston to extend between the inner surface and the outer surface of the piston, and transmitting a fluid between the piston cavity and the cylinder, wherein a substantially fixed quantity of fluid is encapsulated within the piston cavity and the cylinder.",BORGWARNER INC,KEITH B COBB;;MARK PATTON;;XIAOJIAN LU;;KEVIN TODD;;DALE N SMITH;;FABIO MAGNI;;RON J MIELBRECHT;;GLENN SWANSON;;GIUSEPPE BADDARIA,,https://lens.org/148-520-721-987-981,Patent Application,no,0,0,5,5,0,F16H7/08;;F16H7/08;;F16H7/08;;F02B67/06;;F16H7/08;;F16H2007/0806;;F16H2007/0806;;F16H2007/0806;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0859;;F16H2007/0859;;F16H2007/0859;;F16H2007/0893;;F16J15/16,F16H7/08;;F02B67/06;;F16J15/16,,0,0,,,,PENDING
284,US,A,US 5626778 A,155-681-600-254-870,1997-05-06,1997,US 46568895 A,1995-06-06,US 46568895 A;;US 43048095 A,1995-04-28,Multi-wavelength programmable laser processing mechanisms and apparatus utilizing spectrometer verification,"A desired design for electronic structures is converted into a graphic design format and sorted into a pseudo-raster format corresponding to scan lines. A laser or other machining beam is controlled by a separate tracking beam utilizing a mid-objective scanning system. The firing frequency of the machining beam is determined by the position of the tracking beam on a detector, as compared to the scan line data. Accuracy is verified by detection of plume or spectra generated during machining. Alignment of the machining and tracking beams is by interferometric methods. The system improves optical performance parameters of telecentricity, angle of scanned beam line, location of line in which the scanned line resides, astigmatism and field curvature.",IBM,FREEDENBERG CANDACE J;;LONG DAVID C;;COBB JOSHUA M;;LAPLANTE MARK J;;ZIEMINS ULDIS A;;PATTERSON DANIEL G;;BALZ JAMES G,INTERNATIONAL BUSINESS MACHINES CORPORATION (1995-07-31),https://lens.org/155-681-600-254-870,Granted Patent,yes,26,9,3,5,0,B23K26/04;;B23K26/04;;B23K26/043;;B23K26/043;;H05K3/0017;;H05K3/0017,B23K26/04;;H05K3/00,219/121.74;;219/121.74;;219/121.75;;219/121.8;;219/121.83,3,0,,,"IBM Technical Disclosure Bulletin, vol. 13, No. 9, Feb. 1971, p. 2536.;;IBM Technical Disclosure Bulletin, vol. 16, No. 12, May 1974, pp. 3933 3934.;;IBM Technical Disclosure Bulletin, vol. 20, No. 4, Sep. 1977, pp. 1379 1380.",EXPIRED
285,US,A1,US 2019/0316657 A1,087-067-538-139-008,2019-10-17,2019,US 201916378873 A,2019-04-09,US 201916378873 A;;US 201862656252 P,2018-04-11,SEALED HYDRAULIC TENSIONER,"A sealed hydraulic tensioner includes a cylinder having a cylinder surface formed in a housing; a piston, received by the cylinder, having an inner surface forming a piston cavity and an outer surface that closely conforms in shape to the cylinder inhibiting the flow of fluid between the outer surface of the piston and the cylinder surface; a tensioner biasing member engaging the piston and the cylinder forcing the piston in an axial direction; a check valve regulating fluid flow between a high-pressure chamber and a low-pressure chamber; one or more apertures formed in the piston extending between the inner surface and the outer surface of the piston that communicate fluid between the piston cavity and the cylinder, wherein a substantially fixed quantity of fluid is encapsulated within the piston cavity and the cylinder.",BORGWARNER INC,COBB KEITH B;;PATTON MARK;;LU XIAOJIAN;;TODD KEVIN;;SMITH DALE N;;MAGNI FABIO;;MIELBRECHT RON J;;SWANSON GLENN;;BADDARIA GIUSEPPE,,https://lens.org/087-067-538-139-008,Patent Application,yes,0,6,5,5,0,F16H7/08;;F16H7/08;;F16H7/08;;F02B67/06;;F16H7/08;;F16H2007/0806;;F16H2007/0806;;F16H2007/0806;;F16H2007/0812;;F16H2007/0812;;F16H2007/0812;;F16H2007/0859;;F16H2007/0859;;F16H2007/0859;;F16H2007/0893;;F16J15/16,F16H7/08;;F01L1/02;;F01L1/047;;F02B67/06;;F02F11/00,,0,0,,,,DISCONTINUED
286,EP,B1,EP 2861789 B1,177-520-868-496-978,2020-09-09,2020,EP 13783124 A,2013-06-11,US 201261660115 P;;US 2013/0045127 W,2012-06-15,FLAME RESISTANT SPUN STAPLE YARNS MADE FROM BLENDS OF FIBERS DERIVED FROM SULFONATED NAPHTHALENE POLYOXADIAZOLE POLYMERS,,DUPONT SAFETY & CONSTRUCTION INC,BROWN PETER A;;CHAN JUSTIN W;;COBB MICHAEL W;;TADROS ANDREW;;TRENTACOSTA JOSEPH D;;WEINBERG MARK GARY;;WILLIAMS SHARLENE RENEE;;ZHU REIYAO,"DUPONT SAFETY & CONSTRUCTION, INC. (2020-04-01)",https://lens.org/177-520-868-496-978,Granted Patent,yes,5,0,8,8,0,D01F6/74;;D01F6/78;;D02G3/04;;D02G3/045;;D02G3/44;;D02G3/443;;D01F6/74;;D02G3/443;;D01F6/78,D02G3/04;;D01F6/74;;D01F6/78;;D02G3/44,,0,0,,,,ACTIVE
287,WO,A3,WO 2014/007948 A3,020-553-850-841-451,2014-05-30,2014,US 2013/0045127 W,2013-06-11,US 201261660115 P,2012-06-15,FLAME RESISTANT SPUN STAPLE YARNS MADE FROM BLENDS OF FIBERS DERIVED FROM SULFONATED NAPHTHALENE POLYOXADIAZOLE POLYMERS,"Described is a flame-resistant spun yarn having: about 50 to about 95 parts by weight of a sulfonated naphthalene polyoxadiazole based staple fiber comprising repeat units of Formula (I) and one or both of Formula (II) and (Ila) wherein Q is H or SO 3 M, and M is one or more cations; and about 5 to about 50 parts by weight of a textile staple fiber having limiting oxygen index of 24 or greater and a tenacity of about 2 grams per denier or greater, based on the total amount of the polymeric fiber and the textile fiber in the yarn.",DU PONT,BROWN PETER A;;CHAN JUSTIN W;;COBB MICHAEL W;;TADROS ANDREW;;TRENTACOSTA JOSEPH D;;WEINBERG MARK GARY;;WILLIAMS SHARLENE RENEE;;ZHU REIYAO,,https://lens.org/020-553-850-841-451,Search Report,yes,5,0,8,8,0,D01F6/74;;D01F6/78;;D02G3/04;;D02G3/045;;D02G3/44;;D02G3/443;;D01F6/74;;D02G3/443;;D01F6/78,D02G3/04;;D01F6/74;;D01F6/78;;D02G3/44,,0,0,,,,PENDING
288,WO,A2,WO 2014/007948 A2,075-288-660-085-377,2014-01-09,2014,US 2013/0045127 W,2013-06-11,US 201261660115 P,2012-06-15,FLAME RESISTANT SPUN STAPLE YARNS MADE FROM BLENDS OF FIBERS DERIVED FROM SULFONATED NAPHTHALENE POLYOXADIAZOLE POLYMERS,"Described is a flame-resistant spun yarn having: about 50 to about 95 parts by weight of a sulfonated naphthalene polyoxadiazole based staple fiber comprising repeat units of Formula (I) and one or both of Formula (II) and (Ila) wherein Q is H or SO3M, and M is one or more cations; and about 5 to about 50 parts by weight of a textile staple fiber having limiting oxygen index of 24 or greater and a tenacity of about 2 grams per denier or greater, based on the total amount of the polymeric fiber and the textile fiber in the yarn.",DU PONT,BROWN PETER A;;CHAN JUSTIN W;;COBB MICHAEL W;;TADROS ANDREW;;TRENTACOSTA JOSEPH D;;WEINBERG MARK GARY;;WILLIAMS SHARLENE RENEE;;ZHU REIYAO,,https://lens.org/075-288-660-085-377,Patent Application,no,29,0,8,8,0,D01F6/74;;D02G3/04;;D01F6/74;;D01F6/78;;D01F6/78;;D02G3/045;;D02G3/44;;D02G3/443;;D02G3/443,D01F6/74,,0,0,,,,PENDING
289,CN,A,CN 104540987 A,139-426-436-875-553,2015-04-22,2015,CN 201380041417 A,2013-06-11,US 2013/0045127 W;;US 201261660115 P,2012-06-15,Flame resistant spun staple yarns made from blends of fibers derived from sulfonated naphthalene polyoxadiazole polymers,"Described is a flame-resistant spun yarn having: about 50 to about 95 parts by weight of a sulfonated naphthalene polyoxadiazole based staple fiber comprising repeat units of Formula (I) and one or both of Formula (II) and (Ila) wherein Q is H or SO3M, and M is one or more cations; and about 5 to about 50 parts by weight of a textile staple fiber having limiting oxygen index of 24 or greater and a tenacity of about 2 grams per denier or greater, based on the total amount of the polymeric fiber and the textile fiber in the yarn.",DU PONT,BROWN PETER A;;CHAN JUSTIN W;;COBB MICHAEL W;;TADROS ANDREW;;TRENTACOSTA JOSEPH D;;WEINBERG MARK GARY;;WILLIAMS SHARLENE RENEE;;ZHU REIYAO,,https://lens.org/139-426-436-875-553,Patent Application,no,5,1,8,8,0,D01F6/74;;D02G3/04;;D01F6/74;;D01F6/78;;D01F6/78;;D02G3/045;;D02G3/44;;D02G3/443;;D02G3/443,D02G3/04;;D01F6/74;;D01F6/78;;D02G3/44,,0,0,,,,ACTIVE
290,EP,A2,EP 2861789 A2,136-961-147-586-494,2015-04-22,2015,EP 13783124 A,2013-06-11,US 201261660115 P;;US 2013/0045127 W,2012-06-15,FLAME RESISTANT SPUN STAPLE YARNS MADE FROM BLENDS OF FIBERS DERIVED FROM SULFONATED NAPHTHALENE POLYOXADIAZOLE POLYMERS,,DU PONT,BROWN PETER A;;CHAN JUSTIN W;;COBB MICHAEL W;;TADROS ANDREW;;TRENTACOSTA JOSEPH D;;WEINBERG MARK GARY;;WILLIAMS SHARLENE RENEE;;ZHU REIYAO,"DUPONT SAFETY & CONSTRUCTION, INC. (2020-04-01)",https://lens.org/136-961-147-586-494,Patent Application,yes,0,1,8,8,0,D01F6/74;;D02G3/04;;D01F6/74;;D01F6/78;;D01F6/78;;D02G3/045;;D02G3/44;;D02G3/443;;D02G3/443,D02G3/04;;D01F6/74;;D01F6/78;;D02G3/44,,1,0,,,See references of WO 2014007948A2,ACTIVE
291,DE,D1,DE 602006003237 D1,061-588-549-192-680,2008-12-04,2008,DE 602006003237 T,2006-02-02,US 5352205 A,2005-02-08,Kapazitive Wägezelle mit einer Matrix aus synthetischen Fasern zwischen zwei Schichten aus Gewebe,"A capacitive load cell apparatus (12) includes upper and lower capacitor plates (30, 28) and an intermediate dielectric (22) in the form of a synthetic knit spacer material having upper and lower fabric layers (22a, 22b) interconnected by an array of deflectable synthetic fibers (22c). When occupant weight is applied to the seat (10), the synthetic fibers (22c) deflect to locally reduce the separation between the upper and lower capacitor plates (30, 28), and the consequent change in capacitance is detected as a measure of the applied weight (14). The load cell (12) or just the dielectric (22) may be encased in a polymeric sheath (40, 42) to prevent intrusion of foreign matter, and a fluid such as silicone may be dispersed in woven dielectric (22).",DELPHI TECH INC,SANFTLEBEN HENRY M;;FULTZ WILLIAM W;;BERG ERIC M;;MURPHY MORGAN D;;GRIFFIN DENNIS P;;FORTUNE DUANE D;;CREER MICHAEL D;;COBB GREGORY A;;HANSEN MARK C;;KOORS MARK A,,https://lens.org/061-588-549-192-680,Granted Patent,no,0,0,5,5,0,G01G7/06;;G01G19/4142;;G01G19/4142;;G01G7/06,G01G7/06,,0,0,,,,ACTIVE
292,EP,B1,EP 1688717 B1,056-580-020-435-34X,2008-10-22,2008,EP 06075227 A,2006-02-02,US 5352205 A,2005-02-08,Capacitive load cell having an array of synthetic fibers between two fabric layers,"A capacitive load cell apparatus (12) includes upper and lower capacitor plates (30, 28) and an intermediate dielectric (22) in the form of a synthetic knit spacer material having upper and lower fabric layers (22a, 22b) interconnected by an array of deflectable synthetic fibers (22c). When occupant weight is applied to the seat (10), the synthetic fibers (22c) deflect to locally reduce the separation between the upper and lower capacitor plates (30, 28), and the consequent change in capacitance is detected as a measure of the applied weight (14). The load cell (12) or just the dielectric (22) may be encased in a polymeric sheath (40, 42) to prevent intrusion of foreign matter, and a fluid such as silicone may be dispersed in woven dielectric (22).",DELPHI TECH INC,SANFTLEBEN HENRY M;;FULTZ WILLIAM W;;BERG ERIC M;;MURPHY MORGAN D;;GRIFFIN DENNIS P;;FORTUNE DUANE D;;CREER MICHAEL D;;COBB GREGORY A;;HANSEN MARK C;;KOORS MARK A,,https://lens.org/056-580-020-435-34X,Granted Patent,yes,3,0,5,5,0,G01G7/06;;G01G19/4142;;G01G19/4142;;G01G7/06,G01G7/06,,0,0,,,,ACTIVE
293,AT,T1,AT E412167 T1,154-370-617-880-46X,2008-11-15,2008,AT 06075227 T,2006-02-02,US 5352205 A,2005-02-08,KAPAZITIVE WÄGEZELLE MIT EINER MATRIX AUS SYNTHETISCHEN FASERN ZWISCHEN ZWEI SCHICHTEN AUS GEWEBE,"A capacitive load cell apparatus (12) includes upper and lower capacitor plates (30, 28) and an intermediate dielectric (22) in the form of a synthetic knit spacer material having upper and lower fabric layers (22a, 22b) interconnected by an array of deflectable synthetic fibers (22c). When occupant weight is applied to the seat (10), the synthetic fibers (22c) deflect to locally reduce the separation between the upper and lower capacitor plates (30, 28), and the consequent change in capacitance is detected as a measure of the applied weight (14). The load cell (12) or just the dielectric (22) may be encased in a polymeric sheath (40, 42) to prevent intrusion of foreign matter, and a fluid such as silicone may be dispersed in woven dielectric (22).",DELPHI TECH INC,SANFTLEBEN HENRY M;;FULTZ WILLIAM W;;BERG ERIC M;;MURPHY MORGAN D;;GRIFFIN DENNIS P;;FORTUNE DUANE D;;CREER MICHAEL D;;COBB GREGORY A;;HANSEN MARK C;;KOORS MARK A,,https://lens.org/154-370-617-880-46X,Granted Patent,no,0,0,5,5,0,G01G7/06;;G01G19/4142;;G01G19/4142;;G01G7/06,,,0,0,,,,INACTIVE
294,EP,A1,EP 1688717 A1,093-107-065-792-840,2006-08-09,2006,EP 06075227 A,2006-02-02,US 5352205 A,2005-02-08,Capacitive load cell having an array of synthetic fibers between two fabric layers,"A capacitive load cell apparatus (12) includes upper and lower capacitor plates (30, 28) and an intermediate dielectric (22) in the form of a synthetic knit spacer material having upper and lower fabric layers (22a, 22b) interconnected by an array of deflectable synthetic fibers (22c). When occupant weight is applied to the seat (10), the synthetic fibers (22c) deflect to locally reduce the separation between the upper and lower capacitor plates (30, 28), and the consequent change in capacitance is detected as a measure of the applied weight (14). The load cell (12) or just the dielectric (22) may be encased in a polymeric sheath (40, 42) to prevent intrusion of foreign matter, and a fluid such as silicone may be dispersed in woven dielectric (22).
",DELPHI TECH INC,SANFTLEBEN HENRY M;;FULTZ WILLIAM W;;BERG ERIC M;;MURPHY MORGAN D;;GRIFFIN DENNIS P;;FORTUNE DUANE D;;CREER MICHAEL D;;COBB GREGORY A;;HANSEN MARK C;;KOORS MARK A,,https://lens.org/093-107-065-792-840,Patent Application,yes,8,0,5,5,0,G01G7/06;;G01G19/4142;;G01G19/4142;;G01G7/06,G01G7/06,,0,0,,,,ACTIVE
295,US,B2,US 8604138 B2,075-928-336-374-030,2013-12-10,2013,US 25524308 A,2008-10-21,US 25524308 A;;US 2085908 P,2008-01-14,Extrusion blow molded articles,"Extrusion blow molded (EBM) articles comprising a polyester having a dicarboxylic acid component and a glycol component. The dicarboxylic acid component comprises at least 90 mole % terephthalic acid residues. The glycol component comprises at least 75 mole % ethylene glycol residues and 15 to 25 mole % residues of a difunctional glycol such as, for example, 1,4-cyclohexanedimethanol. Such EBM articles can exhibit reduced haze, reduced sharkskin, and/or increased compatibility in PET recycling.",PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE;;EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,EASTMAN CHEMICAL COMPANY (2008-12-01),https://lens.org/075-928-336-374-030,Granted Patent,yes,27,3,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/00,525/437;;264/537;;264/540;;428/36.9;;428/36.91;;428/39.92;;528/272,14,0,,,"Copending U.S. Appl. No. 12/255,245, filed Oct. 21, 2008, Thomas Joseph Pecorini et al.;;Copending U.S. Appl. No. 12/255,237, filed Oct. 21, 2008, Thomas Joseph Pecorini et al.;;ASTM D1003, Method A, 2007.;;ASTM D3418, 2003.;;International Search Report for corresponding PCT/US2009/000137, Filed Jan. 9, 2009.;;Notification of Transmittal of the International Serach Report and the Written Opinion of the International Searching Authority, or the Declaration for corresponding PCT/US2009/00167, Filed Jan. 9, 2009.;;Notification of Transmittal of the International Serach Report and the Written Opinion of the International Searching Authority, or the Declaration for corresponding PCT/US2009/00152, Filed Jan. 9, 2009.;;USPTO Office Action dated Aug. 26, 2011 in copending U.S. Appl. No. 12/255,237.;;USPTO Office Action dated Nov. 2, 2011 in copending U.S. Appl. No. 12/255,245.;;USPTO Office Action dated May 2, 2012 in copending U.S. Appl. No. 12/255,245.;;USPTO Office Action dated Feb. 24, 2012 in copending U.S. Appl. No. 12/255,237.;;USPTO Office Action dated Aug. 2, 2012 in copending U.S. Appl. No. 12/255,237.;;USPTO Office Action dated Nov. 28, 2012 for co-pending U.S. Appl. No. 12/255,245.;;USPTO Office Action dated Dec. 28, 2012 for co-pending U.S. Appl. No. 12/255,237.",ACTIVE
296,CN,A,CN 101910243 A,040-048-126-179-709,2010-12-08,2010,CN 200980102189 A,2009-01-09,US 2009/0000167 W;;US 2085908 P;;US 25523708 A;;US 25524308 A;;US 25524508 A,2008-01-14,Extrusion profile articles,"Extrusion profile articles comprising a polyester having a dicarboxylic acid component and a glycol component. The dicarboxlyic acid component compriss at least 90 mole % terephthalic acid residues. The glycol component comprises at least 75 mole % ethylene glycol residues and 15 to 25 mole % residues of a difunctional glycol such as, for example, 1,4-cyclohexanedimethanol. Such extrusion profilearticles can exhibit reduced haze, reduced sharkskin, and/or increased compatibility in PET recycling.",EASTMAN CHEM CO,JOSEPH PECORINI THOMAS;;ALLEN GILLIAM SPENCER;;IGNACIO GARCIA;;KEITH PHILLIPS ALAN;;ELLIS MCCRARY ROBERT;;ALLAN TREECE MARK;;CHRISTOPHER COBB DANIEL;;EUGENE DOBBS HAROLD,,https://lens.org/040-048-126-179-709,Patent Application,no,0,1,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/199;;C08G63/20,,0,0,,,,ACTIVE
297,US,B2,US 8604139 B2,054-922-764-800-818,2013-12-10,2013,US 25524508 A,2008-10-21,US 25524508 A;;US 2085908 P,2008-01-14,Extrusion profile articles,"Extrusion profile articles comprising a polyester having a dicarboxylic acid component and a glycol component. The dicarboxlyic acid component comprises at least 90 mole % terephthalic acid residues. The glycol component comprises at least 75 mole % ethylene glycol residues and 15 to 25 mole % residues of a difunctional glycol such as, for example, 1,4-cyclohexanedimethanol. Such extrusion profile articles can exhibit reduced haze, reduced sharkskin, and/or increased compatibility in PET recycling.",PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE;;EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,EASTMAN CHEMICAL COMPANY (2008-12-01),https://lens.org/054-922-764-800-818,Granted Patent,yes,27,3,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/00,525/437;;264/537;;264/540;;428/36.9;;428/36.91;;428/36.92;;528/272,14,0,,,"Copending U.S. Appl. No. 12/255,243, filed Oct. 21, 2008, Thomas Joseph Pecorini et al.;;Copending U.S. Appl. No. 12/255,237, filed Oct. 21, 2008, Thomas Joseph Pecorini et al.;;ASTM D1003, Method A, 2007.;;ASTM D3418, 2003.;;International Search Report for corresponding PCT/US2009,000167, Filed Jan. 9, 2009.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration for corresponding PCT/US2009/000137, Filed Jan. 9, 2009.;;Notification of Transmittal of the International Serach Report and the Written Opinion of the International Searching Authority, or the Declaration for corresponding PCT/US2009/00152, Filed Jan. 9, 2009.;;USPTO Office Action dated Aug. 26, 2011 in copending U.S. Appl. No. 12/255,237.;;USPTO Office Action dated Nov. 2, 2011 in copending U.S. Appl. No. 12/255,243.;;USPTO Office Action dated Apr. 6, 2012 in copending U.S. Appl. No. 12/255,243.;;USPTO Office Action dated Feb. 24, 2012 in copending U.S. Appl. No. 12/255,237.;;USPTO Office Action dated Aug. 2, 2012 in copending U.S. Appl. No. 12/255,237.;;USPTO Office Action dated Nov. 28, 2012 for co-pending U.S. Appl. No. 12/255,243.;;USPTO Office Action dated Dec. 28, 2012 for co-pending U.S. Appl. No. 12/255,237.",ACTIVE
298,JP,A,JP H11265878 A,052-661-083-133-620,1999-09-28,1999,JP 1309499 A,1999-01-21,US 1416998 A,1998-01-27,METHOD AND DEVICE FOR PROVIDING DETECTION OF END POINT BY ANALYSIS OF RESIDUAL GAS,"PROBLEM TO BE SOLVED: To accurately determine an etching process end point so as to avoid excess etching by a method wherein gases such as etching seed, etchant, and additional gas in a processing chamber are analyzed by a residual gas analyzer. SOLUTION: An RGA process monitoring system as a residual gas analyzer(RGA) end point system is composed of a mass spectrometer 11, vacuum valves V1 , V2 , and V3 represented by 2, 3, and 4 respectively, a real time calibration independent-type gas unit 5, a control valve V4 6, and an RGA control unit 7. The RGA control unit 7 is equipped with a control processor and related software for high-speed data acquisition and generating data analysis command, and process control command. The RGA device is mounted on a processing chamber 8 or an exhaust vent 10, and an RGA ionization device can be installed in the chamber itself.",IBM,JOHN M BAKER;;HARRY DOUGLAS CLARK;;MICHAEL A COBB;;DOREEN DOMINICA DIMILIA;;LEE YOUNG HOON;;MARK LELAND REES;;EDMUND MARION SIKORSKI;;IN ZHANG,,https://lens.org/052-661-083-133-620,Patent Application,no,0,13,1,1,0,,H01L21/302;;H01L21/3065,,0,0,,,,PENDING
299,EP,B1,EP 2231745 B1,113-466-412-351-686,2016-09-21,2016,EP 09702650 A,2009-01-09,US 2009/0000167 W;;US 2085908 P;;US 25524308 A;;US 25524508 A;;US 25523708 A,2008-01-14,EXTRUSION PROFILE ARTICLES,,EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,,https://lens.org/113-466-412-351-686,Granted Patent,yes,2,0,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/199;;C08G63/20,,0,0,,,,ACTIVE
300,EP,A1,EP 2231745 A1,023-915-398-238-262,2010-09-29,2010,EP 09702650 A,2009-01-09,US 2009/0000167 W;;US 2085908 P;;US 25524308 A;;US 25524508 A;;US 25523708 A,2008-01-14,EXTRUSION PROFILE ARTICLES,,EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,,https://lens.org/023-915-398-238-262,Patent Application,yes,0,0,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/199;;C08G63/20,,0,0,,,,ACTIVE
301,US,A1,US 2009/0181201 A1,046-084-662-129-293,2009-07-16,2009,US 25524308 A,2008-10-21,US 25524308 A;;US 2085908 P,2008-01-14,EXTRUSION BLOW MOLDED ARTICLES,"Extrusion blow molded (EBM) articles comprising a polyester having a dicarboxylic acid component and a glycol component. The dicarboxylic acid component comprises at least 90 mole % terephthalic acid residues. The glycol component comprises at least 75 mole % ethylene glycol residues and 15 to 25 mole % residues of a difunctional glycol such as, for example, 1,4-cyclohexanedimethanol. Such EBM articles can exhibit reduced haze, reduced sharkskin, and/or increased compatibility in PET recycling.",EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,EASTMAN CHEMICAL COMPANY (2008-12-01),https://lens.org/046-084-662-129-293,Patent Application,yes,21,4,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,B32B1/08;;B29C49/00,428/36.9;;264/544,0,0,,,,ACTIVE
302,EP,A1,EP 2231744 A1,136-141-462-256-256,2010-09-29,2010,EP 09701882 A,2009-01-09,US 2009/0000137 W;;US 2085908 P;;US 25524508 A;;US 25523708 A;;US 25524308 A,2008-01-14,EXTRUSION BLOW MOLDED ARTICLES,,EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,,https://lens.org/136-141-462-256-256,Patent Application,yes,0,0,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/199;;C08G63/20,,0,0,,,,ACTIVE
303,WO,A1,WO 2009/091519 A1,015-758-786-419-667,2009-07-23,2009,US 2009/0000167 W,2009-01-09,US 2085908 P;;US 25524308 A;;US 25524508 A;;US 25523708 A,2008-01-14,EXTRUSION PROFILE ARTICLES,"Extrusion profile articles comprising a polyester having a dicarboxylic acid component and a glycol component. The dicarboxlyic acid component compriss at least 90 mole % terephthalic acid residues. The glycol component comprises at least 75 mole % ethylene glycol residues and 15 to 25 mole % residues of a difunctional glycol such as, for example, 1,4-cyclohexanedimethanol. Such extrusion profile articles can exhibit reduced haze, reduced sharkskin, and/or increased compatibility in PET recycling.",EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,,https://lens.org/015-758-786-419-667,Patent Application,yes,2,1,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/20;;C08G63/199,,0,0,,,,PENDING
304,CN,B,CN 101910243 B,180-308-806-447-53X,2013-09-18,2013,CN 200980102189 A,2009-01-09,US 2009/0000167 W;;US 2085908 P;;US 25523708 A;;US 25524308 A;;US 25524508 A,2008-01-14,Extrusion profile articles,,EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,,https://lens.org/180-308-806-447-53X,Granted Patent,no,0,0,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/199;;C08G63/20,,0,0,,,,ACTIVE
305,CN,A,CN 101910242 A,014-926-321-812-251,2010-12-08,2010,CN 200980102187 A,2009-01-09,US 2009/0000137 W;;US 2085908 P;;US 25524508 A;;US 25523708 A;;US 25524308 A,2008-01-14,Extrusion blow molded articles,"Extrusion blow molded (EBM) articles comprising a polyester having a dicarboxylic acid component and a glycol component. The dicarboxlyic acid component comprises at least 90 mole % terephthalic acid residues. The glycol component comprises at least 75 mole % ethylene glycol residues and 15 to 25 mole % residues of a difunctional glycol such as, for example, 1,4- cyclohexanedimethanol. Such EMB articles can exhibit reduced haze, reduced sharkskin, and/or increased compatibility in PET recycling.",EASTMAN CHEM CO,JOSEPH PECORINI THOMAS;;ALLEN GILLIAM SPENCER;;IGNACIO GARCIA;;KEITH PHILLIPS ALAN;;ELLIS MCCRARY ROBERT;;ALLAN TREECE MARK;;CHRISTOPHER COBB DANIEL;;EUGENE DOBBS HAROLD,,https://lens.org/014-926-321-812-251,Patent Application,no,0,5,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/199;;C08G63/20,,0,0,,,,ACTIVE
306,US,A1,US 2009/0181202 A1,055-981-930-533-855,2009-07-16,2009,US 25524508 A,2008-10-21,US 25524508 A;;US 2085908 P,2008-01-14,EXTRUSION PROFILE ARTICLES,"Extrusion profile articles comprising a polyester having a dicarboxylic acid component and a glycol component. The dicarboxlyic acid component comprises at least 90 mole % terephthalic acid residues. The glycol component comprises at least 75 mole % ethylene glycol residues and 15 to 25 mole % residues of a difunctional glycol such as, for example, 1,4-cyclohexanedimethanol. Such extrusion profile articles can exhibit reduced haze, reduced sharkskin, and/or increased compatibility in PET recycling.",EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,EASTMAN CHEMICAL COMPANY (2008-12-01),https://lens.org/055-981-930-533-855,Patent Application,yes,20,7,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08L67/02;;B29C39/02;;B29C49/04;;B32B1/00;;C08G63/02,428/36.92;;528/272;;528/308;;524/605;;264/540,0,0,,,,ACTIVE
307,CN,B,CN 101910242 B,179-138-296-210-270,2013-09-11,2013,CN 200980102187 A,2009-01-09,US 2009/0000137 W;;US 2085908 P;;US 25524508 A;;US 25523708 A;;US 25524308 A,2008-01-14,Extrusion blow molded articles,,EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,,https://lens.org/179-138-296-210-270,Granted Patent,no,0,0,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/199;;C08G63/20,,0,0,,,,ACTIVE
308,EP,B1,EP 2231744 B1,064-374-544-671-848,2016-05-04,2016,EP 09701882 A,2009-01-09,US 2009/0000137 W;;US 2085908 P;;US 25524508 A;;US 25523708 A;;US 25524308 A,2008-01-14,EXTRUSION BLOW MOLDED ARTICLES,,EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,,https://lens.org/064-374-544-671-848,Granted Patent,yes,2,0,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/199;;C08G63/20,,0,0,,,,ACTIVE
309,WO,A1,WO 2009/091512 A1,196-184-979-791-231,2009-07-23,2009,US 2009/0000137 W,2009-01-09,US 2085908 P;;US 25524508 A;;US 25523708 A;;US 25524308 A,2008-01-14,EXTRUSION BLOW MOLDED ARTICLES,"Extrusion blow molded (EBM) articles comprising a polyester having a dicarboxylic acid component and a glycol component. The dicarboxlyic acid component comprises at least 90 mole % terephthalic acid residues. The glycol component comprises at least 75 mole % ethylene glycol residues and 15 to 25 mole % residues of a difunctional glycol such as, for example, 1,4- cyclohexanedimethanol. Such EMB articles can exhibit reduced haze, reduced sharkskin, and/or increased compatibility in PET recycling.",EASTMAN CHEM CO,PECORINI THOMAS JOSEPH;;GILLIAM SPENCER ALLEN;;GARCIA IGNACIO;;PHILLIPS ALAN KEITH;;MCCRARY ROBERT ELLIS;;TREECE MARK ALLAN;;COBB DANIEL CHRISTOPHER;;DOBBS HAROLD EUGENE,,https://lens.org/196-184-979-791-231,Patent Application,yes,2,0,26,26,0,B29C49/04;;C08J5/00;;C08J2367/00;;C08G63/199;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/0691;;Y10T428/139;;Y10T428/1393;;Y10T428/1352;;Y10T428/1397;;B29C49/04;;C08J5/00;;C08J2367/00;;B29C49/0691;;C08G63/199,C08G63/20;;C08G63/199,,0,0,,,,PENDING
310,WO,A1,WO 2003/016784 A1,006-341-344-513-808,2003-02-27,2003,US 0219615 W,2002-06-20,US 93037101 A,2001-08-15,LIGHT GUIDE FOR USE WITH BACKLIT DISPLAY,"A light guide (14) including a light guide body having a light re-directing side (22) positioned opposite from a light output side (20). A plurality of elongate prisms are located adjacent the light output side of the light guide body. The prisms extend side-by-side relative to one another along lengths. The prisms include upper edges defining heights of the prisms. The upper edges extend along the lengths of the prisms. Each upper edge includes a plurality of edge segments having different magnitudes of slope. The light guide (14) also includes a plurality of light extraction structures located adjacent the light re-directing side (22) of the light guide body for reflecting light toward the light output side (20). The light extraction structures include elongated projections (50) each having a plateau segment (54) and first and second facets (56, 58). The elongated projections (50) are separated by lands (52) that are recessed relative to the plateau segments (54). The first and second facets (56, 58) extend from the plateau segments (54) to the lands (52).",3M INNOVATIVE PROPERTIES CO,WHITNEY LELAND R;;BOYD GARY T;;KOTCHICK KEITH M;;EPSTEIN KENNETH A;;COBB SANFORD JR;;WATSON PHILIP E;;LAMB DAVID J;;GARDINER MARK E,,https://lens.org/006-341-344-513-808,Patent Application,yes,3,0,10,10,0,G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901;;G02F1/1335;;G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901,F21V8/00;;G02B6/00;;F21Y101/02;;F21Y103/00;;G02F1/13357,,0,0,,,,PENDING
311,CA,C,CA 2457664 C,083-580-603-972-664,2007-01-23,2007,CA 2457664 A,2002-06-20,US 93037101 A;;US 0219615 W,2001-08-15,LIGHT GUIDE FOR USE WITH BACKLIT DISPLAY,A light guide including a light guide body having a light re-directing side positioned opposite from a light output side. A plurality of elongate prisms are locate d adjacent the light output aide of the light guide body. The prisms extend side-by-side relative to one another along lengths. The prisms include upper edges defining heights of th e prisms. The upper edges extend along the lengths of the prisms. Each upper edge includes a plurality of edge segments having different magnitudes of slope. The light guide also includes a plurality of light extraction structures located adjacent the lig ht re-directing side of the light guide body for reflecting light toward the light output side. T he light extraction structures include elongated projections each having a plateau segment and first and second facets. The elongated projections are separated by lands that are recessed relative to the plateau segments. The first and second facets extend from th e plateau segments to the lands.,3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;COBB SANFORD JR;;BOYD GARY T;;KOTCHICK KEITH M;;EPSTEIN KENNETH A;;WATSON PHILIP E;;WHITNEY LELAND R;;LAMB DAVID J,,https://lens.org/083-580-603-972-664,Granted Patent,no,0,0,10,10,0,G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901;;G02F1/1335;;G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901,G02B6/00;;F21V8/00;;F21Y101/02;;F21Y103/00,,0,0,,,,EXPIRED
312,US,B1,US 7043280 B1,131-818-635-840-785,2006-05-09,2006,US 97573201 A,2001-10-11,US 97573201 A,2001-10-11,Mechanically rotatable wireless RF data transmission subscriber station with multi-beam antenna,"A wireless RF data transmission system subscriber station has a fixed, overhead bracket secured, spindle. An open sided housing is rotatably mounted to the spindle. The housing has a finned heat sink and is interiorly coated with heat absorbing paint. Emissions shielding enclosures secured within the housing house an RF transceiver. An antenna array mounted to an enclosure is operatively connected to the transceiver through the enclosures for communicating RF data signals. An A/D-D/A board is mounted to an enclosure on an opposite side from the array. A radome is secured over a face of the array, sealed to the housing by a carbon impregnated gasket. An electric motor mounted within the housing and operatively engaging the spindle is controlled by antenna aiming logic for aiming the station and its array. An orifice sealed with a waterproof, breathable membrane allows moisture to escape the housing and prevents moisture infiltration.",ADAPTIX INC,SHIELDS RICHARD A;;KARR RANDY J;;DEMARIA JAMES E;;GREEN CARTER K;;PERRIGO GREGORY D;;COBB BARRY S;;OLSON KENT W;;REUDINK MARK D,VECTRAD NETWORK CORP (2001-12-10);;ADAPTIX INC (2004-12-17);;NETGEAR INC (2010-08-02),https://lens.org/131-818-635-840-785,Granted Patent,yes,18,44,2,2,0,H01Q1/246;;H01Q1/42;;H01Q3/04;;H01Q21/065;;H01Q25/005;;H01Q1/02;;H01Q3/04;;H01Q1/246;;H01Q1/42;;H01Q25/005;;H01Q21/065;;H01Q1/02,H04M1/00;;H01Q1/24,455/575.1;;455/90.3;;455/575.5;;455/575.7;;455/562.1;;X343700 MS;;343/702;;343/841;;343/872,0,0,,,,EXPIRED
313,EP,A1,EP 1417438 A1,060-656-844-382-52X,2004-05-12,2004,EP 02737560 A,2002-06-20,US 0219615 W;;US 93037101 A,2001-08-15,LIGHT GUIDE FOR USE WITH BACKLIT DISPLAY,,3M INNOVATIVE PROPERTIES CO,WHITNEY LELAND R;;BOYD GARY T;;KOTCHICK KEITH M;;EPSTEIN KENNETH A;;COBB SANFORD JR;;WATSON PHILIP E;;LAMB DAVID J;;GARDINER MARK E,,https://lens.org/060-656-844-382-52X,Patent Application,yes,0,3,10,10,0,G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901;;G02F1/1335;;G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901,G02B6/00;;F21V8/00;;F21Y101/02;;F21Y103/00;;G02F1/13357,,0,0,,,,DISCONTINUED
314,US,B2,US 7670760 B2,169-148-317-635-144,2010-03-02,2010,US 36951306 A,2006-03-06,US 36951306 A,2006-03-06,Treatment for reduction of line edge roughness,"A method for reducing line edge roughness (LER) in a layer of photoresist is provided. In accordance with the method, a layer of photoresist is applied to a substrate. The layer of photoresist is then patterned and annealed in an atmosphere comprising at least one gas selected from the group consisting of hydrogen, nitrogen and fluorine-containing materials. Preferably, the anneal is performed after patterning the photoresist, but either immediately after, or subsequent to, the trim.",FREESCALE SEMICONDUCTOR INC,SHEN JINMIAO JAMES;;COBB JONATHAN L;;DARLINGTON WILLIAM D;;FISHER BRIAN J;;HALL MARK D;;SHETH VIKAS R;;SHROFF MEHUL D;;VASEK JAMES E,NORTH STAR INNOVATIONS INC (2015-10-02);;FREESCALE SEMICONDUCTOR INC (2006-03-03),https://lens.org/169-148-317-635-144,Granted Patent,yes,8,6,2,2,0,G03F7/168;;G03F7/168,G03F1/00,430/330,0,0,,,,INACTIVE
315,CA,A1,CA 2457664 A1,183-443-880-479-418,2003-02-27,2003,CA 2457664 A,2002-06-20,US 93037101 A;;US 0219615 W,2001-08-15,LIGHT GUIDE FOR USE WITH BACKLIT DISPLAY,"A light guide (14) including a light guide body having a light re-directing side (22) positioned opposite from a light output side (20). A plurality of elongate prisms are located adjacent the light output side of the light guid e body. The prisms extend side-by-side relative to one another along lengths. The prisms include upper edges defining heights of the prisms. The upper edg es extend along the lengths of the prisms. Each upper edge includes a plurality of edge segments having different magnitudes of slope. The light guide (14) also includes a plurality of light extraction structures located adjacent th e light re-directing side (22) of the light guide body for reflecting light toward the light output side (20). The light extraction structures include elongated projections (50) each having a plateau segment (54) and first and second facets (56, 58). The elongated projections (50) are separated by land s (52) that are recessed relative to the plateau segments (54). The first and second facets (56, 58) extend from the plateau segments (54) to the lands (5 2).",3M INNOVATIVE PROPERTIES CO,GARDINER MARK E;;BOYD GARY T;;KOTCHICK KEITH M;;LAMB DAVID J;;WHITNEY LELAND R;;EPSTEIN KENNETH A;;WATSON PHILIP E;;COBB SANFORD JR,,https://lens.org/183-443-880-479-418,Patent Application,no,0,0,10,10,0,G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901;;G02F1/1335;;G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901,G02B6/00;;F21V8/00;;F21Y101/02;;F21Y103/00;;G02F1/13357,,0,0,,,,EXPIRED
316,US,B2,US 8146591 B2,029-039-015-800-424,2012-04-03,2012,US 15816205 A,2005-06-21,US 15816205 A;;US 62913704 P;;US 60571704 P,2004-08-31,Capnometry system for use with a medical effector system,"Disclosed is a capnometry apparatus for receiving respiratory gas from a respiratory cannula positioned on a patient. An integrated host controller alerts a user if the capnometry apparatus is connected or not connected to the respiratory cannula based in part on a signal output from a capnometer located in the capnometry apparatus. The host controller also includes the functionality to shut off the capnometer pump with or without a time delay when the capnometer signal output indicates the capnometer pump is not connected to the cannula. An ambient-air pressure sensor located in the capnometry apparatus alerts the host controller if the capnometry apparatus has been moved to a new location with a substantially different altitude than the first location, in which case the host controller will issue an alert to a user prompting a calibration of the capnometry apparatus.",NIKLEWSKI PAUL J;;BURDORFF MARK A;;DONOFRIO WILLIAM T;;EYSTER CURT R;;MARTIN JAMES F;;NALAGATLA ANIL K;;ADAIR WILLIAM P;;COBB NICHOLAS E;;ETHICON ENDO SURGERY INC,NIKLEWSKI PAUL J;;BURDORFF MARK A;;DONOFRIO WILLIAM T;;EYSTER CURT R;;MARTIN JAMES F;;NALAGATLA ANIL K;;ADAIR WILLIAM P;;COBB NICHOLAS E,SCOTT LABORATORIES INC (2016-12-05);;ETHICON ENDO-SURGERY INC (2005-09-12),https://lens.org/029-039-015-800-424,Granted Patent,yes,53,21,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M16/00;;A61M15/08;;A62B18/02;;G16H10/60;;G16H20/17;;G16H40/63,128/204.23;;128/200.24;;128/200.26;;128/204.18;;128/207.18;;128/207.14;;128/206.21,2,0,,,"European Search Report dated Oct. 27, 2009 for corresponding European application EP05789936.;;International Search Report dated Jun. 11, 2008 for corresponding PCT application PCT/US05/30201.",ACTIVE
317,US,B2,US 6576887 B2,173-568-688-573-312,2003-06-10,2003,US 93037101 A,2001-08-15,US 93037101 A,2001-08-15,Light guide for use with backlit display,"
    A light guide including a light guide body having a light re-directing side positioned opposite from a light output side. A plurality of elongate prisms are located adjacent the light output side of the light guide body. The prisms extend side-by-side relative to one another along lengths. The prisms include upper edges defining heights of the prisms. The upper edges extend along the lengths of the prisms. Each upper edge includes a plurality of edge segments having different magnitudes of slope. The light guide also includes a plurality of light extraction structures located adjacent the light re-directing side of the light guide body for reflecting light toward the light output side. The light extraction structures include elongated projections each having a plateau segment and first and second facets. The elongated projections are separated by lands that are recessed relative to the plateau segments. The first and second facets extend from the plateau segments to the lands. 
",3M INNOVATIVE PROPERTIES CO,WHITNEY LELAND R;;BOYD GARY T;;KOTCHICK KEITH M;;EPSTEIN KENNETH A;;COBB JR SANFORD;;WATSON PHILIP E;;LAMB DAVID J;;GARDINER MARK E,3M INNOVATIVE PROPERTIES COMPANY (2001-11-12),https://lens.org/173-568-688-573-312,Granted Patent,yes,34,114,10,10,0,G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901;;G02F1/1335;;G02B6/0038;;G02B6/0046;;G02B6/0065;;Y10S385/901,F21V8/00;;F21Y101/02;;F21Y103/00;;G02B6/00;;G02F1/13357,250/227.11;;385/133;;385/147;;385/901,0,0,,,,EXPIRED
318,US,B1,US 7366553 B1,073-534-490-598-302,2008-04-29,2008,US 37243206 A,2006-03-09,US 37243206 A;;US 97573201 A,2001-10-11,Mechanically rotatable wireless RF data transmission subscriber station with multi-beam antenna,"A wireless RF data transmission system subscriber station has a fixed, overhead bracket secured, spindle. An open sided housing is rotatably mounted to the spindle. The housing has a finned heat sink and is interiorly coated with heat absorbing paint. Emissions shielding enclosures secured within the housing house an RF transceiver. An antenna array mounted to an enclosure is operatively connected to the transceiver through the enclosures for communicating RF data signals. An A/D-D/A board is mounted to an enclosure on an opposite side from the array. A radome is secured over a face of the array, sealed to the housing by a carbon impregnated gasket. An electric motor mounted within the housing and operatively engaging the spindle is controlled by antenna aiming logic for aiming the station and its array. An orifice sealed with a waterproof, breathable membrane allows moisture to escape the housing and prevents moisture infiltration.",ADAPTIX INC,SHIELDS RICHARD A;;KARR RANDY J;;DEMARIA JAMES E;;GREEN CARTER K;;PERRIGO GREGORY D;;COBB BARRY S;;OLSON KENT W;;REUDINK MARK D,VECTRAD NETWORK CORP (2005-12-11);;ADAPTIX INC (2004-12-17);;NETGEAR INC (2010-08-02),https://lens.org/073-534-490-598-302,Granted Patent,yes,20,22,2,2,0,H01Q1/246;;H01Q1/42;;H01Q3/04;;H01Q21/065;;H01Q25/005;;H01Q1/02;;H01Q3/04;;H01Q1/246;;H01Q1/42;;H01Q25/005;;H01Q21/065;;H01Q1/02,H04M1/00;;H01Q1/24,455/575.1;;455/90.3;;455/575.5;;455/575.7;;455/562.1;;X343700 MS;;343/702;;343/841;;343/872,0,0,,,,EXPIRED
319,US,A1,US 2006/0042635 A1,132-582-872-244-563,2006-03-02,2006,US 15816205 A,2005-06-21,US 15816205 A;;US 62913704 P;;US 60571704 P,2004-08-31,Capnometry system for use with a medical effector system,"Disclosed is a capnometry apparatus for receiving respiratory gas from a respiratory cannula positioned on a patient. An integrated host controller alerts a user if the capnometry apparatus is connected or not connected to the respiratory cannula based in part on a signal output from a capnometer located in the capnometry apparatus. The host controller also includes the functionality to shut off the capnometer pump with or without a time delay when the capnometer signal output indicates the capnometer pump is not connected to the cannula. An ambient-air pressure sensor located in the capnometry apparatus alerts the host controller if the capnometry apparatus has been moved to a new location with a substantially different altitude than the first location, in which case the host controller will issue an alert to a user prompting a calibration of the capnometry apparatus.",NIKLEWSKI PAUL J;;BURDORFF MARK A;;DONOFRIO WILLIAM T;;EYSTER CURT R;;MARTIN JAMES F;;NALAGATLA ANIL K;;ADAIR WILLIAM P;;COBB NICHOLAS E,NIKLEWSKI PAUL J;;BURDORFF MARK A;;DONOFRIO WILLIAM T;;EYSTER CURT R;;MARTIN JAMES F;;NALAGATLA ANIL K;;ADAIR WILLIAM P;;COBB NICHOLAS E,SCOTT LABORATORIES INC (2016-12-05);;ETHICON ENDO-SURGERY INC (2005-09-12),https://lens.org/132-582-872-244-563,Patent Application,yes,22,18,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A62B7/10;;A61M15/08;;G16H10/60;;G16H20/17;;G16H40/63,128/207.18;;128/206.11,0,0,,,,ACTIVE
320,CY,B1,CY 2319 B1,110-978-972-180-950,2003-11-14,2003,CY 0300026 A,2003-03-12,GB 9604242 A,1996-02-28,Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma.,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;KALDOR ISTVAN;;DEATON DAVID NORMAN;;COBB JEFFREY EDMOND;;SHARP MATTHEW JUDE;;ERICKSON GREG ALAN;;MOOK ROBERT ANTHONY JR;;COLLINS JON LOREN;;BRACKEEN MARCUS;;O'CALLAGHAN JOHN MARK;;BOSWELL GRADY EVAN,,https://lens.org/110-978-972-180-950,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
321,US,A1,US 2007/0207404 A1,177-647-297-290-244,2007-09-06,2007,US 36951306 A,2006-03-06,US 36951306 A,2006-03-06,Treatment for reduction of line edge roughness,"A method for reducing line edge roughness (LER) in a layer of photoresist is provided. In accordance with the method, a layer of photoresist is applied to a substrate. The layer of photoresist is then patterned and annealed in an atmosphere comprising at least one gas selected from the group consisting of hydrogen, nitrogen and fluorine-containing materials. Preferably, the anneal is performed after patterning the photoresist, but either immediately after, or subsequent to, the trim.",FREESCALE SEMICONDUCTOR INC,SHEN JINMIAO J;;COBB JONATHAN L;;DARLINGTON WILLIAM D;;FISHER BRIAN J;;HALL MARK D;;SHETH VIKAS R;;SHROFF MEHUL D;;VASEK JAMES E,NORTH STAR INNOVATIONS INC (2015-10-02);;FREESCALE SEMICONDUCTOR INC (2006-03-03),https://lens.org/177-647-297-290-244,Patent Application,yes,8,4,2,2,0,G03F7/168;;G03F7/168,G03C1/00,430/270.1,0,0,,,,INACTIVE
322,US,A1,US 2017/0165844 A1,130-200-023-725-101,2017-06-15,2017,US 201514963487 A,2015-12-09,US 201514963487 A,2015-12-09,Multifunction End Effector,"An end effector is provided. The end effector comprises a housing, a movement system within the housing, an inspection system, a collar installation system, and a sealant application system. The housing has an operating window. The movement system comprises at least one of a rotation mechanism or a number of linear slides. The inspection system is associated with the movement system. The collar installation system is associated with the movement system. The sealant application system is associated with the movement system. Activating the movement system positions any of the inspection system, the collar installation system, or the sealant application system in an active position relative to the operating window.",BOEING CO,BROCKWAY MONICA JOY;;SISCO TANNI;;CAI FEI;;GROSSAINT TODD CHRISTOPHER;;DUNAJ MATTHEW RYAN;;BROWN MARK WILLIAM;;COBB BRIAN JOSEPH;;PAYIONK MICHAEL GEORGE;;VIA JUSTIN RONALD,THE BOEING COMPANY (2015-12-04),https://lens.org/130-200-023-725-101,Patent Application,yes,0,5,2,2,0,Y10S901/31;;Y10S901/44;;Y10S901/41;;B21J15/022;;B21J15/142;;H04N23/56;;H04N23/51;;Y10S901/31;;Y10S901/44;;Y10S901/41;;H04N23/56;;H04N23/51,B25J11/00;;B25J9/16;;B65G51/00;;G06T7/00;;H04N5/225,,0,0,,,,ACTIVE
323,US,B2,US 10306122 B2,070-405-911-901-374,2019-05-28,2019,US 201514963487 A,2015-12-09,US 201514963487 A,2015-12-09,Multifunction end effector,"An end effector is provided. The end effector comprises a housing, a movement system within the housing, an inspection system, a collar installation system, and a sealant application system. The housing has an operating window. The movement system comprises at least one of a rotation mechanism or a number of linear slides. The inspection system is associated with the movement system. The collar installation system is associated with the movement system. The sealant application system is associated with the movement system. Activating the movement system positions any of the inspection system, the collar installation system, or the sealant application system in an active position relative to the operating window.",BOEING CO,BROCKWAY MONICA JOY;;SISCO TANNI;;CAI FEI;;GROSSAINT TODD CHRISTOPHER;;DUNAJ MATTHEW RYAN;;BROWN MARK WILLIAM;;COBB BRIAN JOSEPH;;PAYIONK MICHAEL GEORGE;;VIA JUSTIN RONALD,THE BOEING COMPANY (2015-12-04),https://lens.org/070-405-911-901-374,Granted Patent,yes,6,0,2,2,0,Y10S901/31;;Y10S901/44;;Y10S901/41;;B21J15/022;;B21J15/142;;H04N23/56;;H04N23/51;;Y10S901/31;;Y10S901/44;;Y10S901/41;;H04N23/56;;H04N23/51,H04N5/225,,1,0,,,"Brockway et al., “Method and Apparatus for Multi-Stage Spar Assembly,” U.S. Appl. No. 14/614,886, filed Feb. 5, 2015, 71 pages.",ACTIVE
324,BR,B1,BR 9707786 B1,069-496-705-476-574,2009-12-01,2009,BR 9707786 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,composto.,,,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/069-496-705-476-574,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D263/56;;C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
325,HK,A1,HK 1015369 A1,152-794-761-427-789,1999-10-15,1999,HK 99100498 A,1999-02-05,EP 9700916 W;;GB 9604242 A,1996-02-28,SUBSTITUTED 4-HYDROXYPHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/152-794-761-427-789,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;C07D295/18;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
326,SK,B6,SK 282753 B6,054-594-898-987-34X,2002-12-03,2002,SK 116398 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma,"A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered heterocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3 alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3 alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5; their production method, pharmaceutical preparation containing the claimed compounds and their use for medical purposes.",GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/054-594-898-987-34X,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;C07D295/18;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
327,YU,A,YU 36998 A,069-462-983-761-767,1999-09-27,1999,YU 36998 A,1998-08-28,GB 9604242 A,1996-02-28,SUBSTITUTED 4-HYDROXY-PHENYL ALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR GAMMA,"Jedinjenje koje ima formulu (I) u kojoj se A bira iz grupe koju čine: (i) fenil, pri čemu je pomenuti fenil opciono supstituisan sa jednim ili više halogenih atoma. C1-6 alkil, C1-3 alkoksi, C1-3 fluoroalkoksi, nitril, ili -NR7R8, gde su R7 i R8 nezavisno vodonik ili C1-3 alkil: (ii) 5- ili 6-člana heterociklična grupa koja sadrži najmanje jedan heteroatom koji se bira izmedju kiseonika, azota i sumpora, i (iii) spojeni biciklični presten (a) u kome C predstavlja heterocikličnu grupu definisanu pod tačakom (ii) gore, a ovaj biciklični prsten je vezan za grupu B preko atoma iz prstena u prstenu C; B se bira iz grupe koju čine: (iv) C1-6 alkenil; (v) -MC1-6 alkilen ili C1-6 alkilen, gde je M kiseonik, sumpor ili -NR2, gde R2 predstavlja vodonik ili C1-3 alkil; (vi) 5- ili 6-člana heterociklična grupa koja sadrži najmanje jedan azot kao heteroatom i opciono har još jedan heteroatom koji se bira izmedju kiseonika, azota i sumpora, a opciono je supstituisana sa C1-3 alkilom; i (vii) Het-C1-6 alkilen, gde Het predstavlja heterocikličnu grupu definisanu u tački (vi) gore, Alk predstavlja C1-3 alkilen; R1 predstavlja vodonik ili C1-3 alkil; Z se bira iz grupe koju čine: (viii) -(C1-3 alkilen)fenil, gde je fenil opciono supstituisan sa jednim ili više halogenih atoma; i (ix) -NR3R4, gde R3 predstavlja vodonik ili C1-3 alkil, a R4 predstavlja-Y-(C=O)-T-R5 ili -Y-(CH(OH))-T-R5.",GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/069-462-983-761-767,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
328,PT,E,PT 888317 E,145-006-561-483-491,2002-03-28,2002,PT 97906130 T,1997-02-26,GB 9604242 A,1996-02-28,DERIVADOS DO ACIDO 4-HIDROXI-FENILALCANOICO SUBSTITUIDO COM ACTIVIDADE AGONISTA PARA PPAR-GAMA,,GLAXO GROUP LTD,BOSWELL GRADY EVAN;;O'CALLAGHAN JOHN MARK;;WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;ERICKSON GREG ALAN,,https://lens.org/145-006-561-483-491,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;C07D295/18;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
329,NZ,A,NZ 331381 A,085-904-237-934-30X,2000-06-23,2000,NZ 33138197 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,Substituted 4-hydroxy-phenylalcanoic acid derivatives,"The compound has the formula I wherein: A is optionally substituted phenyl, 5 or 6 membered heterocyclic group containing at least one heteroatom selected from O, N or S or a fused bicyclic ring containing a heterocyclic ring as defined above wherein the bicyclic ring is attached to group B via a ring atom of heterocyclic ring; B is alkylene, M-alkylene, alkylene-M, 5 or 6 membered heterocyclic group containing at least one N heteroatom and optionally at least one heteroatom selected from O, N or S or Het-alkylene; M is O, S or NR2; R2 is H or alkyl; Het is 5 or 6 membered heterocyclic group containing at least one N heteroatom and optionally at least one heteroatom selected from O, N or S; Alk is alkylene; R1 is H or alkyl; Z is (alkylene)-optionally substituted phenyl or NR3R4; R3 is H or alkyl; R4 is -Y-CO-T-R5 or -Y(CH(OH))-T-R5 and Y, T and R5 are as defined in the specification. A pharmaceutical composition thereof is useful in the treatment of a PPAR-gamma mediated disease.",GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/085-904-237-934-30X,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;C07D295/18;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,DISCONTINUED
330,EC,A,EC SP972039 A,020-157-893-367-417,1998-04-24,1998,EC SP972039 A,1997-02-26,EC SP972039 A,1997-02-26,COMPUESTOS QUIMICOS,"La presente invención se refiere a ciertos compuestos novedosos, a procesos para su preparación, a composiciones farmacéuticas que los contienen y a su uso en la medicina. En forma más particular se refiere a compuestos que exhiben activación incluyendo actividad antagonista, al receptor gamma, activado por el proliferador de la peroxisoma (PPARgamma, por sus siglas en inglés) por lo cual les permite modular los niveles de glucosa en la sangre, en mamíferos.",,HENKE BRAD RICHARD;;BRACKEEN MARCUS;;WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY;;KALDOR ISIVAN;;DEATON DAVID NORMAN;;COLLIN JOHN LOREN;;COBB JEFFREY EDMOND;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRANDY EVAN,,https://lens.org/020-157-893-367-417,Patent Application,no,0,0,1,1,0,,A61K38/28;;C07C331/00,,0,0,,,,PENDING
331,US,B1,US 6294580 B1,104-959-124-996-032,2001-09-25,2001,US 12575098 A,1998-08-25,EP 9700916 W;;GB 9604242 A,1996-02-28,Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma,"A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C.sub.1-6 alkyl, C.sub.1-3 alkoxy, C.sub.1-3 fluoroalkoxy, nitrile, or --NR.sup.7 R.sup.8 where R.sup.7 and R.sup.8 are independently hydrogen or C.sub.1-3 alkyl; (ii) a 5- or 6-membered hetrocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C.sub.1-6 alkylene; (v) --MC.sub.1-6 alkylene or C.sub.1-6 alkyleneMC.sub.1-6 alkylene, wherein M is O, S, or --NR.sup.2 wherein R.sup.2 represents hydrogen or C.sub.1-3 alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C.sub.1-3 alkyl; and (vii) Het-C.sub.1-6 alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C.sub.1-3 alkylene; R.sup.1 represents hydrogen or C.sub.1-3 alkyl; Z is selected from the group consisting of: (viii) --(C.sub.1-3 alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) --NR.sup.3 R.sup.4, wherein R.sup.3 represents hydrogen or C.sub.1-3 alkyl, and R.sup.4 represents --Y--(C.dbd.O)--T--R.sup.5, or --Y--(CH(OH))--T--R.sup.5. ##STR1##",GLAXO WELLCOME INC,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,GLAXO WELLCOME INC (1997-03-26),https://lens.org/104-959-124-996-032,Granted Patent,yes,21,48,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;C07D295/18;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,514/570;;514/561;;514/649;;514/445;;514/351;;514/352;;514/375;;560/61;;562/471;;564/344;;549/65;;546/290;;546/312;;548/225;;548/230,1,0,,,"""Chemical Abstracts"", vol. 126, no. 9, 3 Mar. 1997, Columbus, Ohio, US; abstract no. 117964d. XP002032261.",EXPIRED
332,PL,B1,PL 191118 B1,060-611-603-566-775,2006-03-31,2006,PL 32887197 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,Substituted derivatives of 4-hydroxyphenyloalcanic acid exhibiting antagonistic activity in respect to PPAR-gamma,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/060-611-603-566-775,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D263/32;;A61K31/00;;C07D295/18;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
333,HR,A2,HR P970110 A2,029-324-519-503-346,1998-04-30,1998,HR P970110 A,1997-02-26,GB 9604242 A,1996-02-28,CHEMICAL COMPOUNDS,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/029-324-519-503-346,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;C07D295/18;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
334,TR,T2,TR 199801707 T2,141-004-428-561-53X,1998-12-21,1998,TR 9801707 T,1997-02-26,GB 9604242 A,1996-02-28,PPAR-gama karsisinda agonist aktivite gösteren ikameli 4-hidroksi-fenilalkanoik asit türevleri.,"(Formül I) formülüne sahip bir bilesik olup bu bilesikte su gruptan seçilmektedir: (i) fenil, ki bu fenil seçmeli olarak bir ya da daha fazla halojen atomu, C1-6 Alkil, C1-3 alkoksi, C1-3 fluoroalkoksi, nitril ya da -NR7R8 ile ikameli, R7 and R8 bagimsiz olarak hidrojen ya da C1-3 alkildir; (ii) oksijen, azot ve kükürt arasindan seçilen en az bir heteroatom içeren 5 ya da 6 elemanli bir heterosiklik grup ve (iii) kaynasmis bir (a) bisiklik halkasi, ki burada C halkasi yukaridaki gibi bir heteroksiklik gruptur ve bu bisiklik grup B grubuna C halkasinin bir atomu yoluyla baglidir.",GLAXO GROUP LTD,WILSON TIMOTHY MARK;;JR ROBERT ANTHONY MOOK;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/141-004-428-561-53X,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;C07D295/18;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,PENDING
335,AU,B2,AU 717699 B2,171-221-687-723-272,2000-03-30,2000,AU 1997/020935 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/171-221-687-723-272,Granted Patent,no,1,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
336,AU,A,AU 1997/020935 A,168-301-899-844-238,1997-09-16,1997,AU 1997/020935 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/168-301-899-844-238,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
337,HU,A2,HU P0004845 A2,003-310-390-157-268,2001-05-28,2001,HU P0004845 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM,"Az (I) általános képletű vegyületek - a képletben A jelentése i)fenilcsoport, amely lehet szubsztituálva;lehet halogénatommal 1-6szénatomos alkilcsoporttal, 1-3 szénatomos alkoxicsoporttal, 1-3szénatomos fluor-alkoxi-csoporttal, nitrilcsoporttal vagy -NR7R8általános képletű csoporttal, ahol R7 és R8 jelentése hidrogénatomvagy 1-3 szénatomos alkilcsoport; ii) 5- vagy 6-tagú heterociklusoscsoport, amely oxigén-, nitrogén- és kénatom közül választott legalábbegy heteroatomot tartalmaz, és iii) (a) általános képletű kondenzáltbiciklusos csoport, ahol a C-gyűrű valamely, a ii) pontban definiáltheterociklusos csoportot jelent, B jelentése iv) 1-6 szénatomosalkiléncsoport; v) -M-(1-6 szénatomos)alkilén vagy (1-6szénatomos)alkilén-M- (1-6 szénatomos)alkilén csoport, ahol Mjelentése O, S, vagy -NR2, ahol R2 jelentése hidrogénatom vagy 1-3szénatomos alkilcsoport; vi) 5- vagy 6-tagú heterociklusos csoport,amely legalább egy nitrogén heteroatomot, és adott esetben legalábbegy, oxigén-, nitrogén- és kénatom közül választott továbbiheteroatomot tartalmaz 1-3 szénatomos alkilcsoporttal lehetszubsztituáltva; vagy vii) Het-(1-6 szénatomos)alkilén csoport, aholHet jelentése a (vi) pontban definiált heterociklusos csoport, Alkjelentése 1-3 szénatomos alkiléncsoport; R1 jelentése hidrogénatomvagy 1-3 szénatomos alkilcsoport; Z jelentése viii) (1-3szénatomos)alkilén-fenil csoport, ahol a fenilcsoport halogénatommallehet szubsztituálva; vagy ix) -NR3R4 általános képletű csoport, aholR3 jelentése hidrogénatom vagy 1-3 szénatomos alkilcsoport, és R4jelentése -Y-C=(O)-T-R5 vagy -Y-CH(OH)-T-R5 általános képletű csoport- PPAR-gamma agonista aktivitásuk következtében gyógyászatikészítmények hatóanyagaként alkalmazhatók. Ó",GLAXO GROUP LTD,BOSWELL GRADY EVAN;;BRACKEEN MARKUS;;COBB JEFFREY EDMOND;;COLLINS JON LOREN;;DEATON DAVID NORMAN;;ERICKSON GREG ALAN;;HENKE BRAD RICHARD;;KALDOR ISTVAN;;MOOK ROBERT ANTHONY JR;;O'CALLAGHAN JOHN MARK;;SHARP MATTHEW JUDE;;WILLSON TIMOTHY MARK,,https://lens.org/003-310-390-157-268,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;C07D295/18;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,PENDING
338,PL,A1,PL 328871 A1,061-596-393-777-294,1999-03-01,1999,PL 32887197 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,SUBSTITUTED DERIVATIVES OF 4-HYDROXYPHENYLOALCANIC ACID EXHIBITING ANTAGONISTIC ACTIVITY IN RESPECT TO PPAR-GAMMA,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/061-596-393-777-294,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;C07D295/18;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
339,IS,B,IS 1869 B,108-235-126-866-460,2003-05-09,2003,IS 4822 A,1998-08-12,GB 9604242 A;;EP 9700916 W,1996-02-28,"Afleiður af setinni 4-hýdroxýfenýlalkanósýru með gerandefnisvirkni á PPAR-gamma, lyfjaefnablöndur sem innihalda þær, notkun þeirra og aðferð til framleiðslu þeirra",,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;JRTH ROBERT ANTHONY MOOK;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COBB JEFFREY EDMOND;;SHARP MATTHEW JUDE;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN;;COLLINS JON LOREN;;BRACKEEN MARKUS;;O'CALLAGHAN JOHN MARK,,https://lens.org/108-235-126-866-460,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;C07D295/18;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
340,AP,A,AP 780 A,053-249-418-929-48X,1999-11-22,1999,AP 9700935 A,1997-02-27,GB 9604242 A,1996-02-28,Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist to PPAR-gamma.,"A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered heterocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkyiene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or-NR2 wherein R2 represents hydrogen or C1-3 alkyi; (vi) a 5-or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3 alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydroqen or C1-Salkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-Salkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5.",GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;OCALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/053-249-418-929-48X,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,1,0,,,NONE,EXPIRED
341,CA,C,CA 2247443 C,184-047-025-419-23X,2009-01-27,2009,CA 2247443 A,1997-02-26,GB 9604242 A;;EP 9700916 W,1996-02-28,SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA,"A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered heterocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3 alkyl; (vi) a 5- or 6- membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3 yl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5.",GLAXO GROUP LTD,ERICKSON GREG ALAN;;WILLSON TIMOTHY MARK;;KALDOR ISTVAN;;MOOK ROBERT ANTHONY JR;;COBB JEFFREY EDMOND;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;SHARP MATTHEW JUDE;;BRACKEEN MARCUS;;BOSWELL GRADY EVAN;;HENKE BRAD RICHARD;;O'CALLAGHAN JOHN MARK,,https://lens.org/184-047-025-419-23X,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D263/56;;C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/275;;A61K31/33;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/41;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C229/62;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/09;;C07D207/12;;C07D213/55;;C07D213/62;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D235/16;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D277/24;;C07D277/30;;C07D277/42;;C07D285/06;;C07D295/192;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
342,NO,B1,NO 311516 B1,041-855-695-924-34X,2001-12-03,2001,NO 983940 A,1998-08-27,EP 9700916 W;;GB 9604242 A,1996-02-28,"Derivater av substituerte 4-hydroksy-fenylalkanosyrer med agonistisk aktivitet for PPAR-gamma, farmasöytiske preparaterinneholdende dem, anvendelse av dem og fremgangsmåte forfremstilling av dem",,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK JR ROBERT ANTHONY;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COBB JEFFREY EDMOND;;SHARP MATTHEW JUDE;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN;;COLLINS JON LOREN;;BRAKEEN MARCUS;;O'CALLAGHAN JOHN MARK,,https://lens.org/041-855-695-924-34X,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;C07D295/18;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
343,ZA,B,ZA 971645 B,190-349-612-486-681,1997-12-10,1997,ZA 971645 A,1997-02-26,GB 9604242 A,1996-02-28,Chemical compounds.,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;BRACKEEN MARKUS;;COBB JEFFREY EDMOND;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/190-349-612-486-681,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;C07D295/18;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
344,SI,T1,SI 0888317 T1,125-842-021-409-790,2002-04-30,2002,SI 9730233 T,1997-02-26,EP 9700916 W;;EP 97906130 A;;GB 9604242 A,1996-02-28,SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/125-842-021-409-790,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;C07D295/18;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
345,DK,T3,DK 0888317 T3,186-472-204-579-749,2002-01-21,2002,DK 97906130 T,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,Substituerede 4-hydroxy-phenylalkansyrederivater med agonistaktivitet over for PPAR-gamma,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/186-472-204-579-749,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;C07D295/18;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
346,BR,A,BR 9707786 A,067-276-677-434-184,1999-07-27,1999,BR 9707786 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,Composto processos para tratamento ou prevenção de doença ou condição mediada por ppar-gama para redução da glucose no sangue para tratamento ou prevenção de hiperglicemia diabete tipo ii diabete tipo i hipertrigliceridemia síndrome x resistência a insulina falha cardíaca dislipidemia diabética hiperlipidemia hipercolesteremia hipertensão obesidade anorexia bulimia anorexia nervosa e doença cardiovascular especialmente aterosclerose para a preparação de compostos e uso de um composto,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GEG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/067-276-677-434-184,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
347,OA,A,OA 10843 A,029-333-419-189-681,2001-08-14,2001,OA 9800148 A,1998-08-25,GB 9604242 A,1996-02-28,Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;KALDOR ISTVAN;;DEATON DAVID NORMAN;;COBB JEFFREY EDMOND;;SHARP MATTHEW JUDE;;ERICKSON GREG ALAN;;MOOK ROBERT A JR;;HENKE BRAD RICHARD;;COLLINS JON LOREN;;BRACKEEN MARCUS;;O'CALLAGHAN JOHN MARK;;BOSWELL GRADY EVAN,,https://lens.org/029-333-419-189-681,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;C07D295/18;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
348,IS,A,IS 4822 A,094-625-404-292-821,1998-08-12,1998,IS 4822 A,1998-08-12,GB 9604242 A;;EP 9700916 W,1996-02-28,"Afleiður af setinni 4-hýdroxýfenýlalkanósýru með gerandefnisvirkni á PPAR-gamma, lyfjaefnablöndur sem innihalda þær, notkun þeirra og aðferð til framleiðslu þeirra",,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;JRTH ROBERT ANTHONY MOOK;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COBB JEFFREY EDMOND;;SHARP MATTHEW JUDE;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN;;COLLINS JON LOREN;;BRACKEEN MARKUS;;O'CALLAGHAN JOHN MARK,,https://lens.org/094-625-404-292-821,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;C07D295/18;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
349,CA,A1,CA 2247443 A1,150-374-690-822-437,1997-09-04,1997,CA 2247443 A,1997-02-26,GB 9604242 A;;EP 9700916 W,1996-02-28,SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA,"A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6membered heterocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C16alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3 alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3 alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C13alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y- (CH(OH))-T-R5.",GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;KALDOR ISTVAN;;O'CALLAGHAN JOHN MARK;;COBB JEFFREY EDMOND;;ERICKSON GREG ALAN;;HENKE BRAD RICHARD;;MOOK ROBERT ANTHONY JR;;COLLINS JON LOREN;;BOSWELL GRADY EVAN;;DEATON DAVID NORMAN,,https://lens.org/150-374-690-822-437,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
350,RS,B,RS 49586 B,160-180-347-346-960,2007-04-10,2007,YU 36998 A,1998-08-28,GB 9604242 A,1996-02-28,SUPSTITUTED 4-HYDROXY- PHENYLALCANOIC ACID DERIVATIVES WITH AGONISTS ACTIVITY TO PPAR-GAMA,"Jedinjenje koje ima formulu (I): naznačeno time, što A se bira iz grupe koju čine: (i) fenil, gde je pomenuti fenil opciono supstituisan sa jednim ili više halogenih atoma, C1-6alkil, C1-3alkoksi, C1-3fluoroalkoksi, nitril ili –NR7R8, gde su R7 i R8, nezavisno, vodonik ili C1-3alkil; (ii) 5- ili 6-člana heterociklična grupa koja sadrži najmanje jedan heteroatom, koji se bira između kiseonika, azota i sumpora; i (iii) pripojeni biciklični prsten , gde C predstavlja heterocikličnu grupu definisanu pod tačkom (ii) gore, a ovaj biciklični prsten je vezan za grupu B preko jednog atoma iz prstena u prstenu C; B se bira iz grupe koju čine: (iv) C1-6 alkilen; (v) –MC1-6alkilen ili C1-6alkilenMC1-6alkilen, gde M predstavlja O, S ili –NR2, gde R2 predstavlja vodonik ili C1-3alkil; (vi) 5- ili 6-člana heterociklična grupa koja sadrži najmanje jedan azot kao heteroatom i opciono još jedan heteroatom, koji se bira između kiseonika, azota i sumpora, a opciono jesupstituisan sa C1-3alkil; i (vii) Het-C1-6alkilen, gde Het predstavlja heterocikličnu grupu definisanu u tački (vi) gore; Alk predstavlja C1-3alkilen; R1 predstavlja vodonik ili C1-3alkil; Z se bira iz grupe koju čine: (viii) –(C1-3alkilen)fenil, gde je fenil opciono supstituisan sa jednim ili više halogenih atoma; i (ix) –NR3R4, gde R3 predstavlja vodonik ili C1-3alkil, a R4 predstavlja –Y-(C=O)- T-R5 ili –Y-(CH(OH))-T-R5, gde (a) Y predstavlja ili fenil, opciono supstituisan sa jednom ili više C1-3alkil grupa i/ili jednim ili više halogenih atoma; (b) T predstavlja vezu, C1-3alkilenoksi, -O- ili –N(R6)-, gde R6 predstavlja vodonik ili C1-3alkil; (C) R5 predstavljaC1-6alkil, C4-6cikloalkil ili cikloalkenil, fenil (opciono supstituisan sa jednim ili više: halogenih atoma, C1-3alkil, C1-3alkoksi grupe, C0-3alkilenNR9R10, gde je svaki od R9 i R10, nezavisno, vodonik, C1-3alkil, -SO2C1-3alkil, ili -SO2C1-3alkil, -SO2NHC1-3alkil, C0-3alkelinCO2H, C0-3alkilen CO2C1-3alikl ili –OCH2C(O)NH2, 5- ili 6-člana heterociklična grupa definisana u tački (ii) gore, ili pripojeni biciklični prsten , gde prsten D predstavlja 5- ili 6-člana heterociklična grupa koja sadrži najmanje jedan heteroatom, koji se bira između kiseonika, azota i sumpora, a opciono je supstituisana sa (=O), biciklični prsten je vezan za T preko jednog atoma iz prstena u prstenu D; ili –C1-6alkilenMR11, gde M predstavlja O, S ili –NR2, i gde su R2 i R11, nezavisno, vodonik ili C1-3alkil; ili njegov tautomerni oblik i/ili njegova farmaceutski prihvatljiva so ili solvat. Prijava sadrži još 33 zavisna patentna zahteva. <patent>",GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK JR ROBERT ANTONY;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;OCALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/160-180-347-346-960,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D263/56;;A61K31/00;;C07D295/18;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
351,EP,B1,EP 0888317 B1,155-667-670-370-729,2001-09-12,2001,EP 97906130 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/155-667-670-370-729,Granted Patent,yes,4,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;C07D295/18;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,1,0,,,"CHEMICAL ABSTRACTS, vol. 126, no. 9, 3 March 1997 Columbus, Ohio, US; abstract no. 117964d, XP002032261 & JP 08 325 264 A (SUMITOMO METAL IND) 10 December 1996",EXPIRED
352,ID,A,ID 15985 A,043-912-754-067-204,1997-08-21,1997,ID 970584 A,1997-02-27,GB 9604242 A,1996-02-28,SENYAWA KIMIA,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ITSVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/043-912-754-067-204,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;C07D295/18;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,PENDING
353,MY,A,MY 119425 A,076-504-488-416-92X,2005-05-31,2005,MY PI9700725 A,1997-02-25,GB 9604242 A,1996-02-28,SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA,"A COMPOUND HAVING THE FORMULA (I):(FORMULA 1)WHEREIN @A IS SELECTED FROM THE GROUP CONSISTING OF:(I)PHENYL, WHEREIN SAID PHENYL IS OPTIONALLY SUBSTITUTED BY ONE OR MORE HALOGEN ATOMS, C1-6ALKYL, C1-3 ALKOXY, C1-3 FLUOROALKOXY, NITRILE, OR -NR7R8 WHERE R7 AND R8 ARE INDEPENDENTLY HYDROGEN OR C1-3ALKYL;(II)A 5- OR 6- MEMBERED HETEROCYCLIC GROUP CONTAINING AT LEAST ONE HETEROATOM SELECTED FROM OXYGEN, NITROGEN AND SULFUR; AND(III)A FUSED BICYCLIC RING (FORMULA) WHEREIN RING C REPRESENTS A HETEROCYCLIC GROUPS DEFINED IN POINT (II) ABOVE, WHICH BICYCLIC RING IS ATTACHED TO GROUP B VIA A RING ATOM OF RING C;B IS SELECTED FROM THE GROUP CONSISTING OF:(IV) C1-6 ALKYLENE;(V)-MC1-6 ALKYLENE OR C1-6 ALKYLENEMC1-6ALKYLENE, WHEREIN M IS O, S, OR-NR2 WHEREIN R2 REPRESENTS HYDROGEN OR C1-3ALKYL;(VI)A 5- OR 6- MEMBERED HETEROCYCLIC GROUP CONTAINING AT LEAST ONE NITROGEN HETEROATOM AND OPTIONALLY AT LEAST ONE FURTHER HETEROATOM SELECTED FROM OXYGEN, NITROGEN AND SULFURAND OPTIONALLY SUBSTOTUTED BY C1-3 ALKYL; AND (VIII) HET-C1-6ALKYLENE, WHEREIN HET REPRESENTS A HETEROCYCLIC GROUP AS DEFINED IN POINT (VI) ABOVE;ALK REPRESENTS C1-3ALKYLENE;R1REPRESENTS HYDROGEN OR C1-3 ALKYL;Z IS SELECTED FROM THE GROUP CONSISTING OF:(VIII)-(C1-3 ALKYLENE) PHENYL, WHICH PHENYL IS OPTIONALLY SUBSTITUTED BY ONE OR MORE HALOGEN ATOMS; AND(IX)-NR3R4, WHEREIN R3 REPRESENTS HYDROGEN OR C1-3 ALKYL, AND R4 EPRESENTS -Y- (C=O)-T-R5, OR -Y-(CH(OH))-T-R5, WHEREIN:(A) Y REPRESENTS A BOND, C1-6 ALKYLENE, C2-6 ALKENYLENE, C4-6 CYCLOALKYLENE OR CYCLOALKENYLENE, A HETEROCYCLIC GROUP AS DEFINED IN POINT (VI) ABOVE, OR PHENYL OPTIONALLY SUBSTITUTED BY ONE OR MORE C1-3 ALKYL GROUPS AND/OR ONE OR MORE HALOGEN ATOMS;(B)T REPRESENTS A BOND, C1-3 ALKYLENEOXY, -0- OR -N(R6)-, WHEREIN R6 REPRESENTS HYDROGEN OR C1-3 ALKYL;(C) R5 REPRESENTS C1-6 ALKYL, C4-6 CYCLOALKYL OR CYCLOALKENYL, PHENYL (OPTIONALLY SUBSTITUTED BY ONE OR MORE: HALOGEN ATOMS, C1-3 ALKYL, C1-3 ALKOXY GRUPS, C0-3 ALKYLENENR9R10 WHERE EACH R9 AND R10 IS INDEPENDENTLY HYDROGEN, C1-3 ALKYL, -SO2C1-3ALKYL, OR -CO2C1-3ALKYL, -SONHC1-3ALKYL, C0-3ALKYLENECO2H, C0- ALKYLENECO2C1-3ALKYL, OR -OCH2(O)NH2), A 5- OR 6- MEMBERED HETEROCYCLIC GROUP AS DEFINED IN PINT (II) ABOVE, OR A BICYLIC FUSED RING (FORMULA) WHEREIN RING D REPRESENTS A 5- OR 6- MEMBERED HETEROCYCLIC GROUP CONTAINING AT LEAST ONE HETEROATOM SELECTED FROM OXYGEN, NITROGEN AND SULFUR AND OPTIONALLY SUBSTITUTED BY (=O), WHICH BICYCLIC RING IS ATTACHED TO T VIA A RING ATOM OF RING D, OR -C1-6 ALKYLENEMR11 M IS O, S, OR -NR2 WHEREIN R2 AND R11 ARE INDEPENDENTLY HYDROGEN OR C1-3 ALKYL;OR A TAUTOMERIC FORM THEREOF, AND/OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF.",GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE,,https://lens.org/076-504-488-416-92X,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D263/56;;A61K31/00;;C07D295/18;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
354,EE,A,EE 9800288 A,053-104-435-469-115,1999-02-15,1999,EE 9800288 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,PPAR-gamma agonistaktiivsusega asendatud 4-hüdroksüfenüülalkaanhapete derivaadid,,GLAXO GROUP LTD,ROBERT ANTHONY MOOK JR;;BRAD RICHARD HENKE;;DAVID NORMAN DEATON;;JON LOREN COLLINS;;JEFFREY EDMOND COBB;;MATTHEW JUDE SHARP;;JOHN MARK O'CALLAGHAN;;GREG ALAN ERICKSON;;GRADY EVAN BOSWELL;;TIMOTHY MARK WILLSON;;ISTVAN KALDOR;;MARKUS BRACKEEN,,https://lens.org/053-104-435-469-115,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;C07D295/18;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,PENDING
355,GE,B,GE P20012580 B,109-045-334-069-780,2001-11-26,2001,GE AP1997004466 A,1997-02-26,GB 9604242 A,1996-02-28,"Substituted 4-Hydroxy-Phenylalcanoic Acid Derivatives With Agonist Activity to PPAR-Gamma, Methods for Their Production, Pharmaceutical Conposition and Methods for Treatment","1. Technical Result Increase in treatment efficiency of the diseases caused by PPAR-Gamma receptor. 2. Essence A composition of the formula wherein A, B, Z and R1 have values indicated in the description, methods for their production and pharmaceutical conposition comprised therein. 3. Field of Application Organic chemistry, medicine. Tables: 1",GLAXO GROUP LTD,BOSWELL GRADY EVAN;;O'CALLAGHAN JOHN MARK;;BRACKEEN MARKUS;;COLLINS JON LOREN;;HENKE BRAD RICHARD;;WILLSON THIMOTHY MARK;;ERICKSON GREG ALAN;;SHARP MATTHEW JUDE;;COBB JEFFREY EDMOND;;KALDOR ISTVAN;;MOOK ROBERT ANTHONY JR;;DEATON DAVID NORMAN,,https://lens.org/109-045-334-069-780,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D263/32;;A61K31/00;;C07D295/18;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/12,,0,0,,,,EXPIRED
356,EP,A1,EP 0888317 A1,113-673-553-548-169,1999-01-07,1999,EP 97906130 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/113-673-553-548-169,Patent Application,yes,4,1,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;C07D295/18;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,2,0,,,"CHEMICAL ABSTRACTS, vol. 126, no. 9, 3 March 1997, Columbus, Ohio, US; abstract no. 117964d, XP002032261;;See also references of WO 9731907A1",EXPIRED
357,WO,A1,WO 1997/031907 A1,047-581-082-593-181,1997-09-04,1997,EP 9700916 W,1997-02-26,GB 9604242 A,1996-02-28,SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA,"A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R?7 and R8¿ are independently hydrogen or C¿1-3?alkyl; (ii) a 5- or 6-membered heterocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR?2¿ wherein R2 represents hydrogen or C¿1-3? alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3 alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R?1¿ represents hydrogen or C¿1-3?alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR?3R4¿, wherein R3 represents hydrogen or C¿1-3?alkyl, and R?4¿ represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5.",GLAXO GROUP LTD;;WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;CALLAGHAN JOHN MARK O;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/047-581-082-593-181,Patent Application,yes,4,215,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;C07D295/18;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,2,0,,,"CHEMICAL ABSTRACTS, vol. 126, no. 9, 3 March 1997, Columbus, Ohio, US; abstract no. 117964d, XP002032261;;See also references of EP 0888317A1",PATENTED
358,HR,B1,HR P970110 B1,078-207-530-788-551,2003-06-30,2003,HR P970110 A,1997-02-26,GB 9604242 A,1996-02-28,CHEMICAL COMPOUNDS,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;JR ROBERT ANTHONY MOOK;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARKUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVANS,,https://lens.org/078-207-530-788-551,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;C07D295/18;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
359,PE,A1,PE 43098 A1,122-600-561-314-708,1998-08-30,1998,PE 00013797 A,1997-02-26,GB 9604242 A,1996-02-28,DERIVADOS DEL ACIDO 4-HIDROXI FENILALCANOICO,"SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: ""A"" ES FENILO, PIRIDILO O BENZOXAZOILO, ENTRE OTROS; ""B"" ES -N(CH3)(CH2)2 O HET-(ALQUILENO C1-C6), EN DONDE HET ES OXAZOLILO O TIAZOLILO, LOS CUALES SE ENCUENTRAN SUSTITUIDOS POR ALQUILO C1-C3; ALK ES PREFERENTEMENTE METILENO; R1 ES H o ALQUILO C1-C3; ""Z"" ES -NR3R4, EN DONDE: R3 ES H o ALQUILO C1-C3; R4 ES -Y-CO-T-R5 o -Y-CHOH-T-R5, EN DONDE: ""Y"" ES UN ENLACE o ES FENILO, ENTRE OTROS; ""T"" ES UN ENLACE o ES -O-, ENTRE OTROS; R5 ES ALQUILO C1-C6 o FENILO OPCIONALMENTE SUSTITUIDO POR ALQUILO C1-C3, ENTRE OTROS. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE (I). LOS COMPUESTOS OBTENIDOS ACTUAN COMO ACTIVADORES DEL RECEPTOR GAMMA ACTIVADO POR EL PROLIFERADOR DE PEROXISOMA (PPAR GAMMA), SUGIRIENDOSE QUE AMPLIFICAN LAS UNIONES POSTRECEPTOR EN LAS CASCADAS DE SENALIZACION INSULINICA Y ADIPOGENICA, SIENDO UTILES EN EL TRATAMIENTO DE LA DIABETES MELLITUS TIPO II (NIDDM) Y TIPO I, DE LA HIPERGLICEMIA, ADEMAS SON UTILES COMO REGULADORES DEL APETITO EN SUJETOS QUE SUFREN DE OBESIDAD, ANOREXIA O BULIMIA",GLAXO GROUP LTD,O'CALLAGHAN JOHN MARK;;KALDOR ISTVAN;;MOOK ROBERT ANTHONY JR;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;WILLSON TIMOTHY MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN;;SHARP MATTHEW JUDE;;COBB JEFFREY EDMOND;;HENKE BRAD RICHARD;;BRACKEEN MARCUS,,https://lens.org/122-600-561-314-708,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D263/56;;A61K31/00;;C07D295/18;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/12,,0,0,,,,EXPIRED
360,CZ,A3,CZ 275098 A3,077-000-718-719-975,1999-01-13,1999,CZ 275098 A,1997-02-26,GB 9604242 A,1996-02-28,"DERIVATIVES OF 4-HYDROXYPHENYLALKANOIC ACIDS, PROCESS OF THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF",,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/077-000-718-719-975,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
361,US,B2,US 10640393 B2,124-780-787-932-844,2020-05-05,2020,US 201715850016 A,2017-12-21,US 201715850016 A;;US 201662440175 P,2016-12-29,Faucet conversion system,A water treatment apparatus that includes: at least one module which operatively and selectively treats one or both of an original household hot water received from the household hot water line and water flowing through the module and treats cold water received from an original household cold water line that flows through; a process control unit whereby a user selects a desired treatment option for the water flowing through the apparatus to be dispensed to the user; one or more plumbing connections which operatively divert the original household hot and cold water flow to the user selected water treatment module so as to dispense to the user the selected treated water; and one or more valves which operatively cooperate with the process control unit to direct the water flow within the apparatus so as to provide the user with the selected treated water.,WHIRLPOOL CO,COBB DOMINIQUE;;ERGICAN ERDOGAN;;GARY JR WYNDHAM F;;GRAFF MARK;;HILL ERIC;;JACKSON BETH;;KIRK ANTONY;;KUEHL STEVEN J;;PETERS JOSEPH R;;SEELEY MICHAEL;;WILSON REX D,WHIRLPOOL CORPORATION (2017-12-06),https://lens.org/124-780-787-932-844,Granted Patent,yes,27,3,2,2,0,E03C1/0411;;E03C1/044;;E03C2201/40;;E03C2201/45;;C02F1/001;;C02F1/68;;C02F2201/007;;C02F2209/005;;E03C1/055;;C02F1/78;;C02F2201/005;;C02F2209/40;;C02F1/283;;C02F9/20;;C02F1/008;;E03C1/055;;C02F1/78;;C02F1/003;;C02F2209/02;;C02F2307/06;;C02F2201/005;;C02F2101/322;;C02F2209/40;;C02F1/283;;E03C2201/45;;E03C2201/40;;C02F1/001;;C02F2201/007;;C02F1/68;;E03C1/044;;C02F2209/005;;E03C1/0411;;C02F9/20,C02F1/00;;C02F1/28;;C02F1/68;;C02F1/78;;C02F9/00;;C02F101/32;;E03C1/04;;E03C1/044;;E03C1/05,,0,0,,,,ACTIVE
362,AT,T1,AT E205485 T1,075-618-224-968-383,2001-09-15,2001,AT 97906130 T,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,SUBSTITUIERTE 4-HYDROXYPHENYLALKANSAURE-DERIVATE MIT AGONISTISCHER WIRKUNG AUF PPAR-GAMMA,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;DRIVE;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/075-618-224-968-383,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,DISCONTINUED
363,NO,D0,NO 983940 D0,014-608-850-274-416,1998-08-27,1998,NO 983940 A,1998-08-27,EP 9700916 W;;GB 9604242 A,1996-02-28,Derivater av substituert 4-hydroksy-fenylalcanosyre med agostisk aktivitet for ppargamma,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK JR ROBERT ANTHONY MOOK;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COBB JEFFREY EDMOND;;SHARP MATTHEW JUDE;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN;;COLLINS JON LOREN;;BRAKEEN MARCUS;;O'CALLAGHAN JOHN MARK,,https://lens.org/014-608-850-274-416,Patent Application,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;C07D295/18;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
364,US,A1,US 2018/0186655 A1,081-136-181-272-84X,2018-07-05,2018,US 201715850016 A,2017-12-21,US 201715850016 A;;US 201662440175 P,2016-12-29,FAUCET CONVERSION SYSTEM,A water treatment apparatus that includes: at least one module which operatively and selectively treats one or both of an original household hot water received from the household hot water line and water flowing through the module and treats cold water received from an original household cold water line that flows through; a process control unit whereby a user selects a desired treatment option for the water flowing through the apparatus to be dispensed to the user; one or more plumbing connections which operatively divert the original household hot and cold water flow to the user selected watertreatment module so as to dispense to the user the selected treated water; and one or more valves which operatively cooperate with the process control unit to direct the water flow within the apparatus so as to provide the user with the selected treated water.,WHIRLPOOL CO,COBB DOMINIQUE;;ERGICAN ERDOGAN;;GARY JR WYNDHAM F;;GRAFF MARK;;HILL ERIC;;JACKSON BETH;;KIRK ANTONY;;KUEHL STEVEN J;;PETERS JOSEPH R;;SEELEY MICHAEL;;WILSON REX D,WHIRLPOOL CORPORATION (2017-12-06),https://lens.org/081-136-181-272-84X,Patent Application,yes,4,29,2,2,0,E03C1/0411;;E03C1/044;;E03C2201/40;;E03C2201/45;;C02F1/001;;C02F1/68;;C02F2201/007;;C02F2209/005;;E03C1/055;;C02F1/78;;C02F2201/005;;C02F2209/40;;C02F1/283;;C02F9/20;;C02F1/008;;E03C1/055;;C02F1/78;;C02F1/003;;C02F2209/02;;C02F2307/06;;C02F2201/005;;C02F2101/322;;C02F2209/40;;C02F1/283;;E03C2201/45;;E03C2201/40;;C02F1/001;;C02F2201/007;;C02F1/68;;E03C1/044;;C02F2209/005;;E03C1/0411;;C02F9/20,C02F1/00;;C02F1/28;;C02F1/78;;E03C1/05,,0,0,,,,ACTIVE
365,CZ,B6,CZ 295383 B6,036-321-312-773-605,2005-07-13,2005,CZ 275098 A,1997-02-26,GB 9604242 A,1996-02-28,Derivative of substituted 4-hydroxyphenylalkanoic acid and pharmaceutical composition,"In the present invention, there is disclosed substituted 4-hydroxyphenylalkanoic acid derivative of the general formula I, in which A is selected from the group consisting of: (i) an optionally substituted phenyl; (ii) 5- or 6-mebered heterocyclic group containing at least one heteroatom being selected from the group consisting of oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring; B is selected from the group consisting of: -MCi1-6alkylene or Ci1-6alkyleneMCi1-6alkylene, wherein M represents oxygen, sulfur, or -NRe2, wherein Re2 denotes a hydrogen atom or Ci1-3 alkyl containing 1 to 3 carbon atoms; -Het Ci1-6alkylene, wherein Het represents an optionally substituted 5- or 6-membered heterocyclic group having at least one nitrogen heteroatom and optionally at least one another heteroatom being selected from the group consisting of oxygen, nitrogen and sulfur; Alk represents alkylene containing 1 to 3 carbon atoms; Re1 represents a hydrogen atom or alkyl containing 1 to 3 carbon atoms; Z denotes: -NRe3Re4, wherein Re3 represents a hydrogen atom or alkyl containing 1 to 3 carbon atoms, and Re4 represents -Y-(C=O)-T-Re5, or -Y-(CH(OH))-T-Re5, wherein: (a) Y denotes an optionally substituted phenyl; (b) T represents a bond, Ci1-3 alkyleneoxy containing 1 to 3 carbon atoms, -O- or -N(Re6)-, wherein Re6 represents a hydrogen atom or alkyl containing 1 to 3 carbon atoms; (c) Re5 represents alkyl containing 1 to 6 carbon atoms, cycloalkyl containing 4 to 6 carbon atoms or cycloalkenyl; an optionally substituted phenyl, 5- or 6-membered heterocyclic group as defined under point (ii) above, or a bicyclic fused ring, or a tautomeric form thereof and/or pharmaceutically acceptable salt or solvate thereof. Disclosed is also a pharmaceutical composition in which the above-described derivative is comprised. Such derivatives find use in the treatment of diseases conditioned by PPAR-gamma, such as reduction of glucose level in blood, dyslipidemia, diabetes of the type I and II, heart failure, hypertension, obesity etc.",GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK ROBERT ANTHONY JR;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JON LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O CALLAGHAN JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/036-321-312-773-605,Granted Patent,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,C07D295/18;;A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
366,NO,L,NO 983940 L,004-922-234-173-403,1998-10-27,1998,NO 983940 A,1998-08-27,EP 9700916 W;;GB 9604242 A,1996-02-28,Derivater av substituert 4-hydroksy-fenylalkanosyre med agonistisk aktivitet for PPAR-gamma,,GLAXO GROUP LTD,WILLSON TIMOTHY MARK;;MOOK JR ROBERT ANTHONY MOOK;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COBB JEFFREY EDMOND;;SHARP MATTHEW JUDE;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN;;COLLINS JON LOREN;;BRAKEEN MARCUS;;O'CALLAGHAN JOHN MARK,,https://lens.org/004-922-234-173-403,Abstract,no,0,0,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;C07D295/18;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
367,EP,A1,EP 2642852 A1,041-981-849-833-131,2013-10-02,2013,EP 11843106 A,2011-11-18,US 41633810 P;;US 2011/0061294 W,2010-11-23,HERBICIDAL CAPSULE SUSPENSIONS OF ACETOCHLOR CONTAINING REDUCED AMOUNTS OF SAFENER,,DOW AGROSCIENCES LLC,DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON MATTHEW;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,,https://lens.org/041-981-849-833-131,Patent Application,yes,0,0,14,14,0,A01N25/28;;A01N25/32;;A01N37/18;;A01N37/26;;A01N43/76;;A01N25/28;;A01N37/26;;A01N25/28;;A01N37/26,A01N25/32,,0,0,,,,DISCONTINUED
368,US,A1,US 2012/0129694 A1,187-946-616-678-936,2012-05-24,2012,US 201113299391 A,2011-11-18,US 201113299391 A;;US 41633810 P,2010-11-23,HERBICIDAL CAPSULE SUSPENSIONS OF ACETOCHLOR CONTAINING REDUCED AMOUNTS OF SAFENER,"Aqueous herbicidal capsule suspensions of acetochlor, containing microcapsules of defined size, shell wall composition, and thickness which contain acetochlor and reduced levels of herbicide safener are provided. The aqueous herbicidal capsule suspensions of acetochlor provide commercially acceptable weed control and selectivity in corn.",DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON M;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY;;DOW AGROSCIENCES LLC,DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON M;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,,https://lens.org/187-946-616-678-936,Patent Application,yes,2,22,14,14,0,A01N25/28;;A01N25/32;;A01N37/18;;A01N37/26;;A01N43/76;;A01N25/28;;A01N37/26;;A01N25/28;;A01N37/26,A01N25/32;;A01N25/34;;A01P13/00,504/107;;504/112,0,0,,,,DISCONTINUED
369,EP,A4,EP 2642852 A4,098-257-586-261-960,2014-04-16,2014,EP 11843106 A,2011-11-18,US 41633810 P;;US 2011/0061294 W,2010-11-23,HERBICIDAL CAPSULE SUSPENSIONS OF ACETOCHLOR CONTAINING REDUCED AMOUNTS OF SAFENER,,DOW AGROSCIENCES LLC,DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON MATTHEW;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,,https://lens.org/098-257-586-261-960,Search Report,no,2,0,14,14,0,A01N25/28;;A01N25/32;;A01N37/18;;A01N37/26;;A01N43/76;;A01N25/28;;A01N37/26;;A01N25/28;;A01N37/26,A01N25/32,,0,0,,,,DISCONTINUED
370,CA,A1,CA 2817243 A1,050-728-436-615-678,2012-05-31,2012,CA 2817243 A,2011-11-18,US 41633810 P;;US 2011/0061294 W,2010-11-23,HERBICIDAL CAPSULE SUSPENSIONS OF ACETOCHLOR CONTAINING REDUCED AMOUNTS OF SAFENER,"Aqueous herbicidal capsule suspensions of acetochlor, containing microcapsules of defined size, shell wall composition, and thickness which contain acetochlor and reduced levels of herbicide safener are provided. The aqueous herbicidal capsule suspensions of acetochlor provide commercially acceptable weed control and selectivity in corn.",DOW AGROSCIENCES LLC,DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON MATTHEW;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,,https://lens.org/050-728-436-615-678,Patent Application,no,0,0,14,14,0,A01N25/28;;A01N25/32;;A01N37/18;;A01N37/26;;A01N43/76;;A01N25/28;;A01N37/26;;A01N25/28;;A01N37/26,A01N25/32,,0,0,,,,ACTIVE
371,CA,C,CA 2817243 C,118-340-970-591-666,2019-02-12,2019,CA 2817243 A,2011-11-18,US 41633810 P;;US 2011/0061294 W,2010-11-23,HERBICIDAL CAPSULE SUSPENSIONS OF ACETOCHLOR CONTAINING REDUCED AMOUNTS OF SAFENER,"The invention relates to an aqueous acetochlor microcapsule suspension comprising: a) from 200 to 700 g/L of a microcapsule comprising: i) a water insoluble polyurea shell wall, the shell wall has a thickness of greater than 50 nm and less than 150 nm, and the average particle size is from 2 to 15 µm, and ii) an inner liquid core having from 200 to 550 g/L of acetochlor and from 0 to 50 g/L of an herbicide safener which is dichlormid, wherein the weight ratio of the acetochlor to the herbicide safener is greater than 10, wherein the weight ratio of the inner liquid core to the water insoluble polyurea shell wall is from 6 to 30; b) from 250 to 750 g/L of water of a continuous aqueous phase; c) from 1 to 100 g/L of a dispersing surfactant; and d) an addition herbicide which is atrazine.",DOW AGROSCIENCES LLC,DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON MATTHEW;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,,https://lens.org/118-340-970-591-666,Granted Patent,no,0,0,14,14,0,A01N25/28;;A01N25/32;;A01N37/18;;A01N37/26;;A01N43/76;;A01N25/28;;A01N37/26;;A01N25/28;;A01N37/26,A01N25/32,,0,0,,,,ACTIVE
372,BR,A2,BR PI1105907 A2,167-657-851-085-966,2015-08-04,2015,BR PI1105907 A,2011-11-22,US 41633810 P,2010-11-23,"Suspensão aquosa de cápsula contendo herbicida à base de cloroacetamida e protetor de herbicida, seu método de preparação e método para aumentar a segurança para o milho em aplicações de herbicidas","Suspensão aquosa de cápsula contendo herbicida à base de cloroacetamida e protetor de herbicida, seu método de preparação e método para aumentar a segurança para o milho em aplicações de herbicidas. A presente invenção refere-se a suspensões herbicidas aquosas de cápsulas de acetoclor, contendo microcápsulas de tamanho definido, composição de envoltório, e espessura que contém acetoclor e níveis reduzidos de protetor de herbicida. As suspensões herbicidas aquosas de acetodor em cápsulas proporcionam controle de ervas daninhas e seletividade em milho comercialmente aceitáveis.",DOW AGROSCIENCES LLC,DITMARSEN SCOTT;;LINSCOTT DOUGLAS L;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON M;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,,https://lens.org/167-657-851-085-966,Patent Application,no,0,0,14,14,0,A01N25/28;;A01N25/32;;A01N37/18;;A01N37/26;;A01N43/76;;A01N25/28;;A01N37/26;;A01N25/28;;A01N37/26,A01N25/32;;A01N25/28;;A01N37/18;;A01N37/26;;A01N43/76,,0,0,,,,DISCONTINUED
373,MX,A,MX 2013005840 A,058-235-483-395-001,2013-08-01,2013,MX 2013005840 A,2011-11-18,US 41633810 P;;US 2011/0061294 W,2010-11-23,HERBICIDAL CAPSULE SUSPENSIONS OF ACETOCHLOR CONTAINING REDUCED AMOUNTS OF SAFENER.,"Aqueous herbicidal capsule suspensions of acetochlor, containing microcapsules of defined size, shell wall composition, and thickness which contain acetochlor and reduced levels of herbicide safener are provided. The aqueous herbicidal capsule suspensions of acetochlor provide commercially acceptable weed control and selectivity in corn.",DOW AGROSCIENCES LLC,WILSON STEPHEN L;;OUSE DAVID G;;HOWARD PHILLIP J;;DOWNER BRANDON MATTHEW;;DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,,https://lens.org/058-235-483-395-001,Patent Application,no,0,0,14,14,0,A01N25/28;;A01N25/32;;A01N37/18;;A01N37/26;;A01N43/76;;A01N25/28;;A01N37/26;;A01N25/28;;A01N37/26,A01N25/32,,0,0,,,,ACTIVE
374,CN,A,CN 103327813 A,157-187-284-456-524,2013-09-25,2013,CN 201180065755 A,2011-11-18,US 2011/0061294 W;;US 41633810 P,2010-11-23,Herbicidal capsule suspensions of acetochlor containing reduced amounts of safener,"Aqueous herbicidal capsule suspensions of acetochlor, containing microcapsules of defined size, shell wall composition and thickness which contain acetochlor and reduced levels of herbicide safener are provided. The aqueous herbicidal capsule suspensions of acetochlor provide commercially acceptable weed control and selectivity in cereal.",DOW AGROSCIENCES LLC,DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON MATTHEW;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,,https://lens.org/157-187-284-456-524,Patent Application,no,4,7,14,14,0,A01N25/28;;A01N25/32;;A01N37/18;;A01N37/26;;A01N43/76;;A01N25/28;;A01N37/26;;A01N25/28;;A01N37/26,A01N25/32,,0,0,,,,ACTIVE
375,UA,C2,UA 114595 C2,004-154-622-317-369,2017-07-10,2017,UA A201307931 A,2011-11-18,US 2011/0061294 W;;US 41633810 P,2010-11-23,HERBICIDAL CAPSULE SUSPENSIONS OF ACETOCHLOR CONTAINING REDUCED AMOUNTS OF SAFENER,"Aqueous herbicidal capsule suspensions of acetochlor, containing microcapsules of defined size, shell wall composition, and thickness which contain acetochlor and reduced levels of herbicide safener are provided. The aqueous herbicidal capsule suspensions of acetochlor provide commercially acceptable weed control and selectivity in com.",DOW AGROSCIENCES LLC,DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON MATTHEW;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,,https://lens.org/004-154-622-317-369,Limited Patent,no,0,0,14,14,0,A01N25/28;;A01N25/32;;A01N37/18;;A01N37/26;;A01N43/76;;A01N25/28;;A01N37/26;;A01N25/28;;A01N37/26,A01N25/32;;A01P13/02,,0,0,,,,EXPIRED
376,WO,A1,WO 2012/071248 A1,148-637-170-267-281,2012-05-31,2012,US 2011/0061294 W,2011-11-18,US 41633810 P,2010-11-23,HERBICIDAL CAPSULE SUSPENSIONS OF ACETOCHLOR CONTAINING REDUCED AMOUNTS OF SAFENER,"Aqueous herbicidal capsule suspensions of acetochlor, containing microcapsules of defined size, shell wall composition, and thickness which contain acetochlor and reduced levels of herbicide safener are provided. The aqueous herbicidal capsule suspensions of acetochlor provide commercially acceptable weed control and selectivity in corn.",DOW AGROSCIENCES LLC;;DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON MATTHEW;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,DITMARSEN SCOTT;;LINSCOTT DOUGLAS J;;WILSON STEPHEN L;;HOWARD PHILLIP J;;OUSE DAVID G;;DOWNER BRANDON MATTHEW;;SCHERDER ERIC;;COBB JOEY;;WOODRUFF MARK;;BOEKER RICARDO;;FERGUSON SAMUEL M;;GALLUP COURTNEY,,https://lens.org/148-637-170-267-281,Patent Application,yes,3,10,14,14,0,A01N25/28;;A01N25/32;;A01N37/18;;A01N37/26;;A01N43/76;;A01N25/28;;A01N37/26;;A01N25/28;;A01N37/26,A01N25/32,,0,0,,,,PENDING
377,EA,B1,EA 001403 B1,171-999-798-430-445,2001-02-26,2001,EA 199800664 A,1997-02-26,EP 9700916 W;;GB 9604242 A,1996-02-28,SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA,"1. A compound having the formula (I) wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR<7>R<8>, where R<7> an d R<8> are independently hydrogen or C1-3alkyl; (ii) a 5- or 6- membered heterocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and optionally substituted by one or more halogen atoms, C1-3alkyl, C1-3alkoxy group, C0-3alkylene-NR<9>R<10> (where each R<9> and R<10> is independently hydrogen, C1-3alkyl, -SO2C1-3alkyl, or -CO2C1-3alkyl, -SO2NHC1-3alkyl, C0-3alkyleneCO2H, C0-3alkyleneCO2C1-3alkyl, -OCH2C(O)NH2, -C1-3fluoroalkyl, -CN or -SC1-6alkyl; and (iii) a fused bicyclic ring wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR<2> wherein R<2> represents hydrogen or C1-3alkyl; (vi) a 5- or 6- membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R<1> represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene)phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR<3>R<4>, wherein R<3> represents hydrogen or C1-3alkyl, and R<4> represents -Y-(C=O)-T-R<5>, or-Y-(CH(OH))-T-R<5>, wherein: (a) Y represents a bond, C1-6alkylene, C2-6alkenylene, C4-6cycloalkylene or cycloalkenylene, a heterocyclic group as defined in point (vi) above, or phenyl optionally substituted by one or more C1-3alkyl groups and/or one or more halogen atoms; (b) T represents a bond, C1-3alkyleneoxy group, -O- or -N(R<6>)-, wherein R<6> represents hydrogen or C1-3alkyl; (c) R<5> represents C1-6alkyl, C4-6cycloalkyl or cycloalkenyl, phenyl (optionally substituted by one or more: halogen atoms, C1-3alkyl, C1-3alkoxy group, C0-3alkylene-NR<9>R<10> where each R<9> and R<10> is independently hydrogen, C1-3alkyl, -SO2-C1-3alkyl, or -CO2C1-3alkyl, -SO2NHC1-3alkyl, C0-3alkyleneCO2H, C0-3alkyleneCO2C1-3alkyl or -OCH2C(O)NH2), a 5- or 6-membered heterocyclic group as defined in point (ii) above, a bicylic fused ring wherein ring D represents a 5- or 6-membered heterocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by (=O), which bicyclic ring is attached to T via a ring atom of ring D, or -C1-6alkyleneMR<11>, M is O, S, or -NR<2> wherein R<2> and R<11> are independently hydrogen or C1-3alkyl; or a tautomeric form thereof, and/or a pharmaceutically acceptable salt or solvate thereof. 2. The compound of claim 1 wherein each of said 5- or 6- membered heterocyclic groups is independently selected from the group consisting of substituted or unsubstituted imidazolidinyl, piperidyl, piperazinyl pyrrolidinyl, morpholinyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, pyrrolyl, pyrazolyl, imidazolyl, pyranyl, furyl, thienyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, thiadiazolyl, triazolyl, or tetrazolyl, each of them is optionally substituted by substituents, mentioned in claim 1. 3. A compound according to claim 1 or 2, wherein A represents phenyl, pyridyl, piperazinyl or benzoxazolyl, any of which is optionally substituted by one or more C1-3alkyl. 4. A compound according to claim 3, wherein A represents phenyl, piperazinyl or pyridyl. 5. A compound according to any of claims 1-4, wherein B represents C1-3alkylene, -N(CH3)C1-3alkylene or HetC1-6alkylene wherein Het represents a 5-membered heterocyclic group containing at least one nitrogen atom and optionally at least one further heteroatom selected from oxygen and sulphur, substituted or unsubstituted by C1-3alkyl. 6. A compound according to claim 5 wherein B represents -N(CH3)(CH2)2, oxazolyl-C1-6alkylene wherein said oxazolyl is optionally substituted by C1-3 alkyl, or thiazolyl which is optionally substituted by C1-3alkyl. 7. A compound according to any of claims 1-6, wherein Alk represents methylene. 8. A compound according to any of claims 1-7, wherein R<1> represents hydrogen, methyl or ethyl. 9. A compound according to claim 8, wherein R<1> is hydrogen. 10. A compound according to any of claims 1-9, wherein Z represents -NR<3>R<4> wherein R<3> and R<4> are as defined in claim 1. 11. A compound according to claim 10 wherein R<3> is hydrogen. 12. A compound according to claim 10 or 11, wherein R<4> represents -Y(C=O)-T-R<5> wherein R<5> is as defined in claim 1. 13. The compound of claim 8 wherein Y is phenyl optionally substituted by one or more C1-3alkyl groups and/or one or more halogen atoms. 14. The compound of claim 9 wherein T is a bond or -O-. 15. A compound according to claim 12, 13 or 14 wherein R<5> represents C1-3 alkyl or phenyl (optionally substituted by one or more halogen atoms or one or more C1-3alkyl groups). 16. The compound of claim 10 wherein said NH and said (C=O) are positioned ortho to each other on Y (which is phenyl), T is a bond or -O-, R<5> is C1-6alkyl, or phenyl (optionally substituted by one or more: halogen atoms, C1-3alkyl, C1-3 alkoxy groups, C0-3alkylene-NR<9>R<10> where each R<9> and R<10> is independently hydrogen, C1-3alkyl, -SO2C1-3alkyl, or -CO2C1-3alkyl, -SO2NHC1-3alkyl, C0-3alkyleneCO2H, C0-3alkyleneCO2C1-3alkyl or -OCH2C(O)NH2). 17. A compound according to claim 15 or 16 wherein R<4> represents wherein R<13> is phenyl or OCH3. 18. A compound according to claim 1 of formula (Ia) wherein A and B are as described in claim 1 and Ar represents a phenyl or a 5 or 6 membered heteoaryl group containing at least the heteroatom selected from oxygen, nitrogen and sulphur and optionally substituted by one or more: halogen atoms, C1-3alkyl, C1-3 alkoxy groups, C0-3alkylene-NR<9>R<10> (where each R<9> and R<10> is independently hydrogen, C1-3alkyl, -SO2C1-3alkyl, or -CO2C1-3alkyl, -SO2NHC1-3alkyl), C0-3alkyleneCO2H, C0-3alkyleneCO2C1-3alkyl or -OCH2C(O)NH2, -C1-3fluoroalkyl, -CN or -SC1-6alkyl and solvates thereof. 19. A compound according to claim 1 having the formula (I) wherein A is selected from the group consisting of: (i) phenyl optionally substituted by one or more halogen atoms; (ii) a 5- or 6- membered heterocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; andand optionally substituted by one or more: halogen atoms, C1-3alkyl, C1-3 alkoxy groups, C0-3alkylene-NR<9>R<10> (where each R<9> and R<10> is independently hydrogen, C1-3alkyl, -SO2C1-3alkyl, or -CO2C1-3alkyl, -SO2NHC1-3alkyl), C0-3alkyleneCO2H, C0-3alkyleneCO2C1-3alkyl, -OCH2C(O)NH2, -C1-3fluoroalkyl, -CN or -SC1-6alkyl; and (iii) a fused bicyclic ring wherein ring C represents a heterocyclic group as defined in (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -NR<2>C1-6alkylene, wherein R<2> represents hydrogen or C1-3alkyl; (vi) a 5- or 6- membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R<1> represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene)phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR<3>R<4>, wherein R<3> represents hydrogen or C1-3alkyl, and R<4> represents -Y-(C=O)-T-R<5>, or -Y-(CH(OH))-T-R<5>, wherein: (a) Y represents a bond, C1-6alkylene, C2-6alkenylene, C4-6cycloalkylene or cycloalkenylene, a heterocyclic group as defined in point (vi) above, or phenyl optionally substituted by one or more C1-3alkyl groups and/or one or more halogen atoms; (b) T represents a bond, C1-3alkyleneoxy group, -O- or -N(R<6>)-, wherein R<6> represents hydrogen or C1-3alkyl; (c) R<5> represents C1-6alkyl, C4-6 cycloalkyl or cycloalkenyl, phenyl optionally substituted by one or more halogen atoms or one or more C1-3alkyl groups, a 5- or 6- membered heterocyclic group as defined in point (ii) above, or a bicylic fused ring wherein ring D represents a 5- or 6-membered heterocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by (=O), which bicyclic ring is attached to T via a ring atom of ring D, or a tautomeric form thereof, and/or a pharmaceutically acceptable salt or solvate thereof. 20. A compound as claimed in claim 1 which is selected from the group consisting of: 3-(4-benzyloxy-phenyl)-2(S)-(1-methyl-3-oxo-3-phenyl-propenylamino)-propionic acid dicyclohexylamine salt; 3-(4-benzyloxy-phenyl)-2(S)-(1-methyl-3-oxo-3-phenyl-propenylamino)-propionic acid methyl ester; 2(S)-(2-benzoyl-cyclohex-1-enylamino)-3-(4-benzyloxy-phenyl)-propionic acid dicyclohexylamine salt; 2-(2-benzoylphenylamino)-3-(4-benzyloxyphenyl) propanoic acid; 3-(4-benzyloxy-phenyl)-2-(2-benzyloxy-phenylamino)-propionic acid methyl ester; 3-(4-benzyloxy-phenyl)-2-(phenylcarbamoyl-phenylamino)-propionic acid methyl ester; 3-(4-benzyloxy-phenyl)-2-[2-(piperidine-1-carbonyl)-phenylamino]-propionic acid methyl ester; 2-(3-benzoyl-thiophen-2-yl-amino)-3-(4-benzyloxy-phenyl)-propionic acid; 2-(2-benzoyl-thiophen-3-yl-amino)-3-(4-benzyloxy-phenyl)-propionic acid; 3-(4-benzyloxy-phenyl)-2(S)-[(4-oxo-4H-chromene-3-carbonyl)-amino]-propionic acid methyl ester; 2-(2-benzoyl-phenylamino)-3-{4-[2-(methyl-pyridin-2-yl-amino)-ethoxy]-phe",GLAXOGROUP LTD,WILLSON TIMOTHY MARKMOOK ROBER;;KALDOR ISTVAN;;HENKE BRAD RICHARD;;DEATON DAVID NORMAN;;COLLINS JOHN LOREN;;COBB JEFFREY EDMOND;;BRACKEEN MARCUS;;SHARP MATTHEW JUDE;;O'CALLAGHAM JOHN MARK;;ERICKSON GREG ALAN;;BOSWELL GRADY EVAN,,https://lens.org/171-999-798-430-445,Granted Patent,no,0,1,61,61,0,A61K31/192;;A61K31/216;;A61K31/353;;A61K31/415;;A61K31/4184;;A61K31/42;;A61K31/422;;A61K31/423;;A61K31/425;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/4453;;A61K31/454;;A61K31/495;;C07C229/36;;C07C229/56;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04;;C07C2601/14;;C07C2601/16;;A61P3/00;;A61P3/10;;A61P3/04;;A61P3/06;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07D213/64;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D401/04;;C07D413/04;;C07D417/04;;C07D213/64;;C07D263/32;;C07D213/74;;C07D235/12;;C07D233/64;;C07D401/04;;C07C229/36;;A61K31/423;;A61K31/454;;A61K31/216;;A61K31/422;;A61K31/4439;;C07D261/08;;C07D263/56;;A61K31/415;;C07D207/08;;C07D231/12;;C07D213/70;;C07D277/24;;C07D417/04;;C07D311/22;;A61K31/4184;;A61K31/192;;C07C237/40;;A61K31/427;;A61K31/44;;C07D277/42;;C07D413/12;;A61K31/4402;;C07D237/14;;C07D333/36;;A61K31/42;;A61K31/4453;;C07D249/08;;C07C255/54;;C07D413/04;;A61K31/353;;C07C229/56;;A61K31/495;;C07D213/65;;C07D405/04;;A61K31/425;;C07C323/12;;C07C2601/16;;C07C2601/14,A61K31/00;;A61K31/192;;A61K31/195;;A61K31/215;;A61K31/216;;A61K31/353;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/415;;A61K31/4164;;A61K31/4184;;A61K31/42;;A61K31/421;;A61K31/422;;A61K31/423;;C07D295/18;;A61K31/425;;A61K31/426;;A61K31/427;;A61K31/44;;A61K31/4402;;A61K31/4439;;A61K31/445;;A61K31/4453;;A61K31/454;;A61K31/495;;A61K31/496;;A61K31/535;;A61K31/5375;;A61K31/5377;;A61P3/00;;A61P3/06;;A61P3/10;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;C07C229/36;;C07C229/56;;C07C235/30;;C07C237/40;;C07C255/54;;C07C323/12;;C07D207/08;;C07D207/12;;C07D213/64;;C07D213/65;;C07D213/70;;C07D213/74;;C07D231/12;;C07D233/54;;C07D233/64;;C07D235/12;;C07D237/14;;C07D249/08;;C07D261/08;;C07D263/32;;C07D263/56;;C07D277/24;;C07D277/42;;C07D311/22;;C07D333/36;;C07D401/04;;C07D405/04;;C07D413/04;;C07D413/12;;C07D417/04,,0,0,,,,EXPIRED
378,US,A,US 5987370 A,124-564-469-443-483,1999-11-16,1999,US 92302097 A,1997-09-03,US 92302097 A,1997-09-03,Vehicle occupant weight estimation apparatus having fluid-filled seat bladder,"An improved weight estimation apparatus includes a closed elastomeric bladder filled with fluid and installed in the foam cushion of a vehicle seat bottom, with at least one pressure sensor installed in a closed exit port of the bladder. A temperature sensor disposed in proximity to the bladder provides a temperature signal, and a controller estimates the weight of the occupant based on the temperature and pressure signals. The pressure sensor is preferably configured to sense the gage pressure--that is, the differential pressure between the fluid and atmospheric pressure--at the center of gravity of the fluid in order to provide a stable output independent of changing atmospheric pressure and changing orientation of the bladder due to vehicle pitch and roll.",DELCO ELECTRONICS CORP,MURPHY MORGAN DANIEL;;MYERS ROBERT JOSEPH;;ROE PAMELA ANN;;PIPER WILLIAM LLOYD;;FORTUNE DUANE DONALD;;BORZABADI HAMID REZA;;STONE KARL EDWARD;;VINCEN MARK ROBERT;;SULLIVAN STUART STITES;;PERISHO JR ROBERT ALLAN;;CONSTABLE ROBERT KEITH;;COBB GREGORY ALLEN,DELCO ELECTRONICS CORPORATION (1997-09-23);;DELPHI TECHNOLOGIES INC (2005-09-30),https://lens.org/124-564-469-443-483,Granted Patent,yes,9,131,14,14,0,B60R21/01516;;B60R21/01516;;B60N2/002;;B60N2/002;;B60R21/0152;;B60R21/0152;;G01G5/04;;G01G5/04;;G01G19/4142;;G01G19/4142;;G01L1/02;;G01L1/02,B60N2/00;;B60N2/90;;B60N5/00;;B60R21/01;;B60R21/015;;B60R21/16;;G01G5/04;;G01G5/06;;G01G19/414;;G01G19/52;;G01G23/48;;G01L1/02,701/45;;701/49;;701/36;;280/735;;340/436;;340/665;;340/667;;180/271,0,0,,,,EXPIRED
379,JP,A,JP H11148855 A,055-560-382-543-757,1999-06-02,1999,JP 23368798 A,1998-08-20,US 92302097 A,1997-09-03,WEIGHT ESTIMATING DEVICE FOR CREW OF VEHICLE,"PROBLEM TO BE SOLVED: To provide a appropriate crew imobilization device by making the device to be attached easily to an existing seat and accurately estimating the weight of the crew seating on the seat by the minimum amount of processing. SOLUTION: A weight estimating device is provided with an elastomer bag 20 containing a fluid. The bag 12 is attached to a foamed cushion 16 at the bottom of the seat 12 in a vehicle and at least one pressure sensor is attached to the closed outlet port 22 of the bag 20. A temperature sensor 30 is arranged closely to the bag 20 and supplies a temperature signal. A controller 50 estimates the weight of the crew seating on the seat 12 based on the temperature signal from the temperature sensor 30 and a pressure signal from the pressure sensor. It is preferable to form the pressure sensor in such a way that the sensor can detect a gauge pressure (namely, the difference between the fluid pressure and atmospheric pressure) at the center of gravity of the fluid. Therefore, the weight estimating device can stably supply its output regardless of the variation of the direction of the bag 20 caused by the fluctuation of the atmospheric pressure or the pitching or rolling of the vehicle.",DELCO ELECTRONICS CORP,MURPHY MORGAN DANIEL;;ROE PAMELA ANN;;MYERS ROBERT JOSEPH;;PIPER WILLIAM LLOYD;;DUAN DONALD FORTUNE;;HAMID REZA BOOZABADI;;CARL EDWARD STONE;;MARK ROBERT VINCEN;;SULLIVAN STUART S;;ROBERT ALAN PERISHO JR;;ROBERT KEITH CONSTABLE;;GREGORY ALLEN COBB,,https://lens.org/055-560-382-543-757,Patent Application,no,0,1,14,14,0,B60R21/01516;;B60R21/01516;;B60N2/002;;B60N2/002;;B60R21/0152;;B60R21/0152;;G01G5/04;;G01G5/04;;G01G19/4142;;G01G19/4142;;G01L1/02;;G01L1/02,B60N2/00;;B60N2/90;;B60N5/00;;B60R21/01;;B60R21/015;;B60R21/16;;G01G5/04;;G01G5/06;;G01G19/414;;G01G19/52;;G01G23/48;;G01L1/02,,0,0,,,,EXPIRED
380,CN,B,CN 101954138 B,058-931-851-197-850,2013-01-02,2013,CN 201010266569 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medical executor system operating room unit and medical executor system,,ETHICON DEDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCROIRIE JOHNSON W;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/058-931-851-197-850,Granted Patent,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;A61M16/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
381,CN,A,CN 101961519 A,045-922-424-206-947,2011-02-02,2011,CN 201010266604 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medical effector subsystem and a drug delivery pump sub-component,"The invention relates to a medical effector subsystem and a drug delivery pump sub-component. The medical effector subsystem includes: a drug delivery pipe which contains drugs with a variable controlled flow speed and is disposable for delivering drugs to patients; b) a pressure sensor which has output signals and is suitable for sensing inner pressure of drugs in the delivery pipe; and c) a storer containing a block program which is operatively connected to the output signal of the pressure sensor when it is operated on an operator, wherein the block program has a variable pressure alarm setting value and alarm the user that the drug delivery pipe is blocked when the output signal of the pressure sensor exceeds the variable pressure alarm setting value; and the alarm program is able to at least partly, directly or indirectly change the variable pressure alarm setting value according to the variable controlled flow speed of drugs.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCROIRIE JOHNSON W;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/045-922-424-206-947,Patent Application,no,0,4,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;A61M16/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
382,CN,B,CN 101961516 B,082-006-958-653-643,2014-03-19,2014,CN 201010266588 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medicine delivery pump unit,,ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCROIRIE JOHNSON W;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/082-006-958-653-643,Granted Patent,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M5/142;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
383,CN,B,CN 101961519 B,164-908-041-907-758,2012-05-23,2012,CN 201010266604 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medical effector subsystem and a drug delivery pump sub-component,"The invention relates to a medical effector subsystem and a drug delivery pump sub-component. The medical effector subsystem includes: a drug delivery pipe which contains drugs with a variable controlled flow speed and is disposable for delivering drugs to patients; b) a pressure sensor which has output signals and is suitable for sensing inner pressure of drugs in the delivery pipe; and c) a storer containing a block program which is operatively connected to the output signal of the pressure sensor when it is operated on an operator, wherein the block program has a variable pressure alarm setting value and alarm the user that the drug delivery pipe is blocked when the output signal of the pressure sensor exceeds the variable pressure alarm setting value; and the alarm program is able to at least partly, directly or indirectly change the variable pressure alarm setting value according to the variable controlled flow speed of drugs.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCROIRIE JOHNSON W;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/164-908-041-907-758,Granted Patent,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;A61M16/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
384,CN,A,CN 101954138 A,023-767-609-353-235,2011-01-26,2011,CN 201010266569 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medical executor system operating room unit and medical executor system,"The invention relates to a medical executor system operating room unit and a medical executor system. The medical executor system operating room unit comprises (a) an operating room unit main controller; (b) a carbon dioxide monitoring instrument which has a carbon dioxide monitoring instrument gas input receiving breathe gas directly or indirectly obtained from a disposable cannula arranged at the face of a patient and a carbon dioxide monitoring instrument signal output connected to the operating room unit main controller in operation, wherein, the operating room unit main controller sends the alarm that the carbon dioxide monitoring instrument is in the fluid connecting or no fluid connecting with the cannula to the user at least partly according to the carbon dioxide monitoring instrument signal output.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCROIRIE JOHNSON W;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/023-767-609-353-235,Patent Application,no,1,5,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;A61M16/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
385,EP,A3,EP 2491969 A3,095-775-352-660-257,2016-10-05,2016,EP 12157430 A,2005-08-24,EP 05789936 A;;US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medical effector system,"A medical effector system comprised of a bedside unit and a procedure unit. The bedside unit contains connection points for an oral nasal cannula and for receiving inputs from a series of patient monitors. The procedure unit contains a patient monitoring and a medical effector program, and a drug delivery pump and drug cassette or a magnetic flux generator capable of delivering therapeutic energy to a patient. The medical effector program operates the pump or magnetic flux generator based upon at least some of the patient outputs and program inputs. A removable umbilical cable connects the two units and allows gases, the patient monitors as well as other information to travel between the two units.
",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;ADAIR WILLIAM P;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;MARTIN JAMES F;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P,,https://lens.org/095-775-352-660-257,Search Report,yes,8,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M31/00;;A61B5/00;;A61B5/083;;A61M5/142;;A61M5/162;;A61M5/168;;A61M5/172;;A61M16/00;;A61M16/04;;A61M16/06;;A61M16/08;;A61M16/10;;A61M21/00;;A61M21/02;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,DISCONTINUED
386,BR,A,BR PI0515134 A,111-399-247-395-879,2008-07-08,2008,BR PI0515134 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A;;US 2005/0030201 W,2004-08-31,sistema de atuador medicinal,"SISTEMA DE ATUADOR MEDICINAL. A invenção refere-se a um sistema de atuador medicinal compreendido de uma unidade de cabeceira e uma unidade de procedimentos. A unidade de cabeceira contém pontos de conexão para uma cânula oral - nasal e para receber as entradas de uma série de monitores do paciente. A unidade de procedimentos contém um programa de monitoramento de paciente e de atuador medicinal, e uma bomba de aplicação de fármacos e um cassete de fármacos ou um gerador de fluxo magnética capaz de aplicar uma energia terapêutica em um paciente. O programa de atuador medicinal opera a bomba ou o gerador de fluxo magnético com base em pelo menos algumas das saídas do paciente e das entradas do programa. Um cabo umbilical removível conecta as duas unidades e permite que os gases, os monitores do paciente assim como outras informações desloquem-se entre as duas unidades.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCROIRIE JOHNSON W;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/111-399-247-395-879,Patent Application,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,DISCONTINUED
387,CN,A,CN 101961516 A,065-071-676-169-567,2011-02-02,2011,CN 201010266588 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medicine delivery pump unit,"A medicine delivery pump unit includes: a medicine delivery pump shell; b) medicine delivery cassette unit which is connected with the delivery pump shell and has a medicine bottle pin; and c) a pump shell door which has an opening position and a closing position, a medicine bottle aligning finger that centralizes and aligns medicine bottles with different diameters in following conditions including connection of the cassette unit and the delivery pump shell, placement in the closing position of the pump shell door and engagement of the medicine bottl and the pin when the medicine bottle is inserted between medicine bottle aligning fingers.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCROIRIE JOHNSON W;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/065-071-676-169-567,Patent Application,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M5/142;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
388,EP,A3,EP 2491970 A3,187-576-854-168-696,2016-10-05,2016,EP 12157438 A,2005-08-24,EP 05789936 A;;US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medical effector system,"A medical effector system comprised of a bedside unit (300) and a procedure unit (200). The bedside unit contains connection points for an oral nasal cannula and for receiving inputs from a series of patient monitors. The procedure unit contains a patient monitoring and a medical effector program, and a drug delivery pump and drug cassette or a magnetic flux generator capable of delivering therapeutic energy to a patient. The medical effector program operates the pump or magnetic flux generator based upon at least some of the patient outputs and program inputs. A removable umbilical cable (160) connects the two units and allows gases, the patient monitors as well as other information to travel between the two units.
",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;ADAIR WILLIAM P;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;MARTIN JAMES F;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P,,https://lens.org/187-576-854-168-696,Search Report,yes,6,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M31/00;;A61B5/00;;A61B5/083;;A61M5/142;;A61M5/162;;A61M5/168;;A61M5/172;;A61M16/00;;A61M16/04;;A61M16/06;;A61M16/08;;A61M16/10;;A61M21/00;;A61M21/02;;G16H10/60;;G16H20/17;;G16H40/63,,1,1,058-373-646-945-270,10.1097/00000542-200104000-00010;;11379677,"DOUFAS A G ET AL: ""Automated responsiveness test (ART) predicts loss of consciousness and adverse physiologic responses during propofol conscious sedation"", ANESTHESIOLOGY, AMERICAN SOCIETY OF ANESTHESIOLOGISTS, PHILADELPHIA, PA, US, vol. 94, no. 4, April 2001 (2001-04-01), pages 585 - 592, XP002525319, ISSN: 0003-3022, DOI: 10.1097/00000542-200104000-00010",DISCONTINUED
389,EP,A1,EP 2952223 A1,011-619-737-868-09X,2015-12-09,2015,EP 15173879 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A;;EP 05789936 A,2004-08-31,MICROPROCESSOR-BASED MEDICAL EFFECTOR SYSTEM,"A medical effector system comprised of a bedside unit and a procedure unit. The bedside unit contains connection points for an oral nasal cannula and for receiving inputs from a series of patient monitors. The procedure unit contains a patient monitoring and a medical effector programme, and a drug delivery pump and drug cassette or a magnetic flux generator capable of delivery therapeutic energy to a patient. The medical effector programme operates the pump or magnetic flux generator based upon at least some of the patient outputs and programme inputs. A removable umbilical cable connects the two units and allows gases, the patient monitors as well as other information to travel between the two units.
",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E,,https://lens.org/011-619-737-868-09X,Patent Application,yes,9,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M31/00;;A61B5/00;;A61B5/083;;A61M5/142;;A61M5/162;;A61M5/168;;A61M5/172;;A61M16/00;;A61M16/04;;A61M16/06;;A61M16/08;;A61M16/10;;A61M21/00;;A61M21/02;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,DISCONTINUED
390,AU,A1,AU 2012/201651 A1,138-283-972-712-203,2012-04-12,2012,AU 2012/201651 A,2012-03-20,AU 2005/280197 A;;AU 2012/201651 A,2005-08-24,Medical effector system,"Abstract A sedation delivery system comprising: a) a microprocessor-based bedside monitoring unit having a bedside monitoring-unit host controller which contains a first program which performs the 5 steps of: issuing a request to a non-sedated patient for a non-sedated patient response; receiving a signal based on the non-sedated patient response; and calculating a non sedated response time for the patient based at least in part on a time difference between issuing the request and receiving the signal; b) a microprocessor-based procedure room unit having a procedure-room-unit 10 host controller which contains a second program which performs the steps of: issuing requests through the bedside monitoring unit to a sedated patient for a sedated patient response; receiving a signal through the bedside monitoring unit based on the sedated patient response; calculating a sedated response time for the sedated patient, and calculating a response time difference between the non-sedated and sedated response 15 times; and c) an umbilical cable having a first end attached or attachable to the bedside monitoring unit and having a second end attached or attachable to the procedure room unit, wherein at least one of the first and second ends is detachable from the corresponding bedside monitoring unit or the procedure room unit.",ETHICON ENDO SURGERY INC,MARTIN JAMES F;;WUENNEMANN JEFFREY J;;STEVENS III FRED B;;CUSHING TOMMY C;;ADAIR WILLIAM P;;KULLE LEE K;;COBB NICHOLAS E;;KROGH ROSS;;MILLER MICHAEL J;;PRIVITERA SALVATORE;;LILES JEFF S;;KEILHOLZ DAVID J;;DEROUEN JASON P;;DAVIS DEWAYNE A;;BRUGGEMAN PAUL J;;DONOFRIO WILLIAM T;;EYSTER CURT R;;NIKLEWSKI PAUL J;;COLLINS JR WILLIAM L;;FLAKER RICHARD W;;BISHOP GREGORY D;;NALAGATLA ANILL K;;BURDORFF MARK A;;BURFORD CHARLES B;;MCRORIE JR JOHNSON W;;SABO LOUIS;;HICKLE RANDALL S;;KATZ HAL H,,https://lens.org/138-283-972-712-203,Patent Application,no,0,0,4,4,0,,A61M31/00,,0,0,,,,INACTIVE
391,CA,A1,CA 2579071 A1,051-816-994-222-98X,2006-03-09,2006,CA 2579071 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A;;US 2005/0030201 W,2004-08-31,MEDICAL EFFECTOR SYSTEM,,ETHICON ENDO SURGERY INC,DONOFRIO WILLIAM T;;EYSTER CURT R;;BURDORFF MARK A;;BISHOP GREGORY D;;SABO LOUIS;;STEVENS FRED B III;;FLAKER RICHARD W;;HICKLE RANDALL S;;KULLE LEE K;;KROGH ROSS;;MCRORIE JOHNSON W JR;;DEROUEN JASON P;;KATZ HAL H;;KEILHOLZ DAVID J;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S;;PRIVITERA SALVATORE;;DAVIS DEWAYNE A;;NIKLEWSKI PAUL J;;ADAIR WILLIAM P;;BURFORD CHARLES B;;NALAGATLA ANILL K;;MILLER MICHAEL J;;BRUGGEMAN PAUL J;;MARTIN JAMES F;;COLLINS WILLIAM L JR;;CUSHING TOMMY C,,https://lens.org/051-816-994-222-98X,Patent Application,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
392,AU,B2,AU 2012/201651 B2,067-117-392-454-183,2013-01-31,2013,AU 2012/201651 A,2012-03-20,AU 2005/280197 A;;AU 2012/201651 A,2005-08-24,Medical effector system,"Abstract A sedation delivery system comprising: a) a microprocessor-based bedside monitoring unit having a bedside monitoring-unit host controller which contains a first program which performs the 5 steps of: issuing a request to a non-sedated patient for a non-sedated patient response; receiving a signal based on the non-sedated patient response; and calculating a non sedated response time for the patient based at least in part on a time difference between issuing the request and receiving the signal; b) a microprocessor-based procedure room unit having a procedure-room-unit 10 host controller which contains a second program which performs the steps of: issuing requests through the bedside monitoring unit to a sedated patient for a sedated patient response; receiving a signal through the bedside monitoring unit based on the sedated patient response; calculating a sedated response time for the sedated patient, and calculating a response time difference between the non-sedated and sedated response 15 times; and c) an umbilical cable having a first end attached or attachable to the bedside monitoring unit and having a second end attached or attachable to the procedure room unit, wherein at least one of the first and second ends is detachable from the corresponding bedside monitoring unit or the procedure room unit.",ETHICON ENDO SURGERY INC,MARTIN JAMES F;;WUENNEMANN JEFFREY J;;STEVENS III FRED B;;CUSHING TOMMY C;;ADAIR WILLIAM P;;KULLE LEE K;;COBB NICHOLAS E;;KROGH ROSS;;MILLER MICHAEL J;;PRIVITERA SALVATORE;;LILES JEFF S;;KEILHOLZ DAVID J;;DEROUEN JASON P;;DAVIS DEWAYNE A;;BRUGGEMAN PAUL J;;DONOFRIO WILLIAM T;;EYSTER CURT R;;NIKLEWSKI PAUL J;;COLLINS JR WILLIAM L;;FLAKER RICHARD W;;BISHOP GREGORY D;;NALAGATLA ANILL K;;BURDORFF MARK A;;BURFORD CHARLES B;;MCRORIE JR JOHNSON W;;SABO LOUIS;;HICKLE RANDALL S;;KATZ HAL H,,https://lens.org/067-117-392-454-183,Granted Patent,no,1,0,4,4,0,,A61M31/00,,0,0,,,,INACTIVE
393,AU,A1,AU 2012/201650 A1,086-663-734-316-977,2012-04-12,2012,AU 2012/201650 A,2012-03-20,AU 2005/280197 A;;AU 2012/201650 A,2005-08-24,Medical effector system,"Abstract A drug-delivery infusion pump assembly and drug-delivery cassette assembly combination comprising: a) a drug-delivery infusion pump housing; b) a drug-delivery cassette assembly attachable to the infusion pump housing, having a tubing and a luer 5 combination, and having a drug-delivery-cassette main board including a luer-site base portion, wherein the luer is attachable to and detachable from the luer-site base portion, and a tubing storage portion, wherein the tubing is releasably stored in a coiled state in the tubing storage portion; c) a pump-housing door attached to the infusion pump housing and having door-open and door-closed positions; and d) a pump-housing door 10 lock which, when the cassette assembly is attached to the infusion pump housing and the pump-housing door is in the door-closed position, cannot unlock unless the luer is attached to the luer-site base portion.",ETHICON ENDO SURGERY INC,MARTIN JAMES F;;WUENNEMANN JEFFREY J;;STEVENS III FRED B;;CUSHING TOMMY C;;ADAIR WILLIAM P;;KULLE LEE K;;COBB NICHOLAS E;;KROGH ROSS;;MILLER MICHAEL J;;PRIVITERA SALVATORE;;LILES JEFF S;;KEILHOLZ DAVID J;;DEROUEN JASON P;;DAVIS DEWAYNE A;;BRUGGEMAN PAUL J;;DONOFRIO WILLIAM T;;EYSTER CURT R;;NIKLEWSKI PAUL J;;COLLINS JR WILLIAM L;;FLAKER RICHARD W;;BISHOP GREGORY D;;NALAGATLA ANILL K;;BURDORFF MARK A;;BURFORD CHARLES B;;MCRORIE JR JOHNSON W;;SABO LOUIS;;HICKLE RANDALL S;;KATZ HAL H,,https://lens.org/086-663-734-316-977,Patent Application,no,0,0,4,4,0,,A61M31/00,,0,0,,,,INACTIVE
394,CN,A,CN 101961522 A,131-464-412-257-255,2011-02-02,2011,CN 201010266487 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medical oxygen-delivery apparatus and medical effector system operating room unit,"The invention relates to a medical oxygen-delivery apparatus and a medical effector system operating room unit. The medical oxygen-delivery apparatus comprises an oxygen-delivery manifold having an oxygen-delivery flow path, a fixed-size-orifice flow restrictor, and a variable-size-orifice flow restrictor, wherein the oxygen-delivery flow path includes a flow-path inlet fluidly-connectable to a source of pressurized oxygen and a flow-path outlet fluidly-connectable to a cannula disposable on the face of a patient, wherein the fixed-size-orifice flow restrictor is disposed in the flow path downstream of the flow-path inlet, and wherein the variable-size-orifice flow restrictor is disposed in the flow path downstream of the fixed-size-orifice flow restrictor.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DE WAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/131-464-412-257-255,Patent Application,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M16/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,DISCONTINUED
395,CN,A,CN 101905056 A,146-301-048-782-106,2010-12-08,2010,CN 201010266109 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Drug delivery cassette component,"A drug delivery cassette component includes: a) a luer; b) a pipe fitting with a drug receiving end connected with a medicine bottle flow containing drug and a drug delivery end communicated with the luer fluid; and c) a drug delivery cassette mainboard with a luer part base, wherein the luer is able to be assembled and disassembed with respect to the luer part base and the luer part base has a deflective luer part sensor crossbeam; when the luer and the luer part base are connected, the crossbeam is deflected from the luer and when the luer is disassembed from the luer part, the crossbeam is configured to be non-deflection.",ETHICON ENDO SURGERY INC,MARTIN JAMES F;;WUENNEMANN JEFFREY J;;STEVENS FRED B III;;CUSHING TOMMY C;;ADAIR WILLIAM P;;KULLE LEE K;;COBB NICHOLAS E;;ROSS KROGH;;MILLER MICHAEL J;;SALVATORE PRIVITERA;;LILES JEFF S;;KEILHOLZ DAVID J;;DEROUEN JASON P;;DAVIS DEWAYNE A;;BRUGGEMAN PAUL J;;DONOFRIO WILLIAM T;;EYSTER CURT R;;NIKLEWSKI PAUL J;;COLLINS WILLIAM L JR;;FLAKER RICHARD W;;BISHOP GREGORY D;;NALAGATLA ANILL K;;BURDORFF MARK A;;BURFORD CHARLES B;;MCRORIE JOHNSON W JR;;LOUIS SABO;;HICKLE RANDALL S;;KATZ HAL H,,https://lens.org/146-301-048-782-106,Patent Application,no,0,5,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M16/00;;A61M31/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
396,CN,B,CN 101954137 B,172-678-816-521-180,2014-04-02,2014,CN 201010266399 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medical executor system operating room unit,,ETHICON DEDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DE WAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B IIL;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/172-678-816-521-180,Granted Patent,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;A61M16/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
397,CN,A,CN 101961523 A,029-475-298-555-879,2011-02-02,2011,CN 201010266470 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,"Occlusion rim, intubation member and occlusion rim member","The invention relates to an occlusion rim, an intubation member and an occlusion rim member. The occlusion rim includes a main body inserted into oral cavity of patient, wherein the occlusion rim main body includes a throughway and an air sampling channel spaced to the throughway, wherein the throughway is suitable for accepting a medical appliance and the air sampling channel has an inlet for accepting air output from patient when the occlusion rim main body is inserted into the oral cavity of patient and an outlet capable of connected with a respiratory gas sampling port of a cannula.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DE WAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;IIL STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/029-475-298-555-879,Patent Application,no,0,2,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M16/04;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,DISCONTINUED
398,WO,A2,WO 2006/026335 A2,033-013-227-462-761,2006-03-09,2006,US 2005/0030201 W,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,MEDICAL EFFECTOR SYSTEM,"A medical effector system comprised of a bedside unit and a procedure unit. The bedside unit contains connection points for an oral nasal cannula and for receiving inputs from a series of patient monitors. The procedure unit contains a patient monitoring and a medical effector program, and a drug delivery pump and drug cassette or a magnetic flux generator capable of delivering therapeutic energy to a patient. The medical effector program operates the pump or magnetic flux generator based upon at least some of the patient outputs and program inputs. A removable umbilical cable connects the two units and allows gases, the patient monitors as well as other information to travel between the two units.",ETHICON ENDO SURGERY INC;;BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/033-013-227-462-761,Patent Application,yes,1,5,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,PENDING
399,AU,B2,AU 2012/201650 B2,054-447-623-205-249,2013-01-31,2013,AU 2012/201650 A,2012-03-20,AU 2005/280197 A;;AU 2012/201650 A,2005-08-24,Medical effector system,"Abstract A drug-delivery infusion pump assembly and drug-delivery cassette assembly combination comprising: a) a drug-delivery infusion pump housing; b) a drug-delivery cassette assembly attachable to the infusion pump housing, having a tubing and a luer 5 combination, and having a drug-delivery-cassette main board including a luer-site base portion, wherein the luer is attachable to and detachable from the luer-site base portion, and a tubing storage portion, wherein the tubing is releasably stored in a coiled state in the tubing storage portion; c) a pump-housing door attached to the infusion pump housing and having door-open and door-closed positions; and d) a pump-housing door 10 lock which, when the cassette assembly is attached to the infusion pump housing and the pump-housing door is in the door-closed position, cannot unlock unless the luer is attached to the luer-site base portion.",ETHICON ENDO SURGERY INC,MARTIN JAMES F;;WUENNEMANN JEFFREY J;;STEVENS III FRED B;;CUSHING TOMMY C;;ADAIR WILLIAM P;;KULLE LEE K;;COBB NICHOLAS E;;KROGH ROSS;;MILLER MICHAEL J;;PRIVITERA SALVATORE;;LILES JEFF S;;KEILHOLZ DAVID J;;DEROUEN JASON P;;DAVIS DEWAYNE A;;BRUGGEMAN PAUL J;;DONOFRIO WILLIAM T;;EYSTER CURT R;;NIKLEWSKI PAUL J;;COLLINS JR WILLIAM L;;FLAKER RICHARD W;;BISHOP GREGORY D;;NALAGATLA ANILL K;;BURDORFF MARK A;;BURFORD CHARLES B;;MCRORIE JR JOHNSON W;;SABO LOUIS;;HICKLE RANDALL S;;KATZ HAL H,,https://lens.org/054-447-623-205-249,Granted Patent,no,1,0,4,4,0,,A61M31/00,,0,0,,,,INACTIVE
400,CA,C,CA 2579071 C,022-435-972-750-385,2014-08-05,2014,CA 2579071 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A;;US 2005/0030201 W,2004-08-31,MEDICAL EFFECTOR SYSTEM,"A medical effector system comprised of a bedside unit and a procedure unit. The bedside unit contains connection points for an oral nasal cannula and for receiving inputs from a series of patient monitors. The procedure unit contains a patient monitoring and a medical effector program, and a drug delivery pump and drug cassette or a magnetic flux generator capable of delivering therapeutic energy to a patient. The medical effector program operates the pump or magnetic flux generator based upon at least some of the patient outputs and program inputs. A removable umbilical cable connects the two units and allows gases, the patient monitors as well as other information to travel between the two units.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANIL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/022-435-972-750-385,Granted Patent,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
401,CN,A,CN 101954137 A,020-892-355-174-563,2011-01-26,2011,CN 201010266399 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Medical executor system operating room unit,"A medical executor system operating room unit comprises an operating room unit main controller containing an oxygen conveying program, the program executes the following steps: when the patient is determined to suck and discharge air by an oral cavity, with a variable first rate to control the oxygen conveying by being connected to at least one breathe gas conveying port pin of a cannula assembly of the patient; when the patient is determined to breathe by nares and the patient is determined to suck air, with a variable second rate to control the oxygen conveying by being connected to at least one breathe gas conveying nares pin of the cannula assembly of the patient; when the patient is determined to breathe by nares and the patient is determined to breathe the air, with a variable third rate to control the oxygen conveying by arriving in at least one breathe gas conveying nares pin, wherein, the patient has variable blood-oxygen saturation percent, and the first, second and third rates are dependent on the blood-oxygen saturation percent.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DE WAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;IIL STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/020-892-355-174-563,Patent Application,no,5,1,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;A61M16/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
402,AU,B2,AU 2005/280197 B2,083-576-621-278-631,2012-01-12,2012,AU 2005/280197 A,2005-08-24,US 62913704 P;;US 15816105 A;;US 60571704 P;;US 2005/0030201 W,2004-08-31,Medical effector system,"A medical effector system comprised of a bedside unit and a procedure unit. The bedside unit contains connection points for an oral nasal cannula and for receiving inputs from a series of patient monitors. The procedure unit contains a patient monitoring and a medical effector program, and a drug delivery pump and drug cassette or a magnetic flux generator capable of delivering therapeutic energy to a patient. The medical effector program operates the pump or magnetic flux generator based upon at least some of the patient outputs and program inputs. A removable umbilical cable connects the two units and allows gases, the patient monitors as well as other information to travel between the two units.",ETHICON ENDO SURGERY INC,MARTIN JAMES F;;WUENNEMANN JEFFREY J;;STEVENS FRED B III;;CUSHING TOMMY C;;ADAIR WILLIAM P;;KULLE LEE K;;COBB NICHOLAS E;;ROSS KROGH;;MILLER MICHAEL J;;SALVATORE PRIVITERA;;LILES JEFF S;;KEILHOLZ DAVID J;;DEROUEN JASON P;;DAVIS DEWAYNE A;;BRUGGEMAN PAUL J;;DONOFRIO WILLIAM T;;EYSTER CURT R;;NIKLEWSKI PAUL J;;COLLINS WILLIAM L JR;;FLAKER RICHARD W;;BISHOP GREGORY D;;NALAGATLA ANILL K;;BURDORFF MARK A;;BURFORD CHARLES B;;MCRORIE JOHNSON W JR;;LOUIS SABO;;HICKLE RANDALL S;;KATZ HAL H,,https://lens.org/083-576-621-278-631,Granted Patent,no,1,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M31/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
403,MX,A,MX 2007002549 A,186-248-582-403-736,2007-07-13,2007,MX 2007002549 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A;;US 2005/0030201 W,2004-08-31,MEDICAL EFFECTOR SYSTEM.,"A medical effector system comprised of a bedside unit and a procedure unit. Thebedside unit contains connection points for an oral nasal cannula and for receivinginputs from a series of patient monitors. The procedure unit contains a patientmonitoring and a medical effector program, and a drug delivery pump and drug cassetteor a magnetic flux generator capable of delivering therapeutic energy to a patient.The medical effector program operates the pump or magnetic flux generator basedupon at least some of the patient outputs and program inputs. A removable umbilicalcable connects the two units and allows gases, the patient monitors as well asother information to travel between the two units.",JOHNSON & JOHNSON,MARTIN JAMES F;;BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/186-248-582-403-736,Patent Application,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,PENDING
404,CN,B,CN 101905056 B,067-239-771-616-483,2012-05-23,2012,CN 201010266109 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Drug delivery cassette component,"A drug delivery cassette component includes: a) a luer; b) a pipe fitting with a drug receiving end connected with a medicine bottle flow containing drug and a drug delivery end communicated with the luer fluid; and c) a drug delivery cassette mainboard with a luer part base, wherein the luer is able to be assembled and disassembed with respect to the luer part base and the luer part base has a deflective luer part sensor crossbeam; when the luer and the luer part base are connected, the crossbeam is deflected from the luer and when the luer is disassembed from the luer part, the crossbeam isconfigured to be non-deflection.",ETHICON ENDO SURGERY INC,MARTIN JAMES F;;WUENNEMANN JEFFREY J;;STEVENS FRED B III;;CUSHING TOMMY C;;ADAIR WILLIAM P;;KULLE LEE K;;COBB NICHOLAS E;;ROSS KROGH;;MILLER MICHAEL J;;SALVATORE PRIVITERA;;LILES JEFF S;;KEILHOLZ DAVID J;;DEROUEN JASON P;;DAVIS DEWAYNE A;;BRUGGEMAN PAUL J;;DONOFRIO WILLIAM T;;EYSTER CURT R;;NIKLEWSKI PAUL J;;COLLINS WILLIAM L JR;;FLAKER RICHARD W;;BISHOP GREGORY D;;NALAGATLA ANILL K;;BURDORFF MARK A;;BURFORD CHARLES B;;MCRORIE JOHNSON W JR;;LOUIS SABO;;HICKLE RANDALL S;;KATZ HAL H,,https://lens.org/067-239-771-616-483,Granted Patent,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M16/00;;A61M31/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
405,CN,A,CN 101912655 A,167-081-652-179-557,2010-12-15,2010,CN 201010266446 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Cannula assembly and cannula dewatering sub-assembly,The present invention relates to a cannula assembly and a cannula dewatering sub-assembly. The cannula assembly comprises the following components: a) a disposable oral-nasal cannula which is provided on the face of the patient and comprises a respiratory-gas-sampling nasal prong and a respiratory-gas-sampling oral prong; and b) a slidable tube which is slidably connected with one selected from the respiratory-gas-sampling nasal prong and the respiratory-gas-sampling oral prong for providing different distances between the nose and the oral cavity of different patients.,ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DE WAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;IIL STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/167-081-652-179-557,Patent Application,no,0,5,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;A61M5/142;;A61M5/172;;A61M15/00;;A61M16/06;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,DISCONTINUED
406,WO,A3,WO 2006/026335 A3,186-573-665-433-868,2009-06-04,2009,US 2005/0030201 W,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,MEDICAL EFFECTOR SYSTEM,"A medical effector system comprised of a bedside unit and a procedure unit. The bedside unit contains connection points for an oral nasal cannula and for receiving inputs from a series of patient monitors. The procedure unit contains a patient monitoring and a medical effector program, and a drug delivery pump and drug cassette or a magnetic flux generator capable of delivering therapeutic energy to a patient. The medical effector program operates the pump or magnetic flux generator based upon at least some of the patient outputs and program inputs. A removable umbilical cable connects the two units and allows gases, the patient monitors as well as other information to travel between the two units.",ETHICON ENDO SURGERY INC;;BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/186-573-665-433-868,Search Report,yes,3,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M31/00;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,PENDING
407,CN,A,CN 101912656 A,154-123-646-679-628,2010-12-15,2010,CN 201010266550 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Cannula-assembly connector and cannula assembly,"The present invention relates to a cannula-assembly connector and a cannula assembly. The cannula-assembly connector comprises at least one cannula-assembly connector component and comprises the following components: a nosal carbon diode monitor port, an oral carbon diode monitor port, a nosal pressure port and a respiratory-gas transmission port, wherein each port is connected with a bed side monitoring unit of a medical effector fluidically.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DE WAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;IIL STEVENS FRED B;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/154-123-646-679-628,Patent Application,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;A61M5/142;;A61M5/172;;A61M15/00;;A61M16/06;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,DISCONTINUED
408,CR,A,CR 9023 A,179-878-853-390-651,2010-01-21,2010,CR 9023 A,2007-03-28,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,SISTEMA EFECTOR MEDICO,"Se describe un sistema efector medico constituido de una unidad de cabecera y una unidad de procedimiento; la unidad de cabecera contiene una serie de monitores de paciente; la unidad de procedimiento contiene un programa de monitoreo de paciente y efector medico, y una bomba de suministro de medicamento y un casete de medicamento o un generador de flujo magnetico capaz de suministrar energia terapeutica a un paciente.",ETHICON ENDO SURGERY INC,PAUL J BRUGGEMAN;;WILLIAM P ADAIR;;GREGORY D BISHOP;;MARK A BURDORFF;;CHARLES B BURFORD;;WILLIAM L COLLINS JR;;TOMMY C CUSHING;;DEWAYNE A DAVIS;;JASON P DEROUEN;;WILLIAM T DONOFRIO;;CURT R EYSTER;;RICHARD W FLAKER;;RANDALL S HICKLE;;HAL H KATZ;;DAVID J KEILHOLZ;;LEE K KULLE;;JAMES F MARTIN;;JOHNSON W MCRORIE JR;;MICHAEL J MILLER;;ANILL K NALAGATLA;;PAUL J NIKLEWSKI;;SALVATORE PRIVITERA;;LOUIS SABO;;FRED B STEVENS III;;JEFFREY J WUENNEMANN;;NICHOLAS E COBB;;JEFF S LILES;;ROSS KROGH,,https://lens.org/179-878-853-390-651,Patent Application,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,DISCONTINUED
409,AU,A1,AU 2005/280197 A1,184-409-202-633-049,2006-03-09,2006,AU 2005/280197 A,2005-08-24,US 62913704 P;;US 15816105 A;;US 60571704 P;;US 2005/0030201 W,2004-08-31,Medical effector system,,ETHICON ENDO SURGERY INC,MARTIN JAMES F;;WUENNEMANN JEFFREY J;;STEVENS FRED B III;;CUSHING TOMMY C;;ADAIR WILLIAM P;;KULLE LEE K;;COBB NICHOLAS E;;KROGH ROSS;;MILLER MICHAEL J;;PRIVITERA SALVATORE;;LILES JEFF S;;KEILHOLZ DAVID J;;DEROUEN JASON P;;DAVIS DEWAYNE A;;BRUGGEMAN PAUL J;;DONOFRIO WILLIAM T;;EYSTER CURT R;;NIKLEWSKI PAUL J;;COLLINS WILLIAM L JR;;FLAKER RICHARD W;;BISHOP GREGORY D;;NALAGATLA ANILL K;;BURDORFF MARK A;;BURFORD CHARLES B;;MCRORIE JOHNSON W JR;;SABO LOUIS;;HICKLE RANDALL S;;KATZ HAL H,,https://lens.org/184-409-202-633-049,Patent Application,no,0,1,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,INACTIVE
410,KR,A,KR 20070106964 A,108-584-870-873-832,2007-11-06,2007,KR 20077007221 A,2005-08-24,US 15816105 A;;US 60571704 P;;US 62913704 P;;US 2005/0030201 W,2004-08-31,MEDICAL EFFECTOR SYSTEM,"A medical effector system comprised of a bedside unit and a procedure unit. The bedside unit contains connection points for an oral nasal cannula and for receiving inputs from a series of patient monitors. The procedure unit contains a patient monitoring and a medical effector program, and a drug delivery pump and drug cassette or a magnetic flux generator capable of delivering therapeutic energy to a patient. The medical effector program operates the pump or magnetic flux generator based upon at least some of the patient outputs and program inputs. A removable umbilical cable connects the two units and allows gases, the patient monitors as well as other information to travel between the two units.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DE WAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B IIL;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/108-584-870-873-832,Patent Application,no,0,7,4,59,0,A61M16/024;;A61B5/0836;;A61B5/4821;;A61B5/4839;;A61B5/6819;;A61B5/682;;A61B5/7445;;A61B5/7465;;A61B5/7495;;A61M5/142;;A61M5/1723;;A61M16/0051;;A61M16/01;;A61M16/0493;;A61M16/0672;;A61M16/0677;;A61M16/0688;;A61M16/0808;;A61M16/085;;A61M16/0858;;A61M2016/0027;;A61M2016/1025;;A61M2016/103;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/82;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;G16H20/17,A61M15/08;;A61M16/00;;A61M16/01,,0,0,,,,INACTIVE
411,CN,A,CN 101927049 A,048-661-127-679-058,2010-12-29,2010,CN 201010266598 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,Operation room unit of medical actuator system,"An operation room unit of a medical actuator system comprises a moisture analyzer which is suitable for receiving breathing gas from a cannula capable of being used disposably on the face of a single patient, and a bar code reading instrument assembly which is suitable for reading a bar code of a package containing the cannula.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/048-661-127-679-058,Patent Application,no,0,1,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M15/08;;A61M5/142;;A61M5/172;;A61M15/00;;A61M16/06;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,DISCONTINUED
412,CN,A,CN 101961521 A,139-686-776-997-46X,2011-02-02,2011,CN 201010266360 A,2005-08-24,US 60571704 P;;US 62913704 P;;US 15816105 A,2004-08-31,"Drug delivery unit, box unit and combination of infusion pump unit and cassette unit","The invention relates to a drug delivery unit, a cassette unit and a combination of an infusion pump unit and the cassette unit. The drug delivery unit includes: a pipe fitting which has a drug receiving end poriton and a drug delivering end portion which are in fluid connection with a medicine bottle containing drugs; b) a storing position which releasably stores the drug delivering end portion of the pipe fitting when the drug receiving end poriton is not communicated with the drug delivering end for patients; c) a pump for controlling drugs to flow in the pipe fitting when the pipe fitting is operationally connected to the pump in order to purify the pipe fitting by air and deliver drugs to the patient via the pipe fitting; and d) a sensor which has an output end and is configured to determine whether the drug delivering end portion of the pipe fitting exists in the storing position.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS WILLIAM L JR;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;ROSS KROGH;;KULLE LEE K;;MARTIN JAMES F;;MCRORIE JOHNSON W JR;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;SALVATORE PRIVITERA;;LOUIS SABO;;STEVENS FRED B III;;WUENNEMANN JEFFREY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/139-686-776-997-46X,Patent Application,no,0,0,54,59,0,A61B5/0836;;A61B5/411;;A61B5/6819;;A61B5/682;;A61M5/142;;A61M5/14228;;A61M5/162;;A61M5/16831;;A61M5/172;;A61M2205/05;;A61M2205/12;;A61M2205/123;;A61M2205/14;;A61M2210/0625;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;A61M2230/63;;A61M16/0493;;A61M16/0677;;A61M16/0051;;A61M16/0808;;A61M21/02;;A61M2016/0027;;A61M2016/1025;;A61M2021/0027;;A61M2202/0208;;A61M2202/048;;A61M2202/062;;A61M2205/13;;A61M2205/273;;A61M2205/3334;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/7536;;A61M2209/084;;A61M2210/0618;;A61M2210/0662;;A61M2230/04;;A61M16/0672;;A61M16/0688;;A61M16/085;;A61M16/0858;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63;;A61B1/00154;;A61M5/142;;A61M2230/06;;A61M2230/30;;A61B5/6819;;A61M5/162;;A61M5/14228;;A61M2230/205;;A61M5/16831;;A61B5/411;;A61M2205/05;;A61M2205/12;;A61M2210/0625;;A61M2205/123;;A61M2230/63;;A61B5/0836;;A61B5/682;;A61M2230/432;;A61M2205/14;;A61M5/172;;A61M16/0677;;A61M16/0493;;A61M2209/084;;A61M2016/1025;;A61M2205/6072;;A61M16/0688;;A61M2205/3561;;A61M2205/505;;A61M16/085;;A61M16/0808;;A61M2230/04;;A61M2205/13;;A61M16/0672;;A61M2205/7536;;A61M16/0051;;A61M2210/0618;;A61M2202/048;;A61M2205/3584;;A61M21/02;;A61M2205/3334;;A61M2202/062;;A61M2021/0027;;A61M2205/273;;A61M2205/3553;;A61M16/0858;;A61M2202/0208;;A61M2210/0662;;A61M2016/0027;;A61B5/7495;;A61M16/024;;G16H20/17;;G16H40/63,A61M16/00;;A61M5/14;;A61M5/142;;G16H10/60;;G16H20/17;;G16H40/63,,0,0,,,,DISCONTINUED
413,NO,B1,NO 336780 B1,193-441-341-505-481,2015-11-02,2015,NO 20071635 A,2007-03-28,US 60571704 P;;US 62913704 P;;US 15816105 A;;US 2005/0030201 W,2004-08-31,Medisinsk effektorsystem,"Et medisinsk effektorsystem innbefatter en sengekantenhet og en prosedyreenhet. Sengekantenheten innbefatter forbindelsessteder for en oral-nasal kanyle og for mottak av inngangssignaler fra en serie pasient-monitorer. Prosedyreenheten innbefatter et pasientovervåkings- og medisinsk effektorprogram, og en medikamentleveringspumpe og en medikamentkassett eller en magnetfluksgenerator kan levere terapeutisk energ til en pasient. Det medisinske effektorprogrammet driver pumpen eller magnetfluksgeneratoren basert på i det minste noen av pasientutgangssignalene og programinngangssignalene. En løsgjørbar umbilikalkabel forbinder de to enheter med hverandre og muliggjør at gasser, pasientovervåkingsinformasjon så vel som annen informasjon kan sendes mellom de to enhetene.",ETHICON ENDO SURGERY INC,BRUGGEMAN PAUL J;;ADAIR WILLIAM P;;BISHOP GREGORY D;;BURDORFF MARK A;;BURFORD CHARLES B;;COLLINS JR WILLIAM L;;CUSHING TOMMY C;;DAVIS DEWAYNE A;;DEROUEN JASON P;;DONOFRIO WILLIAM T;;EYSTER CURT R;;FLAKER RICHARD W;;HICKLE RANDALL S;;KATZ HAL H;;KEILHOLZ DAVID J;;KROGH ROSS;;KULLE LEE K;;JAMES MARTIN F;;MCRORIE JR JOHNSON W;;MILLER MICHAEL J;;NALAGATLA ANILL K;;NIKLEWSKI PAUL J;;PRIVITERA SALVATORE;;SABO LOUIS;;STEVENS FRED B III;;WUENNEMANN JEFFERY J;;COBB NICHOLAS E;;LILES JEFF S,,https://lens.org/193-441-341-505-481,Granted Patent,no,0,0,4,59,0,A61M16/024;;A61B5/0836;;A61B5/4821;;A61B5/4839;;A61B5/6819;;A61B5/682;;A61B5/7445;;A61B5/7465;;A61B5/7495;;A61M5/142;;A61M5/1723;;A61M16/0051;;A61M16/01;;A61M16/0493;;A61M16/0672;;A61M16/0677;;A61M16/0688;;A61M16/0808;;A61M16/085;;A61M16/0858;;A61M2016/0027;;A61M2016/1025;;A61M2016/103;;A61M2205/3553;;A61M2205/3561;;A61M2205/3584;;A61M2205/505;;A61M2205/6072;;A61M2205/82;;A61M2230/06;;A61M2230/205;;A61M2230/30;;A61M2230/432;;G16H20/17,A61M15/08,,0,0,,,,INACTIVE
